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Summary
Hepatitis C virus (HCV) encodes two glycoproteins, termed El and E2, which are 
presumed to constitute the proteinaceous components of the virion envelope. From a 
number of studies, E l and E2 associate to form a complex however, the nature of the types 
of interaction between the proteins is the subject of controversy. Two types of complex, 
termed the native and aggregated forms, have been identified. In native complexes, E l and 
E2 associate by non-covalent interactions while disulphide bonds form intermolecular links 
between the glycoproteins in aggregated complexes.
The aim of my project was to characterise the complex formed by E l and E2 from a local 
genotype la  strain, called strain Glasgow. Studies were later expanded to include analysis 
of the glycoproteins from strain H77, another genotype la  strain that is infectious in 
chimpanzees. Due to the lack of efficient virus replication in tissue culture, the Semliki 
Forest virus vector was used for expression of the glycoproteins. This involved the 
introduction of in vitro transcribed RNA molecules into mammalian cells by 
electroporation and conditions to optimise the system were ascertained.
In the absence o f sufficient immunological reagents during the early phases of the project, 
a histidine tag was inserted at the N-terminus of El from strain Glasgow (Elhis) to provide 
a means for purification by metal chelate chromatography. This method co-eluted E2 with 
Elhis which was later verified by the ability of polyclonal sera against E2 to co-precipitate 
E l with E2. Thus, a heteromeric complex formed between E l and E2 from strain 
Glasgow, a finding which is in agreement with studies on the glycoproteins from other 
strains. Using the available reagents for identifying El and E2 and by analysis under 
reducing and non-reducing electrophoretic conditions, most of the complex was in the 
form of disulphide-linked aggregates with little detectable native complex.
The requirement for disulphide bonds to enable El and E2 association was examined by 
treatment of cells synthesising the proteins with the reducing agent dithiothreitol (DTT). 
Addition of DTT to cells did not prevent cleavage and processing of the glycoproteins. 
Significantly, the intermolecular disulphide links in aggregates were disrupted by DTT but 
El and E2 continued to associate, indicating that both covalent and non-covalent 
intermolecular interactions occur in the aggregated complex. El and E2, synthesised in the
2
presence of DTT, also formed a complex and therefore disulphide bond formation is not a 
prerequisite for interactions between the proteins.
Comparisons between strain Glasgow and strain H77 showed that native E1E2 complexes 
were more readily detected from strain H77. It is proposed that this may be a consequence 
of alterations in the number of glycosylation sites in E2 between the strains as well as 
changes in amino acid sequences in El and E2. Moreover, E l from strain Glasgow had 
reduced mobility as compared to strain H77 El protein which could be not be accounted 
by changes in the relative sizes of the nascent proteins or glycosylation patterns. Two 
deletion mutants in El from both strains also displayed higher apparent molecular weights 
than predicted. The behaviour of these mutant proteins may result from the deletion of 
hydrophobic segments in E l. However, the apparent molecular weight difference between 
El from strain Glasgow and strain H77 could not be explained.
In an attempt to identify regions of El and E2 in strain Glasgow that may account for the 
high level of aggregation by these proteins, deletion mutants were created in El and E2; 
for comparative purposes, an identical set of deletion mutants were created also for El 
from strain H77. Immunoprecipitation studies revealed that multiple regions were 
involved in interactions between E l and E2. No single deletion was able to completely 
abolish E1E2 interactions although native complex formation in strain H77 was decreased 
on removal of sequences from E l. Further analysis of complexes and the role of 
disulphide bond formation was undertaken by constructing a series of mutants in which the 
cysteine residues in El were replaced with either serine or alanine. With each of these 
mutants, El and E2 continued to associate but the amounts of native, non-aggregated E2 
were reduced to undetectable levels. Hence, native complexes of El and E2 were highly 
sensitive to changes in either protein such that alteration even at a single cysteine residue 
was sufficient to reduce the abundance of native complex.
Examination of El expressed in the presence and absence of E2 provided a set of criteria 
for assessing the folding status of the protein. In the absence of E2, El remained in the 
reduced state and formed homo-oligomeric molecules that could be identified under 
reducing electrophoretic conditions. The formation and stability of these homo-oligomers 
were not entirely dependent on disulphide bond formation. Moreover, there was an 
increase in the quantities of glycosylated forms of El in the absence of E2. Using these 
criteria, the region in E2 that is necessary for folding of El was analysed by constructing
3
chimeric proteins between E2 and segments of foreign glycoproteins. It was found that a 
peptide sequence of 58 residues, which spans the cleavage site between E2 and p7 and thus 
contains the transmembrane domain of E2, was sufficient to permit E l oxidation and 
prevent oligomerisation. By contrast, the ectodomain of E2 was unable promote El 
folding. This suggests that the transmembrane domain of E2 plays a key role in El folding 
and hence in native complex formation.
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1.1. Clinical Features of HCV
1.1.1. Brief Historical Background
During the 1970s and 1980s high incidences of transfusion-associated hepatitis were 
diagnosed that could not be ascribed to any known viral agent for which serological tests 
had been developed at that time. The exclusion of hepatitis A or B virus infections led to 
the assignment of the unknown agent as non-A, non-B (NANB) hepatitis (Prince et al., 
1974). In 1989, modem techniques of molecular cloning aided the discovery of a novel 
RNA vims that accompanied NANB hepatitis and the agent was termed hepatitis C vims 
(HCV; Choo et al., 1989). HCV has now been shown to be the cause of most cases of 
NANB hepatitis. In addition, a much larger number of infected individuals have been 
observed without overt liver disease (DiBisceglie, 1998).
1.1.2. Discovery of HCV
Serological tests developed during the 1970s for infection by hepatitis A vims (HAV) and 
hepatitis B vims (HBV) effectively eliminated the role of these viruses in causing 
transfusion associated hepatitis (Houghton, 1996). A substantial number o f hepatitis cases 
with clinical and biochemical features of viral hepatitis not resulting from HAV or HBV 
continued to be diagnosed. The term non-A, non-B hepatitis was coined for these cases. 
The agent associated with this disease was observed initially to cause a mild illness in 
blood transfusion recipients, but chronic hepatitis often ensued with progression to 
cirrhosis and liver failure in approximately 20% of cases (Houghton, 1996). Intravenous 
administration of filtered human sera from patients led to the transmission of NANB 
hepatitis to chimpanzees. The early studies in chimpanzees confirmed the role of an 
enveloped vims of approximately 60 nm as the causative agent (Houghton, 1996).
Despite research conducted for over a decade, attempts to identify the infectious agent 
associated with NANB hepatitis had failed using conventional virological and 
immunological approaches that had been employed to characterise HAV and HBV. This 
may have resulted from insufficient concentrations of viral antibodies as well as viral
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antigen in NANB hepatitis infections. Several groups focused on the application of 
recombinant DNA cloning technology as an alternative. Choo et al. (1989) devised a 
technique to increase viral antigen concentrations by employing a cDNA library expressed 
in bacteria. The cDNA library was derived from chimpanzee plasma containing a 
relatively high infectious titre [chimpanzee infectious doses per ml (CID m l'1)], using 
reverse transcriptase or DNA polymerase and random primers directed towards both DNA 
and RNA. Following introduction into a bacterial expression vector, the library was 
screened for rare clones expressing viral antigen with serum from a chronic NANB 
hepatitis patient as a presumed source of viral antibodies. Hybridisation to human and 
chimpanzee DNA tested the origin of possible positive clones by Southern blot analysis. 
Such attempts failed to identify any novel nucleotide sequences, which led to the use of 
total RNA extracted from infected chimpanzee liver. A hybridisation signal was detected 
specifically to the cloned cDNA. The same signal was not observed when ribonuclease 
treatment was applied to purified RNA or when RNA derived from uninfected liver was 
employed. Hence, it appeared that the identified clones were from an exogenous RNA 
molecule associated with NANB hepatitis infection. Since only one of the strands of the 
cDNA clones hybridised, it was concluded that the RNA from infectious plasma was 
single-stranded.
The size of the RNA species homologous to the cDNA clones was elucidated by separating 
RNA obtained from infectious chimpanzee liver by electrophoresis under denaturing 
conditions, followed by hybridisation with one of the cDNA clones. The detected RNA 
fragments were estimated to represent a molecule of at least 10,000 nucleotides. 
Furthermore, the binding of oligo(dT)-cellulose indicated the presence of either a 3’ 
terminal polyadenylated sequence or an internal A-rich tract. A single large cDNA clone 
indicated that one continuous, translational open reading frame (ORF) was encoded by the 
RNA (Choo et al., 1989). The agent was called hepatitis C virus and thereafter various 
serological assays were developed (Kuo et al., 1989). Such assays have demonstrated that 
HCV represents the predominant cause of transfusion-associated NANB hepatitis around 
the world.
1.1.3. Classification of HCV
The successful isolation of HCV cDNA was followed by cloning of almost the entire HCV
genome by several groups (Kato et al., 1990; Choo et al., 1991; Takamizawa et al., 1991).
10
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The characteristics of the HCV genome were found to be remarkably similar to viruses 
belonging to the Flaviviridae family. Sequence analysis of the single-stranded RNA 
genome revealed that the large ORF encoded a polyprotein comparable in size to those of 
flavi- and pestiviruses. By comparison with these viruses, the HCV polyprotein was 
assumed to be proteolytically digested to give the individual virus products. Although the 
overall amino acid sequence homology of the putative HCV proteins with the Flaviviridae 
family of viruses is low, alignment of HCV and Flaviviridae genomes provided evidence 
for the existence of regions of sequence homology. This indicated a similar genetic 
organisation. For example, regions of the primary sequence of a putative HCV protein 
were homologous with helicases encoded by animal pestiviruses, plant potyviruses, and 
human flavi viruses (Miller & Purcell, 1990; Choo et al., 1991). Hydrophobicity profiles 
of the N-terminal region of the HCV polyprotein were more similar to the Pestivirus genus 
than the genus Flavivirus (Choo et al., 1991). However, despite these similarities, 
pestiviruses and HCV did differ significantly in primary amino acid sequence. As a result, 
a third genus of the Flaviviridae family, the Hepaciviruses, was proposed for classification 
of HCV (Robertson et al., 1998).
cDNA sequence data has revealed the presence of nucleotide sequence variations within 
the HCV genome (Kato et al., 1989). Based upon the available sequence data, all currently 
known isolates of HCV have been be placed into one of six phylogenetically distinct 
groups (Fig 1.1). These groups are described as clades 1 to 6. Clades 1, 2, 4, and 5 
correspond to genotypes 1, 2, 4, and 5 while clade 3 comprises genotype 3 and subtype 10, 
and clade 6 comprise genotypes 6, 7, 8, 9, and 11 (Davidson et al., 1995; Robertson et al., 
1998). Genotypes 1, 2, and 3 are widely distributed throughout the world, while type 4 is 
predominant in the Middle East. HCV types 5 and 6 appear to be restricted to South Africa 
and Hong Kong respectively (Houghton, 1996).
1.1.4. Virus Morphology
HCV is the first virus whose identification was based almost entirely on examination of its 
genomic sequence. There is little reported characterisation by classical virological 
methods, mainly due to the inability to isolate substantial quantities of virus from infected 
individuals. However, indirect immunogold electron microscopy studies have been carried 
out on plasma samples with particularly high HCV RNA titres using polyclonal and
monoclonal antibodies specific to the putative HCV envelope proteins (Kaito et al., 1994).
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This revealed spherical virus-like particles, 55 to 65 nm in diameter with spike-like 
projections, which were present in 1.14 to 1.16 g/ml fractions after sucrose density gradient 
centrifugation. Monoclonal and polyclonal antibodies to the HCV envelope protein, E2 
(Section 1.3.3), specifically identified these virus-like particles. The size and 
morphological features of the HCV virion particles are similar to those of flaviviruses 
(Yuasa et al., 1991; Kaito et al., 1994).
1.1.5. Other Hepatitis Viruses
Epidemics of jaundice were recognised as early as the Middle Ages, but the notion that 
such outbreaks were the result of hepatitis caused by infectious agents were only 
considered in the present century. To date, five different human hepatitis viruses have 
been identified and characterised in detail; HAV, HBV, HCV, hepatitis D virus (HDV) and 
hepatitis E virus (HEV). A sixth potential hepatitis-associated agent, termed hepatitis G 
virus (HGV), has been discovered recently, but subsequent research has failed to 
demonstrate a link with hepatitis (Dejean et al., 1999). Although all of these viruses cause 
a similar systemic disease affecting the liver, they do not all belong to the same virus 
family. All have an RNA-based genome, with the exception of HBV, which has a DNA 
genome (Reid & Dienstag, 1997).
1.1.5.1. HAV
HAV is an enterically transmitted virus causing an acute and self-limiting infection 
(Feinstone & Gust, 1997). The infection is frequently asymptomatic particularly in infants 
and young children. Chronic infection has not been reported although fulminant hepatitis 
and death are occasional consequences of infection (more then hepatitis B). The virus is a 
member of the Picornaviridae family, which includes the enteroviruses and rhinoviruses. 
Due to unique features, HAV has been assigned to the Hepatavirus genus, of which it is 
the only member. It is an non-enveloped virus of ~27-28 nm in diameter, and contains a 
positive-sense, single-stranded linear RNA genome approaching 7,500 nucleotides in 
length. The genome encodes a single polyprotein flanked by extensive 5’ and 3’ 
untranslated regions, which are involved in viral replication. Unlike cellular messenger 
RNA molecules that possess a cap, the 5’ end of the HAV genome has a small, covalently 
linked viral protein known as VPg, a feature common to picomaviruses. An internal 
ribosomal entry site (IRES) is also located within the 5’ untranslated region. The
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polyprotein may be divided into three domains: PI (capsid proteins), P2 and P3 (non- 
structural proteins). Each domain is ultimately cleaved to produce up to four polypeptides 
(Feinstone & Gust, 1997).
1.1.5.2. HBV
HBV is a blood-borne agent transmitted primarily by sexual intercourse, maternal-child 
transmissions and percutaneous routes. The virus is sustained through chronic infection in 
human hosts, rather than environmental reservoirs such as water or food as is the case for 
HAV and HEV. Chronic HBV infection is a common disease with an estimated global 
prevalence of over 300 million carriers with viral antigen markers (e.g. HBsAg), 
approximating to 5% of the world’s population (Maynard, 1990). Patients with chronic 
HBV infection are at risk of developing long-term complications, including cirrhosis and 
hepatocellular carcinoma (HCC). HBV is the prototype member of the family 
Hepadnaviridae, which also contains other members found in wild animals (Wright et al.,
1997). Its virions are double-shelled particles of ~40-42nm with an outer lipoprotein 
envelope containing multiple related envelope glycoproteins. The encapsidated genome is 
a relaxed circular, partially duplexed DNA molecule of approximately 3 kb. The limited 
coding information within the small genome is used with extraordinary efficiency to such 
an extent that every nucleotide is translated. There are four overlapping ORFs in the 
genome, which encode envelope proteins, core protein, viral polymerase and a small 
regulatory protein (Wright et al., 1997). Initiation sites for the translation of the seven 
known viral gene products occur from alternate AUG codons located within the ORF, thus 
maximising the number of viral proteins made (Wright et al., 1997).
1.1.5.3. HDV
Disease progression in hepatitis B carriers is markedly accelerated upon superinfection 
with HDV. This agent is the only prototype of the Deltaviridae family that relies on helper 
functions provided by HBV to establish in vivo infections. Such a subviral agent is unique 
amongst animal viruses so far described. Transmission occurs by the parenteral route. The 
HDV virion is a chimera assembled with viral genome and antigen enveloped by the 
surface antigen of HBV. The genome consists of a 1.7 kb closed circular, rod-shaped, 
negative-sense, single-stranded RNA molecule capable of internal hybridisation, self­
cleavage, and self-ligation (Smedile et al., 1997).
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1.1.5.4. HEV
In 1955, a large outbreak of epidemic hepatitis in New Delhi, India, was later confirmed to 
have been caused by HEV and not HAV, since it is also a faecal-orally-transmitted agent. 
HEV was first cloned by molecular methods in 1990 (Reyes et al., 1990) and was 
identified as a positive-sense, single-stranded RNA virus distinct from all other known 
positive-sense RNA viruses of humans. The genome is contained within a non-enveloped 
icosahedral particle that ranges between -27-32 nm in diameter, and encodes at least three 
partially overlapping ORFs. The virus is grouped with the Caliciviridae, a family of small, 
round, structured viruses, including agents associated with non-bacterial gastroenteritis in 
humans and animals.
1.1.5.5. HGV
During attempts to develop an animal model for hepatitis A, marmosets (Saguinas spp.) 
were administered a series of inocula derived from patients with suspected infectious 
hepatitis (Shimotohno & Feinstone, 1997). Serum from a surgeon (GB) with NANB 
hepatitis, was unique in inducing disease in marmosets. It was later demonstrated that GB 
virus was a distinct agent from HCV, by its failure to establish disease in chimpanzees in a 
manner akin to HCV. Using a PCR-based cDNA subtraction technology called 
representational difference analysis (RDA), the genome of this infectious agent was 
isolated from the marmoset serum pool. The genome had the organisational structure of 
Flaviviridae organisms and seemed to be generally related to HCV and the pestiviruses 
(Scott et al., 1995). The genome of this agent, GBV-C, encodes a single ORF coding for a 
polyprotein of -3  000 amino acids. Although GBV-C co-exists frequently with HCV, its 
role in affecting the rate o f disease progression in HCV-infected individuals remains to be 
established. At present, specific diagnosis can be made by antibody assay and by 
amplification of the viral genome by PCR. In the absence of serologic assays, the clinical 
and epidemiological aspects of the agent are yet to be defined (Dejean et al., 1999).
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1.1.6. Epidemiology and Transmission of HCV
Although HCV infection is found throughout the world, there are significant geographic 
variations in the prevalence of antibodies to HCV in serum. It is estimated that about 170 
million persons world-wide may be infected with HCV (Lavanchy et al., 1999). The 
prevalence is estimated at approximately 1.5% in the developed countries, but relatively 
higher infection rates are found in parts of Eastern Europe and Africa (Alter, 1995; 
DiBisceglie, 1998). The highest prevalence rate occurs in Egypt, approaching 15% of the 
general population (Saeed et al., 1991).
The discovery of HCV was made in the context of blood transfusion and, before the 
development of appropriate screening tests, this was the major route of HCV transmission 
in the West. However, the risk of HCV infection from tested donated blood is now 
estimated to be as low as 1 in 103,000 recipients (Schreiber et al., 1996). HCV was also a 
common cause of liver disease in individuals exposed to unscreened blood products, such 
as haemophiliacs receiving blood clotting factors (Alter, 1993; Lavanchy et al., 1999).
Presently, intravenous drug abuse is the predominant cause of transmission in the West 
(DiBisceglie, 1998). However, there has been a decline in rates of infection since 1989, 
presumably as a result of safer needle practices (Alter, 1993). Other individuals at 
increased risk include renal dialysis patients either with or without associated blood 
transfusion, and organ transplant patients. Spread of HCV may also have occurred through 
the practice of traditional healing techniques involving puncture of the skin (DiBisceglie,
1998). Health-care employment with occupational exposure to blood and haemodialysis 
are additional risk factors (Alter et al., 1990).
Household or sexual transmission present lower levels of risk for HCV infection. Various 
studies indicate that transmission between spouses and other family members may have 
been due to routes of infection involving inapparent percutaneous exposure (Kao et al., 
1993; Rice et al., 1993).
Transmission may happen in utero (Weiner et al., 1993), at an estimated rate of about 5% 
from affected mothers to offspring (Ohto et al., 1994). Transmission is likely to be related 
to the level of viremia in the mother because women transmitting HCV had significantly 
higher levels of virus (as assayed using RT-PCR) at the time of delivery. However, the
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rate of infection was observed to be substantially increased in mothers co-infected with 
HCV and human immunodeficiency virus (HIV) possibly due to an increase in HCV titre 
as a result of immunosuppression by HIV co-infection (Thaler et al., 1991). The majority 
of HCV infections are identified in individuals from low socio-economic backgrounds 
where infection is often associated with some form of high-risk behaviour. However, the 
exact cause of infection remains undetermined in a low percentage of infected persons 
(DiBisceglie, 1998).
1.1.7. Clinical Manifestation and Natural History of HCV Infection
HCV infection can progress through three broad stages of clinical manifestations in the 
liver: acute HCV infection, chronic HCV infection, and chronic liver disease including 
cirrhosis, which can lead to HCC. In addition, HCV may be associated also with certain 
non-hepatic diseases that may result either directly from viral replication or the immune 
response to chronic viral infection (Table 1.1).
1.1.7.1. Acute HCV
Most patients with acute infection are symptom-free and only 20-30% of infected persons 
develop jaundice (Lavanchy et al., 1999). As a result, there are few reliable studies on the 
natural history of acute infection. However, prospective studies of post-transfusion HCV 
indicate that the incubation period averages 7 to 8 weeks as determined by analysis of 
alanine transaminase (ALT) levels (DiBisceglie et al., 1991). In a typical HCV infection, 
levels of ALTs, released from damaged hepatocytes, fluctuate markedly during this phase 
of infection. Fulminant liver failure associated with HCV was observed in Japan, however 
its occurrence appears to be rare elsewhere geographically (Yoshiba et al., 1994).
1.1.7.2. Chronic HCV
In about 80% of individuals, HCV infection becomes chronic as demonstrated by the 
persistence of viral RNA in serum (DiBisceglie, 1998). Chronic HCV infection is a 
leading cause of severe liver disease (chronic hepatitis) which can necessitate liver 
transplantation due to liver failure (Esteban, 1993). In chronically HCV-infected patients 
there is a slow course of disease development with the vast majority of patients remaining 
well after approximately 10 years post infection. These individuals display normal liver
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enzyme levels and relatively normal liver histology (Lavanchy et al., 1999). Other factors 
such as associated alcohol consumption, co-infection with HBV or immune deficiency due 
to co-infection with HIV exacerbate the effects of infection (DiBisceglie, 1998). Different 
viral factors have been suggested to influence the persistence of infection such as the 
degree of viral genetic diversity (quasispecies) found in an individual patient, mode of 
infection (level of viral inocula), and HCV genotype (especially type 1; Booth, 1998; 
Gomez et al., 1999).
1.1.7.3. Chronic Liver Disease
Disease progression during chronic HCV infection is typically slow, but patients with 
chronic hepatitis who have presumably elevated ALT enzymes have an increased 
likelihood of progressing to more serious disease (DiBisceglie, 1998). ALT enzymes are 
released by damaged hepatocytes and thus their levels are an indirect, although imperfect, 
indicator of insult to the liver. Cirrhosis of the liver occurs in less than 20% of the patients 
with HCV and is usually observed in the second or third decade after infection. The initial 
appearance of hepatic fibrosis (during tissue repair) seems to be an important predictor of 
the later development of cirrhosis (Yano et al., 1996).
HCC may develop in as many as 1 to 4% of patients with established cirrhosis 
(DiBisceglie, 1997) and is a late complication of HCV. In some countries, dual infection 
with HCV and HBV appears to potentiate the development of HCC (Idilman et al., 1998). 
Although epidemiological, clinical, and molecular data demonstrated a close association 
between chronic HBV infection and HCC development, the contribution of chronic HCV 
infection to the development of this malignancy is less clear (Idilman et al., 1998). In the 
case of HCV, development of HCC may be related to the presence of cirrhosis (Idilman et 
al., 1998).
1.1.7.4. Extra-Hepatic HCV Associated Diseases
A variety of extra-hepatic clinical syndromes that are thought to be either “autoimmune” or 
immune complex-related diseases have been associated with HCV infection. They include 
cryoglobulinemia (aggregation of certain immunoglobulins at low temperatures, resulting 
in obstruction of small blood vessels), glomerulonephritis (a kidney disorder involving the 
glomeruli and antibody-antigen reaction), and arthralgias (pain in joints in the absence of
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inflammation characteristic of arthritis; Johnson et al., 1993). Porphyria cutanea tarda 
presents an example of the type of autoimmune disease strongly associated with HCV 
infection. The disease is characterised by photosensitivity, increased skin fragility, 
hyperpigmentation, and sclerodermoid plaques (Decastro et al., 1993). The role of HCV 
as a causative factor is not clear for a number of these conditions.
1.1.8. Immune Response
Disease states associated with HCV infection may occur not only through a direct 
cytopathic effect of the virus but also through the immunological response to infection by 
the infected host (Lavanchy et al., 1999). Challenge experiments on a convalescent 
infected chimpanzee with the same or a different HCV strain resulted in the reappearance 
of viremia that corresponded to the challenge virus. This observation suggests that HCV 
infection does not elicit protective immunity against re-infection with homologous or 
heterologous strains (Okamoto et al., 1994b). However, the extent to which these 
observations can be reproduced in other infected chimpanzees is not clear. In humans, 
antibodies against the non-structural protein 4 (NS4) and structural core protein are 
detected during acute HCV infection, which makes them useful diagnostic markers 
(Hosein et al., 1991; Chang et al., 1999).
Comparison of the amino acid sequences of many HCV isolates (from all types) revealed 
two highly variable regions, the first of which is located at the N-terminus of E2 and is 
termed hypervariable region 1 (HVR-1). During chronic HCV infection, mutations in 
HVR-1 have been suggested to provide a mechanism for escape from the 
immunsurveillance system (Kato et al., 1993). An asymptomatic carrier with viremia but 
with a low titre of anti-HVR-1 antibody is thought to develop amino acid alterations at 
intervals of several months (Kato et al., 1994). However, immunisation with envelope 
glycoproteins has been associated with partial protection against an intravenous challenge 
with homologous HCV in five out of seven chimpanzees (Choo et al., 1994). Therefore, 
anti-E2 antibodies are suggested to be involved in virus neutralisation, although the scope 
of neutralisation with such antibodies may be limited to certain isolates of HCV due to 
strain sequence variability (Choo et al., 1994). A HCV-specific cytotoxic T-lymphocyte 
(CTL) response has been demonstrated in intra-hepatic inflammatory infiltrates and in 
circulating blood of patients with chronic hepatitis C (Kita et al., 1993). This supports the 
possibility that liver injury by HCV infection is mediated immunologically (Kita et al.,
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1993). However, CD8+ CTL activated by class I major histocompatibility complex 
(MHC-1) response is weak, because although conserved epitopes in the HCV non- 
structural protein 3 (NS3) were recognised, the T cells failed to detect the minor variants 
within HCV quasispecies (Weiner et al., 1995). This may allow the emergence of HCV 
escape mutants (Weiner et al., 1995). Thus, chronic infection by HCV is believed not to 
occur because of a lack of humoral or cellular immune responses. Rather, any response 
may be rendered ineffective by the high mutation rate of the virus which produces escape 
variants. More recent evidence suggests that core protein can modulate antigen 
presentation (Large et al., 1999). Therefore, the virus may also have evolved other 
mechanisms to circumvent the immune response.
1.1.9. Diagnosis and Histopathology
Established methods to detect HCV infection include identification of antibodies against 
HCV antigens and detection of the viral genome by PCR. However, the detection of HCV 
antigens themselves in the infected host is generally inefficient. There are several sensitive 
enzyme-linked immunosorbent assays (ELISAs) to detect HCV antibodies to peptides from 
core, NS3, NS4, and NS5 proteins or to a combination of recombinant viral proteins. 
Despite several modifications to maximise sensitivity, these assays are still plagued by 
some false-positive reactivity. In PCR-negative cases, specificity can be confirmed with a 
supplementary assay such as the recombinant immunoblot assay (RIBA), which detects 
antibodies to each of the HCV proteins in a nitrocellulose strip format (DiBisceglie, 1998).
During early stages of acute infection with HCV and in immunosuppressed individuals 
(e.g. those with chronic renal failure and AIDS) anti-HCV antibodies may not be detected. 
Under these circumstances direct detection of HCV nucleic acid is performed by reverse 
transcription followed by PCR (RT-PCR). This has proved to be especially important for 
accurate monitoring of the antiviral effects in patients undergoing therapy (Alter et al.,
1995). In addition, liver biopsies have also become an important tool to determine chronic 
hepatitis by permitting estimation of the degree of inflammation (grade of hepatitis) and 
the amount of fibrosis present (stage of hepatitis), as well as to exclude other coincidental 
disease (Dhillon & Dusheiko, 1995). However, these genetic and serological diagnostic 
tests are not able to detect the heterogeneous HCV strains that may exist in a given patient 
with equal sensitivity (Lavanchy et al., 1999).
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1.1.10. Detection of HCV RNA and Antigen in the Liver
HCV antigen localisation using antibodies against several epitopes has been reported 
(Gonzalez-Peralta et al., 1994). Overall, in any given tissue section only a few antigen 
containing cells may be detected. In hepatocytes from an infected chimpanzee, granular 
cytoplasmic staining was detected by monoclonal antibodies raised against HCV core 
antigen, and the pattern was repeated in liver biopsies from patients positive for HCV RNA 
and anti-HCV antibodies (Yap et al., 1994). Detection of immunopositive cells showed no 
relationship with inflammation or necrosis (Dhillon & Dusheiko, 1995). A report 
described increasing immunopositivity with advanced disease, but HCV viremia was found 
to be lowest in these patients (Magrin et al., 1994). Furthermore, immunostaining for 
HCV RNA showed similar cytoplasmic staining patterns were observed, with perinuclear 
localisation in hepatocytes (Nouri Aria et al., 1993). These HCV RNA-positive cells 
appeared to be bile duct cells and lymphocytes (Tanaka et al., 1993; Walker et al., 1998). 
Employing the novel technique of in situ hybridisation (ISH) followed by PCR (ISH/PCR), 
the sensitivity has been significantly enhanced to detect positive cells containing less then 
20 copies of the viral genome (Nuovo et al., 1993). A study of strand-specific localisation- 
ISH, showed that the replicative intermediates of HCV were most closely associated with 
inflammation at the periphery of fibrosis cavities. However, there also is a lack of 
reproducibility reported with these techniques (Hiramatsu et al., 1992; Yap et al, 1994;
Park et al., 1996).
1.1.11. Prevention and Treatment
The incidence of transfusion-associated hepatitis C has decreased to less than 1% per 
recipient since the implementation of screening volunteer donors for HCV antibodies. To 
prevent transmission by potentially contaminated blood products, inactivation of nucleic 
acid by photo-reactivation chemicals has proved to be effective compared to traditional 
protein denaturation procedures where both viral and non-viral proteins were 
simultaneously destroyed (Houghton, 1996). Additional prevention strategies (e.g. needle 
and syringe availability) are targeted at other routes of transmission (see Section 1.1.6).
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The primary goal of treatment for HCV infection is to prevent serious chronic liver disease 
including cirrhosis, end-stage liver disease, and HCC. The secondary goal is to reduce or 
eliminate the infectivity of the infected person so that the virus is not transmitted to others 
in the community. At present, alpha interferon (IFN-a) is the most widely accepted form 
of therapy for chronic HCV infection (Davis et al., 1989). The optimal response is defined 
by persistently normal serum ALT concentrations and absence of HCV RNA from serum 
at the end of therapy and for at least 6 months thereafter (Poynard et al., 1996). This is 
referred to as a sustained response, which occurs in only 20-25% of patients treated for 6 
months. In addition, other factors are also associated with an increased chance of 
responding, including the absence of cirrhosis, lower pre-treatment HCV RNA levels, and 
infection with HCV genotypes other than type 1 (DiBisceglie, 1998). However, certain 
patient groups may continue to be difficult to manage, including those with immune 
deficiency due to the use of immunosuppressive drugs, HIV infection, or chronic renal 
failure. Furthermore, patients with features o f both HCV infection and autoimmune liver 
disease may be at risk of developing further liver damage by the use of interferon.
Alternatives to interferon therapy have been considered because of the low proportion of 
patients who show sustained response, the high cost, and side effects associated with this 
cytokine. An adjunct to interferon, ribavirin, is an orally administered nucleoside analogue 
with a broad spectrum of antiviral properties. Current studies suggest that when ribavirin 
is used together with interferon, there is a significantly higher rate of sustained response 
than with interferon alone (Brillanti et al., 1994). The mechanism by which ribavirin 
enhances the effect of interferon is not fully understood, although it may act as an immune 
stimulant in conjunction with other cytokines (Gish, 1999).
At present the field of HCV treatment awaits the development of new agents with specific 
antiviral properties targeted towards the viral protease, helicase, or RNA-dependent RNA 
polymerase. The crystal structure and tertiary structure of the protease and helicase have 
been determined recently, which could aid the search for compounds to inhibit their 
functions (Section 1.2.6).
Advances in molecular characterisation of HCV may help in the development of vaccine 
production. Analysis of HCV variation, serology and in vitro experiments testing HCV 
infectivity, suggested the requirement for the development of a broadly reactive vaccine 
against HCV (Kato et al., 1993 and 1994, Shimizu et al., 1994). However, the
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development of a vaccine against HCV has faced multiple challenges. Although reliable 
neutralising determinants against immunogenic antigens are yet to be documented, 
preliminary data suggest that HVR-1 in the N-terminal part of envelope glycoprotein E2 
contains B-cell and CTL epitopes (Zibert et a l 1995). CTL responses against non- 
structural protein NS3 have also been studied (Ferrari et al., 1994). The obstacles that 
hinder the development of an efficient HCV vaccine include: a) the lack of an in vitro 
replication assay; b) the lack of a small susceptible animal model (Inchauspe, 1999).
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1.2. Molecular Features of HCV
1.2.1. Comparison of the HCV, Flavi- and Pestivirus Genomes
Members of the Flaviviridae family are divided into three genera, flaviviruses, pestiviruses 
and hepaciviruses (Rice, 1996). The genera have diverse biological properties and show 
no serological cross-reactivity, however, they appear to be similar in terms of virion 
morphology, genome organisation, and presumed RNA replication strategy. The genomes 
of Flaviviridae consist of a positive-sense, single-stranded RNA of between 9.5 to 12.5 kb, 
with HCV having the shortest genome (Rice, 1996). The viral RNA encodes a single 
polyprotein of approximately 3 460, 3 960, and 3 010 amino acids for yellow fever virus 
(YFV), bovine viral diarrhoea virus (BVDV), and HCV, respectively, with structural 
proteins at the N-terminus followed by the non-structural proteins. Generally, the 
structural proteins are generated by processing of the polyprotein by host proteinases while 
the majority of mature non-structural proteins are produced by virally encoded proteinases. 
Features of the genomic organisation of Flaviviridae are illustrated in Fig 1.2 and Table
1.2 .
The genome of the prototype flavivirus, YFV is approximately 11 kb, with a type I cap at 
its 5’ end (m7GpppAmp) containing two methyl groups, followed by a conserved 
dinucleotide sequence AG (Rice, 1996). Although this is the predominant type of cap in 
all eukaryotic messenger RNAs (mRNAs), genome-length RNAs appear to be the only 
virus-specific mRNA molecules in flavivirus-infected cells. Genomic RNAs of insect- 
borne flaviviruses lack a 3 ’ terminal poly (A) tract and terminate with the conserved 
dinucleotide CU. The single ORF encoded by the genome is flanked by 5’ (118 
nucleotides) and 3 ’ (511 nucleotides) untranslated regions (UTRs) containing conserved 
elements, which play a role in replication (Brinton & Dispoto, 1988; Mandl et al., 1993). 
Secondary structures can be predicted for the 3 ’ terminal 90 bases of the genome of all 
flaviviruses, however there is little conservation of nucleotide sequences (Mandl et al.,
1993). For most viruses in this genus, translational initiation occurs at the first AUG in the 
genome, but in a small number of mosquito-borne flaviviruses [e.g. YFV and Dengue 
(DEN) type 1-4 viruses], a second in-frame AUG is located 12 to 14 codons downstream. 
Ten viral proteins are cleaved co-translationally and post-translationally from the primary 
translation product. Fig 1.3 illustrates the membrane topology of the flavivirus proteins;
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PrM, the precursor to structural protein M, envelope protein E and non-structural protein 
NS1 are located in the lumen of the endoplasmic reticulum (ER), while the nucleocapsid 
(C) and remaining non-structural proteins, NS2 to NS5 are found in the cytoplasm (Rice, 
1996).
The genomic RNA of B VDV, the prototype of the pestiviruses, has a single-stranded RNA 
of 12.5 kb in length (Brock et al., 1992). The ORF is ~11.9 kb and is flanked by a 5’ UTR 
of 385 bases and a 3’ UTR of 229 bases (Collett et al., 1988). Pestivirus genomic RNA 
does not contain a 3’ poly (A) tract but appears to terminate with a short stretch of poly(C). 
Direct analysis of the 5’ terminus suggested that the genomic RNA lacked a cap structure 
(Brock et al., 1992; Deng & Brock, 1993). The failure to detect subgenomic RNAs, as for 
flaviviruses, has led to the belief that genome-length RNAs serve as mRNAs for translation 
of the viral polyprotein. The long pestivirus 5’ UTR is predicted to form a highly 
structured RNA element that may behave as an IRES to initiate cap-independent 
translation of the ORF (Brown et al., 1992; Deng & Brock, 1993; Poole et al., 1995). The 
combination of host and virally encoded proteinases generates eleven distinct proteins 
from the polyprotein. Unlike the flaviviruses and HCV, the first pestivirus protein encoded 
in the ORF is a non-structural autoproteinase (Npro) involved in the processing between 
Npro and core protein (Table 1.2 and Fig 1.2).
By comparison with flaviviruses and pestiviruses, HCV genomic RNA is considerably 
shorter at about 9.4 kb in length and is separated into 3 regions (5’ UTR, ORF and 3’ UTR; 
Okamoto et al., 1994a). Given the considerable genetic divergence among isolates, the 
HCV 5’ UTR is the most conserved RNA sequence element and is 341 to 344 bases long. 
The 3 ’ UTR consists of three distinct segments, a short region variable in composition and 
length (28 to 42 bases), a variable length polyuracil tract [poly (U)] and a highly conserved 
stretch of 98 nucleotides termed the 3’X tail (Han et al., 1991; Tanaka et al., 1995). 
Conserved secondary structures, predicted at the 3’ end of the ORF and the 3’X tail, may 
be important in the replication of HCV RNA. The length of the ORF varies slightly among 
isolates, encoding polyproteins of between 3,010 to 3,033 amino acid residues 
(Chamberlain et al., 1997). Fig 1.4 illustrates details of the genome structure of HCV. 
There are a number of short amino acid sequence homologies with NS3 and NS5 of the 
flaviviruses (Miller & Purcell, 1990; Choo et al., 1991). The region between residues 1230 
to 1500 of the HCV polyprotein (located in NS3) has sequence similarities with a putative 
NTP-binding helicase encoded by flavi-, pesti-, and plant potyviruses (Hijikata et al.,
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1993b). A region upstream of the NTP-binding helicase shares similar features with the 
putative (chymo)trypsin-like serine proteinase from flaviviruses and pestiviruses 
(Bartenschlager et al., 1993; Hijikata et al., 1993a). Finally, the amino acid segment 2703- 
2739, contains the characteristic Gly-Asp-Asp motif, which is highly conserved among 
viral-encoded RNA-dependent RNA polymerases (Koonin, 1991a).
In the absence of an efficient viral replication system and a small animal model the 
majority of the molecular characterisation HCV has been conducted using a number of 
heterologous expression systems. Additional information has been provided by structural 
crystallography studies for one viral protein, NS3 (Kim et al., 1996; Love et al., 1996).
1.2.2. 5’ Untranslated Region (5’ UTR) and Translation of HCV RNA
The 341 (to 344) nucleotides of the 5’ UTR and adjacent core protein coding sequences are
extremely well conserved between HCV isolates (Simmonds, 1995). The HCV 5’ UTR is
much longer than that of flaviviruses and no significant sequence homologies with this
region of flaviviruses exist (Heinz, 1992). However, the HCV 5’ UTR does closely
resemble the 5’ UTRs of pestiviruses BVDV and classical swine fever virus (CSFV) in
terms of length and several short regions of significant homology (Houghton et al., 1991).
This region of the genome is predicted to be capable of forming extensive secondary
structures and this has been confirmed from biochemical structural studies (Brown et al.,
1992). Four major structural domains have been identified, designated I to IV, that consist
of stem-loop and pseudoknot structures (Fig 1.5). A number of AUG codons are located in
the 5 ’ UTR, but these are apparently not used for initiation of translation. The presence of
such a long highly ordered untranslated region containing non-functional initiation codons
resembles the situation in picomaviruses. The picomaviral genomes are translated by a
mechanism of internal ribosome binding and initiate translation at a specific AUG codon in
a cap-independent manner (Jackson et al., 1990b); such RNA elements have been termed
internal ribosomal entry sites (IRES). Similar to the picomaviral 5’ UTR, in vitro
expression systems have been used to identify IRES function for the HCV 5’ UTR
(Tsukiyamakohara et al., 1992). However, unlike picomaviruses, the 3’ boundary of the
HCV IRES element is located within the coding sequence of the core protein and therefore
is not entirely contained within untranslated sequences. Mapping studies have revealed
that optimal IRES activity resides within a segment from nucleotides 40 to 370, and thus
incorporates at least 29 nt from the core protein coding region (Reynolds et al., 1995). The
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AUG codon at position 342, utilised for initiation of translation, is located in stem-loop IV 
(see Fig 1.5). The genomes of some HCV genotypes are translated less efficiently than 
others. RNA-RNA interactions between the extreme 5’ UTR and core protein coding 
sequences adjacent to the IRES are responsible for this regulated translation (Honda et al., 
1999). In tissue culture studies, the 5’ UTR from genotype 2b was three times more 
efficient than that for genotype 6a in directing translation from a reporter construct (Collier 
et al., 1998).
Despite the conceptual similarities between the IRES elements o f HCV and picomaviruses 
(Jackson et al., 1990b), they differ in both primary and predicted secondary structures. 5’ 
UTRs of HCV and pestiviruses mediate initiation of translation by a different mechanism 
of internal ribosomal entry from that of picomaviruses (Fig 1.6; Stewart & Semler, 1997), 
in that cap-dependent translation is not abolished in the cell following HCV infection. In 
addition, this mechanism has unique features compared with those for other known 
mRNAs, including capped mRNAs and cellular RNAs translated via IRES elements of 
genes such as homeotic gene Antennapedia (Macejak & Samow, 1991). Briefly, a 43S 
preinitiation complex is formed by the assembly of eukaryotic initiation factor 3 (eIF-3), 
eIF-2, GTP, initiator tRNA (met-tRNA) and a 40S ribosomal subunit (Fig 1.6). Capped 
mRNA requires additional factors (eIF-4A, -4B, -4E, -4F, and -4G ) to unwind any 
secondary structure adjacent to the capped 5’ end to create a binding site for the 43S 
complex (Pestova et al., 1996). The HCV IRES recruits and directly binds to components 
of the 43 S complex, without the requirements of eIF-4A, -4B, -4E, -4F, and -4G. The 
structural determinants in the IRES ensure the correct spatial orientation of these binding 
sites for attachment of the final initiation complex at the initiation codon (Hellen & 
Pestova, 1999). UV cross-linking studies have identified several cellular RNA-binding 
proteins such as La autoantigen (Meerovitch et al., 1993; Isoyama et al., 1999) and 
polypyrimidine tract-binding protein (PTB; Borman et al., 1993) that associate with the 5’ 
UTR. These proteins have been implicated in the function of picomavirus IRES elements 
although they are not required for initiation from the HCV IRES (Hellen & Pestova, 1999). 
Nevertheless, these and other such proteins may affect the efficiency of translation in vivo, 
or ensure that only a full length genomic RNA is translated (Ito & Lai, 1999).
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1.2.3. 3’ UTR
As stated previously, the 3’ UTR is considered to be a tripartite structure comprising the 
short variable sequence, a poly(U) tract and the highly conserved 3’X sequence (Fig 1.7). 
Computer modelling has predicted that this sequence can fold into an elaborate stem-loop 
structure suggestive of a critical functional component in virus replication as shown for 
other members of the Flaviviridae family (Kolykhalov et al., 1996). UV cross-linking 
experiments and the yeast three-hybrid system have revealed the binding of PTB (Ito &
Lai, 1997) and human ribosomal protein L22 (Wood & Patel, 1999) to the 3’X segment of 
the 3’ UTR. Both or either protein may participate in the regulation of HCV RNA 
synthesis or translation, however such proposals await functional analysis. Interestingly, 
PTB binds to the 5’ UTR of HCV and may also have a role in the translation of the virus 
(Ito & Lai, 1999).
1.2.4. HCV Virus-Encoded Non-Structural Proteins
As stated earlier, the HCV genome encodes a single polyprotein. Cellular enzymes are 
responsible for the cleavage events which generate the structural proteins while processing 
of the NS2-NS5B region is mediated by two virus-encoded proteolytic activities. The 
NS2-NS3 junction is cleaved by a NS2/3 proteinase and the NS3/4A serine proteinase is 
responsible for the processing at sites between NS3/4A, NS4A/B, NS4B/5A, and NS5A/B. 
The polyprotein is processed into at least 10 distinct viral proteins (illustrated in Fig 1.4). 
The structural proteins are located in the N-terminal one-third and the non-structural and 
replicative enzymes located within the C-terminal two-thirds of the polyprotein. The 
properties of the non-structural (NS) proteins are briefly discussed in this section and are 
followed by a description of the structural core and envelope proteins (Section 1.3).
1.2.5. NS2
The NS2 protein extends from aa 810 to 1026 and is a transmembrane protein with its C- 
terminus translocated into the lumen of the ER while its N-terminus lies in the cytosol 
(Santolini et al., 1995). Further evidence has suggested that NS2 is concentrated near the 
nucleus in the perinuclear space and at the edges of the cell (Kim et al., 1999).
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Immunoprecipitation studies have shown that NS2 can associate with the structural 
proteins (Matsuura et al., 1994). Aside from its hydrophobic character, no significant 
sequence homology exists between the HCV NS2 protein and the analogous flavivirus or 
pestivirus proteins. Nonetheless, detailed study of the proteolytic processing of this region 
of the polyprotein has revealed a unique proteinase function contributed by the C-terminal 
portion of NS2 and the NS3 serine proteinase domain. Although cleavage at the NS2-NS3 
junction involves amino acid residues 846 to 1237, which span NS2 and NS3 (Santolini et 
al., 1995), the catalytic activity of the serine proteinase is not required (Hijikata et al., 
1993a). The NS2-NS3 precursor is co-translationally targeted via signal recognition 
particle (SRP) and SRP-receptor pathways to the ER membrane. This membrane 
association enhances cleavage at the NS2-NS3 junction, resulting in translocation o f the C- 
terminus of NS2 to the ER lumen and the N-terminus being located in the cytosol, as 
shown by site directed mutagenesis and proteinase digestion (Santolini et al., 1995). 
Mutagenesis studies have also identified His and Cys residues (at positions 952 and 993 in 
the polyprotein) that may form a catalytic dyad or, together with a Glu residue (at aa 972), 
a catalytic triad (Fig 1.8; Hijikata et al., 1993a; Bartenschlager, 1999). However, 
mutations at residues 952, 972, and 993 has no effect on the processing of NS3 cleavage 
sites, suggesting that despite the overlap between the proteinases, their activities are 
independent of each other. Finally, the NS2/3 autoproteinase is proposed to be a 
metalloproteinase (containing a zinc ion) based on metal chelating studies. Proteolysis was 
shown to be tolerant to amino acid mutations in the region from P5 to P3’ of the NS2-NS3 
junction (aa 1022 to 1029; Reed et al., 1995). However, a preference for hydrophobic 
amino acids at the PI and P I ’ positions (aa 1026 and 1027) showed similarities to neutral 
metalloproteinases, such as a mammalian enzyme, endopeptidase 24.11, which is involved 
in processing of peptide hormones (Erdos & Skidgel, 1989; Clarke, 1997). The 
requirement of a cysteine residue and a metal ion for NS2/3 proteinase catalytic activity 
suggests employment of a unique mechanism, and thus this enzyme cannot be grouped 
with any of the currently known proteinase families (cysteine, metallo, serine or aspartic 
proteinases; Bartenschlager, 1999).
1.2.6. NS3
This HCV protein has been the subject of intensive study due to its potential as an anti­
viral target. NS3 is the only HCV protein for which structural information is available. 
The protein is proposed to be the functional homologue of the flavivirus NS3 and the
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pestivirus 125/p80 proteins. It extends from amino acids 1027 to 1658, has an apparent 
molecular weight of 70 kDa and is a multifunctional molecule with three enzymatic 
activities; a serine-type proteinase function located in the N-terminal domain and 
nucleoside triphosphatase (NTPase)/helicase activities in the C-terminal region (Fig 1.9; 
Grakoui et al., 1993b; Hijikata et al., 1993a). NS3 may have other non-enzymatic 
properties. There is evidence that it has a role in modulating protein kinase A (PKA)- 
mediated signal transduction and thus may influence host cell function (Borowski et al.,
1996). In HCV-infected liver cells, NS3 is present in the cytoplasm, but in a minority of 
HCV-infected cells both the cytoplasmic and the nucleus or the nucleus on its own is 
positive for NS3 (Errington et a l, 1999).
I.2.6.I. NS3 Proteinase
The minimal NS3 domain required for full proteolytic activity has been mapped to about 
180 residues at the N-terminus (Bartenschlager et al., 1994; Failla et al., 1994). NS4A is a 
cofactor of the NS3 proteinase and essential for its proteolytic activity at most NS cleavage 
sites (Bartenschlager et al., 1994; Failla et al., 1994). Release of the N-terminus of NS3 by 
cleavage at the NS2-NS3 junction and formation of the NS3/4A serine proteinase may be 
an essential step in HCV replication. In pestiviruses, viral replication is able to proceed in 
the absence of cleavage at a similar position, but the resultant viruses are rendered non- 
cytopathic (Ryan et al., 1998). The HCV NS3 serine proteinase appears to more closely 
resemble its pestivirus counterpart, rather then the flavivirus homologue, where there is a 
functional requirement for NS2 as a closely associated cofactor (Ryan et al., 1998).
Based on comparative sequence analyses with several viral and cellular proteinases, NS3 
contains a (chymo)trypsin superfamily motif, composed of a catalytic triad of His (1083), 
Asp (1107) and Ser (1165), in the N-terminal domain (Fig 1.9; Miller & Purcell, 1990). 
Substitutions affecting these residues abolish cleavage at the NS3-NS4A, NS4A-NS4B, 
NS4B-NS5A, and NS5 A-NS5B junctions but not at the NS2-NS3 junction (Bartenschlager 
et al., 1993). The processing between NS3 and NS4A is rapid, co-translational, and occurs 
in cis, while cleavage at the other NS3/4A-dependent sites occurs in trans (Bartenschlager 
et al., 1994). NS4A cofactor is required for cleavage at the NS3-NS4A, NS4A-NS4B, and 
NS4B-NS5A sites and enhances cleavage at the NS5A-NS5B junction (Failla et al., 1994). 
Sequence analysis of various HCV isolates revealed a consensus sequence for NS3/4A- 
dependent cleavage characterised by an acidic amino acid at the P6-postion, a Cys/Thr at
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PI, and a residue with a small side-chain at position PI*. The consensus is Asp/Glu-X-X- 
X-X-Cys/Thr^Ser/Ala-X-X-X, where X is variable (Grakoui et al., 1993a).
The NS3 proteinase domain and NS4A form a detergent-stable, non-covalent complex. 
Association requires 22 N-terminal residues of NS3 and a 12 residue sequence in the centre 
of NS4A (Fig 1.9; Bartenschlager et al., 1995; Lin et al., 1995). Mutagenesis studies 
suggested that NS4A enhances proteinase activity by inducing conformational changes to 
stabilise NS3 (Kim et al., 1996; Steinkuhler et al., 1996). The three dimensional structure 
of the proteinase domain of NS3 has been determined in the presence (Kim et al., 1996) 
and absence (Love et al., 1996) of a synthetically produced region o f NS4A. In the 
presence of the NS4A peptide, the proteinase domain adopts a chymotrypsin-like fold.
This consists of N- and C-terminal domains which contain 8 (one o f which is contributed 
by NS4A) and 6 P-barrels respectively, separated by a cleft. In the absence of NS4A, the 
N-terminal domain adopts an open conformation that extends away from the protein.
Under these conditions, the P-strands at the N-terminus contact exposed hydrophobic 
patches on adjacent molecules (Love et al., 1996). This open conformation affects two 
residues of the catalytic triad (His-1083 and Asp-1107) such that the Asp residue no longer 
forms a hydrogen bond with His. Thus, binding of NS4A may effect conformational 
changes at the triad, which in turn have a bearing on proteolytic activity (Love et al.,
1998).
Analysis of the crystal structure of NS3 serine proteinase has indicated that the enzyme 
contains a zinc binding site co-ordinated by three Cys residues (Cys 1123, 1127, and 
1171), and via a water molecule, by His (1175; Fig 1.8; Kim et al., 1996; Love et al.,
1996). The role of the zinc ion appears to be strictly structural, because it can be 
substituted by cadmium or cobalt ions (De Francesco et al., 1996). Mutagenesis of any of 
these residues negatively affects the serine proteinase as well as the NS2/3 autoproteinase 
(Hijikata et al., 1993a). This suggests that both the NS2/3 proteinase and NS3 serine 
proteinase share the same metal binding site. Interestingly, a zinc ion co-ordinated in this 
way (i.e. to three amino acids and one water molecule) is generally viewed as having a 
catalytic role, and therefore the zinc-bound water molecule may have an essential function 
in the hydrolysis of the NS2-NS3 site (Wu et al., 1998). Catalytically-active zinc is 
usually co-ordinated by nitrogen and oxygen atoms. For those enzymes where zinc has a 
structural role, it is ligated by cysteine thiolates, as is the case in NS3 (Berg & Shi, 1996).
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It is possible that zinc co-ordinated in this way could have both catalytic (for NS2-3 
cleavage) and structural (for stability of the NS3/4 complex) functions. The residues 
involved in the binding of zinc by NS3 are conserved among HCV genotypes although this 
is not the case in the flavivirus and pestivirus homologues (Ryan et al., 1998), which do 
not possess metalloproteinase activity.
I.2.6.2. NS3 NTPase/Helicase
The two other enzymatic processes associated with NS3 are NTPase and RNA helicase 
activities, for which the C-terminal 465 amino acid residues are sufficient (Kim et a l , 
1997a). From biochemical studies, the proteinase domain is required for the optimal 
binding of polynucleotides and RNA to the NS3 NTPase/helicase domain and thus there is 
interplay between both regions of NS3 (Gallinari et al., 1998). Hence, combination of the 
proteinase domain along with regions with NTPase/helicase activities into a single 
polypeptide may have occurred to optimise the overall function of the protein. In the 
flavivirus counterpart protein, two functionally distinct domains also reside in the same 
polypeptide (Gorbalenya et al., 1989).
In common with other RNA helicases, the HCV NS3 helicase domain contains four 
conserved motifs, designated A, B, C, and D (Fig 1.9). Motif A, Ala-X-X-X-X-Gly-Lys- 
Ser, is required for ATP binding and consequently for ATP hydrolysis and RNA 
unwinding (Kim et al., 1997b). The second motif, Asp-Glu-Cys-His (DECH; Yamada et 
al., 1994), suggests NS3 is a member of DExH (Asp-Glu-X-His) subfamily belonging to 
the DEAD (Asp-Glu-Ala-Asp) box family of RNA helicases (Koonin, 1991b). Mutational 
analysis of the helicase domain showed that the conserved residues within the DEAD box 
motif are essential for NTPase and helicase activities (Kim et al., 1997b, Wardell et al., 
1999). Similar to NS3, a number of DEAD box family proteins contain NTPase and RNA 
helicase activities (e.g. eIF-4A; Kim et al., 1997b). Motifs C and D are TAT (Thr-Ala- 
Thr) and QRRGRTGR (Gln-Arg-Arg-Gly-Arg-Thr-Gly-Arg). The former is believed to 
be important in RNA unwinding and the latter is important in ATP hydrolysis and RNA 
unwinding (Kim et al., 1997b). The NTPase activity is dependent on Mg2+ and enhanced 
by the presence of polynucleotides, poly(U) in particular (Tai et al., 1996). This region of 
NS3 is able to unwind RNA, DNA and RNA/DNA duplexes in a 3’ to 5’ direction 
although activity is dependent on a 3’ single-stranded region (Tai et al., 1996). This 
property of NS3 makes it unique among RNA helicases including the related pestivirus
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enzymes. The minimal RNA-binding size for the HCV helicase is estimated to be between 
seven and twenty nucleotides (Bartholomeus & Thompson, 1999). The X-ray crystal 
structure of this region of NS3 indicates that the NTPase and RNA binding domains are 
distinct (Kim et al., 1998).
1.2.7. NS4A and NS4B
NS4A extends from amino acid residues 1658 to 1712 and is approximately 8 kDa in size. 
As described above, it functions as a co-factor to the NS3 serine proteinase. The protein 
also forms a non-covalent, detergent-stable complex with the NS4B-NS5A polyprotein, 
which may allow efficient cleavage at the NS4B-NS5A junction (Lin et al., 1997). The N- 
terminal hydrophobic region of NS4A forms a 20 residue transmembrane helix that is 
followed by highly charged residues. In addition to enhancing proteolytic cleavage 
activity of NS3, NS4A mediates the association of NS3 with intracellular membranes, 
probably via the transmembrane helix. This may contribute to the activity of the 
proteinase in vivo (Hijikata et al., 1993b).
NS4B has an apparent molecular weight of ~27 kDa and is generated by processing at 
residues 1712/1713 and 1972/1973 of the polyprotein. It is highly hydrophobic and may 
be membrane associated (Shimotohno and Feinstone, 1997). No functions have been 
ascribed to NS4B proteins of the Flaviviridae family including that encoded by HCV. 
Recent studies suggest the HCV protein may have a role in the phosphorylation of NS5A 
(Koch & Bartenschlager, 1999) and could be important for anchoring replication 
complexes to membranes. The NS4 region as a whole has two strong antigenic elements, 
one of which overlaps the C-terminus of NS4A and the N-terminus of NS4B. The other 
region is located at the C-terminus of the NS4B protein (Chang et al., 1999).
1.2.8. NS5A
NS5A is generated by processing at residues 1972/1973 and 2419/2420. Expression of 
NS5A produces two proteins of different electrophoretic mobilities, p56 and p58. Both 
species are phosphoproteins and the difference in size of the two forms is a consequence of 
differential phosphorylation (Tanji et al., 1995). Evidence suggests that both proteins are 
phosphorylated at serine residues in the C-terminal region of NS5A and that p58 has
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additional phosphorylation sites at serine residues in the central region spanning residues 
2197 to 2204 (Tanji et al., 1995). Mutagenesis studies showed hyperphosphorylation to 
produce p58 was most efficient when NS5A was expressed as part of a continuous NS3- 
NS5A polyprotein (Koch & Bartenschlager, 1999). Direct interaction of NS5A with NS4A 
occurs via amino acids at 2135 to 2139 in NS5A (Asabe et al., 1997). NS5A protein of 
DEN-2 is also phosphorylated, which affected its subcellular localisation and affinity for 
NS3 (Kapoor et al., 1995). However, the physiological role of the phosphorylation of 
NS5A and its role in viral replication is not known as yet.
Apart from any role in virus replication, NS5A has been implicated as a factor that 
determines the susceptibility of the virus to treatment with interferon (Enomoto et al.,
1996). Clinical observations indicate that mutations in the amino acid sequence of NS5A, 
especially in a region between amino acids 2209 and 2248, are associated with improved 
responsiveness to IFN. This segment of the protein has been designated the IFN- 
sensitivity determining region (ISDR). Studies have shown that binding of NS5A directly 
with double-stranded RNA-dependent protein kinase (PKR) occurs through the ISDR 
(Gale et al., 1997; Song et al., 1999). PKR is an important antiviral activity, induced by 
IFN-a (Katze, 1995), which modulates apoptosis responses of the host cell to infection and 
is a tumour suppressor. Interaction with NS5A interferes with PKR kinase activity (Gale 
et al., 1997) and the PKR-binding function of NS5A disrupts apoptosis by blocking the 
PKR-dependent host signal pathways (Gale et al., 1999). It is proposed that this may be a 
mechanism by which HCV evades the host immune response.
1.2.9. NS5B
NS5B, generated by processing between residues 2419 and 2420 of the polyprotein, is a 65 
kDa protein and is believed to be the viral RNA-dependent RNA polymerase (RdRp). The 
NS5B sequence is conserved not only between different strains of HCV but also in 
pestiviruses, flaviviruses and in other RNA viruses (Rice, 1996). Inspection of its amino 
acid sequence reveals the presence of four conserved motifs, termed A, B, C, and D in the 
central region of the NS5B polypeptide (Fig 1.10). Motif A is likely to have a role in NTP 
binding and catalysis while motif B may be involved in template and primer positioning. 
Mutations within the first motif (A) completely abolish polymerase activity, whereas 
changes made within the second motif (B) substantially reduce polymerase activity. Motif
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C is GDD (Gly-Asp-Asp), a characteristic feature of RNA polymerase active sites and is 
essential for polymerase activity (Behrens et al., 1996). Motif D, present in most RdRp 
and reverse transcriptases, also may be involved in NTP binding and catalysis. The NS5B 
polymerase is resistant to rifampicin, an inhibitor of prokaryotic RNA polymerases, but 
like other enzymes involved in the creation or breakage of phosphodiester bonds, it has an 
absolute requirement for divalent metal ions, Mg2+ or Mn2+ (Lohmann et al., 1997). The 
polymerase can copy the entire HCV genome in vitro, as well as other non-specific 
templates without any additional viral or cellular factors (Lohmann et al., 1997; Oh et al.,
1999). Additional factors would probably be necessary to confer specificity and may be 
involved also in the regulation of RNA synthesis. In vitro studies have shown that it uses 
the 3’ end sequences of both plus and minus strands of HCV RNA as templates, implying 
that these sequences act in cis in a primer-independent manner (Oh et al., 1999). These 
findings were confirmed in a study showing that all of the 3 ’ UTR and a portion of the 
3’coding nucleotide sequences, contain conserved stem-loop structures necessary for 
specific NS5B binding (Cheng et al., 1999).
1.2.10. HCV RNA Replication
The viral genome of positive-sense, single-stranded RNA viruses functions also as mRNA 
in infected cells. During the replication process, HCV must synthesise negative-stranded 
RNA as a template for generating progeny virion RNAs. By analogy to related 
flaviviruses and pestiviruses, the synthesis of an intermediate negative strand RNA is 
likely to be catalysed by a cytoplasmic membrane-associated replicase complex formed by 
the non-structural proteins. The three viral proteins most likely to be directly involved in 
RNA synthesis are NS3, NS4A and NS5B (Behrens et al., 1996; Tai et al., 1996). 
Molecular studies of HCV replication have been hampered by the low efficiency of 
propagation with currently available cell culture systems and by the fact that the only 
animal model is the chimpanzee. Recently, Lohmann et al. (1999) established human 
hepatoma cell lines using bicistronic constructs. These were composed of the HCV IRES 
(nt 1 to 377) linked to the neomycin phosphotransferase (neo) gene, followed by the IRES 
of the encephalomyocarditis virus to direct translation of HCV sequences from NS2 or 
NS3 to NS5B, and the 3’ UTR. These constructs generated approximately 108 positive- 
strand RNA copies per microgram of total cellular RNA, which corresponded to 100 to 
500 molecules per cell. The amount of negative-strand RNA was 5- to 10-fold lower, 
consistent with the notion that negative-sense RNA serves as a template for the synthesis
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of excess positive-sense RNA; a similar ratio is detected in flavivirus replication (Cleaves 
et al., 1981). The NS3 and NS5A produced from replicon templates were localised 
predominantly in the cytoplasm thus providing evidence for the site of HCV RNA 
replication. Based on the localisation of double-stranded RNA (an indicator of replication) 
and cell-fractionation studies, flavivirus RNA synthesis is thought to occur principally on 
the membranes of the perinuclear ER (Westaway, 1987). The HCV structural proteins and 
NS2 were not required for replication of the replicon emphasising the close evolutionary 
relationship between HCV and pestiviruses (Behrens et al., 1998). For pestiviruses, these 
replicons appear to replicate more efficiently (~1.5 x 104 genomes per cell) than HCV.
The reduced amount of RNA detected for HCV replicons could reflect the intrinsic lower 
replication capacity of HCV.
As mentioned above, HCV RNA replication is proposed to take place on ER membranes, 
which has been based on available experimental evidence and replication strategies used 
by other RNA viruses. From Kunjin virus (KUN), DEN-2 and BVDV RNA-labelling 
studies, it is thought that virus RNA synthesis occurs through a semi-conservative and 
asymmetric replication cycle (Bartholomeus & Thompson, 1999). One model suggests 
that NS4A anchors the helicase and the polymerase complex to the ER (Fig 1.11; 
Bartholomeus & Thompson, 1999). However, since the experimental data has been gained 
using proteins expressed at high levels, further investigation is necessary. It is also 
believed that the proteins forming the RNA replication complex may also have a role in 
virus assembly and packaging of the viral RNA (Hijikata et al., 1993b).
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1.3. HCV Structural Proteins
1.3.1. Core
Core protein is located at the N-terminal end of the HCV polyprotein. Cleavage between 
core and El at residue 191 generates a 23 kDa product. The presumed mature core protein 
is produced by further cleavage at residue 174, resulting in a 21 kDa species. Although 
p21 is the major product from precursor polyprotein, a small proportion of p23 is detected 
also in tissue culture systems (Liu et al., 1997). Processing at residues 174 and 191 in 
vitro is achieved only in the presence of microsomal membranes, suggesting that cleavage 
is directed by membrane-associated proteinases. The C-terminus o f p23 is highly 
hydrophobic and constitutes the signal sequence that directs insertion of El sequences into 
the ER, while processing at residue 174 probably takes place on the cytoplasmic face of the 
ER. The majority of core is found in the cytoplasm, associated with ER membranes and 
lipid droplets (Barba et al., 1997). There is evidence also of core protein in the nucleus 
that is conformationally different from the cytoplasmic form (Yasui et al., 1997). A 
hydrophobicity profile and examination of the amino acid content of core highlight three 
separate domains (Fig 1.12). The first domain consists of residues 1 to 122 and is 
characterised by a high proportion of basic residues. Domain 2, defined by aa 123-174, is 
generally more hydrophobic than domain 1 and contains very few basic residues. The 
third region (aa 175-191) is highly hydrophobic and acts as the signal sequence for E l, but 
is absent from the mature core protein (Yasui et al., 1998; Hope & McLauchlan, 1999). 
Some studies conducted using strain HCV-1 detected a smaller core-specific protein (p i6), 
which was located in the nucleus (Lo et al., 1995). The difference in localisation of p21 
and p 16 suggested that the two forms might have varying biological function. However, 
this lower molecular weight p 16 species is not observed for other strains of HCV.
By comparison with the related flaviviruses and pestiviruses, core protein is presumed to 
form the capsid of virus particle. However, in this respect, very little is known about the 
protein, particularly since virus particles have not been efficiently detected in mammalian 
cells either expressing the structural region or the complete HCV genome. The only tissue 
culture system from which virus particles have been isolated are insect cells infected with 
recombinant baculovirus expressing the entire HCV structural region (Baumert et al.,
1998). The core protein detected in these particles is similar in size to the mature form
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detected in other heterologous expression systems. To adopt a capsid structure, core 
protein is anticipated to homo-oligomerise. Regions for homotypic interaction of core 
have been identified in both domains 1 and 2 (Matsumoto et al., 1996; Yan et al., 1998). 
Sequences between residues 36 to 102 in domain 1 were critical for oligomerisation in the 
yeast-2-hybrid system, while regions involved in homotypic interactions in domain 2 
remain less well defined.
Studies to understand additional functions of core protein have concentrated on its affect 
on host cell processes and the cellular proteins with which it interacts. It has proved to be 
difficult to establish association of core protein with viral proteins probably because, in 
heterologous expressing systems, core is highly insoluble and mainly membrane-bound 
(Santolini et al., 1994; Matsumoto et al., 1996). However, a putative interaction between 
core and envelope protein El has been observed (Lo et al., 1996). In terms of other factors, 
core binds RNA (Santolini et al., 1994) and interactions with cellular proteins have been 
identified. These include heterogeneous nuclear ribonucleoprotein K (hnRNP K; Hsieh et 
al., 1998), lymphotoxin p receptor (LTfR; Matsumoto et al., 1997), tumour necrosis factor 
receptor 1 (TNFR1; Zhu et al., 1998) and a presumed DEAD box protein helicase 
(Owsianka & Patel, 1999; Mamiya & Worman, 1999). The majority of these interactions 
were identified through yeast-2-hybrid screening followed by validation by biochemical 
analyses. In all cases, domain 1 of core has been implicated as necessary for association 
(Fig 1.12).
From studies on cellular processes, it has become apparent that core can exert a variety of 
effects on cell metabolism. However, in the absence of a system modelling both virus 
replication and the pathological conditions seen in humans, correlating the observed in 
vitro affects with the situation in vivo has proved to be difficult. Nonetheless, various 
studies have shown that core can modulate apoptosis (Ruggieri et al., 1997; Marusawa et 
al., 1999), cell transformation (Ray et al., 1996), transcriptional regulation (Shih et al.,
1993 and 1995), immune presentation (Large et al., 1999), lipid metabolism (Moriya et al.,
1997) and the development of HCC (Moriya et al., 1998). Supporting evidence is 
provided by data which show that core can interact directly with some factors involved in 
these cellular processes, e.g. LTpR and TNFR1 which play roles in the early stages of 
apoptosis. Although the mechanism by which core operates in these cellular processes is 
not thoroughly understood, it is suggested that core is functionally a pleiotropic protein and 
does point to its potential critical role in HCV pathogenesis.
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1.3.2. p7
p7 is represented by residues 746 to 810 and is located between E2 and NS2. The cleavage 
events between the E2/p7 and p7/NS2 are mediated by host signal peptidase, although 
processing at the E2/p7 site is incomplete in a number of HCV strains (Lin et al., 1994). In 
pestiviruses, cleavage at a similar position can also be inefficient (Elbers et al., 1996). 
Analysis of BVDV and CSFV virions suggest that neither p7 nor E2-p7 are major 
structural constituents (Elbers et al., 1996). Whether this feature is true for HCV p7 and 
E2-p7 has not yet been elucidated. p7 is mainly hydrophobic but such segments are 
interrupted by conserved charged residues.
1.3.3. E l and E2 Glycoproteins
Sequence comparison studies between HCV and members of the Flaviviridae family 
suggested that putative envelope proteins followed core protein (Choo et al., 1991).
Studies using recombinant vaccinia viruses to express cDNA clones encompassing the 
HCV ORF in human hepatoma lines identified two membrane-associated species which 
were extensively glycosylated (Grakoui et al., 1993b; Ralston et al., 1993). These proteins 
had apparent molecular weights of approximately 31-35 kDa and 65-70 kDa, and were 
designated E l and E2, respectively.
The glycoproteins are released from the polyprotein by the action of cellular proteinases 
and signal peptidases. The signal sequences that direct these events are located in 
hydrophobic domains upstream from each of the cleavage sites (Fig 1.13). Analysis of the 
amino termini of both El and E2 indicated that the polyprotein is processed by cleavage 
between amino acids 191/192 and 383/384 (Fig 1.4; Grakoui et al., 1993b; Selby et al.,
1994). Cleavage at these sites generated a single E l species. However, various E2- 
specific proteins have been detected which correspond to E2, E2-p7 and E2-p7-NS2 that 
are produced by cleavage between residues 745/746, 810/811 and 1027/1028, respectively. 
The E2-p7-NS2 precursor is relatively short-lived and is cleaved to produce either E2 or 
E2-p7 (Grakoui et al., 1993b; Selby et al., 1994). For some HCV strains, processing at the 
E2-p7 site is inefficient, leading to the production of a reasonably stable E2-p7 species 
(Dubuisson et al., 1994; Lin et al., 1994; Mizushima, et al., 1994; Selby et al., 1994).
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Sensitivity of transiently-expressed glycoproteins to deglycosylation with endo-p-N- 
acetylglucosaminidase Hf (endo Hf) confirmed that E l and E2 are modified by N-linked 
glycosylation (Dubuisson et al., 1994). For strain H77 (genotype la), El has 5 predicted 
glycosylation sites while there are presumed to be 11 in E2 (Fig 1.13); in other strains and 
genotypes, the number of predicted glycosylation sites varies by up to 3 sites. Two studies 
have suggested that one of the five predicted glycosylation sites in E l from strain H is not 
processed (Foumillier-Jacob et al., 1996; Meunier et al., 1999). From analysis of 
sequential mutants at each of the predicted sites, the site at residue 325 (Fig 1.13) is not 
glycosylated (Meunier et al., 1999). The predicted glycosylation site at residue 325 has the 
amino acid sequence Asn-Trp-Ser-Pro (N-W-S-P). Large, hydrophobic amino acids such 
as Trp within the core sequence of N-glycosylation sites can generate a locally 
unfavourable protein conformation or block access o f the cellular glycosylation machinery 
to the Asn residue (Bause, 1983). Moreover, a Pro residue immediately downstream of the 
core glycosylation sequence also is associated with blocking glycosylation. Alteration of 
Trp to Thr did not restore glycosylation, however an additional mutation of Pro to Gly 
overcame the block in processing (Meunier et al., 1999). Thus, the Pro residue 
immediately downstream from the core glycosylation site at position 325 appears to the 
principle cause of the lack of processing at this site. This agrees with other studies on the 
effect of Pro on N-linked glycosylation (Bause, 1983).
Expression of truncated forms of the glycoproteins, lacking their C-terminal hydrophobic 
regions promoted secretion of the ectodomains (Matsuura et al., 1994; Selby et al., 1994; 
Hussy et al., 1996). This implied that both species are type 1 transmembrane 
glycoproteins, anchored by their C-terminal regions. Predictions indicate that for E2, the 
hydrophobic anchor domain begins at residue 713 (Fig 1.13; Mizushima et al., 1994). 
Within E l, the situation is slightly more complicated since two hydrophobic segments 
exist (residues 269-286 and 342-378). Expression of El truncated at residue 340 by 
recombinant baculoviruses in insect cells required also the removal of amino acids 262-290 
for secretion (Matsuura et al., 1994). By contrast, Hussy et al. (1996) provided evidence 
that El truncated at residue 334, and which therefore retained the N-terminal hydrophobic 
sequences, was efficiently secreted from insect cells using the same expression system. In 
mammalian cells, secretion of E l was observed on truncation at residue 311 but not at 
residues 330, 354 and 360 (Michalak et al., 1997). The C-terminal ends of El and E2 are 
thought to provide bi-functional roles. Firstly, they act as signal sequence elements to
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direct E2 and perhaps p7 respectively to the ER. Secondly, signals for ER retention also 
have been mapped to these regions of El and E2 (see Section 1.3.9).
In immune responses to HCV infection, the envelope proteins are presumed to be the 
primary viral antigens encountered since they exist on the surface of the virus particle. As 
a possible consequence of this, El and E2 have evolved to contain regions susceptible to 
sequence variation, which span approximately aa 210-223 and 315-327 in El and residues 
384-411 and 474-481 in E2 (Fig 1.13; Kato et al., 1992; Lesniewski et al., 1993). The 
most variable region in the entire HCV genome is contained within region 384-411, which 
is termed HVR-1 (Weiner et a l, 1991). However, sequence alignments do reveal that 
certain amino acid positions in HVR-1 are less variable e.g. threonine at position 385, and 
glycine at positions 389 and 406 (Puntoriero et al., 1998). Both B and T cell epitopes have 
been identified in HVR-1 that elicit neutralising antibodies (Rosa et al., 1996). Moreover, 
anti-HRV-1 antibodies from human sera display a degree of cross-reactivity to different 
HVR-1 variants, suggesting that the conservation pattern observed could be responsible for 
this cross-reactivity (Puntoriero et al., 1998).
1.3.5. HCV Glycoprotein Complexes
Using viral and non-viral expression systems, including transgenic mice, several groups 
have shown that E l and E2 interact to form complexes (Grakoui et al., 1993b; Lanford et 
al., 1993; Ralston et al., 1993; Dubuisson et al., 1994; Koike et al., 1995; Deleersnyder et 
al., 1997). Two early attempts to characterise the complexes were contradictory in terms 
of the nature of the interaction that occurred between the two glycoproteins. Both studies 
employed vaccinia virus recombinants to express El and E2 in mammalian cells. One 
group suggested that the two proteins associated non-covalently (Ralston et al., 1993), 
while the second reported that the interactions were dependent on intermolecular 
disulphide bonds (Grakoui et al., 1993b). Subsequent investigations showed that both 
forms of the complex could be detected in the same cell extract following an extended 
incubation period using either recombinant vaccinia or adenovirus expression systems 
(Dubuisson et al., 1994; Dubuisson & Rice, 1996; Young et al., 1998). Temporally, the 
first type of complex detected contain heterogeneous disulphide-linked high molecular 
weight material, while heterodimers of El and E2 stabilised by non-covalent interactions 
are identified at later times.
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Procedures employed to distinguish between the two forms of complex include non­
reducing gel electrophoresis conditions and conformation-specific antibodies. Non- 
covalently-linked complexes can be distinguished from those that are disulphide-linked by 
separating purified proteins by SDS-PAGE in the absence of reducing agents such as p- 
mercaptoethanol (p-ME) or DTT (Hames, 1990). The covalently-linked proteins are 
retarded at the top of gels while the proteins in non-covalently linked complexes migrate 
into gels as monomers. Deleersnyder et al. (1997) also provided evidence for a 
conformation-sensitive E2-reactive monoclonal antibody (H2) which selectively 
recognises E1E2 heterodimers that are non-covalently linked. The proteins detected by 
monoclonal antibody (MAb) H2, when analysed under non-reducing conditions, migrate as 
monomers. More recently, another antibody (H53) from the same group displays similar 
properties (Cocquerel et al., 1998). Other antibodies raised against El and E2 (e.g. A4 and 
Al 1) are less able to discriminate between the two types of complex (Dubuisson et al., 
1994; Deleersnyder et al., 1997). This includes human monoclonal antibodies which 
recognise both non-covalently-linked and disulphide-linked complexes suggesting that 
both forms of complex could occur in vivo (Siemoneit et al., 1995; Cardoso et al., 1998; 
Habersetzer et al., 1998).
For the purposes of this thesis, complexes of El and E2 that dissociate and migrate as 
monomers under non-reducing conditions and are therefore non-covalently-linked will be 
referred to as the “native”. This does not imply that such complexes are present on the 
virus envelope or that they play a specific role in virion morphogenesis. The second type 
of complex, in which El and E2 fail to migrate into gels in the absence of any reducing 
agent and are therefore linked by intermolecular disulphide bonds, will be referred to as 
“aggregated” complexes.
1.3.6. Properties of Native E1E2 Complexes
For the prototype strain HCV-1, immunopurified native E1E2 complexes sediment at 
approximately 15 S on glycerol density gradients which correspond to an apparent 
molecular weight of 310-320 kDa, indicative of a trimeric complex formed by the non- 
covalently-attached heterodimers (Ralston et al., 1993). Another report indicated that 
agarose column-purified native E1E2 heterodimers formed dimeric and trimeric complexes 
by non-covalent interactions (Young et al., 1998). By contrast, complexes co-precipitated
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with anti-calnexin antibodies (an ER resident chaperone) and with MAb H2 revealed that 
oligomers sediment between molecular mass standards of 68-158 kDa (Deleersnyder et al.,
1997). These differences may result from the alternative methods used for purification.
E2 and E2-p7 proteins have been detected in non-covalently linked complexes, implying 
that the presence or absence of p7 does not hinder the formation of a native complex 
(Dubuisson et al., 1994; Lin et al., 1994). For the BK strain of HCV (genotype lb), 
processing at the E2/p7 site is efficient and leads to the cleavage o f the majority of E2-p7 
species, suggesting that, at least for this strain, unprocessed E2-p7 would not be 
incorporated into HCV particles (Dubuisson et al., 1994; Lin et al., 1994). In the case of 
BVDV, the prototype pestivirus, processing in this region of the polyprotein also occurs 
inefficiently but E2-p7 is either not present in mature virus particles or at levels too low to 
be detected (Elbers et al., 1996). Pulse labelling experiments, followed by 
immunoprecipitation using conformation-sensitive MAb H2, have revealed that the 
kinetics o f native complex formation are slow, requiring a chase period o f at least 80 min 
before reaching detectable levels (Deleersnyder et al., 1997). For HCV glycoproteins 
expressed separately, conformation-sensitive MAb H2 does recognise E2 but not the E2 
precursor, E2-p7-NS2 (Deleersnyder et al., 1997).
Despite the high degree of sequence variability observed for E l and E2, the glycoproteins 
contain highly conserved cysteine residues (8 and 20 , respectively), throughout the 
genotypes (Robertson et al., 1998). Like other cellular and viral glycoproteins, these 
residues are involved in the formation of intra- or intermolecular disulphide bonds, 
essential for some proteins to attain and stabilise their correctly folded state (Sections 1.4.2 
and 1.4.3; Creighton, 1988). The kinetics of intramolecular disulphide bond formation has 
been monitored for E 1 and E2 by analysing pulse-labelled proteins under non-reducing 
SDS-PAGE conditions (Dubuisson & Rice, 1996). This provides the means to distinguish 
between denatured, oxidised proteins, which have greater electrophoretic mobility than 
their denatured, reduced counterparts; oxidised proteins adopt a more compact 
conformation due to the presence of intramolecular disulphide bonds (Braakman et al., 
1992a and b; Hammond et al., 1994). For a given protein, this increase in mobility over 
time can also reflect progressive folding towards the native state o f the protein. Disulphide 
bond formation occurs rapidly in E2 (by ~15min) and precedes processing of precursor E2- 
NS2 (Dubuisson & Rice, 1996). However, the electrophoretic mobility of E l increases
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only after longer periods of chase (> 60min), suggesting that oxidation of E l is slow. This 
step may be rate limiting for native complex formation (Dubuisson & Rice, 1996).
1.3.7. Properties of Aggregated E1E2 Complexes
Purified E l and E2 proteins subjected to sucrose density gradient sedimentation and 
separation of gradient fractions by non-reducing SDS-PAGE revealed that aggregates may 
have a molecular mass greater than 158 kDa (Young et al., 1998). The tendency of 
individually expressed E l and E2 to form aggregates suggests that disulphide bonds may 
occur via homologous covalent interactions between E l-E l and E2-E2 as well as 
heterologously between E1E2 (Michalak et al., 1997). The non-physiologically high level 
of protein production achieved by viral expression systems, especially of glycoproteins 
which are processed co- and post-translationally in the ER, could promote abnormal 
aggregation. However, analysis of HCV glycoprotein assembly in cell lines where the 
level of expression is controlled by the tetracycline-regulated system yield similar results 
(Duvet et al., 1998; Moradpour et al., 1998). Thus, it is possible that aggregation may be 
an intrinsic property o f HCV glycoproteins. The data derived from tissue culture systems 
could apply to characteristics of natural HCV infection. With regards to virus replication, 
inefficient formation of HCV glycoprotein complexes could down-regulate particle 
formation and virus replication to minimise exposure of viral antigens to the immune 
system. In conclusion, it is proposed that interactions between the HCV glycoproteins 
follow two distinct folding pathways, leading to the formation of either non-covalent E1E2 
complexes or aggregates of the two proteins.
1.3.8. Requirements for E1E2 Complex Formation
From initial studies, truncated forms of E2 (truncated at aa 661, 699, 701, and 715) fail to 
co-precipitate co-expressed El (Selby et al., 1994). By contrast, E2 species terminating at 
aa 730 or beyond are capable of co-precipitating equivalent levels of E l. Thus, sequences 
between aa 715-730 in E2 appear to be important for efficient El association as well as 
anchorage of E2 to membranes (Sections 1.3.3 and 1.3.9; Selby et al., 1994). However, 
co-expression of truncated forms of both proteins (E I311 and E266i) from separate 
transcription units reveal that complexes formed between the two proteins are released into 
the supernatant of culture medium (Lanford et al., 1993; Matsuura et al., 1994; Hussy et
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al., 1996; Michalak et al., 1997). This suggests that additional sequences important for 
HCV glycoprotein interaction are located in their ectodomains. Analysis of truncated forms 
of E2 under non-reducing SDS-PAGE conditions showed that the majority of these 
secreted proteins form aggregates, although a small proportion of E266i alone migrates into 
a non-reducing gel as monomers (Michalak et al., 1997). Furthermore, the conformation- 
specific antibody H2 fails to recognise all forms of secreted E2 except for truncated E266i 
protein (Michalak et al., 1997).
Far-Western blotting studies and in vitro binding assays using N-terminal truncated and 
internal deletion mutant E2 proteins derived from bacterial expression systems showed that 
the highly variable regions in E2 are not necessary for interaction (Yi et al., 1997a). The 
major El-interacting site of E2 maps within the N-terminal part of E2 (aa 415 to 500 of the 
polyprotein). Based on the assumption that a degree o f sequence conservation was required 
in regions involved in complex formation, Yi et al. (1997a) implicated a conserved region 
within the N-terminal region of E2, termed the Y box (aa 484-491), as important for E l 
association. This region contains amino acid residues Trp-His-Tyr (aa 489-491), which, 
upon mutation, markedly impair El binding. In the same report, the N-terminal part of El 
(192-238) was implicated in E2 binding. However, it should be noted that the assays 
utilised would not distinguish between native and aggregated complexes.
As described in Section 1.3.3, one predicted glycosylation site (at residue 325) in El from 
strain H is not utilised (Meunier et al., 1999). These authors analysed also the effect of 
mutation at each of the other sites (at residues 196, 209, 234 and 305) on complex 
formation. Using a conformation-sensitive MAb, mutations affecting positions 2 and 3 has 
minor effects on the assembly of the E1E2 complex. However, mutation at position 1 and 
predominantly at position 4 dramatically reduce the efficiency of non-covalently linked 
complex formation. The absence of one glycan addition site at positions 1,2,3 and 4 did 
not reduce interaction between El and calnexin (discussed further in Sections 1.3.11.2 and 
1.4.4), which suggests that the lower level of non-covalent complex observed for mutants 
is not due to an alteration in their association with this chaperone.
1.3.9. Subcellular Localisation of HCV Glycoproteins
The failure to detect HCV glycoproteins on the cell surface, the lack of complex glycans,
and sensitivity to endo H f deglycosylation indicate that these proteins do not leave the ER
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(Spaete et al., 1992; Ralston et al., 1993; Dubuisson et al., 1994; Deleersnyder et al.,
1997). From immunostaining experiments, intracellular mature complexes co-localise with 
protein disulphide-isomerase (PDI), an ER resident marker (Duvet et al., 1998). The 
absence of complex forms of glycosylation on HCV glycoproteins excludes their transit 
through the medial Golgi (see Fig 1.14; Duvet et al., 1998). It is possible that the 
glycoproteins could cycle between the ER and the cis Golgi and not reach the medial 
compartment. Under such circumstances, oligosaccharides on glycoproteins transported 
from the ER to the cis Golgi would be exposed to Golgi a-mannosidase I. This enzyme 
processes high mannose (Man9GlaNAc2) sugar chains into Man5GlcNAc2 (Komfeld & 
Komfeld, 1985), which renders the proteins sensitive to endo D as they accumulate in the 
ER after several cycles through the cis Golgi. However, E l and E2 remain endo D- 
resistant, thus suggesting that they do not cycle between the ER and the cis Golgi 
compartment (Duvet et al., 1998). HPLC analysis of glycans released by PNGase F, which 
removes all N-linked glycans, and endo H f treatment demonstrated that the oligosaccharide 
moieties released by both enzymes were similar oligomannoside species (Mang, Mang, and 
Man7GlaNAci/2; see Fig 1.14). To examine whether the N-glycosylation sites could be 
modified in the presence of Golgi mannosidases and glycosyltransferases, oligosaccharides 
obtained from brefeldin A- (BFA-)treated cells were analysed by affinity chromatography. 
Twenty-four percent of glycans were found to be processed into complex types, while 75% 
remained of oligomannoside type, which indicates that the absence of processing of HCV 
glycoprotein glycans is not because of inaccessibility of Golgi oligosaccharide modifying 
enzymes (Duvet et al., 1998).
Recently, using chimeric proteins in which E2 domains are exchanged with corresponding 
domains of a protein normally transported to the plasma membrane (CD4), an ER-retention 
signal has been mapped to the C-terminal 29 amino acids of E2 (Cocquerel et al., 1998). 
Similarly, the fusion of the C-terminal 31 residues of E l to the ectodomains of CD4 and 
CD8 result in localisation of these chimeric proteins to the ER (Cocquerel et al., 1999).
The ability of the C-terminal domains of El and E2 to act as ER retention signals with 
heterologous proteins has been confirmed by others (Flint & McKeating, 1999). Although 
both El and E2 contain signals for ER retention, they do not show any sequence similarity 
apart from stretches of hydrophobic residues. Hereafter, the stretches of hydrophobic 
residues at the C-terminal ends of E l and E2 will be referred to as transmembrane 
domains. Several specific signals have been identified for the retention/retrieval of ER 
proteins and these are described in Section 1.4.8.
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1.3.10. Association of HCV Glycoproteins with Viral Proteins
From immunoprecipitation studies, E l could co-precipitate with core and detection of this 
interaction did not require linkage of the two proteins in cis (Lo et al., 1996). However, 
association of core with E2 was not observed. NS2 and NS4A also were shown to 
associate with E2 through residues 699-730 (Selby et al., 1994). This was confirmed in a 
separate study, where either anti-El or anti-E2 antibodies co-precipitated NS2 and NS3, 
although the reciprocal experiments using anti-NS2/NS3 antibody yielded negative results 
(Matsuura et al., 1994). At present, no viral proteins have been shown to interact with 
native E1E2 complexes, but for viral assembly interaction by the envelope with other viral 
species may occur.
1.3.11. Association of HCV Glycoproteins with Folding Proteins
1.3.11.1. The Role of E2 in the Folding of E l
Studies evaluating the effect of El and E2 on the folding of each other found that the 
folding kinetics of E2 are similar in the presence and absence of E l based on the 
recognition of E2 using conformation-sensitive MAb H2 (Deleersnyder et al., 1997; 
Michalak et al., 1997). This result led to the conclusion that the presence o f El is not 
necessary for the folding of E2. Using intramolecular disulphide bond formation as an 
assay for El folding, the oxidised form of the protein appears slowly when E2 is co­
expressed (Dubuisson & Rice, 1996). However, in the absence of E2, no oxidised form of 
El is detected, indicating that E2 affects the folding of E l (Michalak et al., 1997). It has 
been proposed that E2 may play a chaperone-like role in E l folding by interaction directly 
with El (Michalak et al., 1997), and this role may complement the functions performed by 
ER-resident chaperones. E2 folds rapidly and its ability to achieve a disulphide-dependent 
conformation may be necessary to confer this chaperone-like function. The structural PrM 
glycoprotein of the Japanese encephalitis virus (JEV) provides a similar function in the 
folding of the envelope E protein (Konishi & Mason, 1993). In this case, co-synthesis of 
PrM is necessary for proper folding, membrane association and assembly of E protein.
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1.3.11.2. The Role of Cellular Folding Proteins
In the ER, a significantly large proportion of the soluble proteins represent molecular 
chaperones such as immunoglobulin heavy-chain binding protein (BiP/GRP78), glucose 
regulated protein (GRP94), and calreticulin as well as membrane-associated calnexin 
(Reddy & Corley, 1998). They function by binding to nascent polypeptides in order to 
prevent aggregation and to correct the folding of proteins trapped in misfolded structures. 
Calnexin and calreticulin are lectin-like chaperones that interact transiently with 
glycoproteins during their folding and maturation (Tatu & Helenius, 1997). An additional 
function of chaperones is to retain incompletely and incorrectly folded proteins in the ER 
and thus act in concert with quality control mechanisms to prevent transport of misfolded 
structures to other organelles (e.g. the Golgi apparatus) involved in protein maturation and 
secretion (Section 1.4).
Calnexin, calreticulin and BiP interact with El and E2, whereas no interaction has been 
detected between GRP94 and HCV glycoproteins (Dubuisson & Rice, 1996; Choukhi et 
al., 1998). However, calnexin associates mainly with native complexes from data based on 
pulse-chase experiments. By contrast, calreticulin and BiP were found to preferentially 
associate with aggregated complexes (Choukhi et al., 1998), as is observed for many 
misfolded proteins, e.g. vesicular stomatitis virus G protein (VSV G; Dorns et al., 1987). 
Both El and E2 expressed alone are co-precipitated with calnexin, calreticulin and BiP 
(Dubuisson & Rice, 1996; Deleersnyder et al., 1997; Choukhi et al., 1998; Liberman et al.,
1999). The association of HCV glycoproteins with calnexin and calreticulin is faster than 
that with BiP, and the kinetics of interaction with calnexin and calreticulin are similar. The 
maximum amounts of E2 that co-precipitate with calnexin and calreticulin reach about 
75% of the total recombinant E2 while -70%  is achieved for binding of E2 to BiP 
(Choukhi et al., 1998). For E l, maximum amounts co-precipitated with calnexin, 
calreticulin and BiP are -40, 20, and 10%, respectively. Over-expression of calnexin, 
calreticulin or BiP with HCV glycoproteins does not improve the proportion of non- 
covalent HCV glycoprotein complexes assembled (Choukhi et al., 1998).
Apart from chaperones, the ER also contains a high level o f other folding proteins such as
PDI (see Section 1.4.3; Dorns et al., 1993). PDI foldase catalyses the shuffling of
inappropriately formed disulphide bonds (discussed further in Section 1.4.3; Dorns et al.,
1993; Reddy & Corley, 1998). Due to the high conservation of cysteine residues in HCV
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glycoproteins, PDI-like foldases are likely to be involved in the formation of covalent 
disulphide bonds in El and E2. However, no direct evidence for this has been observed.
1.3.12. Interactions of HCV Glycoproteins with Other Cellular Proteins 
and Process
1.3.12.1. Effects on PKR
In vitro assays have shown that HCV E2 associates with the cellular regulatory factor PKR 
(Section 1.2.8; Taylor et al., 1999). PKR is activated by interferon and mediates inhibition 
of protein synthesis by phosphorylation of the translation initiation factor eIF2a. It is also 
capable of autophosphorylation. Thus, PKR is an intrinsic component of the antiviral 
response to infection. A segment has been identified in E2 between residues 276 and 287 
which has homology to the sites in eIF2a and PKR that are phosphorylated by PKR. 
However, there is no evidence for phosphorylation of this site in E2. Thus it is proposed 
that E2 may act as a pseudosubstrate for PKR and thereby block the inhibitory effects of 
PKR on protein synthesis and cell growth. The proposed homology between E2 and 
eIF2a/PKR exists in genotypes la/ lb (which display interferon resistance) but not in 
genotypes 2a/2b/3a (which have greater sensitivity to interferon). Inhibition of PKR leads 
to promotion of cell growth and inactivation of apoptosis signalling pathways; such a 
mechanism may contribute to HCV-associated HCC (Taylor et al., 1999).
1.3.12.2 E2 Binding to Lactoferrin
Using both Far-Western blot analysis and in vitro binding assays, E l and E2 bind to 
lactoferrin (Yi et al., 1997). There was evidence also that a truncated form of E2 secreted 
from cells could associate with lactoferrin. This cellular protein is a member of the 
transferrin family of iron-binding glycoproteins and is present mainly in breast milk as 
well as other exocrine secretions. It was proposed that association of lactoferrin with 
extracellular HCV may interfere with the infectivity of the virus. Since lactoferrin is 
present in high concentrations in breast milk and in plasma during pregnancy, this could 
explain the low level of transmission of HCV from mother to baby.
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1.3.12.3. Activation of GRP Protein Synthesis
In a recent study, expression of E2 but not El activated transcription from the promoters of 
two chaperones, GRP78 (BiP) and GRP94, and induced elevated levels of intracellular 
GRP78 protein (Liberman et al., 1999). This activation was dependent on targeting of E2 
to the ER. Interestingly, E2 was bound stably to GRP78 but this was not the case for E l.
It is proposed that accumulation of E2 in the ER may induce a stress response in the ER 
which acts to stimulate levels of certain chaperone proteins (discussed in Section 1.4.9).
1.3.13. Cellular Receptors
Using flow cytometry, a truncated form of E2 (truncated at residue 715), expressed in and 
isolated from mammalian but not insect or yeast cells, could bind to MOLT-4 cells with 
high affinity (K<j « 10"8 M; Shimizu et al., 1992; Rosa et al., 1996). These cells are a 
human cell line reported to allow low-level HCV replication in vitro. Subsequently, a 
cDNA library prepared from this cell line was screened by transient transfection in a 
mouse-derived cell line using truncated E2 protein as a probe (Pileri et al., 1998). A 
cDNA clone containing the coding sequence of a cellular receptor, CD81, was identified 
that conferred E2-binding capacity to the mouse cells. CD81 is a widely expressed 25 kDa 
molecule belonging to the tetraspanin superfamily that span the cell surface membrane four 
times and form two extracellular loops. The interaction between E2 and CD81 has been 
confirmed using several biochemical methods including immunoprecipitation, 
immunoblotting and fluorescence-activated cell sorting (FACS; Pileri et al., 1998; Flint et 
al., 1999a and b). Binding of virus particles, derived from infectious human sera, to CD81 
was prevented also in the presence of anti-E2 antibodies (Pileri et al., 1998). E2 associates 
with the extracellular loop 2 (EC2) region of CD81, although multiple regions in E2 are 
found to be necessary for interaction with EC2 (Flint et al., 1999b; Pileri et al., 1998). 
Binding of CD81 with E2 induces aggregation of lymphoid cells in addition to inhibiting 
B-cell proliferation, suggesting that E2 associated with CD81 could modulate cell function 
(Flint et al., 1999a).
In light of the presence of CD81 on a wide variety of cell types, an alternative study has 
presented evidence for HCV binding to COS-7 cells transiently expressing the human LDL 
receptor (LDLR; Monazahian et al., 1999). RNA-carrying material or particles isolated
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from different groups of patients are heterogeneous with respect to their buoyant density 
and sedimentation. This is probably due to the binding of these particles to p-lipoproteins 
(low density lipoprotein [LDL], very low density lipoprotein [VLDL]) and 
immunoglobulins (IgG/IgM; Prince et al., 1996). It is proposed that HCV and LDL may 
compete directly for the cellular LDLR and that LDL in sera of patients may regulate the 
binding of HCV to this potential HCV receptor (Monazahian et al., 1999). Alternatively, 
LDL, already bound to HCV particles in serum, may act as a ligand for attachment of the 
virus to cells expressing LDLR on their surface.
1.3.14. Assembly and Release of HCV Particles
Due to the absence of an efficient in vitro virus propagation system, the detection of low 
levels of viral particles in infected individuals and the lack of a convenient animal model, 
the factors necessary for HCV particle assembly have not been clearly defined. By 
comparison with the related flaviviruses, hepatitis C virion morphogenesis may occur by 
budding into intracellular vesicles. The lack of complex glycans, the ER localisation of 
expressed HCV glycoproteins, and the absence of these proteins on the cell surface would 
support this model. To date, efficient particle formation and release has not been observed 
in mammalian transient expression assays, suggesting that an appropriate intracellular 
environment has not been identified or that certain viral factors do not function correctly. 
The properties of the HCV particles may reflect those of pestiviruses, for which virion 
release is inefficient. In the case of CSFV, a substantial fraction of the virus remains cell 
associated and the virions are extremely fragile (Laude, 1977). If this were the case for 
HCV, intracellular sequestration of HCV glycoproteins and virion formation could play a 
role in the establishment and maintenance of chronic infections by avoiding immune 
surveillance and preventing lysis of virus-infected cells via antibody and complement. 
Nonetheless, using recombinant baculovirus containing the cDNA of HCV structural 
proteins, HCV-like particles have been purified from insect cells (Baumert et al., 1998). 
The cDNA was designed to encode the capsid protein (core) as well as the envelope 
proteins (El and E2), although the sequence for p7 was not included. From this study, the 
structural proteins assembled into enveloped virus-like particles of between 40 and 60 nm 
in diameter in large cytoplasmic cistemae. This organelle was presumed to have evolved 
from the ER. In addition, HCV RNAs were demonstrated to selectively associate with 
these particles rather than non-HCV transcripts.
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1.4. Properties of the Endoplasmic Reticulum
The ER is a major site of cellular protein synthesis and is subdivided into three distinct but 
continuous subcompartments; the rough ER (RER), smooth ER (SER) and the nuclear 
envelope. The RER can be distinguished from the SER by the ribosomes that coat regions 
of the RER giving it a characteristic speckled appearance and hence its name (Lee & Chen, 
1988). Microsomes generated by homogenisation of cells have demonstrated that the RER 
contains many proteins not present in SER, which may help bind ribosomes and assist in 
producing the flattened shape of this region of the ER (Gilmore, 1991). Proteins destined 
for the ER are directed to the organelle during their synthesis. The processes of translation 
and translocation across the ER membrane are coincident, thus avoiding contact of the 
nascent peptide chain with the cytosol (Rapoport, 1992). Importantly, the newly 
synthesised proteins are monitored for correct folding before they proceed along the 
secretory pathway. Besides protein production, the ER is also the major site for lipid 
biosynthesis (Bishop & Bell, 1988).
The SER is the site for production of vesicles carrying newly synthesised proteins and 
lipids to the Golgi apparatus. Some specialised cells have extended SER for additional 
functions such as synthesis of steroid hormones (Mori & Christensen, 1980). For example, 
hepatocytes, the major cell type in the liver are a major site for the production of 
lipoprotein particles. These particles carry lipids via the bloodstream to other organs in the 
body (Pease & Leiper, 1996). The enzymes that synthesise the lipid components of 
lipoproteins are located in the membrane of the SER.
1.4.1. Signal Peptide Recognition and Translocation
Targeting of ribosomes to the RER is initiated following the synthesis of the first 
hydrophobic segment of a nascent polypeptide (Blobel & Dobberstein, 1975). In vitro 
translation of proteins which would normally be secreted from the cell are slightly larger 
when synthesised in the absence of microsomes as compared to those made in the presence 
of microsomes derived from RER; the observed size difference is due to the presence of a 
N-terminal leader peptide. This serves as a signal peptide for directing membrane and 
secreted proteins to the ER before removal from the peptide chain by cleavage by signal 
peptidases in the ER membrane. Cleavage to remove the signal peptide sequence occurs
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during protein synthesis. Signal sequences are not highly conserved in their primary 
sequence but are defined by their hydrophobic nature (High & Dobberstein, 1992). 
Moreover they are not necessarily present at the N-terminus o f nascent chains. Indeed, for 
transmembrane proteins containing an internal signal peptide, more positively-charged 
amino acids immediately preceding the hydrophobic core can determine the orientation of 
the protein with respect to the membrane (High & Dobberstein, 1992).
The signal peptide is recognised by the SRP as it emerges from the ribosome, which 
mediates the targeting of a ribosome/nascent chain/SRP complex to the ER membrane in a 
GTP-dependent manner (Meyer et al., 1982). This complex docks to the ER membrane via 
the SRP receptor, an integral membrane protein (Fig 1.15). The nascent chain in the 
complex is transferred into an aqueous translocation channel, the translocon, which is 
rapidly sealed from the cytosolic environment by a tight ribosome-membrane junction. 
Critical components of the translocon include the heterotrimeric Sec61 complex and 
translocating-chain associated membrane protein (TRAM; Hedge & Lingappa, 1997). In 
addition to these, signal peptidase (a complex of 5 proteins) and oligosaccharyl transferase 
(a 3-protein complex), important for the maturation of nascent chains, interact with the 
nascent translocating polypeptide on the lumenal side of the ER (Hedge & Lingappa,
1997). Other lumenal proteins, (e.g. BiP, GRP94, calnexin, PDI) associate also with 
nascent chain substrates. These proteins act as molecular chaperones to promote proper 
folding and assembly. Although they are crucial for proper protein maturation, at present 
their roles in the translocation process are not fully understood (Hedge & Lingappa, 1997).
1.4.2. The Lumenal Environment of the ER
Proteins, translocated into the lumen of the ER, begin to fold before translation is 
terminated, although folding to a final conformational state may continue for varying 
periods of time for different proteins. The folding rate is dependent on the complexity of 
the protein, the physiological state of the cell and temperature but other factors such as cell 
type and expression levels also are important. Post-translational folding can be monitored 
by the appearance of conformation-dependent antigenic epitopes, acquisition of enzymatic 
or receptor functions, and physical features such as increased protease resistance (Dorns et 
a l,  1993).
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For transmembrane proteins, folding occurs in three topologically and biochemically 
distinct environments; the ER lumen, the ER membrane, and the cytosol (Dorns et al.,
1993). The transmembrane domain adopts an a-helical configuration within the 
hydrophobic interior of the bilayer, while the cytoplasmic domain follows the parameters 
that apply for folding of cytoplasmic proteins. The ectodomain folds in the ER lumen and 
can be co-translationally modified by acylation, glycosylation, proline isomerisation, and 
disulphide bond formation. Although the information required for a protein to attain its 
final three-dimensional structure resides in its primary sequence, the folding process is 
critically dependent on the presence of chaperones and folding enzymes. These proteins 
increase the efficiency of folding of any nascent chain by preventing irreversible 
aggregation and catalyse rate-limiting steps such as disulphide bond formation (Freedman 
et al., 1994) and proline isomerisation (Lang et al., 1987).
Other factors in the ER also facilitate optimal conditions for folding and oxidation of the 
translocated proteins. Among the properties that distinguish the ER from the cytosol are 
the high concentration of calcium and the reduction-oxidation (redox) potential that is 
sufficiently oxidising to allow disulphide bond formation. Calcium ions (Ca2+) are 
sequestered in the ER from the cytosol and storage in the ER lumen is facilitated by a high
9 +concentration of Ca -binding proteins (e.g. calreticulin and PDI; Helenius et al., 1997) 
which require this ion for their function. The disulphide redox potential of the ER is 
buffered by glutathione, which exists in thiol (GSH) and disulphide (GSSG) forms. In the 
cytoplasm of most cells, glutathione is present at a total concentration of 1-1 OmM, and 
only 1% of this is in the GSSG form. The environment within the ER is considerably more 
oxidising than the cytoplasm. This is achieved by maintaining the oxidised form of 
glutathione at ratios approximating to 1.1 to 3.1 for GSH:GSSG (Hwang et al., 1992) 
through a glutathione transporter in the ER membrane (Ferrari & Soling, 1999). The 
formation of one disulphide bond in a protein requires two sequential thiol-disulphide 
exchanges involving the mixed-disulphide intermediate (Fig 1.16; Creighton, 1988). 
Therefore, disulphide links in proteins only occur if the protein conformation brings pairs 
of Cys residues into suitable proximity. Despite the oxidising environment, shuffling of 
disulphide bonds is permitted in the ER and disulphide links only form between Cys 
residues that are favoured by protein conformation (Creighton, 1988).
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1.4.3. Isomerases Present in the ER
Folding enzymes and molecular chaperones are the most abundant proteins in the ER and, 
at nearly millimolar concentrations, the majority of them greatly outnumber the substrate 
proteins (Tatu & Helenius, 1997). Among the folding enzymes, protein disulphide 
isomerase (PDI) and members of the PDI family are the most important and best 
understood. PDI carries a KDEL ER retention signal (Section 1.4.8), and contains a C-X- 
X-C domain that is homologous to thioredoxin, a ubiquitous small protein active in 
cytoplasmic redox reactions (Freedman et al., 1994). The function of PDI is dependent on 
the disulphide redox potential of the ER, reflected in the ratio of reduced to oxidised 
glutathione (see previous section). The active site of PDI is estimated to be about 50% 
reduced under these conditions. Apart from glutathione, other oxidising equivalents are 
believed to enter the ER via electron transport machinery. For example, Ero lp, a yeast 
protein, can directly oxidise PDI, avoiding the need for glutathione (Frand & Kaiser, 1998 
and 1999; Pollard et al., 1998). Thus, mechanisms may exist for the direct oxidation of 
GSH, of nascent proteins or to re-oxidise the PDI family proteins that introduce disulphide 
bonds into nascent chains (Rietsch & Beckwith, 1998). The main role of PDI is to catalyse 
disulphide-bond formation in nascent proteins through glutathione-protein mixed- 
disulphide species, by acting as an isomerase independent of re-oxidation of GSSG (Ferrari 
& Soling, 1999). The redox/isomerisation activities of PDI enable isomerisation reactions 
to proceed at several thousand times the uncatalysed rate (Fig 1.17).
Peptidyl proline isomerases (PPI) are also considered to be folding enzymes. They 
catalyse the slow cis-trans isomerisation of proline peptide (X-P) bonds in oligopeptides 
and accelerate slow, rate-limiting steps in protein folding (Fischer et al., 1989). However, 
no effect of cyclosporin A, an inhibitor of PPI, on the folding of influenza haemagglutinin 
(HA) is observed (Dorns et a l , 1993). Therefore, it is not known if this enzyme is 
important for folding of certain viral glycoproteins.
1.4.4. Chaperones Present in the ER
The most widely studied molecular chaperones in the ER include BiP, calnexin and 
calreticulin, in addition to GRP94 and Erp72 (Hammond &Helenius, 1995; Helenius et al.,
1997). A chaperone is a protein that can assist unfolded or incorrectly folded protein to
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attain the native state by providing a micro-environment in which competing aggregation 
reactions are reduced (Eisenberg, 1999). Chaperones are capable also of mediating the 
reversal of pathways that lead to incorrectly-folded structures. As proteins fold, 
intermediates may be transferred to different molecular chaperones. Moreover, the sites 
with which different chaperones interact may only be transiently exposed during the 
folding process. These events contribute to the quality control function o f the ER. 
Chaperones also can substitute for each other, thus ensuring the efficient retention of 
misfolded proteins and a backup system for ER quality control. Sequential transfer of 
distinct folding intermediates to molecular chaperones is not pre-determined by the ER, 
and the order of events is dictated by the primary amino acid sequence of the translocated 
protein (Reddy & Corley, 1998).
The soluble lumenal protein, BiP, was initially identified in complexes with 
immunoglobulin heavy chains, which are retained in the ER until they become associated 
with light chains (Dorns et al., 1993). Generally, BiP associates transiently and non- 
covalently via exposed hydrophobic patches in nascent proteins and dissociates during the 
folding process. Synthesis of this protein is induced by increased levels o f secretory 
membrane and misfolded proteins, thus providing indirect evidence for its function 
(Sidrauski et al., 1998; Liberman et al., 1999). Like most resident proteins it contains the 
ER retrieval motif, KDEL, which enables BiP, associated with nascent protein, to remain 
in the ER during folding (Reddy & Corley, 1998).
During folding, polypeptides with N-linked oligosaccharides interact transiently and
specifically with two homologous lectin-like chaperones that are unique to the ER,
membrane-bound calnexin and soluble calreticulin. Both are not glycosylated proteins and
bind specifically to partially trimmed, monoglucosylated forms of N-linked core glycans
(GlciMans-gGlcNAci) present on folding intermediates. They do not bind glycans with
two or more glucose residues (Fig 1.18; Helenius et al., 1997; Tatu & Helenius, 1997).
For these chaperones, oligosaccharide recognition is thought to be the first step prior to
binding to the protein moieties of glycoproteins (Parodi, 1999). Glycoprotein folding
intermediates are retained in the ER by a cycle of glucose removal and addition coupled to
chaperone binding and release (Helenius et al., 1997; Choukhi et al., 1998). An example is
provided by influenza HA (Helenius et al., 1997), where cycling of the molecules on and
off the chaperones is important for proper folding. Although the impact on protein
maturation by calnexin and calreticulin is similar to classically described chaperones, they
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have distinctive features. For example, they do not directly distinguish between folded and 
unfolded proteins, but instead depend on covalent modification in the carbohydrate 
moieties of glycoproteins, catalysed by glycosidase II and glucosyltransferase, to assert 
their chaperone function (Figs 1.18 and 1.19; Helenius et al., 1997).
One effect believed to be induced by calnexin and calreticulin binding to folding 
glycoproteins is the immobilisation of specific cysteine residues, thus preventing incorrect 
disulphide pairing. Recently, specific interaction of a member of the PDI family, ERp57, 
with soluble secretory proteins bearing N-linked carbohydrates has been demonstrated 
(Elliott et al., 1997). Although it is suggested that ERp57 is a cysteine-dependent 
proteinase and a thiol-dependent reductase, its precise function remains to be established. 
However, consistent with its thiol-dependent reductase activity, similar to PDI, ERp57 may 
act in concert with calnexin and calreticulin to modulate glycoprotein folding, and thereby 
facilitate the quality control mechanisms operating in the ER (Elliott et al., 1997).
1.4.5. The Role of Covalent Modifications in Protein Folding
The common forms of covalent modification that occur in the ER are co-translational 
addition of N-linked glycosylation and post-translational exchange of the C-terminal 
transmembrane tail for a glycosylphosphatidylinositol (GPI) anchor. The latter 
modification involves the simultaneous cleavage of the transmembrane domain and 
creation of a covalent bond between the GPI anchor and the ectodomain of the protein 
(Brown, 1992).
N-linked glycans are added to growing polypeptide chains as 14-residue oligosaccharides
(Glc3Man9GlcNAc2) by oligosaccharyltransferase, which is associated with the
translocation machinery. The precursor oligosaccharides are partially assembled and
attached to dolichol lipid on the cytosolic side of the ER membrane. They are
subsequently “flipped” across the membrane to the lumen of the ER, where the addition of
glucose residues is achieved. These precursor molecules are transferred to the side chain
of asparagine residues in the consensus sequence N-X-S/T, where X is any amino acid
except proline. Transfer of the oligosaccharide generally occurs co-translationally as soon
as the acceptor site enters the lumen of the ER. Loss of glycosylation sites on proteins
causes defects in folding, which in turn leads to aggregation, misfolding, and disulphide
cross-linked complexes that are retained in the ER (Dorns et al., 1993). This suggests that
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large, hydrophilic oligosaccharide core units are needed for nascent chains to fold properly. 
In the case of native proteins, their hydrophobic regions are normally buried within the 
protein, leaving the hydrophilic residues exposed on the surface to allow solubility in the 
aqueous environment of the cell. However, folding intermediates are generally more 
hydrophobic than fully folded proteins, and the function of carbohydrate moieties is 
proposed to render these intermediates more soluble and less likely to form irreversible 
aggregates. Hence, this modification is considered to occur prior to folding. The 
importance of individual N-linked carbohydrate moieties within a given protein with 
respect to folding varies, and there appears to be a hierarchy of glycosylation sites in terms 
of folding and stability (Dorns et al., 1993). Moreover, addition of new N-linked sites is 
able to compensate for the loss of others or rescue proteins, which would otherwise be 
retained. This has been shown to be the case for influenza virus HA and VSV G proteins 
(Machamer & Rose, 1988a and b; Gallagher et al., 1992). Thus, the main role of 
carbohydrates is to provide a global function to increase solubility, rather than a localised 
function in the folding process.
Almost immediately following the transfer of oligosaccharides to the nascent proteins, the 
carbohydrate moiety is modified. Sequential removal o f three glucose residues present on 
the core glycan is performed by glucosidase I (for the first glucose residue) and 
glucosidase II (for the remaining two glucose residues) to yield Man9GlcNAc2 glycans (Fig 
1.19). The monoglucosylated glycan (GlciMan7.9GlcNAc2) intermediate, which is formed 
during the stepwise removal of glucose residues, binds to calnexin and calreticulin (see Fig 
1.18; Helenius et al., 1997). In addition, monoglucosylated glycans also result from re- 
glucosylation of fully glucose-trimmed oligosaccharides by action of the ER lumenal 
enzyme, UDP-Glc:glycoprotein glucosyltransferase (GT; Parodi, 1999). The quality 
control mechanism for glycoproteins involves binding of monoglucosylated species to 
calnexin/calreticulin. While associated to these chaperones the final glucose residue on the 
glycans is removed by glucosidase II, thus liberating the glycoprotein from the chaperones. 
If the proteins are properly folded they are transported to the cis Golgi. However, 
improperly folded glycoproteins are recognised by GT and re-glucosylated, to allow re­
association to calnexin/calreticulin (Parodi, 1999).
GT is active in millimolar concentrations of Ca2+ ions, and these levels are readily attained 
in the ER. The enzyme has the ability to glucosylate denatured (misfolded) glycoproteins, 
but not native proteins. This is achieved by the recognition of hydrophobic patches
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exposed on misfolded proteins that are typically buried in native proteins. Additional 
experiments using endo H f revealed that GT recognised not only protein domains exposed 
in misfolded conformations, but also the innermost GlcNAc unit o f oligosaccharides (Fig 
1.14). This suggests that in native glycoproteins, recognition of the innermost GlcNAc 
unit by GT would not occur and thereby glucosylation of proteins in this state would be 
prevented. Since glucosylation/de-glucosylation cycles continue until glycoproteins are 
properly folded, GT appears to function as a sensor of the tertiary structure of 
glycoproteins (Parodi, 1999). Finally, high mannose oligosaccharide moieties are further 
trimmed by ER mannosidase, yielding Mang species, but prolonged residence in the ER 
can result in Man7-glycan containing glycoproteins.
1.4.6. Oligomerisation of Proteins in the ER
Apart from acquiring secondary and tertiary structures prior to exiting the ER, membrane 
or secretory proteins may have to achieve the correct quaternary (oligomeric) structure for 
their function. Oligomeric proteins must also meet quality control standards to exit the ER 
and some mechanisms monitoring their folding are identical to those used for the retention 
of incorrectly folded subunits. For some proteins, oligomerisation begins in the ER and is 
not completed until after exit from the ER (e.g. influenza HA; Tatu et al., 1993). In other 
cases, oligomerisation may not be initiated until leaving the ER (e.g. the HIV-1 envelope 
glycoprotein; Earl et al., 1991). Oligomerisation can proceed post-translationally, as for 
influenza HA and VSV G protein (Dorns et al., 1987) or co-translationally. One example 
is thrombospondin, which folds following oligomerisation by means of its first N-terminal 
domain (Prabakaran et al., 1996). Correct folding is demonstrated by the appearance of 
new antigenic epitopes and the delayed dissociation of the molecular chaperone 
BiP/GRP78. Therefore, quaternary organisation can influence the tertiary structure, giving 
rise to the idea of “oligomerisation-assisted subunit folding”. Procollagen is another 
example where oligomerisation is required for completion of folding (Bulleid et al., 1997). 
Moreover, the interdependence between folding and oligomerisation is an intrinsic 
property of the proteins themselves and not a consequence of information relayed by the 
cellular environment, since the two distinct oligomerisation pathways (i.e. within and 
outside the ER) occur in the same cell type. Events governing the productive folding of 
glycoproteins are summarised in Fig 1.20.
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1.4.7. Transport from the ER
Following folding and assembly, proteins must move away from the HR to other target 
organelles (e.g. the Golgi apparatus) or to the plasma membrane. In the case o f viral 
glycoproteins, they may accumulate at their target site for virus budding. If the protein 
transits into and through the Golgi apparatus, additional post-translational modifications 
such as carbohydrate processing, proteolytic cleavage, and oligomerisation may complete 
the process of conformational maturation. The transport from the ER to Golgi apparatus is 
mediated by membrane cargo vesicles, that are encased by two types of coats, coat protein 
complex (COP) I and COPII (Scales et al., 1997). Although the roles of COPs in the 
secretory membrane traffic are not firmly understood, COPII is believed to mediate 
anterograde traffic, since these are shown to fuse with Golgi membranes, while COPI 
mediates retrograde movement (Section 1.4.8; Scales et al., 1997). Components o f COPI 
are necessary for the retrieval of KDEL/K(X)KXX-bearing proteins to the ER (Jackson et 
al., 1990a) which is essential to maintain ER function. Many membrane proteins that 
function at the interface of the ER and Golgi complex constitutively cycle between the ER 
and the Golgi complex (Cole et al., 1998). These include 1) the KDEL receptor (KDELR), 
which retrieves soluble ER-resident proteins that have escaped into the secretory pathway, 
2) vesicle N-ethylmaleimide-sensitive factor attachment protein receptors (v-SNARE) 
involved in ER to Golgi transport and, 3) putative cargo receptors, such as the ER-Golgi 
intermediate compartment (ERGIC) mannose-binding protein p53.
Cargo exported from the ER by vesicle carriers first appear in pre-Golgi intermediates then 
move on microtubules from the trans to the cis Golgi regions. The movement of cargo 
between the Golgi apparatus and beyond, as well as the endocytic compartments, is 
mediated by vesicles whose formation is initiated by the selection and concentration of 
cargo. The coat and targeting components function together at different steps of the 
exocytic and endocytic pathway to form vesicle sorting machines that move specific types 
of cargo from one destination to the next (Allan & Balch, 1999). It is proposed that 
retrograde and not anterograde vesicles play a prominent role by functionally modifying 
cargo-containing compartments generated by the ER. Ultimately, the movement of 
biosynthetic cargo is controlled by only two sorting steps; one at the ER to select protein 
that is properly folded and a second at the trans Golgi network (TGN), where a sorting 
decision directs biosynthetic cargo to the proper downstream compartment reflecting the 
state of the cell (Allan & Balch, 1999). Recycling between the various compartments of
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the exocytic pathway provides a link with cell surface events, enabling the cell to balance 
and regulate outward membrane flow.
1.4.8. Maintenance of the ER through Retrieval/Retention of Resident 
Proteins
Many lumenal ER-resident proteins contain a C-terminal tetrapeptide KDEL sequence 
(Pelham, 1995). This sequence is utilised to retrieve proteins from the cis Golgi via 
binding to KDEL receptors (KDELR). KDELR specifically bind to KDEL carrying 
ligands in a pH-dependent manner, with an optimum around pH 5.0 (Nilsson and Warren,
1994). The pH along the exocytic pathway becomes increasingly acidic towards the TGN, 
and this allows KDELR to bind ligands with high affinity. Ligand-receptor binding would 
then trigger incorporation of this complex into vesicles to be returned to the ER. The more 
neutral pH in the ER releases the ligand into the lumen and KDELR returns to its original 
location awaiting another round of ligand delivery (Nilsson & Warren, 1994). The 
retrograde movement of KDELR proteins requires a crucial aspartic acid residue, located 
in one of seven membrane-spanning domains of the receptor protein (Townsley, 1993).
The position of the aspartic residue is thought to enable interactions with membrane- 
spanning domains of other KDELR proteins. Retrograde transport may be achieved by 
oligomerisation of the receptors which would form patches at the cis Golgi that induce 
budding. Oligomerisation of receptors could be triggered by binding of the ligand.
Several ER-resident membrane proteins also contain a KDEL motif in their cytoplasmic 
domains (e.g. BiP). However, for other resident type I membrane proteins with the N- 
terminus in the lumen, a signal consisting of two critical lysines has been identified that 
requires the residues to be positioned at -3 and -4/-5 relative to the C-terminus of the 
protein (K(X)KXX, where X is any amino acid). For type II proteins, where the C- 
terminus is in the lumen, two arginines (RR) are part of the signal, and they have to be 
within the first five N-terminal residues of the protein (Nilsson & Warren, 1994). Reporter 
proteins fused with such motifs are found in the ER, but they may acquire also Golgi 
modifications. Thus, these dibasic signals behave similarly to the KDEL motif and act to 
retrieve rather than retain proteins (Jackson et al., 1990a; Nilsson & Warren, 1994).
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The presence of these motifs alone do not necessarily localise other cellular proteins to the 
ER, indicating that they cannot be the sole determinants for correct localisation of ER- 
resident proteins. Interestingly, removal of the K(X)KXX motif from an endogenous ER 
enzyme, GT, did not result in loss of ER retention, and oligosaccharide analysis of other 
endogenous ER proteins (e.g. glucosidase II and hexose-6-phosphate dehydrogenase) 
failed to reveal any Golgi modifications (Brands et al., 1985). This indicated that 
endogenous ER proteins do not leave the organelle in detectable amounts. Therefore, 
retention signals must exist in proteins endogenous to the ER that operate independently of 
ER retrieval signals. Insight into the mechanism for the retention of ER proteins was 
provided by studies based on Golgi-localised proteins, the majority of which are type II 
membrane proteins. Based on such evidence, the membrane-spanning domain (the signal 
anchor) and part of its flanking regions contain sufficient information for correct Golgi 
cistemae localisation (reviewed by Machamer, 1993). Similarly, the membrane-spanning 
domain of lamin B receptor, a resident protein of the inner membrane domain of nuclear 
envelope which is continuous with ER membranes, was found to be sufficient for correct 
localisation (Smith & Blobel, 1993). Two models have been proposed to explain how a 
membrane-spanning domain could mediate retention. The first model is based on retention 
through oligomerisation and exclusion from anterograde transport vesicles (Nilsson & 
Warren, 1994), The second model postulates that retention occurs through differences in 
membrane thickness along the exocytic pathway (Bretscher & Munro, 1993). This model 
relies on the observation that the ER has low cholesterol content as compared with the 
plasma membrane (van Meer, 1989). Studies on the transmembrane domain of a yeast 
protein, UBC6, have shown that it functions as an ER-retention sequence in mammalian 
cells on fusion to the transferrin receptor (Yang et al., 1997). Lengthening of the UBC6 
transmembrane domain from 17 to 21 amino acids permits movement from the ER to the 
Golgi complex. It is proposed that the thicker membranes in the Golgi complex play an 
active role in such sorting mechanisms.
1.4.9. ER Stress Response and Protein Degradation
The quality control mechanisms of the ER ensure the transport of incompletely folded, 
misassembled, and unassembled proteins to the secretory pathway is selectively inhibited. 
These defective proteins are retained in the ER, where their accumulation activates an ER- 
stress response and/or they are eventually degraded. As well as cellular proteins, the fact 
that foreign proteins such as viral glycoproteins are also subject to quality control
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demonstrates that the sorting criteria is based on general rather than specific structural 
properties of the protein products. However, the tendency of viral glycoproteins to form 
large aggregates increases the likelihood of these proteins being retained in the ER. BiP 
forms a stable association with misfolded proteins and, via its KDEL sequence, these 
proteins remain in the ER.
The accumulation of incorrectly-folded proteins triggers an ER-stress response that has at 
least two distinct components. The first is termed the unfolded-protein response (UPR) 
that describes the transcriptional activation of ER resident chaperones (BiP) and foldases 
(PDI; Shamu et al., 1994). The second component consists of a rapid repression of protein 
synthesis. Both responses relieve ER stress by increasing the capacity of the ER to 
actively fold proteins and decrease the demands made on the organelle by attenuating 
protein synthesis rate (Harding et al., 1999).
The first gene known to be required for a functional UPR was IRE1, which encodes a 
transmembrane protein (Cox et al., 1993). Irelp resides in the ER or inner nuclear 
membrane that is continuous with the ER. Its N-terminal region faces the ER lumen, and 
the C-terminal portion faces the nucleus or cytoplasm. The N-terminal half serves as a 
sensor domain that detects the accumulation of unfolded proteins while the C-terminal 
region possesses a protein kinase function. Induction of the UPR is initiated by 
oligomerisation of Irelp via the transmembrane domains resulting in trans­
autophosphorylation by neighbouring Irelp molecules (Fig 1.21). Subsequently, instead of 
triggering a classical kinase cascade, activated Irelp cleaves HAC1U mRNA (u for 
uninduced), which codes for a transcription factor, Haclp, at two splice junctions. tRNA 
ligase, recruited to the activated Irelp joins the two exons to produce the spliced form of 
the message, HAC  mRNA (I for URP-induced). Both forms of HAC1 mRNA exit the 
nucleus and associate with polyribosomes. However, only the spliced form gives rise to 
protein, H aclp1, which enters the nucleus and upregulates genes containing the unfolded 
protein response element (UPRE; Fig 1.21; Sidrauski et al., 1998).
The reduction in protein synthesis in response to ER stress is attained by disassembly of 
polysomes and increased phosphorylation of eIF2a, which interferes with the formation of 
an active 43S translation-initiation complex. Two different eIF2a kinases have been 
identified in mammalian cells, haem-regulated eIF2a kinase (HRI) and the interferon-
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inducible PKR. More recently, an ER-membrane bound protein, with a lumenal domain 
that shares blocks of identity with Irelp and a cytoplasmic portion that has a protein-kinase 
domain similar to that of PKR and HRI, has been named the PKR-like ER kinase (PERK; 
Harding et al., 1999). This protein is proposed to be an alternative eIF2a kinase that 
responds to ER stress.
The efficiency with which chaperones retain proteins in the ER prevents their premature 
degradation. However, prolonged retention of proteins in association with BiP directs 
these proteins towards the degradation pathway. Recent communications have shown 
significant amounts of irreversibly misfolded proteins are dislocated from the ER by 
reverse transport through the Sec61 translocon into the cytosol where they can be degraded 
by the ubiquitin-regulated proteasome pathway. This process has been termed ER- 
associated degradation (ERAD; Brodsky & McCracken, 1997). Incorrectly-folded 
glycoproteins translocated to the cytosol are initially deglycosylated by the action of 
cytosolic N-glycanase (PNGase) prior to proteolytic degradation (Suzuki et al., 1998), 
although the intracellular location of these deglycosylation events is not known. The ER 
membrane protein, calnexin, also recruits cytosolic Ubc7p to the ER surface and thereby 
mediates its activation. Ubc7p is an ubiquitin-conjugating enzyme that catalyses the 
covalent attachment of ubiquitin to specific proteolytic substrates and this process appears 
to be a prerequisite for retrograde transport out of the ER. The involvement of the 
translocon and calnexin suggests that the export and degradation pathway, both of which 
are ATP-dependent, may be coupled in some way. Moreover, certain viral proteins, 
namely human cytomegalovirus (HCMV) US2 and US11, and HIV-1 Vpu, can specifically 
mediate the cytosolic export and subsequent degradation by the ubiquitin-proteasome 
machinery of ER-associated MHC class I and CD4 molecules, respectively (Margottin et 
al., 1998). It is postulated that other cellular protein components interact with Sec61 to 
form a retro-translocon programmed for reverse protein translocation, to operate the ER 
degradation process (Plemper & Wolf, 1999). Indeed, in yeast, proteins called Der and 
Hrd are necessary for ER-associated degradation via the ubiquitin-proteasome pathway. 
Since similar complex degradation pathways exist in higher eukaryotes, it is likely that 
mammalian counterparts of Der and Hrd are present which have similar functions.
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1.5. Viral Glycoproteins of the Flaviviridae
As a member of the Flaviviridae family of viruses, El and E2 glycoproteins of HCV have 
a number of properties in common with the envelope proteins of related pestiviruses and 
flaviviruses. These include their position in the polyprotein, processing to produce 
individual polypeptides by host proteinases, and orientation in the lipid membrane (see Fig 
1.2 ).
1.5.1. Glycoproteins of Pestiviruses
Pestiviruses (BVDV, CSFV, and border disease virus) encode three envelope-associated 
glycoproteins (E proteins), Ems (gp 44), El (gp33), and E2 (gp55). The C-terminus of the 
virion core protein is hydrophobic which is proposed to serve as the signal sequence 
initiating translocation of Ems into the ER lumen. The Ems glycoprotein of CSFV contains 
up to nine potential N-linked glycosylation sites and exists as disulphide-linked 
homodimers of about 97 kDa ( Thiel et al., 1991; Rumenapf et al., 1993). Ems does not 
appear to contain a membrane anchor and is secreted from cells in considerable quantities 
(Rumenapf et al., 1993). El and E2 are predicted to be integral membrane proteins and 
contain three and six N-linked glycosylation sites, respectively (Weiland et al., 1990). 
Similar to Ems, E2 forms homodimers but also associates with E l to generate a 
heterodimeric complex (Thiel et al., 1991). All of the above interactions are mediated by 
covalent, intermolecular disulphide bonds. In virions, it is considered that E l and E2 are 
anchored in the lipid bilayer while the mechanism by which Ems associates is unclear. It is 
possible that it interacts either non-covalently with E1E2 dimers or by hydrophobic 
interactions with the lipid bilayer (Rumenapf et al., 1993). Antibodies that neutralise virus 
infectivity are directed against epitopes located on E2 and Ems (Weiland et al., 1990 and 
1992), but effectively no anti-El antibodies are detected, suggesting that it may be buried 
in the viral envelope. Purified preparations of either Ems or E2 could inhibit infection by 
CSFV but apparently by separate mechanisms (Holst & Moormann, 1997). Moreover, 
CSFV E2 could block infection of cells by BVDV suggesting that the viruses share 
common receptors.
HCV does not appear to encode a protein equivalent to Ems which has been identified as an 
RNase (Schneider et al., 1993). The RNase activity of Eras has been mapped to two short
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regions of amino acids, both containing histidine residues essential for catalysis. Ems 
strongly inhibits the protein synthesis of lymphocytes leading to apoptosis of such cell 
types (Bruschke et al., 1997). Since pestivirus infections are characterised by leukopenia 
(reduction in the number of leucocytes) and immunosuppression, the above data suggests 
that Ems plays an important role in the pathogenesis of pestiviruses. However, a 
contrasting affect of the protein has been reported in non-lymphocytic cells (Hulst et al.,
1998). This study reported that RNase-negative CSFV induced apoptosis in swine kidney 
cells, and the affect was neutralised by rescue of the inactivated Ems gene. The authors 
speculated that the RNase activity may depress levels of cellular and viral RNA in infected 
cells, thus enhancing viral persistence.
1.5.2. Glycoproteins of Flaviviruses
Flaviviruses [e.g. DEN, YFV and JEV] encode two envelope proteins designated PrM 
(precursor to M) and E (50 kDa). E protein is a multi-functional protein that is involved in 
cell receptor binding and virus entry via fusion with a host cell membrane at permissible 
pH (Heinz, 1986). From X-ray crystal studies, the structure of a soluble fragment from the 
E ectodomain of tick-borne encephalitis (TBE) virus, generated by trypsin digestion, has 
been determined (Rey et al., 1995). This has revealed that the ectodomain consists mostly 
of p-sheet and loop structures but long segments of a-helix are absent. By contrast to most 
other known viral fusion proteins that are trimeric spikes in both native and fusogenic 
states (e.g. influenza HA protein; Bullough et al., 1994), the native form of the E 
ectodomain is a head-to-tail dimer oriented parallel to the viral membrane. It is composed 
of three separate domains which contain the antigenic determinants, the putative receptor 
binding site and the fusion peptide. All three domains are involved in interactions between 
monomers of the E ectodomain. The C-terminal region of E protein, referred to as the 
stem-anchor region, is important for interaction with PrM during virus assembly and the 
structural changes associated with membrane fusion at low pH (Allison et al., 1999). In the 
full-length, native state, the C-terminus of each monomer of the ectodomain would be 
followed by the stem-anchor region of the protein at distal ends of the homodimer. The 
stem region contains two regions (H lpred and H2pred) predicted to be a-helical while the 
anchor domain consists of two transmembrane segments (TM1 and TM2). H lpred has a role 
in the trimerisation of homodimers at low pH, a process that is irreversible and necessary
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for fusion activity (Allison et al., 1995 and 1999). H2pred and TM1 are contiguous and 
involved in interactions with PrM (Allison et al., 1999).
PrM is approximately 22 kDa and is a glycosylated precursor to M (7-8 kDa). PrM forms 
a heteromeric complex with E in immature virions (Wengler & Wengler, 1989), an 
interaction that is proposed to prevent acid-induced conformational changes in the E 
protein during virion maturation in the TGN and secretory vesicles (Heinz et al., 1994; 
Stiasny et al., 1996; Pryor et al., 1998). By contrast to the covalent interactions between 
pestivirus El and E2 glycoproteins, PrM and E associate by non-covalent links. E-PrM 
complexes for several flaviviruses (JEV, YFV, DEN and TBE viruses) are immunogenic 
and protective against challenge (Mason et al., 1991; Pincus et al., 1992; Fonseca et al., 
1994; Heinz et al., 1995). Assembly of flaviviruses occurs in the ER and immature virions 
are transported via the secretory pathway to the TGN. For most flaviviruses, just before or 
at the time of release from the cell, cleavage of PrM on immature virions to produce 
mature M is mediated by host furin activities that are located in the vesicles between the 
TGN and plasma membrane (Rice, 1996; Stadler et al., 1997). One exception is DEN 
virus in which cleavage of PrM to M is inefficient, resulting in the release of virions 
containing the precursor protein (Wang et al., 1999). However, infectivity of DEN virus 
does not appear to depend on quantitative cleavage of PrM to M, as virus particles 
containing PrM and no M protein retain about one-eighth the infectivity of normal particles 
(Randolph et al., 1990).
Unlike HCV, flaviviruses encode a non-structural membrane glycoprotein of 45 kDa called 
NS1. The bulk of the protein remains within the cell in a homodimeric form where it 
attaches to membranes (Smith and Wright, 1985; Winkler et al., 1989; Fan and Mason, 
1990). A significant amount of the protein also is secreted and small quantities are present 
on the cell surface. In the secreted form, hexameric species of NS1 have been detected 
(Flamand et al., 1999). Recent evidence suggests that the protein has a role in RNA 
replication such that mutations in NS1 induce reduced accumulation of viral RNA 
(Muylaert et al., 1996 and 1997). Complexes of NS1 dimers and E protein also have been 
detected however these may represent non-specific aggregates (Blitvitch et al., 1995).
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1.6. The Semliki Forest Virus Expression System
Semliki Forest virus (SFV) has been used as a model to study the molecular biology of 
RNA virus multiplication since it grows well and to high titre in a broad range of tissue 
culture cells such as baby hamster kidney (BHK) cells (Berglund et al., 1993) and chick 
embryo cells (Liljestrom & Garoff, 1991b). SFV is a positive-stranded RNA virus of the 
genus Alphavirus of the family Togaviridae. It is a relatively simple virus, encoding only 
nine distinct proteins. Four non-structural proteins are concerned with viral RNA 
synthesis, and four structural proteins form the capsid (the C protein) and the envelope (El, 
E2, and E3) proteins. A small 6 kDa protein encoded by the structural region of the 
genome is not incorporated into virions. The structural proteins are encoded by a sub- 
genomic RNA species, termed 26S, while the non-structural proteins are translated from 
the genomic 42S RNA. The structural and non-structural proteins are generated by post- 
translational cleavage from precursor polyproteins (Atkins et al., 1999). The original 
isolate of SFV, L10, is neurovirulent for mice and rats, causing lethal encephalitis by 
infection of the central nervous system (CNS) and depletion of myelin-forming cells 
(Liljestrom et al., 1991).
The infectious clone of SFV, constructed from the prototype strain, is designated pSP6- 
SFV4; the virus produced by transcription of this infectious clone is labelled SFV4. An 
additional feature from infection of mammalian cells with SFV4 in vitro is increased cell 
death as a result of apoptosis. As with other viruses including alphaviruses, cell death is 
concurrent with infection and is thought to occur from inhibition of cell macromolecular 
synthesis as well as general disruption of cell metabolism and synthetic processes. Use of 
the infectious clone has shown that the non-structural region of the SFV genome is 
necessary for the induction of apoptosis since the structural region may be deleted without 
affecting apoptosis (Glasgow et al., 1998). Moreover, deletion of part of the non-structural 
nsP2 gene abrogates both apoptotic induction and viral RNA synthesis. By contrast, for 
Sindbis virus, another model alphavirus, apoptosis induction, viral virulence and 
counteraction of the effects of the bcl-2 gene (a cellular function involved in cell survival) 
are all functions of the viral E2 envelope protein gene (Rathmell & Thompson, 1999). 
Apoptosis induced by SFV is not dependent on p53 (a cell product which blocks 
proliferation or activates apoptosis), and therefore does not result from damage to cellular 
DNA. Possible mechanisms of SFV-induced apoptosis include activation of PKR or 
caspase 3 due to leakage of cytochrome c from mitochondria.
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The initial vector system developed from the full-length infectious clone of SFV induced 
high-level transient expression of cloned genes in transfected cells (Liljestrom & Garoff, 
1991a). The genes of interest were cloned in place of the structural proteins of SFV, 
normally generated from the sub-genomic 26S RNA species. To achieve production of a 
heterologous gene, RNA is transcribed from the SFV vector in vitro and transfected into 
cultured cells. Viral RNA is replicated from both 42S and 26S promoters and expression 
occurs as in a productive infection. In addition, a helper clone was constructed by deletion 
of the RNA packaging signal which lies in the nsP2 gene. This RNA sequence is 
recognised by the capsid protein for encapsidation. The structural proteins deleted in the 
SFV vector are thus provided in trans by the helper construct. Dual transfection of helper 
and vector constructs result in the packaging of vector RNA into particles, but not the 
helper (Liljestrom & Garoff, 1991b). Particles are subsequently released from the cell and 
are infectious. However, since packaged vector RNA lacks the viral structural protein 
genes, no progeny are produced from cells infected with these particles.
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1.7. Aims of the Project
The major aim of this project was to study the complexes formed by the HCV El and E2 
glycoproteins. Initially, the glycoproteins produced by strain Glasgow, a local genotype la 
strain, were analysed. Subsequently, E l and E2 from another strain, H77, which is 
infectious in chimpanzees, were used to extend the study and for comparative purposes. 
Since no propagation system is available for HCV, expression was achieved using the SFV 
vector, pSFVl. At the outset of the project, little was known about the role of disulphide 
bonds in the formation and stabilisation of complexes. To address this question, disulphide 
bonds were disrupted both biochemically and by site-directed mutation of cysteine 
residues. A set of criteria also were established to distinguish the different types of 
complex (native and aggregated) formed by El and E2. These were employed to 
determine the role of sequences in El and E2 in the formation of native and aggregated 
complexes.
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HCV
associated
disease
Percentage Time period of 
detection
Symptoms and disease
Acute HCV 
infection
- 20% 7-8 weeks 15% clear the virus 
Jaundice in some cases
Chronic HCV 
infection
-80% Over a period of 
10 years post 
infection
Persistent infection with HCV, 
characterised by detection of HCV 
RNA at least 6 months after acute HCV 
infection
Cirrhosis - 20% 20-30 years post 
infection
Liver inflammation in patients with 
chronic HCV infection, characterised by 
abnormal levels of liver ALTs
HCC -4% Beyond 30 years 
post infection
Development of HCC and liver failure
Extra-hepatic NK NK e.g. cryoglobulinemia, arthralgias, 
glomerulonephritis
Table 1.1 Natural history of HCV infection. (NK -  not known; adapted from Lavanchy 
et al., 1999)
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Fig 1.1. Phylogenetic analysis o f whole representative HCV seuqences 
(Taken from Robertson et al., 1998)
5’UTR ORF 3’UTR
5’Cap_ PrM E NS1 2A 2B NS3 4A 4B NS5
Structural Non-structural
YFV (Flaviviruses)
S -s f i l Npr0 C Eras El E2 p54 ! p80 plO p30 p58 p75 — ^ 3 ’
pl25 pl33
Structural Non-structural
BVDV (Pestiviruses)
5 ^ 1 ' E l E2 p7 NS2 NS3 4A NS4b NS5A NS5B — a 3’
Structural Non-structural
HCV (Hepacivirus)
Fig 1.2. Genomic organisation of the Flaviviridae family of viruses.
ER Lumen
Cytoplasm
Fig 1.3. Model for the membrane topology of the flavivirus proteins. A diagram of the 
flavivirus polyprotein cleavage products with respect to the ER membrane is shown. The 
proteins are drawn to scale (areas are proportional to the number o f amino acids) and 
arranged in order (left to right) of their appearance in the polyprotein. Mature structural 
proteins are shaded and C-terminal membrane spanning segments of M and E are indicated. 
Also shown are the cleavage sites for host proteinase ('*), the viral serine protease (*r), and 
an unknown protease responsible for cleavage at the NS1/2A site (?). (Taken from Rice, 
1996)
Ho
st 
pr
ot
ea
se
(s
) 
Vi
ra
l 
m
et
al
lo
pr
ot
ea
se
 
Vi
ra
l 
se
ri
ne
-ty
pe
 
pr
ot
ea
se
*
o
©  ►m
<*3
C /3
Z <N
+ £  On
<N
r—
oo
v>NO
r»<No
o
00
NO
r--
'too
(N
O N
CQm
C / 3
Z
*<«/>
C / 3
Z
T
*2C / 3
Z
n
C / 3
Z
a
<Nw
H
fN
%
atna
13
a
oE
»/)
N
S5
B
R
N
A
de
pe
nd
en
t
R
N
A
po
ly
m
er
as
e
N
S5
A
?
Ph
os
ph
o
-p
ro
te
in
PK
R
m
od
ul
at
or
N
S4
B
«N.
N
S4
A
C
o-
fa
ct
or
 
of
 
N
S3
Re
qu
ire
d 
fo
r
NS
5A
 
(P
)
...
...
...
...
...
...
...
...
..
<*3(Z3
z
Pr
ot
ea
se
H
el
ic
as
e
O
nc
og
en
e-
lik
e
fu
nc
tio
n?
N
S2
i
?
C
-t
er
m
in
us
m
et
al
lo
-p
ro
te
as
e
a CN.
El
 
E2
 
(E
2-
p7
)
E
nv
el
op
e
pr
ot
ei
ns
Vi
rio
n 
C
om
po
ne
nt
s
U
C
or
e
(T 
ra
ns
- 
ac
tiv
at
or
?)
Fig
 
1.4
. 
a. 
G
en
om
e 
st
ru
ct
ur
e 
of 
H
C
V
. 
Th
e 
nu
m
be
rs
 a
bo
ve
 
the
 
sc
he
m
ati
c 
re
pr
es
en
t 
the
 
N
-te
rm
in
i 
of 
ea
ch
 
pr
ot
ein
 
on 
the
 
HC
V 
po
ly
pr
ot
ei
n,
 e
xc
ep
t 
th
e 
nu
m
be
r 
30
10
, 
wh
ich
 
in
di
ca
te
s 
the
 
C-
te
rm
in
us
 o
f 
the
 
po
ly
pr
ot
ei
n.
 
Po
ss
ib
le 
pr
ot
ea
se
s 
in
vo
lv
ed
 
in 
the
 
cl
ea
va
ge
s 
are
 
in
di
ca
te
d.
 
Th
e 
pr
ot
eo
ly
tic
 
fu
nc
tio
n 
for
 t
he 
vi
ra
l 
m
et
al
lo
pr
ot
ea
se
 
sp
an
s 
the
 
C-
te
rm
in
us
 o
f 
NS
2 
and
 
the
 
N
-te
rm
in
us
 o
f 
N
S3
, 
and
 
a 
se
rin
e-
lik
e 
pr
ot
ea
se
 
is 
en
co
de
d 
in 
N
S3
. 
b. 
Fu
nc
tio
ns
 a
nd
 
pu
tat
iv
e 
fu
nc
tio
ns
 o
f 
ea
ch
 
pr
ot
ein
 
are
 
sh
ow
n.
 [
(P
) 
- 
ph
os
ph
or
yl
at
io
n]
 (
Ad
ap
ted
 
fro
m 
Sh
im
ot
oh
no
 
& 
Fe
in
sto
ne
, 
19
97
)
V V
C G
G U
a a u a
7 2 - A  G
a a-
a u  A
C G  
G A
X8
CG
U C 
GGG G 
CCC U
•95
.U
'U
U
UG C
U CACCGG 
G GUGGCC 
A A
155'Agc V
GC 
CG
Sfe
CG  
U A 
GC  
GU
1 4 4 -  U G —249 
G C  
AU  
UA  AG 
GCCG
lllc
"A2"
nt 243
llld
5* 28 IGACACUCCACCA0AC 
G)
"GA" 
nts 34-35
C G  
AU
CU(^
A A 
A G 
G C  
G C  
AU  
ijG C 
G C 
U A
U C A C U C ctG ACCCCCCCUCCC<3GGA u g c c  
GGAGGGCCCC Q
G C u 
&
u u
UAGUG G
CGGA A AGCGC,
131
V U 
AUqU 
CG  
CG  
G U ,
UG
G C
uv
u g g g a u
296 file
383
"UGA" 
nts 11-13 IV
Q cCUAAACCUCAAAGAAAAACCAAACGUAAC...
AU/
CG; 
GC  
U A 
GCCGa&
Fig 1.5. Predicted model for the secondary and tertiary RNA structure of the 
5’UTR of HCV. The segment immediately downstream of the ORF of HCV-lb is 
included. Major structural domains are labeled I, II, III, and IV. The initiator AUG 
codon in stem-loop IV is highlighted. The circled nucleotides indicate differences 
between the sequences of HCV-lb and la, which are clustered at four loci: UGA, 
GA, Ai, and Ai. (Taken from Honda et al., 1999)
AUG codntf r*gi6«t
Fig 1.6. Overview of cap-dependent and cap-independent translation 
initiation. In cap-dependent translation (top), the eIF-4F complex recognises the 
m7GTP cap at the 5' end of an mRNA. ATP-dependent RNA-RNA unwinding 
activities of eIF-4A are stimulated by an additional factor, eIF-4B. After binding 
the mRNA, the 40S ribosome and ternary complex typically initiate translation at 
the first-encountered AUG codon in an appropriate sequence context. Following 
poliovirus infection (bottom), cap-dependent translation in the host cell is 
abolished by the proteolytic cleavage of eIF-4G. Picomavirus RNA lacks a m7GTP 
cap structure and, therefore, initiates translation in an end-independent manner. 
The 43 S preinitiation complex may be recruited to the IRES by viral RNA structure 
determinants and host cell protein factors. Complex RNA and protein interactions 
appear to allow the 40S ribosome and ternary complex to bypass multiple upstream 
AUG sequences, thus directing viral polyprotein synthesis at the appropriate 
downstream AUG. (Taken from Stewart & Semler, 1997)
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Fig 1.7. Predicted model for the secondary structure of the 3’UTR of HCV.
(Taken from Ito and Lai, 1997)
810 NS2
1027
NS3 protease domain
1207 aa
P5 to P5' sequence of 
NS2-NS3 cleavage site
1022-GWRL APITA-1031
Fig 1.8. The HCV polyprotein and proposed model of NS2-NS3 
autoproteolysis. The zinc divalent cation in the NS3 proteinase domain is 
illustrated as are amino acid residues in NS2 that are potentially involved in 
catalysis through a cysteine proteinase mechanism. Amino acid residues are 
numbered according to the HCV-la polyprotein sequence. The P5 to P5* sequence 
(amino acid residues 1022-1031) of the NS2-NS3 cleavage site is included. The 
curved arrows indicate the NS2-NS3 cleavage site between residues 1026 and 1027. 
(Taken from Wu et al., 1998)
aa 1027 1207 1658
N
Proteinase NTPase/Helicase
f t
His Asp Ser T T T T
Motif A B D
Fig 1.9. Schematic showing the features identified in NS3. The NS3 serine proteinase is 
located in the N-terminal 180 aa. The 22 N-terminal residues o f this region are involved in 
binding with NS4A, indicated by (« ) . The catalytic triad is composed o f H (1083), D (1107) 
and S (1165), which are indicated ( ). Finally, the NS3 proteinase structure is maintained by a 
zinc ion that is held by co-ordinates provided by C residues at 1125, 1127, and 1171, and His 
residue at 1175; these are indicated also ( a ) .  Four distinct motifs are identified in the NS3 
NTPase/helicase region designated A, B, C, and D. Motif A is A-X-X-X-X-G-K-S and motif B 
is the DEAD box subfamily sequence of D-E-C-H. Motifs C and D are T-A-T and Q-R-R-G-R- 
T-G-R, respectively.
aa 2420 3010
N ____________________
RNA-dependent RNA polymerase
T T T T
Motif A B C D
Fig 1.10. Schematic representation of NS5B. The four motifs shown within NS5B protein 
have the following sequences (in brackets) and predicted functions. Upper and lower case 
letters represent well- and poorly-conserved residues respectively. Motif A (DtrcfD) 
nucleotide binding and catalysis, motif B (sGvltTscgN) template binding and primer 
positioning, motif C (GDD) NTP binding and catalysis and motif D (amtry), NTP binding and 
catalysis. Motif C is characteristic of most polymerases. In motif D, a lysine residue, highly 
conserved in other polymerases and reverse transcriptases, is replaced by an arginine residue 
in NS5B. (Lohmann et al., 1997)
ER Lumen
NS5B
Viral RNA
Cytoplasm
Fig 1.11. Model for the membrane topology of the HCV proteins. The diagram shows the 
HCV cleaved products with respect to the ER membrane. The proteins are processed according 
to the positions shown in Fig 1.4a. Mature structural proteins are shown in a different colour 
( ) from the non-structural proteins ( ), although NS3 proteinase/helicase domains and NS5 
RdRp are shaded according to Fig 1.9 and Fig 1.10 respectively. Cleavage from the polyprotein 
occurs through the action of cellular proteinases ( ), NS2/3 metalloproteinase ( * ) ,  and by
NS3/4A serine proteinase ( ^ ). The precise function for NS4B and NS5A in the replication of 
viral RNA and/or packaging of RNA and assembly is unknown.
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Fig 1.12. Features identified in core protein. Core protein is divided into three distinct 
domains (D) designated 1, 2 and 3. The amino acid (aa) regions of core involved in an array 
of interactions are indicated.
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MEMBRANE M
I TRANSLATION I 
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TRANSLOCATON 
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SRP rocaptor protein «■ 
in rough ER m«mt>rane
■ignat-rooognitioo pwtide (SRP)
Fig 1.15. ER signal peptides and SRP direct ribosomes to the ER membrane.
The SRP and the SRP receptor are thought to act in concert. The SRP binds to the 
exposed ER signal peptide and to the ribosome, thereby inducing a pause in 
translation. The SRP receptor in the ER membrane, which is composed of two 
different polypeptide chains, binds the SRP ribosome complex. In a poorly 
understood reaction that involves multiple GTP-binding proteins, the SRP is 
released, leaving the ribosome on the ER membrane. A multisubunit protein 
translocation apparatus in the ER membrane then inserts the polypeptide chain into 
the membrane and transfers it across the lipid bilayer. (Taken from Alberts et al., 
1994).
protein
t^GSSG
f» G S H
protein 5^ °
L> GSHi„,
Fig 1.16. Simplified disulphide redox reaction. Formation of one disulphide 
bond requires two sequential thiol-disulphide exchanges involving a mixed- 
disulphide intermediate. Glutathione exists as the thiol (GSH) and disulphide 
(GSSG) forms in the cell.
Fig 1.17. Possible mechanisms of disulphide-bond form ation, reduction and 
isom erisation. Disulphide-bond formation in a substrate protein (p) may be 
catalysed directly (a) or indirectly (b) by Erolp. PDI may also catalyse this step 
(b). Disulphide-bond isomerisation is catalysed by PDI using either the mixed 
protein/GSH disulphide (b) or some other inter- or intra-molecular disulphide (c) as 
substrate. S“ indicates the more reactive, N-terminal cysteine residue in the PDI 
active site. The direct oxidation pathway in (a) followed by an isomerisation 
pathway (c) obviates the requirement for glutathione. In this scheme, the source of 
the oxidising equivalents (ox) for the regeneration of oxidising Erolp (Erolp ox.) 
from the reduced form (Erolp red.) is unknown. (Taken from Ferrari & Soling, 
1999).
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Fig 1.18. Models for calnexin (CNX) and calreticulin (CRT) binding to their 
substrate glycoproteins, (a) Lectin only model. Glucose residues (G) in the core 
oligosaccharides are trimmed. When trimmed to the monoglucosylated form, the 
oligosaccharides mediate the binding of the glycoprotein to calnexin and calreticulin, 
functioning as lectins. Release of the substrate glycoprotein depends on hydrolysis of the 
remaining glucose residue by glucosidase II. If the glycoproteins are not completely 
folded, the high-mannose glycans are selectively re-glucosylated by GT (see Fig 1.19), 
allowing the oligosaccharides to rebind the chaperones. Once glycoproteins reach their 
mature conformation, they are no longer recognised by GT. (b) Dual-mode model. The 
monoglycoslated oligsaccharides are merely needed to bring glycoproteins into contact 
with calnexin. After the initial charbohydrate-mediated association, stronger protein- 
protein interactions occur between the chaperone and peptide elements exposed on the 
surface of the incompletely folded substrate protein. These stabilise the complex until the 
peptides are hidden in the folded protein. Thus, release of the substrate depends on 
conformational changes in substrate glycoprotein that eliminate the protein-protein 
interaction. (Taken from Helenius et al., 1997)
crt-2
a1-3
a1-3
Glucosidase IIGlucosidase
-A sn--A sn - -A sn-
Glucosyl-
transferase
Glucosidase II
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Glucose C D  Manrtose I I N-acetylglucosamine
Fig 1.19. N-glycosylation and glucose trimming in the ER. The core 
oligosaccharide (Glc3Man9GlcNAc2) is synthesised in the ER membrane and 
transferred to the consensus N-glycosylation site (Asn-X-Ser/Thr) on nascent 
polypeptide chains. Immediately after transfer, the glucose residues are removed 
by the sequential action of glucosidases I and II. Glucosidase I removes the 
terminal al-2-linked glucose, whereas glucosidase II removes the two remaining 
a  1-3-linked residues. Fully glucose-trimmed high-mannose glycans can be re- 
glucosylated by UDP-glucose:glycoprotein glucosyltransferase (GT) if  present on 
incompletely folded or assembled proteins. (Taken from Helenius et al., 1997)
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Fig 1.20. Folding and assembly of viral m em brane proteins in the ER. The schematic 
shows the folding pathway utilised by a typical viral membrane protein. Proteins begin to 
fold co-translationally and N-linked oligosaccharides are added to the nascent chain from 
dolichol phosphate. Disulphide bonds also form (red lines), assisted by protein disulphide 
isomerase (PDI). The molecular chaperone BiP associates with many folding polypeptides 
chains at multiple sites. Other chaperones such as calnexin and calreticulin are also involved. 
Sequential folding from the beginning of the polypeptide chain to its end, with independently 
folding sub-domains, also account for the efficiency o f folding in vivo. The third molecule 
shows the completed polypeptide with a folded top subdomain and a stem domain which is 
largely in an unfolded state. When the monomeric subunit is extensively folded, subunit- 
subunit recognition and assembly occurs, with dissociation o f BiP. Only correctly folded and 
assembled proteins are generally transported to the Golgi apparatus. A typical misfolding 
pathway is also shown. Proteins can misfold due to inefficient folding or due to a number of 
factors, including mutations, heat shock, and energy depletion. Misfolded proteins often, but 
do not always, aggregate. The aggregates may be disulphide-bonded, as shown, and typically 
display permanent and stable association with BiP. Misfolded proteins are retained in the ER 
and are eventually degraded, unless they are rescued. Instances in which misfolding is 
reversible include temperature-sensitive folding mutants and situations in which the ER 
environment has been experimentally altered. Restoration o f ATP can enable misfolded 
protein aggregates to dissociate to monomers which then fold normally. (Taken from Dorns 
et al., 1993)
HACr mRNA
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Translating polyribosomes
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Fig 1.21. Model of the unfolded protein response (UPR) signalling 
pathway. Accumulation of unfolded proteins in the ER lumen triggers
activation of Irelp, which cleaves HAC1U mRNA at both splice junctions. 
tRNA ligase then joins the two exons to produce the spliced form of the 
message, HACV mRNA. Both forms of HAC1 mRNA exit the nucleus and 
associate with polyribosomes. However, only the spliced form gives rise to 
protein, H aclp1, which then enters the nucleus and upregulates genes 
containing the unfolded protein response element (UPRE). Whether Irelp  is 
indeed resident in the inner nuclear membrane as depicted in this model has 
not been determined experimentally and hence remains speculative. (Taken 
from Sidrauski e t al., 1998)
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2.1.1. Bacterial Strains
Escherichia coli (E. coli) 
Strain
DH5 a
Top 10 F' (Invitrogen)
GM48
2.1.2. Vectors
Phenotype
F'I end AX hsdRXl (rk’m+) supE44 thi\ recAX gyrA  
(Naf) relAX A(lacZY A-argF) U169 
(<\>80dlac(lacZ)M 15)
F’{/acIq, Tn70(TetR)} mcrA A9mrr-hsdRMS- 
mcrBC) <\>80dlac(lacZ) AM 15 AlacX14 deoR recAl 
araDX39 A{ara-leu)l 691 gaRJ galK  r/?sL(StrR) 
end AX nupG
dam" dcm' strain (obtained from Dr R Thompson)
pGEMl (Fig 3.3, panel a)
pSFVl expression vector (Liljestrom & Garoff, 
1991b; Fig 3.3, panel b)
Promega
Life Technologies, Inc.
2.1.3. Kits and Enzymes for DNA/Protein Modification
Advantage DNA polymerase, dNTPs, PCR buffer Clontech
DNA purification kit 
Endoglycosidase Hf, PNGase F
Restriction enzymes
Qiagen
New England Biolabs
New England Biolabs 
and Boehringer 
Mannheim
SP6 RNA polymerase, T7 DNA polymerase, in vitro Promega 
TnT kit, RNasin, NTPs, Wizard Kit
T4 DNA ligase, alkaline phosphatase Boehringer Mannheim
2.1.4. Cells
Proteins were expressed in BHK (clone C l3) cells (Macpherson & Stoker, 1962).
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2.1.5. Cell culture growth media
Glasgow minimal Eagles Medium (GMEM), new bom calf serum (NBCS), 
penicillin/streptomycin and non-essential amino acids were supplied by Gibco-BRL.
Components of Eagles media used during radiolabelling were produced in-house by the 
media department, as were PBS, versene, trypsin, L-broth, and tryptose phosphate (TP) 
broth.
2.1.6. Radiochemicals
35S-L-Methionine 1175Ci/mmol Amersham
(lOpCi/pl) 
35S-Pro-Mix™ [35S-L- ~1000Ci/mM
methionine/cysteine] (14.3 pCi/pl)
Mannose, D-[2-3H(N)] 23.3Ci/mM (1 jj.Ci/jo.1) DuPont
2.1.7. Antibodies
Polyclonal antisera and MAbs against El and E2 A. Patel 
(some of the characterisation of these antibodies was 
conducted as part of this study; summarised in 
Appendix 5)
Anti-E2 MAbs H2, H33, H47, H53 J. Dubuisson 
(Deleersnyder et al., 
1997)
Anti-gD MAb 4846 A. Cross and H. S. 
Marsden 
T. RiceMAbs E1F and E2G
Human MAbs 1A7, 2H1, 4F7 and 4F1 M. Cardosa (Siemoneit 
et al., 1995)
StressGen
Biotechnologies Corp. 
Qiagen
Anti-calnexin polyclonal antibody (against the N- 
terminus of canine calnexin)
Penta-His MAb
Anti-rabbit protein-A-HRP, anti-mouse-HRP, anti- Sigma 
rabbit Texas Red raised in donkey, anti-mouse-FITC 
raised in sheep and goat, anti-rabbit Cy5 raised in 
goat
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2.1.8. Chemicals
The following companies were used for the supply of the indicated chemicals:
ECL, Hybond nitrocellulose membrane
Boric acid, bromophenol blue (BPB), EDTA, 
glycine, sodium chloride, sodium dodecyl suphate 
(SDS), sucrose
Ampicillin
Tris
En3Hance
Ammonia solution
Dried skimmed milk
Ecoscint A scintillation solution
ATP (for DNA ligation)
Butan-2-ol, chloroform, ethanol, glycerol, 
hydrochloric acid, isopropanol, methanol
Amersham
BDH
Beecham Research
30% acrylamide, TEMED, Coomassie Brilliant blue Bio-Rad 
and ammonium persulphate
Boehringer Mannheim 
DuPont
Fisher Scientific Ltd. 
Marvel
National Diagnostics
Pharmacia
Prolabo
Nickel-NTA agarose Qiagen
Agarose, P-ME, BSA, DTT, EtBr, imidazole, NEM, Sigma 
PFA, phenol, PMSF, protein-A sepherose, RNase A,
Triton X-100, Tween 20, cycloheximide, TCA,
Trypan blue
2.1.9. cDNA clones
Clones encoding the Glasgow strain core, El and E2 proteins were provided by R. M. 
Elliot, M. McElwee and J. McLauchlan. A plasmid, pCV-H77C was provided by J. Bukh 
(Ogata et al., 1991; Yanagi et al., 1997) that carries the full-length cDNA sequence of 
infectious HCV strain H77. The clone encoding the HSV-1 gD glycoprotein was provided 
by V. Preston.
r
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2.1.10. Photographic reagents
Developer and fixer were bought from Kodak for the Kodak X-OMAT. Kodak X-OMAT 
S-Film was used.
2.1.11. Solutions
30 % acrylamide 
solution
Agarose gel loading 
buffer (6x)
Binding buffer
30% acrylamide/0.8% (w/w) N N '-methylene 
bisacrylamide cross-linker (ratio 37.5:1)
5xTBE, 50 % sucrose, lpg/ml bromophenol blue
25mM Tris.HCl, pH 8.0, 300mM NaCl, 1 % (v/v) Triton 
X-100, ImM PMSF, 40mM imidazole, 20mM NEM
Cell lysis buffer
Cell resuspension 
buffer
0.2M NaOH, 1% (w/v) SDS
50mM Tris.HCl, pH 7.5, lOmM EDTA, lOOpg/ml 
RNase A
Column wash 
solution
Coomassie stain 
solution
80mM potassium acetate, 8.3mM Tris.HCl, pH 7.5, 
40|iM EDTA, 55% (v/v) ethanol
Fix solution containing 2% (w/v) Coomassie Brilliant 
blue
Destain solution 
Eagles A
5% (v/v) methanol and 7% (v/v) acetic acid in dH20
1.5mM CaCl2.2H20 , ImM M gS04.7H20 , 0.1ml 
concentrated HC1
Eagles B
Eagles 
(low met)
Eagles
(low met/cys)
Fix solution
Gel loading buffer 
(x3)
50% (v/v) salts/plus, 40% (v/v) amino acids/plus, 3.2% 
(v/v) vitamins (gassed with C 0 2 to pH 6.5)
7:1 (v/v) Eagles A: Eagles B (one-fifth normal 
concentration methionine), 2% (v/v) NBCS
7:1 (v/v) Eagles A: Eagles B (one-fifth normal 
concentration methionine and cysteine), 2% (v/v) NBCS
50% (v/v) methanol, 7%(v/v) acetic acid in dH20
29% SGB, 6% (w/v) SDS, 2M P-ME (excluded for non­
reducing conditions), 29% glycerol, 1 jug/ml 
bromophenol blue
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Immunoprecipitation 
(IP) buffer
L-Broth
L-broth agar 
Ligase buffer (5x)
Neutralisation buffer 
PBS
PBS (A)
Resolving gel buffer 
Running gel buffer 
Stacking gel buffer 
TBE(lOx)
TE
Towbin buffer
Trypsin solution
Versene 
Wash buffer
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50mM Tris.HCl, pH 7.6, 200mM NaCl, ImM EDTA,
1% (v/v) Triton X-100, 20mM NEM, ImM PMSF
lOgr NaCl, lOgr Bactopeptone and 5gr yeast extract per 
litre
L-broth, plus 1.5% (w/v) agar
250mM Tris.HCl, pH 7.6, 50mM MgCl2, 5mM DTT,
25% PEG 8000
1.32M potassium acetate, pH 4.8
PBS (A) plus 6.8mM CaCl2.2H20  and 4mM 
MgCl2.6H20
170mM NaCl, 3.4mM KC1, lOmM Na2H P04, 1.8mM 
KH2P 0 4, 25mM Tris.HCl pH 7.2
1.5M Tris.HCl, pH 8.8, 0.4 % (w/w) SDS
40mM Tris, 185mM glycine, 0.1 % (w/w) SDS
0.5M Tris.HCl, pH 6.9, 0.4 % (w/w) SDS
lOmM Tris.HCl, pH 8.0, 0.3M boric acid, ImM EDTA
lOmM Tris.HCl, pH 8.0, ImM EDTA
25mM Tris.HCl, pH 8.3, 192mM glycine, 20% (v/v) 
methanol
0.25% (w/v) Difco trypsin dissolved in PBS (A), 0.005% 
(w/v) phenol red
0.6mM EDTA in PBS (A), 0.002% (w/v) phenol red 
Binding buffer containing 50mM imidazole
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2.2.1. Manipulation of DNA
2.2.1.1. Small Scale Purification of DNA (mini-preps)
Single colonies of transformed bacteria were inoculated into 2ml of L-broth containing 
lOpg/ml ampicillin and incubated with shaking overnight at 37°C. Aliquots o f 200pl of 
cultures were added to an equal volume of cell lysis buffer and mixed by inversion. 200pl 
of neutralising buffer was then added and the solution was again mixed by inversion. The 
cell debris was removed by centrifugation at 13 000 g for 2 min at room temperature. The 
supernatant was transferred to a fresh tube and mixed with 500pl of isopropanol to 
precipitate DNA. Plasmid DNA was pelleted by centrifugation at 13 000 g for 2 min at 
room temperature. The pellet was dried and resuspended in 20pl of dFLO. 5pl of this 
solution of DNA was used for restriction enzyme digestions.
2.2.1.2. Large Scale Purification of DNA (maxi-preps)
200ml of L-broth containing lOpg/ml ampicillin was inoculated with bacteria and 
incubated with shaking overnight at 37°C. Cells were pelleted by centrifugation at 2 700 g 
for 10 min at 20°C. The cell pellet was resuspended in 10ml of cell resuspension solution 
and mixed gently with 10ml of cell lysis buffer. Following incubation at room temperature 
for 10 min, 10ml of neutralisation solution was added to the lysate and mixed gently for a 
further 10 min. Cell debris was pelleted at 13 000 g for 10 min at 20°C. The supernatant 
was filtered and mixed with 1/2 volume of isopropanol. After a 30 min incubation at 
-20°C, precipitated DNA was pelleted by centrifugation at 13 000 g for 10 min at 20°C. 
The DNA was resuspended in 2ml of TE buffer and mixed with 10ml of Wizard™ 
Maxiprep DNA purification resin. The resin/DNA mix was transferred to a maxicolumn 
attached to a vacuum manifold port. The resin/DNA was washed firstly with 25ml of 
column wash solution and secondly with 5ml of 80% ethanol. Preheated dFLO at 65°C 
was applied to the resin, incubated for 1 min and the DNA was eluted by centrifugation at 
2 700 g for 5 min. The eluate was filtered through a 0.22pm Micropore syringe filter and 
ethanol precipitated. DNA was subsequently pelleted by centrifugation at 13 000 g at 
20°C, vacuum dried and resuspended in 200pl of H2O before storage at -20°C.
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2.2.3. Oligonucleotide Synthesis and Purification
Oligonucleotide synthesis was performed on an automated Cruachem PS250 
Oligonucleotide Synthesiser operated by David McNab and Alex Orr. Oligonucleotides 
were synthesised by cyanoethyl phosphoramidite chemistry on controlled pore glass (CPG) 
columns. The first nucleoside of the 3’end of the oligonucleotide is attached to the CPG 
surface via an ester linkage and a hydrocarbon spacer. The 5’OH of the nucleoside is 
protected with a dimethoxytrityl group (DMT) to allow the correct polarity of chemical 
synthesis (3’—> 5 ’). For the sequential addition of each nucleotide the following steps were 
repeated; a) deprotection by removal of the 5’DMT acid labile group on the nucleoside 
attached to the column to generate a 5’OH, b) the phosphoramidite to be added is activated 
by tetrazole for formation of a covalent bond with the 5‘OH group, c) chains with failed 
additions are capped, and d) oxidation of the phosphite intemucleotide bond by iodine.
To remove synthetic oligonucleotides from the CPG, the ester linkage was cleaved with 
ammonia (specific gravity 0.88) resulting in a free 3’OH. The protecting groups on 
oligonucleotides were removed by incubation at 55°C for 5 h in ammonia and the DNA 
was lyophilised under vacuum. An aliquot of the lyophilised oligonucleotides was 
resuspended in lOOpl dH20 followed by purification using phenol/chloroform extraction. 
After ethanol precipitation and vacuum drying, oligonucleotides were resuspended in 
200pl of dH20 .
2.2.4. Quantitation of Plasmid DNA and Oligonucleotides
A Beckman Du®-62 Spectrophotometer was used to determine DNA concentrations by 
measuring the absorbance at 260nm, assuming 1 A26o=50pg/ml for double-stranded 
plasmid DNA and 1 A26o=20pg/ml for single-stranded oligonucleotides. In addition, purity 
of nucleic acids was confirmed by readings at 260nm and 280nm (A26o/A28o)- A ratio of 
approximately 1.8 indicated that the preparation was relatively free of protein 
contaminants. In vitro transcribed RNA was also measured at 260nm assuming that 
lA 26o=40pg/ml.
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2.2.5. Restriction Enzyme Digestion of DNA
Small scale restriction enzyme digestion of DNA to identify recombinant plasmids was 
carried out at 37°C (or the temperature specified by the supplier) in 20pl volumes using 10 
units of each enzyme per pg DNA in the buffer supplied with the enzyme. Reactions were 
incubated typically for 1 h. Large scale reactions for preparative isolation of DNA 
fragments were carried out in lOOpl volumes using 50 units of enzyme per 15pg DNA. 
Digestion reactions were terminated by addition of 1/5 volume of agarose gel loading 
buffer. The common restriction enzymes used in this study are shown in Appendix 6 along 
with their recognition sequences.
2.2.6. Electrophoretic Separation and Isolation of Digested DNA
2.2.6.1. Agarose Gel Electrophoresis
DNA fragments produced by restriction enzyme digestion or PCR were resolved by 
agarose gel electrophoresis. Slab gels (120 x 90mm) of 1% agarose were used for 
separation of fragments larger then 200 bp and 1.5% agarose gels were employed for 
smaller fragments. Slab gels of approximately 0.5cm thick were prepared in 0.5xTBE 
containing a final concentration of 0.5pg/ml EtBr and run at 100V in 0.5xTBE buffer. 100 
bp DNA ladder standard size markers (Promega) were used where appropriate. Following 
electrophoresis, DNA was visualised either under short-wave UV light or, for preparative 
gels, under long-wave UV light. Photography was carried out using an Appligene Imager.
2.2.6.2. Purification of DNA from Agarose Gels
Agarose slices containing appropriate DNA fragments were excised from gels under long­
wave UV transillumination and the DNA recovered using a QIAGEN gel purification kit. 
Excised agarose slices were dissolved in QC buffer (provided by supplier) and incubated at 
50°C until the gel slice had dissolved. To aid purification, a volume of isopropanol, 
equivalent to the weight of the gel slice, and 5pi of 3M sodium actetate (pH 5.0) was added 
to the solution of dissolved gel. This solution was applied to a QIAGEN column by 
centrifugation at 7 000 g. DNA on the column was washed with 500pl QC buffer and
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750pl of a solution QE (provided by supplier) containing 80% ethanol. DNA was eluted 
with 30pl of d t^O  by centrifugation (10 000 g for 1 min) into a fresh microfuge tube.
2.2.6.3. Purification of Linearised DNA and PCR Fragments
Linearised DNA and PCR fragments were purified using the QIAGEN Nucleotide 
purification kit. The restriction enzyme digestion was mixed with column application 
buffer and applied to the QIAGEN column by centrifugation at 7 000 g. Bound DNA was 
washed with 750pl of solution QE containing 80% ethanol and eluted with 30pl dfLO as 
described in Section 2.2.6.2.
2.2.6.4. Phenol/Chloroform Extraction
Proteins were removed from restriction enzyme digestions by adding an equal volume of a 
1:1 solution of phenol/chloroform. This mixture was then vigorously mixed and the 
organic layer containing the proteins was separated from the aqueous layer containing the 
nucleic acids by centrifugation at 13 000 g for 1 min. The aqueous layer was transferred to 
an equal volume of chloroform and mixed to remove any residual phenol. Following 
centrifugation, the aqueous layer was subjected to ethanol precipitation for concentrating 
the nucleic acids.
2.2.6.5. Ethanol Precipitation
Nucleic acids were precipitated by mixing with ethanol and 5M ammonium acetate to 
achieve final concentrations of 70% and 0.5M respectively. Following precipitation at 
-20°C for at least 1 h, precipitated nucleic acids were collected by centrifugation at 13 000 
g for 10 min, dried and resuspended in 10-50pl of dfLO.
2.2.7. Ligation Reactions
Purified vector and DNA fragments, prepared by restriction enzyme digestion and 
purification, were ligated in a 1:3 ratio. Reactions were carried out in a 25pl volume of 
lxligase buffer with 2 units of T4 DNA ligase containing ImM ATP. Reactions were
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carried out at 16°C for 15-20 h. Ligated DNA was ethanol precipitated and resuspended in 
5 pi of dFLO prior to transformation of competent E.coli.
2.2.8. Preparation of Competent E  c o l i  Cells
2.2.8.1. Electrocompetent DH5a
Plasmids were mostly grown and maintained in E.coli strain DH5a. To prepare 
electrocompetent bacteria, a 50ml overnight culture grown in L-broth from a single colony 
was used to inoculate 11 of L-broth. This culture was grown for 3-3.5 h at 37°C in a 
shaking incubator, until the OD55o was approximately 0.5-0.6. The culture was cooled on 
ice for 30 min and the cells were pelleted by centrifugation at 2 700 g for 15 min at 4°C. 
Cells were washed twice with ice-cold, sterile dFLO and pelleted before resuspending in 
ice-cold sterile dFLO containing 10% glycerol. Cells were pelleted again at 2 700 g for 15 
min at 4°C. The pellet was finally resuspended in 4ml dFLO containing 10% glycerol and 
aliquoted in 40pl volumes for storage at -70°C.
2.2.8.2. Competent GM48
Plasmid DNAs lacking dam/dcm methylation modification (required for certain restriction 
enzymes) were grown in E.coli strain GM48. A 2ml culture grown overnight in L-broth 
from a single colony was used to inoculate 100ml of pre-warmed L-broth. This culture 
was grown in a shaking incubator at 37°C to an OD28o= 0.5-0.6 to obtain bacterial cells 
that were growing during the log phase. Following a 5 min incubation of the bacterial 
culture on ice, the cells were pelleted at 2 700 g for 10 min at 4°C. The cell pellet was 
resuspended in 50ml ice-cold lOOmM CaCb and incubated on ice for 2 h. The cells were 
pelleted, resuspended in 1ml of ice-cold lOOmM CaCL and stored on ice until 
transformation with plasmid DNA.
2.2.9. Transformation of Competent E  c o l i  Cells
2.2.9.I. Electroporation of DH5a and TOP10F’ Cells
An 80pl aliquot of electrocompetent DH5a was thawed on ice before the addition of 2pl of
the products of a ligation reaction. This mixture was transferred to a cold electroporation
cuvette (0.1cm gap, Bio-Rad) and electroporated by a single pulse at 1.6kV and 25pF (Bio-
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Rad Gene Pulser II). The cells were resuspended in 1ml of L-broth and incubated at 37°C 
for 1 h to allow expression of the antibiotic resistance gene. lOOpl o f this culture was 
plated on to a L-broth agar plate containing lOOpg/ml ampicillin and incubated at 37°C 
overnight.
Occasionally, commercially available TOP 10 F ’ cells (Invitrogen) were used to obtain 
plasmid DNA. For transformation of TOPIO F ’ cells, ligation reactions were ethanol 
precipitated and the pelleted DNA was resuspended in 5 pi of dL^O. A 2pi aliquot of the 
ligation products was mixed with 20pl of electrocompetent TOPIO F ’ cells and incubated 
on ice for 1 min. The transformation mixture was transferred to an ice-cold electroporation 
cuvette (0.1cm gap) and electroporated with a single pulse at 1.6kV and 25pF. The cells 
were resuspended in 480pl of L-broth media and incubated at 37°C for 1 h with shaking.
A 50pl aliquot of transformed cells was plated onto a L-broth agar plate containing 
lOOpg/ml ampicillin and incubated at 37°C overnight.
2.2.9.2. Transformation of GM48 Bacteria
lpg  of purified plasmid DNA was added to lOOpl of competent cells (prepared as in 
2.2.8.2) and the mixture was incubated on ice for 40 min. Transformed bacteria were 
placed at 42°C for 4 min before plating out on L-broth agar plates containing 1 OOpg/ml 
ampicillin. Plates were placed at 37°C overnight.
2.2.10. Automated DNA Sequencing
Automated DNA sequencing was carried out (by L. Taylor) using an ABI PRISM 
BigDye™ terminator cycle sequencing ready reaction kit. Sequencing was performed 
using an ABI PRISM™ 377 DNA Sequencer.
2.2.11. PCR Amplification of DNA
A PCR kit from Clontech was used for all PCR reactions. Typically reactions were 
performed in a final volume of 50pl, containing lxPCR reaction buffer (provided by 
supplier), 0.2mM dNTPs, and 2.5 units Advantage DNA polymerase. The DNA template
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and primers were used at final concentrations of 0.5ng and lpg per pi respectively. Prior to 
the PCR cycles, reactions were typically heated at 94°C for 3 min to allow complete 
denaturation of the nucleic acids. PCR reactions were carried out under the following 
reaction conditions: a) strand-separation at 94°C for 30 sec, b) primer annealing at 56-60°C 
(temperature varied depending on primer) for 30 sec, c) strand elongation from primers at 
72°C for 30-60 sec (times varied with length of PCR product) for 30 cycles, d) a final 
elongation step at 72°C for 5 min. PCR reactions were carried out in a Techne (Progen) 
PCR machine.
2.2.12. I n  V itr o  Transcription of Linearised DNA
Recombinant pSFVl DNAs (15pg) were linearised with Spel and purified by 
phenol/chloroform extraction and ethanol precipitation. After pelleting, DNA was 
resuspended in 15pl dt^O . In vitro transcription reactions were typically performed in a 
final volume of 50pl as follows: NTP mix (ImM ATP, UTP, CTP, 0.5mM GTP), 
Transcription buffer (40mM Tris, pH 7.9, 6mM MgCh, 2mM spermidine and lOmM 
NaCl), ImM m7G(5’)ppp(5’)G RNA cap analogue, ImM DTT, 2 units/pl human placental 
ribonuclease inhibitor (RNasin), 2 units/pl SP6 RNA polymerase (as described by 
Liljestrom & Garoff, 1991). 1.5pg of linearised template DNA was added to reactions and 
incubated at 37°C for 1-2 h. 2pl of the in vitro transcription reaction was analysed on a 1% 
agarose gel before proceeding to use the RNA for electroporation into BHK cells.
2.2.13. Maintenance of BHK Cells
BHK cells were cultured in GMEM media containing 10% new bom calf serum (NBCS), 
4% TP broth and 100 units/ml of penicillin/streptomycin (ETC10) at 37°C with 5% CO2 in 
160cm2 tissue culture flasks. Cells were harvested at confluency, with a yield of 2-4x107 
cells per flask.
2.2.14. Electroporation of Recombinant SFV RNA
j
Cells approaching confluency in a 160cm flask were washed with versene at room 
temperature and removed by trypsin treatment. Approximately 10ml of ETC 10 media was
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added to the detached cells and a single cell suspension was achieved by pipetting several 
times with a narrow hole 5ml pipette. The cells were pelleted by centrifugation at 400 g 
for 3 min at 15°C. The cell pellet was resuspended in 10ml PBS (A) and pelleted as 
before. BHK cells were finally resuspended in PBS (A) to a final concentration of ~ lx l0 7 
cells/ml. 0.8ml of resuspended cells was placed in an electroporation cuvette (0.4cm gap) 
with 20pl of recombinant pSFV RNA. The cell/RNA suspension was mixed by inversion 
and electroporated at 1.2kV and 25 pF (Bio-Rad Gene Pulser II) at room temperature. The 
cells were pulsed twice with an inversion step between the pulses. Electroporated cells 
were transferred to 10ml of ETC 10. Thereafter, 35mm tissue culture dishes were seeded 
with 2 x 106 cells (in 3ml medium) and 13mm coverslips in 24-well plates were seeded 
with 105 cells (in 0.8ml medium). Cells were incubated at 37 °C.
2.2.15. Trypan Blue Staining
A 500pl aliquot of electroporated cell suspension was diluted with 0.5% trypan blue stain 
in PBS at a ratio of 1:1 and incubated for 5 min at RTM after gently mixing. The 
exclusion of this dye from live cells allowed stained dead cells to be counted under a light 
microscope.
2.2.16. Metabolic Labelling of Electroporated Cells
2.2.16.1. Radiolabelling with 35S-amino acids
For longer periods of radiolabelling, cells were incubated at 37°C for 4 h then medium was 
replaced with Eagles medium containing one-fifth normal concentration of methionine 
[Eagles (low met)]. Following further incubation at 37°C for 30 min, medium was again
*5 c
replaced with Eagles (low met) containing lOpCi/ml S-methionine. Cells were 
radiolabelled for 12 h at 37°C before harvesting (see Section 2.2.17).
For pulse/chase experiments, cells were radiolabelled 12 h after electroporation. Firstly, 
media was replaced with Eagles containing one-fifth normal concentration methionine and 
cysteine [Eagles (low met/cys)], and incubated for 30 min at 37°C. Cells were then pulse- 
labelled for 2-15 min with fresh Eagles (low met/cys) containing 400 pCi/ml 35S- 
methionine/cysteine (Pro-Mix). To chase radiolabelled proteins, labelling media was
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replaced with Eagles media containing 5x excess methionine/cysteine and incubation at 
37°C was continued for up to 80 min depending on the nature of the experiment.
2.2.16.2. 3H-Mannose Labelling
4 h post-electroporation, cell culture media was replaced with PBS containing 2% (v/v) 
NBCS, and 1% non-essential amino acids (PBSM). Following a 30 min incubation period 
at 37°C, this solution was replaced with PBSM containing lOOpCi/ml H-mannose and 
cells were incubated again at 37°C for 12 h.
2.2.17. Preparation of Cell Extracts and Isolation of Protein from 
Eukaryotic Cells
Cells were washed twice with 1ml ice-cold PBS, containing 20mM N-ethylmaleimide 
(NEM), an alkylating agent which blocks free sulphydryl groups on cysteine residues.
Cells were lysed using 500pl of either binding buffer or immunoprecipitation buffer also 
containing 20mM NEM. Complete lysis was achieved by incubation on ice for 10 min and 
the cell debris was pelleted by centrifugation at 13,000 g for 10 min at room temperature. 
The cleared supernatants were transferred to fresh microfuge tubes. Cell extracts were 
either used directly (e.g. for Western blot analysis) or proteins of interest were isolated 
according to either of the following procedures.
2.2.17.1. Immobilised-Metal Affinity Chromatography (IMAC)
Ni-NTA agarose was equilibrated by washing three times in binding buffer and 
resuspended to achieve a 50% slurry. For the isolation of histidine-tagged protein, lOOpl 
of equilibrated Ni-NTA agarose was added to supernatants from lysed cells and the 
binding was allowed to occur for 1 h at 4°C on a rotator. Ni-NTA agarose was pelleted by 
brief centrifugation to 1 000 g and washed three times with 500pl of wash buffer. Bound 
proteins were eluted with 20pl of gel loading buffer.
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2.2.17.2. Immunoprecipitation
For immunoprecipitation, l-5pl of the appropriate antibody was added to cell lysates and 
the mixture incubated at 4°C overnight. lOmg of protein-A sepharose per precipitation 
was allowed to swell and equilibrated overnight in IP buffer at 4°C. Prior to the addition 
of lOOpl of equilibrated protein-A sepharose to the cell lysate-antibody mixture, the 
equilibrated protein-A resin was washed three times in IP buffer and resuspended in an 
equal volume of the same buffer. The protein-A-antibody binding was allowed to occur 
for 1 h at 4°C on a rotator. Subsequently, the washing (using IP buffer) and protein elution 
stages (using gel loading buffer) were performed as for those described for IMAC.
2.2.18. TCA Precipitation
An aliquot of radiolabelled crude cell extract was blotted onto filter paper discs and placed 
in 15% TCA. Radiolabelled proteins were precipitated for 20 min and then the discs were 
washed twice in methanol before being placed in 1ml of scintillation solution. TCA 
precipitated samples were counted using a PACKARD Liquid Scintillation Analyser 1600 
TR.
2.2.19. Deglycosylation of Proteins Using Endo Hf and PNGase F
Lysates from cells were denatured in 0.5% (w/v) SDS, 1% (v/v) P-ME at 100 °C for 10 
min. Sodium citrate was added to 50mM followed by 2000 units of endo H f or 1000 units 
of PNGase F. For PNGase F digestions 1% (v/v) NP-40 was added to the reaction mix 
following the denaturation step to inactivate SDS. The reactions were incubated at 37°C 
for 1 h.
2.2.20. Coupled I n  V itr o  Transcription and Translation { In  V itr o  TNT)
Cell free protein synthesis was carried out using the TnT coupled transcription/translation 
system from Promega. Reactions were set up in a final volume of 25pl containing 12.5pl
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TnT rabbit reticulocyte lysate, IOxTnT, 2 units/pl T7 RNA polymerase, ImM amino acid 
mixture minus methionine, 1 piCi/pil 35S-methionine, 2 units/pl RNasin and lpg  of 
linearised template DNA. Recombinant pGEM constructs containing El and E2 sequences 
were linearised at the Sail site in El (see Appendix 1). Reactions were carried out at 30°C 
for 60 min and stopped by the addition of 15 pi gel loading buffer before analysis by SDS- 
PAGE.
2.2.21. Protein Analysis by SDS-PAGE
Proteins were resolved by electrophoresis through SDS polyacrylamide gels using the 
discontinuous buffer system (Laemmli, 1970) and a Bio-Rad Miniprotein II apparatus.
The glass plates (10 x 8cm) were assembled according to the manufacturer’s instructions 
using 1.5mm wide spacers. The cavity created by this gel assembly could hold 
approximately 8ml of resolving gel. Resolving gel mix was prepared containing 1 x 
resolving gel buffer and 10 or 12% (v/v) acrylamide solution in df^O. Acrylamide was 
diluted from a 30% stock solution consisting of acrylamide and N ‘,N ’ methylene bis- 
acrylamide (ratio 37.5:1). 12% gels were used to, analyse endo H r and PNGase F-treated 
material while untreated material was analysed on 10% or 12% polyacrylamide gels. The 
cross-linking of acrylamide and bisacrylamide was activated by the addition of 0.06% (v/v) 
APS and 0.05% TEMED. This solution was immediately poured into the gel assembly to 
approximately 2cm from the top of the plates and overlaid with butan-2-ol. After 
polymerisation the top surface of the resolving gel was washed with resolving gel buffer.
Stacking gel mix was prepared containing 1 x stacking gel buffer and 5% acrylamide 
solution in H2O. Polymerisation was initiated by addition of 0.08% (v/v) APS and 0.08% 
TEMED. This mixture was placed on the resolving gel and a 1.5mm wide comb was 
inserted to allow loading wells to form within the polymerised stacking gel. Following 
polymerisation, the comb was removed and the wells were washed with running buffer.
The gel was placed in a tank and the reservoirs filled with running buffer.
Samples that were analysed under reducing electrophoretic conditions alone were 
denatured and reduced in gel loading buffer containing P-ME by heating to 95°C for 5 min 
before loading. Alternatively, for examination of proteins under reducing and non­
reducing conditions, samples were initially denatured in gel loading buffer lacking p-ME
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by heating at 95°C for 5 min. Subsequently, the samples were divided into two parts and 
DTT to a final concentration of 20mM was added to one part. The reduction of disulphide 
bonds on proteins in this sample by DTT was promoted by a further incubation step at 
95°C for 5 min before loading. When reduced and non-reduced samples were analysed on 
the same polyacrylamide gel, NEM to a final concentration of 20mM was added prior to 
loading to prevent reduction of non-reduced samples by diffusion of the reducing agent.
Molecular weight markers (Bio-Rad) were resolved alongside the samples to allow protein 
size determination. Gels were run at 150V until the bromophenol blue dye reached the 
bottom of the resolving gel. Thereafter, the gels were removed from the apparatus and 
treated in either Coomassie Brilliant blue stain solution for 15 min followed by destaining 
in destain solution. Alternatively, gels were immersed in fix solution for 30 min then in 
En3Hance for 30 min and finally washed in water for 15 min. Subsequently, destained or 
gels treated in En3Hance were dried under vacuum and exposed to Kodak XS-1 X-ray film 
for the detection of radiolabelled proteins.
2.2.22. Western Blot Analysis
2.2.22.1. Electroblotting to Nitrocellulose
Proteins resolved by SDS-PAGE were transferred to nitrocellulose membrane essentially 
following the method of Towbin et al. (1979) in a Bio-Rad mini transblot apparatus. A 
blotting sandwich was set up with the gel in contact with the nitrocellulose membrane and 
both were placed between sheets of Whatman 3mm paper cut to the same size as the gel. 
This was in turn placed between fibre pads. All materials were soaked in Towbin buffer 
prior to assembly of the blotting layers. Electrotransfer was carried out at 50mA for 4 h at 
4°C.
2.2.22.2. Immunodetection
After transfer, nitrocellulose membranes were blocked at 4°C overnight in 5% skimmed 
milk (Marvel) prepared in PBS (A). Membranes were then washed three times in PBS (A) 
containing 0.05% (v/v) Tween-20 (PBST) for 10 min per wash prior to incubation with the 
primary antibody (diluted in 1% BSA in PBST) for 2 h. The anti-E2 MAb (ALP98) was
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used at a dilution of 1:1000, anti-E2 antiserum (R141) at 1:200, anti-El antiserum (R528) 
at 1:200, Penta-His MAb at 1:500, and gD MAb (4846) at 1:2000. Membranes were then 
washed as described above, before their incubation for 1 h with either anti-mouse IgG or 
protein-A conjugated to horseradish peroxidase diluted in 1% BSA in PBST. Following a 
final series of three washing steps, proteins on the membranes were detected using the 
Amersham enhanced chemiluminescence (ECL) system. The chemiluminescence reagent 
was prepared by mixing the two supplied reagents at a 1:1 ratio. This mixture was placed 
on to the membranes and agitated for 3 min. Finally, membranes were wrapped in cling 
film and exposed to Kodak XS-1 film for 5-45 sec. All the washing and incubations 
procedures were performed at room temperature with shaking.
2.2.23. Removal of Antibodies and Immunoglobulins from Membranes
Blots were stripped before probing with a different primary antibody by incubation at 55°C 
for 45 min in 60mM Tris, lOmM p-ME and 2% (w/v) SDS. Membranes were then washed 
three times for 10 min per wash in PBST at room temperature with shaking, before being 
placed in blocking solution and re-analysed with another primary antibody as described 
above.
2.2.24. Immunofluorescence
Electroporated cells on coverslips were fixed in methanol (at -20°C) and incubated for 20 
min at -20°C. Alternatively, non-permeabilised cells were prepared by fixing with 
paraformaldehyde (PFA) for 30 min at 4°C. Permeabilised cells were fixed under the same 
conditions in PFA containing 0.1% (v/v) Triton X-100. Cells were rehydrated by 
incubation for 10 min with PBS and blocked with PBS containing 2% (v/v) NBCS (PBSN) 
for 10 min. 200pl of the relevant primary antibody diluted in PBSN was added to cells and 
incubated for 1.5 h at room temperature. The anti-E2 MAb was used at a dilution of 1:200, 
anti-El antiserum at 1:100, anti-gD MAb was used at 1:400 and anti-calnexin antiserum 
was used at 1:100. Cells were washed four times for 5 min per wash with PBSN at RTM 
and then incubated with diluted secondary antibody (200pl). Anti-mouse IgG (conjugated 
with FITC raised in sheep) and anti-rabbit IgG (conjugated with Texas red raised in 
donkey), both were used at a dilution of 1:100. For double-labelling, cells were incubated 
with two primary antibodies and as secondary antibodies anti-mouse conjugated to FITC
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(diluted to 1:100) and anti-rabbit conjugated to Cy5 (diluted to 1:400) both raised in goat, 
were employed. Cells were again washed as described above followed by a final wash in 
dH20  to remove residual saline solution. Coverslips were removed from the wells, gently 
dried and mounted onto slides with 5 pi of Citifluor mounting fluid (supplied by Chem.
Lab. Canterbury).
Fluorescence microscopy was performed using a Nikon MICROPHOT-SA microscope and 
confocal microscopy was performed using a ZEISS LSM 510 microscope and 
accompanying software.
2.2.25. Preparation of PFA Fixative
A quantity of PFA to make a final solution of 4% was heated to 60°C in a volume of dH20  
slightly less than 2/3 the desired final volume o f fixative. This temperature was 
maintained while 1 drop of 2M NaOH was added to the solution to promote the 
solubilisation of PFA. Subsequently 1/3 volume of 3x PBS was added and the pH of the 
solution was adjusted to 7.2 with 1M HC1. The final volume was made up by the addition 
of dH20  and the solution was filtered using a 0.22pm Millipore filter. The solution was 
cooled on ice before applying to cultured cells.
2.2.26. Computer Software
An AGFA StudioScan II si scanner and Adobe Photoshop 4 and Adobe Illustrator 7.0 
programs were used to process the figures. EndoNote 2 Plus was used for creating a 
bibliography. Analysis of DNA and protein sequences was carried out using the programs 
in the Genetic Computer Group sequence analysis package version 7. The ExPASy- 
PeptideMass program fhttp://www.expasy.ch/cgi-bin/peptide-mass.pll was used to predict 
molecular weights.
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Chapter 3 -  Establishment of the SFV Expression System
3.1. Introduction
In the absence of any efficient in vitro HCV replication system, studies conducted on the 
glycosylated proteins E l and E2 have employed various heterologous expression systems. 
Throughout this study, the SFV system was used to achieve expression of the HCV 
glycoproteins. No previous publications have described the use of this system to 
investigate HCV proteins. However, several studies have employed successfully SFV 
vectors to express proteins encoded by other viruses including the neuraminidase and HA 
proteins of influenza virus (Zhou et al., 1994; Berglund et al., 1998). The SFV vector 
offered a number of advantages and part of the project was to establish the suitability of the 
system for expression purposes.
At the start of the project, antibodies against the glycoproteins of strain Glasgow had not 
been raised and initial characterisation of the expressed proteins was performed with 
limited amounts of reagents gifted by others. Since one of the primary aims of the project 
was to study interactions between El and E2, substantial amounts of reagents were 
necessary to conduct appropriate assays. In light of this, a tag consisting of six histidine 
residues was fused to the N-terminus of E l. This tag provided a means to purify the 
protein via IMAC (Fig 3.1; Porath, 1975). In this study Ni-NTA agarose was employed 
which is a complex of Ni-NTA coupled to Sepharose® CL-6B via a spacer arm (Fig 3.2.).
The aim of this chapter is to describe the construction of a recombinant pSFV plasmid 
encoding El and E2 as a polyprotein with a histidine tag fused to the N-terminus of El. 
This construct was used, firstly to optimise the SFV replicon system for the expression of 
these proteins and secondly to establish whether complex formation occurred between El 
and E2 from strain Glasgow. Some preliminary characterisation of El and E2 from this 
strain was also carried out to compare their behaviour with those of other strains described 
by other investigators. For completion purposes, some of the experiments described in this 
chapter make use of antibodies against the glycoproteins of strain Glasgow which 
subsequently became available and were kindly provided by Dr. A. Patel.
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3.2. Construction of Histidine-Tagged E l (E lhiS)
Plasmids containing the coding region for the core, E l and E2 proteins of HCV strain 
Glasgow were obtained by combining fragments from two constructs called core.pTZ18 
and 5'-ANS2 (provided by M. McElwee and R. Elliott). Core.pTZ18 possesses nucleotide 
residues 337-915 of the HCV strain Glasgow genome and 5'-ANS2 contains residues 1- 
2895. DNA fragments from these plasmids were combined in a vector called pGEMl (Fig
3.3. panel a). The resultant plasmid contained nucleotide residues 337-2895 of the HCV 
strain Glasgow genome and therefore encodes the core, E l, E2, and p7 proteins as well as 
the N-terminal region of NS2 of this strain (Appendix 1). For further cloning purposes, 
Bglll sites were introduced at EcoRI and H indlll sites which were upstream and 
downstream from the HCV sequences respectively. The resultant plasmid was called 
pgHCV.CElE2. These flanking B glll sites permitted convenient sub-cloning of the 
resulting fragments into the pSFVl vector at a unique BamHI site (Fig 3.3, panel b). A 
construct expressing a histidine-tagged form of E l was made using the following strategy. 
Firstly, the HCV coding sequences from E l to NS2 (amino acids 195-851), were excised 
as a Fspl-Hindlll fragment. This fragment was reinserted into pGEMl along with an 
oligonucleotide encoding the histidine tag and a unique K pnl site to allow for the 
introduction of the El signal sequence (Fig 3.4). Subsequently, oligonucleotides encoding 
amino acids 169-192 of the signal sequence for E l were inserted (Fig 3.5). The Bglll sites 
engineered into the pGEMl vector, which flanked the sequences encoding El-E2-p7-NS2 
ORF, were then employed to generate a fragment that was directly introduced at the 
BamHI site in the pSFVl vector; this gave a construct called pSFV/ElhiSE2. A 
recombinant SFV construct encoding the untagged Glasgow HCV glycoproteins was 
named pSFV/ElE2cia and was provided by J. McLauchlan. The only difference between 
these two plasmids was the absence of histidine tag sequences in El in pSFV/ElE2cia.
3.3. I n  V itro  Transcription of SFV RNA
The SFV replication system relies on in vitro transcription of RNA from linearised 
recombinant vector template, which, following transfection into eukaryotic cells, is 
replicated in cis by encoded SFV non-structural proteins (Section 1.6). The recombinant
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template DNA is linearised at the Spel site situated downstream of the SFV genomic 
poly(A) tail (Fig 3.3, panel b). Nucleotide sequences beyond the poly(A) stretch direct the 
synthesis of anti-sense RNA and two promoters for 43 S and 26S RNAs direct transcription 
of positive-sense molecules. Thus, input RNA molecules introduced into cells are 
amplified and two populations of mRNA are synthesised.
In vitro transcription reactions were set up according to details provided in section 2.2.11, 
where 1.5pg of linearised template DNA was used per reaction. The amount of RNA 
consistently synthesised in vitro was approximately 60pg per 50pl reaction (as determined 
by absorbance spectrometry). A 2pl aliquot from a typical transcription reaction analysed 
on a 1% agarose gel and compared to approximately ljag of linearised template DNA 
showed a major RNA band representing SFV transcripts synthesised from the SP6 RNA 
polymerase promoter to the Spel cleavage site, a length of approximately 1 lkb (Fig 3.6). 
The minor bands and smeary appearance of the RNA are presumed to be a consequence of 
a combination of partial degradation, incomplete transcription and higher order structures 
formed by the RNA. In addition, RNA does not migrate as a tight band through an agarose 
matrix due to the secondary structures adopted by individual molecules.
3.4. Effect of Electroporation on Survival of BHK Cells and Efficiency of 
Electroporation of SFV RNA
As mentioned previously the SFV system had not been fully established in the laboratory 
at the start of this project. Although a number of studies elsewhere had used this system 
successfully in BHK and COS-K1 cells (Liljestrom & Garoff, 1991b; Berglund et al., 
1993), the optimal conditions for the use of BHK cells for this study had to be established. 
Initially, the affect of electroporation on BHK cells was examined. The trypan blue dye 
exclusion method, which specifically stains dead cells, was used to determine the amount 
of cell death that occurred after each of the pulse steps during electroporation. Data 
presented in Table 3.1 shows that from ~1 x 107 cells used per electroporation reaction, 
approximately 8% of cells are stained by trypan blue at the first pulse step and 18% after 
the second pulse. Thus, approximately 70% of cells survive the electroporation conditions 
that were adopted (i.e. 2 pulses).
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In order to identify the optimal amount of RNA required to achieve highest transfection 
efficiency, 7.5, 15, 30 and 60 pg of RNA transcribed from pSFV/ElhiSE2 construct were 
electroporated into competent BHK cells (Table 3.2). Expression levels of HCV E2 were 
detected in these electroporated cells by indirect immunofluorescence using an E2-specific 
antibody, ALP98 (Fig 3.7). Comparison of cells showing fluorescence to those observed 
under phase contrast indicated that less than 50% of cells expressed the protein with 15pg 
or less RNA. By contrast, expression of E2 was found in over 80% of cells when they 
were electroporated with 30pg or 60pg RNA (Table 3.2.). These transfection efficiencies 
were reproducibly achieved, demonstrating that half (25pl) of the in vitro transcription 
reaction was sufficient to obtain high levels of electroporation. It was estimated that about 
3 x 105 molecules of RNA per cell were available using 25 pi of an in vitro transcription 
reaction.
3.5. Solubilisation of HCV Glycoprotein E lhiS
A hydrophilicity prediction profile (Fig 3.8) indicated that both E l and E2 have a C- 
terminal hydrophobic region that constitutes their transmembrane domains and thus they 
are presumed to be type 1 membrane-bound proteins. Conditions allowing the release of 
the HCV glycoproteins from associated membranes were established by examining their 
solubility following cell lysis by three detergents; deoxycholic acid, an ionic detergent, and 
NP-40 and Triton X-100, which are both non-ionic detergents. Cells electroporated with 
pSFV/ElhiSE2 RNA were lysed in 500pl of Tris-salt buffer [25mM Tris.HCL (pH 8.0), 
300mM NaCl] containing these detergents at a final concentration of 0.1%, and the 
samples were spun at 13 OOOg for 10 min at room temperature to separate the cell debris 
from the soluble material. The cell debris was resuspended in 500pl gel loading buffer and 
equivalent portions of this material were separated by SDS-PAGE alongside the soluble 
fraction. The samples were then probed for histidine-tagged El using a Penta-His antibody 
by Western blot analysis (Fig 3.9, panel a). This monoclonal antibody detected a protein 
of approximately 30 kDa that corresponds to the size of E l identified in the literature 
(Grakoui et al., 1993b; Ralston et al., 1993). The data showed that non-ionic detergents 
NP-40 and Triton X-100 at concentrations of 0.1% released El from the membranes into 
the soluble material more efficiently (panel a, compare lanes 5 and 7 with lanes 6 and 8), 
than deoxycholic acid (panel a, lanes 3 and 4). The use of Triton X-100 in buffer solutions 
was further characterised.
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The optimal detergent concentration to be included in any buffer used for purification of 
the glycoproteins (Section 2.2.15) was determined by testing Tris-salt buffers containing 
Triton X-100 at concentrations of 0.01, 0.1 and 1%. The cell debris was again separated 
from the soluble material and an equal volume of both fractions was analysed by Western 
blotting, once again probing for the histidine tag in El (Fig 3.9, panel b.). The buffer 
containing 1% Triton X-100 was most effective for releasing E l from membranes (lane 6 
compared with lane 5). At this stage it was assumed that the efficient solubilisation of El 
achieved with buffer containing 1% Triton X-100 was sufficient also for the solubilisation 
of E2, and this was confirmed in later experiments (Fig 3.15.).
3.6. Radiolabelling of HCV Glycoproteins and Immunodetection of E2
The previous section has shown the detection of El by indirect immunofluorescence and 
Western blot analysis. The expression of this glycoprotein, and E2, was further examined 
by radiolabelling with 3H-mannose and 35S-methionine. For 3H-mannose, the radioactive 
sugar residue is incorporated during the biosynthesis of high-mannose oligosaccharide by 
oligosaccharyl transferase (Komfeld & Komfeld, 1985). In turn, these structures are 
transferred en bloc by the enzyme to the asparagine residue at N-linked glycosylation sites 
of only those proteins translocated to the ER (Section 1.4.5). Thus, this could provide a 
highly specific means of detecting the El and E2 glycoproteins. By contrast, 35S- 
methionine is directly incorporated into the polypeptide chain (Fig 3.10).
Cells electroporated with pSFV/ElhiSE2 and pSFV/ElE2Gia RNA or mock-electroporated 
cells were incubated overnight in media containing either 3H-mannose or 35S-methionine 
as described in section 2.2.16. These were lysed and the level of radioisotope 
incorporation was quantified by TCA precipitation followed by scintillation counting 
(Section 2.2.18.). Equivalent TCA precipitated radioactive counts were analysed by SDS-
o 'y c
PAGE for both the H-mannose- and S-methionine-labelled samples (Fig 3.11). The 
ratio of TCA precipitatable counts between 3H-mannose- and 35S-methionine-labelled 
crude extracts was approximately 1:14. Crude extracts from mock-electroporated cells 
showed a high number of H-mannose incorporated glycoproteins (lane 6). In cells 
electroporated with recombinant pSFV RNA, novel species of ~65 kDa and ~35 kDa were 
readily apparent and there was a significant reduction in the number of cellular
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glycoproteins detected (Fig 3.11, lanes 4 and 5). Based on other studies these novel 
species correspond in size to E2 (-65 kDa) and El (-30 kDa; Grakoui et al., 1993b, 
Ralston et al., 1993). The diffuse nature of the 3H-mannose-labelled bands is characteristic 
of glycoproteins with multiple glycosylation sites. Also, in the extract from pSFV/ElhiSE2- 
electroporated cells, the E l species is slightly larger than that made from pSFV/ElE2cia; 
this is presumably a consequence of the presence of the histidine tag in E l . Radiolabelling 
with 35S-methionine over the same time interval did not reveal any novel species in crude 
extracts which corresponded to E l and E2 (Fig 3.11, compare lanes 1 and 2 with lane 3). 
Another labelled band of approximately 16 kDa (lane 5) was detected in the extract from 
pSFV/ElE2Gia-electroporated cells. The origin of this band was unclear but was not 
further examined.
For any given expression system, it is important to establish when the system initiates 
protein production and the levels of expression achieved at different time periods after 
transfection or electroporation. Therefore, pSFV/ElhiSE2- and mock-electroporated cells 
were metabolically labelled with 35S-methionine/cysteine for 3 h intervals over a 25 h 
incubation period. The first labelling period was conducted 4 h post electroporation. 
Immediately after the labelling period, cells were washed and lysed in binding buffer 
(Section 2.2.17). An equal volume of the soluble material from each time period was 
analysed by SDS-PAGE (Fig 3.12). Data showed that the level of host cell protein 
synthesis in pSFV/ElhiSE2-electroporated cells started to decline by 10-12 h post 
electroporation (lane 3) and this effect was enhanced at later time points (lanes 4-7).
Indeed, host protein synthesis was considerably reduced by 19 h after electroporation with 
the recombinant SFV RNA (lanes 6 and 7). By contrast, mock-electroporated cells, which 
had been electroporated at the same time in the absence of RNA transcripts, showed no 
alteration in host protein synthesis (lanes 8-14).
Crude cell extracts obtained at 4, 7, 10, 13, 15 and 18 h after electroporation with 
pSFV/ElhiSE2 RNA were also analysed for expression of E2 by Western blot analysis 
using the E2-specific MAb, ALP98 (Fig 3.13). This revealed that E2 expression was not 
apparent at 4 h after electroporation (lane 1). However, the protein was readily detected by 
7 h after electroporation (lane 2) and peak levels were reached by 13 h (lane 4). There does 
not appear to be a significant difference between the levels of expression in cells harvested 
at 13 h compared with cells harvested at 15 or 18 h post electroporation (compare lanes 4- 
6), by which point host cell protein production is reduced (compare Fig 3.12, lanes 4 and
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5). The only other notable difference was the rise in heterogeneity of E2 at later times 
following electroporation. It is assumed that El expression would follow the same pattern, 
since it is made co-translationally with E2 as the N-terminal part of the polyprotein.
3.7. Isolation of E lhiS and E1E2 Complexes by IMAC
Since purification and detection of E l was to be accomplished by IMAC, conditions for 
specific binding and elution of histidine-tagged E l from Ni-NTA resin had to be 
established. In addition, El and E2 glycoproteins from a number o f HCV strains have 
been reported to form a heteromeric complex. Therefore, the histidine-tagged purification 
system would also allow identification of any E1E2 complexes formed by strain Glasgow 
glycoproteins through co-elution of E2 with E l.
Initially, to address the question of Ni-NTA agarose specificity, cells were electroporated 
with RNA transcribed from constructs pSFV/ElhiSE2 and pSFV/ElE2cia, in addition to 
mock-electroporated cells. Following an incubation period of 16 h, cells were lysed in 
500pl binding buffer containing 5mM imidazole, an analogue of histidine with a high 
affinity for nickel ions (Fig 3.14). The soluble material was separated from the insoluble 
cell debris by centrifugation, and then applied to Ni-NTA agarose. Unbound material was 
collected and bound proteins were eluted with gel loading buffer. Subsequently, equal 
volumes of soluble material from each extract and the cell debris fraction, resuspended in 
500pl gel loading buffer, were analysed alongside equal volumes of unbound material and 
total bound material eluted from Ni-NTA resin. Analysis was conducted by Western 
blotting for El using an El-specific MAb, E1F. This data revealed that variable amounts 
of El were detected in the cell debris, soluble and the non-Ni-NTA bound supernatant 
fractions of samples derived from constructs pSFV/ElhiSE2 (Fig 3.15, panel a, lanes 1-3, 
respectively) and pSFV/ElE2cia (lanes 5-7) but El was not found in mock-electroporated 
samples (lanes 9-11). Significantly, El was detected in the Ni-NTA bound and eluted 
material from the pSFV/ElhiSE2 cell extract but not from the pSFV/ElE2cia cell extract 
(Fig 3.15, panel a, compare lanes 4 and 8). Thus, histidine-tagged El is able to associate 
specifically with Ni-NTA agarose while the untagged counterpart protein does not bind to 
the resin.
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To establish whether assembly of a heteromeric complex occurred between strain Glasgow 
El and E2, co-elution of E2 with the histidine-tagged El was examined. Therefore, the 
same nitrocellulose membrane used for the analysis of El (Fig 3.15, panel a) was stripped 
of immunoglobulins and re-probed using E2-specific MAb E2G (panel b). The detection 
pattern for E2 was similar to that for E l, although substantially less E2 was identified in 
the insoluble cell debris samples, which may be a reflection of the efficient solubilisation 
of the protein. However, E2 was readily apparent in the soluble fractions of the cell 
extracts and the unbound material for pSFV/ElhiSE2 and pSFV/ElE2cia samples (Fig 3.15. 
panel b, lanes 2, 3, 6, and 7). Interestingly, E2 was only detected in Ni-NTA-eluted 
material derived from crude extracts containing the histidine-tagged E l (compare lanes 4 
and 8). Since E2 is specifically eluted along with histidine-tagged E l, this indicates that 
the strain Glasgow glycoproteins are able to form a complex.
3.8. Optimisation of Ni-NTA Binding of E lhis
Having established that a complex between strain Glasgow glycoproteins could be detected 
via the nickel-NTA binding assay, optimal conditions for the isolation of histidine-tagged 
El by Ni-NTA agarose binding were determined. Mock-electroporated and pSFV/ElhiSE2 
RNA-electroporated cells were radiolabelled from 4-12 h post-electroporation and lysed in 
binding buffer containing various concentrations of imidazole. Ni-NTA binding of the 
soluble fraction from cell extracts was performed in buffers (Section 2.2.17) with 
imidazole at final concentrations of 5mM, lOmM, 20mM, 30mM and 40mM. Binding in 
the absence of imidazole also was conducted for control purposes. Samples were eluted 
with gel loading buffer and analysed by SDS-PAGE (Fig 3.16). Two major species were 
isolated by Ni-NTA purification from extracts of pSFV/ElhiSE2-electroporated cells that 
correlated in size with El and E2; this again confirmed formation of E1E2 complexes 
(lanes 7-12). In addition, use of various concentrations of imidazole during the binding 
step showed that in the presence of 40mM imidazole, interaction of histidine-tagged El 
with Ni-NTA was not abolished and the level of non-specific binding was reduced to a 
minimum (lane 12). This is observed also in samples eluted from mock-electroporated 
crude extract at the same imidazole concentration (lane 6), where a significant reduction in 
the level of non-specific protein binding was evident. In the absence of imidazole in the 
binding buffer, very little tagged El was eluted (lane 7). In all subsequent experiments, 
binding buffer contained 40mM imidazole.
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To examine whether the co-elution of proteins non-specifically bound to Ni-NTA agarose 
could be further reduced, removal of bound El was attempted with buffers containing 
various concentrations of imidazole. Experimental conditions were as stated for the 
experiment above, except that a 30pl aliquot of binding buffer containing imidazole at 
final concentrations of 200mM, 400mM, 600mM, and 800mM was used as a first elution 
step. Residual proteins remaining on the resin were removed with the same volume of gel 
loading buffer. The eluted samples were again analysed by SDS-PAGE (Fig 3.17.). The 
data showed that although El and E2 could be removed from the column with each 
concentration of imidazole, no significant difference in the level of non-specific protein 
elution was achieved with increases in imidazole concentration in the elution buffer (lanes 
3 ,5 ,7  and 9). This is particularly obvious when compared to the material eluted directly 
with gel loading buffer (lane 2). The remaining lanes on the gel represent the proteins 
strongly bound to Ni-NTA resin, which were only eluted using gel loading buffer (lanes 4, 
6, 8 and 10). In light of this data where no substantial reduction in non-specific protein is 
detected using imidazole as an eluant, proteins bound to Ni-NTA were eluted with gel 
loading buffer in subsequent experiments.
3.9. Immunolocalisation and ER Retention of E lhis and E2 in BHK Cells
Further comparison of the behaviour of strain Glasgow E l and E2 with that reported for 
glycoproteins made by other strains of HCV was performed by indirect 
immunofluorescence. Cells, electroporated with pSFV/ElhiSE2 RNA, were fixed with 
methanol and probed for El and E2 using antibodies (R528 and ALP98 respectively) along 
with anti-calnexin-specific antiserum as a marker for the ER. Localisation of the 
glycoproteins and calnexin was examined by confocal microscopy (Fig 3.18). Both E l and 
E2 had a cytoplasmic, reticular distribution (panels a and b) and co-localised on merging 
the images (panel c). Analysis of the localisation of calnexin revealed that it was widely 
distributed throughout the cell (panel d). Within the same cell, glycoprotein E2 had a more 
restricted distribution (panel e). Merging images in panels d and e (panel f) shows that E2 
co-localises with calnexin but emphasises the wider distribution of the ER chaperone. This 
suggests sub-compartmentalisation of the HCV glycoproteins in the ER.
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Translocated proteins that are processed in the ER are normally destined for secretion or 
the plasma membrane by transport through the secretory pathway. However, other 
proteins, termed ER-resident proteins, are either retrieved from the czs-Golgi sub­
compartment or are specifically retained (Section 1.4.8). The N-linked high-mannose 
oligosaccharides transferred onto proteins in the ER are modified on those proteins which 
are retrieved from the Golgi apparatus. By contrast proteins that remain in the ER are not 
modified (Komfeld & Komfeld, 1985). The oligosaccharide modifications render the 
retrieved proteins insensitive to endo Hf, which removes N-linked high-mannose 
oligosaccharides. This enzyme was employed to identify whether strain Glasgow El and 
E2 were retrieved or specifically retained in the ER.
Extracts from cells electroporated with pSFV/ElhiSE2 RNA were treated with endo Hf, and 
from Western blot analysis (Fig 3.19), both E l (panel a) and E2 (panel b) were sensitive to 
the enzyme (lanes 2). Compared to untreated proteins (lanes 1), endo Hf-treated proteins 
migrated faster on polyacrylamide gels. This analysis suggests that E l and E2 are retained 
in the ER and are not retrieved from the cis Golgi network or transported out of the ER.
Accumulation of proteins retained in the ER can lead to their degradation by the ERAD 
pathway (Section 1.4.9). To examine the stability of El and E2 in the ER over time, cells 
were electroporated with pSFV/ElhisE2 RNA. 7 h after electroporation cells were placed 
in media containing cycloheximide (CHX) to inhibit any further protein synthesis. 
Subsequently, cells were harvested at 3 h intervals following the addition of CHX. The 
crude extracts derived from these cells were examined by Western blot analysis using E2- 
specific MAb ALP98 (Fig 3.20). The result indicated that the level of E2 detected at 7 h 
after electroporation (lane 1) remained constant after the addition of CHX to the media 
(compare lane 1 with lanes 2-5). This suggested that the E2 glycoproteins retained in the 
ER remain relatively stable over a period of time.
3.10. Discussion
In recent years, SFV has been explored as a system for the expression of heterologous 
proteins by replacing the SFV structural coding sequences with those of a gene of interest 
(Liljestrom & Garoff, 1991b). As with almost all expression systems, there are both 
advantages and disadvantages associated with the use of SFV. One of the principle 
reasons for selecting SFV to express the HCV glycoproteins was the ease with which
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mutants could be constructed in inserted genes since the virus vector is plasmid-based.
This facet of the vector was put to use in the construction of a substantial number of 
variants of E l and E2 (Chapters 5 and 6). Expression is dependent on the introduction and 
replication in cells of RNA transcribed in vitro from a SFV plasmid template. Moreover, 
electroporation rather than transfection was employed as the preferred method for 
introducing RNA into cells. The efficiency of transfection of nucleic acid into cells is 
often variable, however, the in vitro transcription and electroporation methods used in this 
study gave consistent results from experiment to experiment. It is also possible to 
manipulate conditions by varying the amount of RNA and electroporation settings to 
modulate the number of cells that express genes inserted into the vector and this adds 
flexibility to the system. The levels of expression of the HCV glycoproteins were readily 
detectable by both Western blot analysis and indirect immunofluorescence. However, 
immunoprecipitation with specific antibodies (Chapters 4-6) or purification of histidine- 
tagged protein by IMAC was necessary to identify the proteins in radiolabelled extracts. 
Another advantage of the SFV vector over other viral expression systems such as vaccinia 
virus is that no progeny virus is produced. This may limit the alterations to cellular 
pathways which can occur by the expression of a large number of genes by the virus 
vector. For example, the vaccinia virus genome encodes about 200 potential gene products 
(Moss, 1996) whereas SFV synthesises only 9 proteins. However, SFV infection does 
induce apoptosis and the gene involved in induction is the non-structural gene nsP2 
(Glasgow et al., 1998). This gene is made by the SFV vector and hence apoptosis is a 
feature of the expression system. Apoptosis markers such as laddering of extracted DNA, 
characteristic of intemucleosomal DNA fragmentation, and terminal deoxynucleotidyl 
transferase-mediated bio-UTP nick end labelling (TUNEL; Gavrieli et al., 1992) have been 
examined in pSFVl-electroporated cells. Positive results for both o f these markers were 
observed at 48 h after electroporation but were not detected at 24 h after electroporation 
(Glasgow et al., 1998). Such a cytopathic effect is a disadvantage since expression in 
SFV-electroporated cells can continue for only a limited period. Moreover, such effects 
could influence the behaviour of the inserted genes that are expressed. In this study, crude 
cell extracts were typically prepared 12-18 h post-electroporation with recombinant SFV 
plasmids and therefore before the reported time at which apoptotic markers are evident.
El and E2 proteins also were glycosylated and of the correct predicted sizes. Thus, 
cleavage and processing at the ER were not inhibited. Moreover, the two proteins formed 
a complex in agreement with reports using alternative expression systems. Recent results
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using SFV to express structural proteins of a flavivirus, louping ill virus, have shown that 
they also are correctly processed and glycosylated (Fleeton et al., 1999).
It was possible that the SFV system could have produced virus particles containing HCV 
structural proteins. Expression of a subgenomic portion of Moloney murine leukemia 
virus (MMLV) along with a region containing MMLV replication and packaging signals 
by the SFV vector resulted in the production o f extracellular virus-like particles (Li & 
Garoff, 1996). These particles possessed reverse transcriptase activity and contained only 
MMLV structural proteins which were authentically processed. In another study, virus­
like particles were detected which consisted of naked replicon RNA and spikes of VSV G 
protein in the absence of any other VSV proteins (Rolls et al., 1994). These particles could 
be propagated in tissue culture. Analysis of culture media from cells expressing HCV 
core, E 1 and E2 by SFV did not indicate that propagation-competent virus particles were 
produced. Moreover, no structures that could correspond to HCV virus-like particles were 
found by electron microscopy analysis of electroporated cells (J. McLauchlan, J. Aitken 
and S. Butcher, personal communication). In early experiments, co-electroporation of 
RNAs from the SFV helper virus vector (Section 1.6) and the recombinant SFV plasmid 
encoding E 1 and E2 did result in the production of extracellular SFV particles. However, 
analysis of these particles revealed no detectable amounts of incorporated HCV 
glycoproteins.
In the absence of any substantial amounts of E l - or E2-specific antibodies, a histidine tag 
was introduced at the N-terminus of El for purification purposes. Although it is not 
possible to predict the consequence of incorporation of short amino acid tags into a 
polypeptide coding region, native proteins which retain their function can be isolated from 
cells by Ni-NTA purification. For example, vaccinia virus has been used to produce 
histidine-tagged human serum response factor from HeLa cells (Janknecht et al., 1991).
The purified protein retained the capacity to form a complex with a second cellular 
component, and stimulate transcription in vitro from a template bearing a promoter with 
the serum response element. Purification conditions were determined for strain Glasgow 
histidine-tagged El that did not require denaturation of the proteins for binding and elution 
from Ni-NTA agarose. As a consequence, E2 was shown to co-elute with tagged El and 
thus El and E2 from strain Glasgow are able to form a complex. These data also indicate 
that the presence of the histidine tag did not abolish complex formation. In a separate 
study using the baculovirus expression system, truncated forms of El and E2 which were
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both histidine-tagged at their N-termini were able to form a complex (Hussy et al., 1996). 
Moreover, truncated forms of histidine-tagged El and E2 expressed in bacteria were 
capable of binding truncated E2 and El respectively (Yi et al., 1997a). However, binding 
in this latter study was performed entirely in vitro and therefore did not take account of any 
active role played by ER proteins in complex formation and protein folding.
Endo H f analysis revealed that glycosylated E l and E2 remain sensitive to the enzyme, 
indicating that the proteins are retained in the ER. The lack of any modifications to 
glycans is consistent with retention of the proteins in the ER as opposed to a cyclical 
mechanism of transport to the Golgi apparatus followed by retrieval (see Section 1.4.8). 
This conclusion agrees with other studies using this enzyme (Dubuisson et al., 1994; 
Cocquerel et al., 1998; Duvet et al., 1998). In addition, Duvet et al. (1998) made use of 
endo D to confirm that cycling did not occur from the ER to the cis Golgi. If cycling 
between these compartments did occur, then the glycans would be modified by a - 
mannosidase I in the cis Golgi and molecules with these modifications would accumulate. 
Such modifications are sensitive to endo D however El and E2 remained endo D-resistant. 
Further HPLC analysis of glycans released by PNGase F treatment also indicated retention 
as opposed to retrieval as the mechanism for localisation of El and E2 in the ER (Duvet et 
al., 1998).
From confocal microscopy analysis, the distribution of El overlapped exactly with that of 
E2, confirming that the localisation of strain Glasgow glycoproteins is similar to that 
detected for those of strain H (Dubuisson et al., 1994). The distribution of E2 was 
coincident with that of calnexin, a chaperone resident in the ER. Moreover, E2 was found 
predominantly in the regions of the ER nearer the cell nucleus. However, calnexin had 
additional ER distribution where E2 was not present which was towards the periphery of 
the cell. Examination of E2 co-localisation with another ER marker, PDI, revealed 
identical results; PDI had broad ER distribution which partially overlapped with that of E2, 
which was localised closer to the nucleus (Duvet et al., 1998). These data suggest El and 
E2 glycoproteins may be retained in subcompartments within the ER. This organelle is 
composed of both rough and the smooth compartments, regions which perform different 
cellular functions and this is reflected in the proteins they contain (Lee & Chen, 1988). 
While the overall protein and lipid composition of the SER and RER are similar, the 
translocon-associated protein complex is mainly restricted to the rough ER (Vogel et al., 
1990). Using cell fractionation, p63, a novel type II integral membrane protein co-
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fractionates with the rough ER marker ribophorin II (Schweizer et al., 1995). From 
immunofluorescence data, the distribution of p63 was broader than a reporter protein 
(cathepsin D) fused to an ER retrieval signal (KDEL) which localised more closely to the 
outer nuclear membrane. Although El and E2 are not considered to be retrieved from the 
Golgi to the ER, this subcompartmentalisation within the ER may suggest that El and E2 
glycoproteins may move away from their site of synthesis.
Incompletely folded and misfolded proteins are retained in the ER by resident chaperones 
and foldases. Prolonged retention and accumulation of proteins induces the ER stress 
response which leads to the production of stress response proteins and the activation of 
ER-associated degradation through the ubiquitin-proteasome pathway (Section 1.4.9; 
Shamu et al., 1994). E l and E2 retained in the ER were relatively stable over a period of 
11 h in the presence of the protein synthesis inhibitor CHX. This procedure may also have 
prevented the synthesis of cellular proteins required for the proper function of the ER- 
stress response. However, studies conducted for the degradation of p35, a neurone-specific 
activator of cyclin-dependent kinase-5 (CDK5), in cultured neurons were performed also in 
the presence CHX (Saito et al., 1998). The amount of p35 in the cytoplasm of neuronal 
cells is balanced through synthesis and degradation pathways. In the presence of CHX, the 
disappearance of p35 was accelerated and was accompanied by parallel inactivation of 
CDK5. Although this is an example of a cytoplasmic protein, it does demonstrate that the 
presence of CHX does not cause disruption of degradation pathways. Thus, El and E2 
may be relatively stable in the ER.
Studies conducted on other proteins [e.g. human asialoglycoprotein receptor (HAR) and 
soluble protein cathepsin D] have revealed that proteins retained in the ER require certain 
determinants to cause their degradation which are separable from retention signals 
(Alberini et al., 1990; Shenkman et al., 1997). HAR subunit H2a contains, next to its 
transmembrane segment, a charged EGHRG (Glu-Gly-His-Arg-Gly) pentapeptide in the 
ectodomain, which is absent from the H2b subunit, an alternatively spliced variant. A 
portion of H2a is cleaved to produce a soluble secreted ectodomain fragment, while H2b 
remains membrane bound and is transported from the ER efficiently. The portion of H2a 
that remains membrane bound is retained in the ER and degraded. The transfer of the 
EGHRG sequence to another subunit, H 1, which is normally transported, resulted in its 
retention in the ER, but it was not degraded (Shenkman et al., 1997). This suggests that 
the determinant for ER retention (the pentapeptide) in uncleaved H2a does not overlap
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with the determinant for its degradation. Therefore, El and E2 also may lack specific 
signals to initiate their degradation also.
Data presented in this chapter has demonstrated that a heteromeric complex forms between 
El and E2 from strain Glasgow, in accord with the behaviour of glycoproteins made by 
other HCV strains. The nature of these complexes was further analysed and the 
experiments conducted are presented in the following chapter.
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No. of pulses applied
1
No. of cells 
counted
No of trypan blue 
stained cells
Percentage of 
dead cells (%)
306 27 8
2 325 60 18
Table 3.1. The approximate level of cell death resulting after electroporation.
Amount of 
RNA used per 
electroporation
(Pg)
Total number 
of cells 
counted
No. of 
fluorescing 
cells
Percentage
electroporation
efficiency
(%)
No. of RNA 
molecules available 
per cell
(x 105)
7.5 685 312 45 0.75
15 502 247 49 1.5
30 542 447 83 3
60 462 397 85 6
Table 3.2. The approximate level of electroporation efficiency achieved with 
increasing amounts of in vitro transcribed RNA.
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immobilized metal affinity chromatography (IMAC). Compound molecules 
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follows: NTA, nitrilo triacetic acid; TED, tris (carboxymethyl) ethylene 
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Fig 3.2. Structure of histidine-Ni-NTA complex. The nickel chelating 
NTA is immobilised to agarose via a spacer arm as shown. The remaining 
two ligand sites on the hexavalent nickel ion are occupied by the imidazole 
group on side chains of histidine residues. (Taken from Qiagen handbook, 
1997)
«  f l  9 1  o
-2 .3 g.
*  J ,  »  “  -S
C/3
w 3  .a
a - d - g  d 
e r g  £  ,ta
DA cn cd O
.9 S
■ —£T
4-
CM
CM
00
• S "
O "O
fe *3 a  a
2 |  
s  ia  c« 
2 w  is »ce "O
>  e  U ©
* 1oa
iP®Qi
4c
*
*
»e
*§
■3
I
I
pGEMl his E l E2
GGh ATT CAG ATC /QC ACC ATG GOG TAC AA GTG CGC CAT CAT CAT CAT CAT CAT CGC AAC
M G Y Q V R H H H H H H R N  
192 195
Fig 3.4. Insertion of a histidine tag at the N-terminus of E l. Schematic shows the 
insertion o f an oligonucleotide (over-lined in red) encoding the histidine (his) tag at the 
FspI site in El (corresponding to codon 195) and at the EcoRI site in pGEMl plasmid. 
This construct was named pGEM/AElhiSE2, because it lacked sequences coding for the 
signal peptide for ER translocation. Nucleotides in italics represent restriction enzyme 
sites, including EcoRI, Bglll, Kpnl and FspI (not regenerated by the oligonucleotide). El 
amino acid sequences are shown in brown, histidine tag residues are in pink and two novel 
amino acid residues in black include an initiating methionine residue. The schematic shows 
only the relevant regions of HCV sequences at which alterations were introduced.
pGEMl ss his E l E2
ATG GCG TAC CTT CCT GGT TGC TCT TTC TCT ATC TTC CTT CTG GCC CTG CTC TCT
M G Y L P G C S F S I F L L A L L S
192 169 183
TGC CTG ACT GTG CCC GCT TCA GCG TAC CAA GTG CGC CAT
C L T V P A S A Y Q V R H  
184 192 193
Fig 3.5 Insertion of E l signal sequence at the N-terminus of the histidine tag in E l.
The El signal sequence (amino acid residues 169-191 in the polyprotein) was introduced 
5’ of the histidine tag coding region in pGEM/AElhiSE2 at the Kpnl site (italicised) by 
introduction o f an oligonucleotide (over-lined in red). This construct was called 
pGEM /ElhisE2.
In vitro
DNA template transcription
DNA
Fig 3.6. In vitro transcription of RNA from SFV templates. 2pl of the
completed in vitro transcription reaction analysed on a 1% agarose gel 
alongside lpg of linearised template DNA (pSFV/ElhisE2) is shown. The 
smear under the major RNA band is indicative of RNA degradation 
products.
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Fig 3.7. Phase contrast and indirect immunofluorescence images of 
electroporated cells. BHK cells were electroporated with 7.5, 15, 30 and 
60pg of in vitro transcribed RNA from pSFV/ElhisE2. Cells were incubated 
for 18 h and fixed in methanol. They were processed for indirect 
immunofluorescence using E2-specific MAb, ALP98. Images were captured 
at x20 magnification.
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Fig 3.9. Solubilisation of E l protein from BHK cells. Panel a. pSFV/ElhisE2 RNA- 
electroporated cells were incubated for 18 h and harvested in Tris-salt buffer containing 
either deoxycholic acid (lanes 3 and 4), NP-40 (lanes 5 and 6) or Triton X-100 (lanes 7 and 
8) detergents at a concentration of 0.1%, or in buffer containing no detergent (lanes 1 and 
2). The cell debris was separated from the soluble material by centrifugation and equal 
volumes of both fractions were analysed by Western blot using the Penta-His MAb probing 
for the histidine tag on E l. Lanes 1, 3, 5, and 7 show the resuspended cell debris and lanes 
2, 4, 6, and 8 contain the soluble material. Panel b. Cells were harvested in Tris-salt buffer 
containing Triton X-100 at a concentration of either 0.01% (lanes 1 and 2), 0.1% (lanes 3 
and 4) or 1% (lanes 5 and 6). Again the amount of E l his in the cell debris (lanes 1, 3 and 5) 
were compared with the soluble material (lanes 2, 4 and 6). The position of Elhis is 
indicated.
Fig 3.10. M olecular structures of radiolabelled amino acid and 
carbohydrate  residues. Panels show: a, 2-3H-mannose; b, 35S- 
cysteine; c, 35S-methionine. The radiolabelled elements are shown in 
red.
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Fig 3.11. Metabolic labelling of cells with 35S-methionine and 3H- 
mannose. Cells electroporated with RNA from pSFV/ElhisE2 (lanes 1 
and 4), pSFV/ElE2Gia (lanes 2 and 5), and mock-electroporated cells 
(lanes 3 and 6) were radiolabelled 4 h after electroporation with either 
35S-methionine (lanes 1-3) or 3H-mannose (lanes 4-6), followed by a 12 
h incubation at 37°C overnight. Cell extracts were TCA precipitated 
and equivalent amounts of precipitated counts were analysed on 10% 
polyacrylamide gels. Bands presumed to correspond to E l his, E l and 
E2 are indicated.
Fig 3.12. Efficiency of expression from recom binant pSFV RNA on protein 
synthesis. pSFV/ElhisE2 RNA-electroporated (lanes 1-7) and mock-electroporated 
cells (lanes 8-14) were seeded onto individual plates, which were 15S- 
methionine/cysteine radiolabelled for 3 h over a time course of 25 h. The first set of 
plates were labeled for 4-6 h after electroporation (lanes 1 and 8), followed by 7-9 h 
(lanes 2 and 9); 10-12 h (lanes 3 and 10); 13-15 h (lanes 4 and 11); 16-18 h (lanes 5 and 
12); 19-21 h (lanes 6 and 13); and 22-24 h (lanes 7 and 14). Immediately after the 
labeling period, cells were harvested and equal aliquots of crude cell extracts, obtained 
from each time period, were analysed on a 10% polyacrylamide gel.
Fig 3.13. Time course of HCV E2 expression. Samples from cells 
electroporated with pSFV/Elh.sE2 RNA were harvested over an 18 h time 
period at 3 h intervals. Samples were electrophoresed on a 10% 
polyacrylamide gel, transferred to nitrocellulose membrane and probed with 
the E2-specific MAb, ALP98. Cells were harvested after electroporation at 4 h 
(lane 1), 7 h (lane 2), 10 h (lane 3), 13 h (lane 4), 15 h (lane 5), and 18 h (lane
6). The position of E2 is indicated.
h 3‘ n - c h - c o o '
cL
HistidineImidazole
Fig 3.14. Schematic showing the structures of the side chain in a 
histidine residue compared with an imidazole molecule. (Taken 
from Qiagen handbook, 1997)
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Fig 3.15. Analysis of binding of tagged E l and E2 to Ni-NTA agarose. The
cell debris (lanes 1, 5 and 9) and soluble fractions (lanes 2, 6 and 10) were 
prepared from cells electroporated with RNA from pSFV/ElhisE2 (lanes 1-4) or 
pSFV/ElE2Gia (lanes 5-8) and mock-electroporated cells (lanes 9-12). Samples 
were analysed alongside proteins bound to Ni-NTA resin (lanes 4, 8 and 12) and 
aliquots of the unbound supernatant (lanes 3, 7 and 11). Following 
electrophoresis on a 12% polyacrylamide gel, proteins were transfered to 
nitrocellulose membrane and analysed by Western blot analysis using an E l- 
specific MAb E1F (diluted 1:500; panel a). Subsequently, the membrane was 
stripped of immunoglobulins and analysed again using E2-specific MAb E2G 
(diluted 1:500; panel b). The positions of E 1 his, El and E2 are indicated. The 
characteristics of E1F and E2G are shown in Table 4.2.
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Fig 3.16. Effect of imidazole concentration on the binding of 
histidine-tagged E l to Ni-NTA agarose. Cells, electroporated with 
RNA transcribed from pSFV/Elh.sE2 (lanes 7-12) or mock- 
electroporated (lanes 1-6), were radiolabelled with 35S-methionine for 
4-12 h after electroporation. Crude extracts obtained from these cells 
were applied to Ni-NTA resin either in the absence (lanes 1 and 7) or 
presence of 5mM (lane 2 and 8), lOmM (lanes 3 and 9), 20mM (lanes 
4 and 10), 30mM (lanes 5 and 11) and 40mM (lanes 6 and 12) 
imidazole. Bound proteins were eluted in loading buffer and analysed 
on a 10% polyacrylamide gel. Positions of El his and E2 are shown.
Fig 3.17. Effect of imidazole concentration on elution of tagged 
E l from nickel-NTA agarose. Cells were electroporated with RNA 
from pSFV/ElhisE2 and radiolabelled for 4-12 h after electroporation. 
Crude extracts obtained from these cells were applied to Ni-NTA 
agarose and eluted in the presence of binding buffer containing 
imidazole at concentrations of 200mM (lane 3), 400mM (lane 5), 
600mM (lane 7) or 800mM (lane 9). Gel loading buffer was then 
applied to the remaining resin to remove residual proteins (lanes 4, 6, 
8 and 10). Lane 1 shows the crude extract applied to Ni-NTA agarose 
and lane 2 represents the bound material eluted directly in loading 
buffer. The positions of El his and E2 are indicated.
c. f.
Fig 3.18. Confocal microscopy analysis of the localisation of E l, E2 and 
calnexin. Cells electroporated with pSFV/ElhisE2 RNA were fixed with 
methanol 16 h after electroporation and processed for indirect
immunofluorescence. Images of these cells, captured by confocal microscopy, 
show intracellular localisation of El using anti-El antiserum, R528 (panel a), 
E2 using anti-E2 MAb, ALP98 (panels b and e), and calnexin using anti- 
calnexin antiserum (panel d). Merged images are shown for El and E2 in panel 
c and E2 and calnexin in panel f.
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Fig 3.19. Endo Hf treatm ent of E l and E2. Cells electroporated with 
RNA from pSFV/ElhisE2 were lysed 16 h post electroporation in binding 
buffer. Duplicate aliquots of crude extract were denatured and incubated 
with endo Hf. Equal volumes of endo Hf-untreated (lanes 1) and -treated 
(lanes 2) samples were separated by electrophoresis on a 12% 
polyacrylamide gel for E l his (panel a) and a 9% polyacrylamide gel for E2 
detection (panel b). Proteins were transferred to membrane and Western 
blot analysis was performed using antiserum R528 (panel a), and MAb 
ALP98 (panel b) to probe for El and E2, respectively. Glycosylated (gly+) 
and endo Hf treated (gly-) El his and E2 are indicated.
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Fig 3.20. Analysis of the stability of E2 in the ER. pSFV/Elh.sE2 
RNA-electroporated cells were placed in media containing 200pg/ml 
CHX, to inhibit protein translation, 7 h after electroporation. Cells 
were harvested at 7 h (lane 1), 10 h (lane 2), 13 h (lane 3), 15 h (lane 
4) and 18 h (lane 5) post electroporation. Aliquots of crude extracts 
were separated by electrophoresis and transferred to membrane for 
analysis by Western blot using E2-specific MAb ALP98. The position 
of E2 is indicated.
Chapter 4 -  Results
Chapter 4 - Characterisation of the Native and Aggregated Complexes 
Formed by E l and E2 
4.1. Introduction
At the start of this project studies by Grakoui et al. (1993) and Dubuisson et al. (1994) on 
strain H, a genotype la  strain of HCV, had shown that intermolecular disulphide bonds 
existed in complexes formed by El and E2. However, Ralston et al. (1993 ) presented 
contrary evidence suggesting the heteromeric complex contained non-covalent E1E2 
interactions. In the light of such contrasting observations, the nature of the interactions 
between the glycoproteins of strain Glasgow were studied by comparing their mobilities 
under reducing and non-reducing electrophoresis conditions. Under non-reducing but 
denaturing conditions, disulphide-linked proteins remain covalently attached, while non- 
covalently associated complexes would dissociate (see Section 1.3.5). Thus, by altering 
the reducing conditions in polyacrylamide gels both types of complex can be discriminated 
and analysed. To extend this analysis, the behaviour o f E1E2 complexes was examined 
also in situ by adding a reducing agent, DTT, directly to cells. The effect of adding this 
reagent during protein synthesis can reversibly disrupt disulphide bonds (Braakman et al., 
1992b).
For comparative purposes, the behaviour of the glycoproteins produced from strain H77, 
which is also genotype 1 a, were examined alongside the proteins produced from strain 
Glasgow. The cDNA clone of strain H77 is infectious in chimpanzees (Yanagi et al.,
1997) and was obtained later in the course of this study.
4.2. Behaviour of Strain Glasgow E lhiS and E2 under Non-Reducing 
Electrophoresis Conditions
Extracts from cells electroporated with pSFV/ElhiSE2 RNA were prepared in binding 
buffer containing NEM, an alkylating agent which blocks free sulphydryl groups of 
cysteine residues. This compound was added to solutions to prevent aberrant disulphide 
bond formation between cysteine residues on proteins during preparation of crude extracts. 
Extracts were then mixed with Ni-NTA agarose from which bound proteins were eluted. 
Examination of bound material under reducing electrophoresis conditions (see Section 
2.2.21) revealed the presence of E 1 his and E2 (Fig 4.1, lane 1, compare with Section 3.8,
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Fig 3.16). However, little monomeric El and E2 were detected under non-reducing 
conditions and most of the eluted material purified from Ni-NTA agarose failed to migrate 
into the resolving component of the gel (labelled Agg; Fig 4.1, lane 2). This indicated that 
the E1E2 complex contained intermolecular disulphide bonds. Therefore, the majority of 
the E1E2 complexes formed by strain Glasgow are characteristic of an aggregated complex 
and not a native complex (see Section 1.3.7).
To address the question of whether this high abundance of covalent E1E2 complex was an 
artefact of the time at which cells were harvested during SFV-mediated expression of the 
proteins, extracts were obtained at regular time points after electroporation with 
pSFV/ElhiSE2 RNA. The presence of E l his was examined by Western blot analysis, under 
both non-reducing and reducing conditions (Fig 4.2). Under reducing electrophoresis 
conditions, E l his was not detected until 6 h after electroporation and its abundance 
increased substantially by 8 h (Fig 4.2, lanes 8-10). Thereafter, there was a further slight 
rise in amount at each of the subsequent time points (Fig 4.2, lanes 11-14). Under non­
reducing electrophoresis conditions, Elhis did not migrate as a discrete band but rather was 
identified as diffuse material (Fig 4.2, lanes 1-6). These are presumably oxidised forms of 
Elhis protein in a variety of conformational states. The diffuse material was not readily 
detected until 8 h after electroporation and did not increase in intensity at later time points. 
Moreover, there was much less monomeric El found under non-reducing as compared to 
reducing electrophoresis conditions (Fig 4.2, compare lanes 1-6 with lanes 9-14). The 
majority of El detected by the antibody was found in a high molecular weight band during 
the time course (labelled Agg in Fig 4.2). This represented material that failed to migrate 
into the gel and corresponds to El which is covalently attached by intermolecular 
disulphide bonds to itself or other proteins. Thus, the low abundance of non-covalently 
associated E1E2 complex is not a feature of extended expression by SFV. The diffuse 
nature of El under non-reducing conditions may also explain the inability to readily 
observe any E l in the non-reduced sample in the previous experiment (Fig 4.1, lane 2). 
Hence, El and E2 encoded by strain Glasgow may produce some non-covalently bound 
complex although they predominantly exist in a covalently-associated complex.
4. 3. Behaviour of E1E2 Complexes under Reducing Conditions I n  S i t u
Thus far, results have indicated that disulphide bonds do seem to have a role in complex 
formation since aggregated material is primarily detected under non-reducing
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electrophoresis conditions. Other studies on HCV El and E2 (Dubuisson et al., 1994; 
Deleersnyder et al., 1997) have found similar complexes as well as significant amounts of 
native complex. To further examine the role of disulphide bonds in E1E2 complex 
formation, the properties of the complex were characterised under reducing conditions in 
situ. From previous studies, treating cells in situ with DTT reversibly reduces disulphide 
bonds within proteins (Braakman et al., 1992b). Therefore, a series of experiments were 
devised employing this method to analyse the effect of DTT addition on the stability of 
pre-formed E1E2 complexes.
1 c
Cells were electroporated with pSFV/ElhiSE2 RNA and proteins radiolabelled with S- 
methionine 4 h after electroporation. Labelling was continued for a further 8 h at which 
point CHX was added to block translation. Following incubation for 30 min in the 
presence of CHX, DTT was added to cells at a final concentration of 5mM and cells were 
harvested after a further 30 min incubation. In parallel, another culture was treated with 
CHX but no DTT was added at any stage. Extracts were then prepared in the presence of 
NEM and, following purification by Ni-NTA affinity chromatography, bound proteins 
were analysed under both reducing and non-reducing conditions (Fig 4.3). The E1E2 
complexes purified from cells that had not been treated with DTT behaved in an identical 
manner to those shown in Fig 4.1. El and E2 migrated as monomers under reducing 
conditions (lane 3) but mainly as a high molecular weight complex in the absence of 
reducing agent (lane 1). From the extracts of cells treated with DTT, E2 continued to co- 
purify with histidine-tagged E l as both proteins are found in gels run under reducing 
conditions (lane 4). Significantly, under non-reducing conditions, El and a band presumed 
to be E2 no longer migrated as a high molecular weight complex but rather as monomeric 
proteins (lane 2). The presence of E2 in non-reducing gels was verified in a separate 
experiment. Cells were electroporated with pSFV/ElhiSE2 and treated with DTT as 
described in the experiment for Fig 4.3. Following purification by Ni-NTA 
chromatography, eluted samples were analysed by Western blot analysis for E2 using an 
anti-E2 antiserum (R141). Under non-reducing electrophoresis conditions, E2 could be 
detected both as a high molecular weight species and as a monomeric protein; in a 
reducing gel, E2 was found to exist almost exclusively as a monomeric species (Fig. 4.4, 
lanes 1 and 2). This confirms that DTT treatment of cells reduces intermolecular 
disulphide bonds in the HCV glycoproteins but E2 and El remain associated. Therefore, 
DTT treatment of cells in situ can break the intermolecular disulphide bonds between El
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and E2 molecules but does not disrupt the complex they form. Hence, within the 
aggregated complex, non-covalent interactions do exist between El and E2.
Following this observation, the effect of DTT on E1E2 complexes was further 
characterised. In the following experiment, the result of varying the concentration of DTT 
added to cells on the aggregated material and the non-covalent E1E2 interactions was 
examined. Again, radiolabelled complexes from pSFV/ElhisE2-electroporated cells were 
isolated by Ni-NTA chromatography and analysed under non-reducing conditions to 
monitor the loss of high molecular weight material (Fig 4.5). At the lowest concentration 
of DTT (0.1 mM), there was no evidence that reduction of E l and E2 had occurred in situ 
and El and E2 remained as high molecular weight material at the top of the gel (lane 3). 
However, addition of DTT to 0.5mM to cells led to the appearance of monomeric E l (lane 
4) and at higher concentrations of DTT, there was a progressive increase in the amount of 
both monomeric El and E2 which entered the gel (lanes 5-8). These data also show that 
even at relatively high concentrations of DTT (5mM and lOmM), the non-covalently- 
linked El and E2 complex is stable. In subsequent experiments, DTT was added to cells at 
a final concentration of 5mM, a concentration that is consistent with that used in other 
studies (Braakman et al., 1992b).
To determine the time required to fully reduce the aggregated material in 5mM DTT, cells 
electroporated with pSFV/ElhiSE2 RNA were radiolabelled and then treated with DTT and 
CHX for various lengths of time. Analysis of isolated complexes revealed that reduction 
was achieved by 5 min following the addition of DTT to cells (Fig 4.6, lane 4) and is 
effectively complete by 20 min (lane 6). Taken together, the results in this and the 
previous experiment provided parameters for further studies on the effect of DTT on E1E2 
complexes and gave conclusive evidence that non-covalent interactions between El and E2 
are not dependent on intermolecular disulphide bonds for stability.
4.4. Effect of Removal of DTT from Cells on E1E2 Complexes
It is possible that in situ reduction of El and E2 by DTT addition to cells mediates a 
change in either the conformation of the glycoproteins or the complex which they form, 
such that reformation of disulphide bonds is not possible. In the previous experiments, the 
effect of DTT on the disruption of the pre-formed complexes was examined, where cells 
were incubated in the presence or absence of DTT and harvested immediately after its
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removal. Here, cells expressing El and E2 synthesised from pSFV/ElhiSE2 RNA were 
treated with CHX and DTT, after which the cultures were washed with medium containing 
CHX but lacking DTT and then harvested at various times following removal of the 
reducing agent (Fig 4.7). As described in the previous experiments, treatment of cells with 
DTT and CHX induced the appearance of monomeric E l and E2 (compare lanes 2 and 3). 
Upon removal of DTT from cells, reformation of aggregated material could be detected 
within 5 min of DTT removal (lane 5) and it was the predominant species by 15 min (lane 
6). Hence, the effect of DTT is reversible and disulphide bond formation recurs upon its 
removal. However, non-aggregated forms of the complex are not recovered, suggesting 
that even transient release from possible incorrect intermolecular covalent linkages does 
not allow re-ordering of the non-covalent interactions to generate complexes which do not 
aggregate.
4.5. Disulphide Bond Formation is not Required for the Initial 
Interactions Between E l and E2
The data described thus far examined the function of disulphide bonds in pre-existing 
complexes. To address any role for such covalent linkages in initial interactions between 
El and E2, complexes formed by de novo synthesised E l and E2 in the presence and 
absence of DTT were analysed. After incubation at 37°C for 12 h, pSFV/ElhiSE2- 
electroporated cells were radiolabelled for 1 hour in the presence o f DTT; a parallel culture 
was incubated in radiolabelling media for the same period but in the absence of DTT. 
Extracts made in the presence of NEM were applied to Ni-NTA agarose and the bound 
material was divided for analysis under non-reducing and reducing conditions (Fig 4.8). 
Synthesis of the ElhisE2 polyprotein in the presence of DTT did not inhibit its processing 
to produce monomeric E l and E2 (compare lanes 3 and 4). The behaviour of the complex 
made in the absence of DTT was similar to that described previously (Fig 4.1, lane 2), 
where the majority o f the complexes remained as high molecular weight material under 
non-reducing electrophoretic conditions (Fig 4.8, lane 2). Significantly, complexes 
purified from DTT-treated cultures showed that the inability to form intermolecular 
disulphide bonds did not prevent association of El and E2 (lanes 1 and 3). It is presumed 
that DTT also prevents intramolecular disulphide bond formation within the individual El 
and E2 glycoproteins. Hence, these data underline the ability of the two proteins to form 
non-covalent interactions in the absence of covalent disulphide linkages.
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To further characterise the behaviour of de novo synthesised E l and E2 in complex 
formation, electroporated cells were pulse-labelled for 2 min with S- 
methinonine/cysteine and then chased for up to 10 min. To prevent disulphide bond 
formation during the pulse/chase period, DTT was added to one set of cells 15 min prior to 
addition of the radiolabelling amino acids and was maintained until the cells were 
harvested. In this experiment, immunoprecipitations were performed with E2-specific 
antiserum R141 as opposed to use of Ni-NTA chromatography. Results showed E l was 
associated with E2 by 2 min after the pulse in both DTT-treated and non-treated samples 
(Fig 4.9, panels c and d, lane 2). The presence of monomeric E l and E2 in non-reducing 
gels verified that intermolecular disulphide bonds had not formed in proteins synthesised in 
the presence of DTT (panel a, lanes 2-4). In comparison with samples not treated with 
DTT, only small quantities of E2 and no El could be detected in monomeric form in non­
reducing gels (panel b, lane 2) and the abundance of the monomeric E2 protein decreased 
at longer chase times (panel b, lane 4). The lack of monomeric E l and the reduced amount 
of monomeric E2 results from the formation of aggregated material, which barely enters 
the resolving gel (panel b, lanes 2-4). It was also evident that monomeric E2 isolated from 
untreated cells consisted of diffuse material whereas E2 from DTT-treated cells was a 
discrete band (compare panels a and b, lanes 2-4). The diffuse nature of E2 in panel b is 
likely to result from intramolecular disulphide bond formation, which gives rise to various 
oxidised forms of the protein. The appearance of E2 as a discrete band in the samples from 
DTT-treated cells is indicative that intramolecular disulphide links are not present in the 
protein. From these data, it was concluded that non-covalent association of El and E2 
occurs rapidly following synthesis and disulphide bond formation, both inter- and 
intramolecular, is not necessary for such interactions.
4.6. Comparison of Glycoproteins Produced from Strains Glasgow and 
H77
During the course of this study, it was reported that RNA synthesised from cDNAs 
comprised of the consensus sequence of HCV strain H77 were infectious in chimpanzees 
(Kolykhalov et al., 1997; Yanagi et al., 1997). Published data also showed that both 
covalently- and non-covalently-linked E1E2 complexes could be identified with the HCV 
H strain which was isolated from a chimpanzee infected with strain H77 and has very high
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homology to H77 (Inchauspe et al., 1991; Dubuisson et al., 1994). Sequence comparisons 
of El and E2 between the Glasgow and H77 strains revealed that there are 9 amino acid 
residue differences in El and 30 in E2 (Appendix 2). These changes do not affect the 
number or the position of the cysteine residues in either of the proteins for both strains. 
Indeed, the cysteine residues in the glycoproteins appear to be highly conserved throughout 
type la  strains of HCV (Robertson et al., 1998). However, the differences in amino acid 
sequences at residues 476, 478 and 532 predict that E2 from strain H77 has two additional 
glycosylation sites as compared to strain Glasgow E2 (Ogata et al., 1991; M. McElwee and 
R.M. Elliott, unpublished data). In E l, the variations in the amino acid sequences do not 
affect the predicted glycosylation sites.
The initial strategy was to clone an ApaLI-Eco4 7III fragment from pCV-H77C (supplied 
by J. Bukh; Yanagi et al., 1997), which encoded residues 1-837 and thus contained the 
coding region for the structural proteins as well as sequences for p7 and the N-terminus of 
NS2 (Appendix 3). The strain H77 DNA fragment was inserted into pGEMl (Fig 3.3, 
panel a) which had been modified to include ApaLI and Eco4 7III  restriction sites and in­
frame stop codons following the Eco47III site within the multiple cloning region (as shown 
in Fig 3.3, panel c). This construct was termed pGEM/CElE2n77. BglH  sites (Fig 3.3, 
panel c) flanking the HCV protein coding region allowed the coding sequences to be 
transferred into the BamHI site of pSFVl (Fig 3.3, panel b); the resultant plasmid was 
named pSFV/CElE2n77. For later experiments on E l (Chapter 5), the sequences encoding 
El to NS2 were excised as a Fspl-Bglll fragment and reintroduced into the pGEMl vector 
along with a PCR fragment to reconstitute the El signal sequence (Fig 4.10). A unique 
N sil site was included in the forward primer and placed upstream of the El signal peptide 
coding sequence. This facilitated subsequent cloning directly into the pSFVl vector (see 
Section 5.4.1). Using the flanking Bglll sites, the coding sequences were introduced into 
pSFVl, giving a construct named pSFV/AElE2n77. Electroporation of RNA from this 
construct into cells did not give rise to detectable levels of recombinant proteins as 
determined by Western blot analysis and immunofluorescence studies. Sequencing data 
did not indicate any sequence errors which would give aberrant frame shifts or deletions. 
The low level of expression may have been due to the context of the AUG start codon or 
inappropriate secondary structure formation at the 5’-terminus of the RNA molecules, thus 
inhibiting translation. In light of this, the authentic start codon of the HCV polyprotein and 
the first 65 amino acid residues of core protein were fused to the N-terminus of the El 
signal sequence. An oligonucleotide was employed to bridge the core and El coding
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sequences as described in Fig 4.11. The resultant construct was called pGEM/ElE2n77 and 
contained residues 1-65 and 169-837 of the strain H77 coding regions; 3 non-HCV 
residues were incorporated between amino acids 65 and 169. A BglH  fragment carrying 
the HCV coding sequences was introduced into the pSFV 1 vector and the construct was 
named pSFV/ElE2n77-
To compare the El and E2 species made by strain H77 with those of strain Glasgow, cells 
were electroporated with pSFV/CElE2n77, pSFV/CElE2Qia and pSFV/ElhiSE2 RNAs and 
the proteins radiolabelled with 35S-methionine from 4-12 h post electroporation. Extracts 
prepared from cells were incubated with an E2-specific monoclonal antibody, ALP98 
(Appendix 5). Electrophoresis of immunoprecipitates under reducing conditions showed 
that E2 made by strain H77 had a greater apparent molecular weight than E2 from strain 
Glasgow (Fig. 4.12, compare lane 5 with lanes 4 and 6). This increased size for strain H77 
E2 is assumed to result from the two additional glycosylation sites in the protein as 
compared to strain Glasgow (Ogata et al., 1991; M. McElwee and R.M. Elliott, 
unpublished data; see above). By contrast, strain H77 E l had a lower apparent molecular 
weight than that for strain Glasgow (Fig. 4.12, compare lane 5 with lanes 4 and 6). The 
difference in mobilities for the El glycoproteins may not be a consequence of the presence 
of the histidine tag since untagged El made by strain Glasgow also has a greater apparent 
molecular weight than strain H77 E l. The predicted molecular weights of nascent and 
fully glycosylated El and E2 proteins from strains Glasgow and H77 are shown in Table 
4.1. This reveals that the predicted size of unmodified E l from both strains is identical, 
although the extra histidine residues in strain Glasgow Elhis do contribute to an increase in 
mass of the nascent protein. However, the difference in migration for unmodified El 
between the two strains, suggests there may be additional processing to the El protein 
from strain Glasgow. This issue is addressed further in Chapter 5 (Section 5.3.2).
Analysis of the complexes made by the two strains under non-reducing conditions revealed 
little, if any, monomeric El and E2 derived from strain Glasgow and the bulk of the 
complexes migrated at the top of the gel (Fig. 4.12, lanes 1 and 3). This is consistent with 
data presented earlier (Fig 4.1) and again shows that this property of the E1E2 complex 
produced by strain Glasgow is not due to the histidine tag in E l. A high proportion of the 
glycoproteins made by strain H77 also ran at the top of the gel, however, monomeric E2 
and El species also could be readily observed (Fig. 4.12, lane 2). Hence, for strain H77, 
both covalently-linked and non-covalently-linked E1E2 complexes were detected.
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In the previous experiment, MAb ALP98, raised against E2 from strain Glasgow, was able 
to precipitate the glycoproteins from both strains. Further comparisons between E l and E2 
encoded by strains H77 and Glasgow were undertaken using a series of human and mouse 
monoclonal antibodies, which recognised conformational epitopes (supplied by M.
Cardosa and J. Dubuisson, Table 4.2). Using extracts prepared from pSFV/CElE2Gia and 
pSFV/ClE2H77 RNA-electroporated cells, none of the antibodies precipitated the strain 
Glasgow glycoproteins (Fig. 4.13 and 4.14, lanes 1-4). However, E1E2 complexes from 
strain H77 were recognised by the antibodies but to variable extents (summarised in Table
4.2). In particular, two human (1A7 and 2H1; Fig 4.14, lanes 5 and 6) and one mouse 
antibody (H33; Fig 4.13, lane 6) had particularly high affinities. The strain-specificity of 
these antibodies precluded their further use in comparing the properties of the complexes 
made by strains Glasgow and H77. However, one antibody, H53, which reportedly has a 
preferred affinity for the non-covalent complex (Cocquerel et al., 1998) was used in 
subsequent analysis of strain H77 E1E2 interactions.
4.7. Behaviour of E l and E2 Produced by Strain H77 in the Presence and 
Absence of DTT I n  S i t u
The previous section described data indicating that strain H77 produced both covalent and 
non-covalent heteromeric E1E2 complexes. To examine the effect of DTT on pre-formed 
complexes made by strain H77 glycoproteins, cells were electroporated with RNA from 
pSFV/CElE2H77, and, for comparative purposes with pSFV/CElE2cia and pSFV/ElhiSE2 
RNAs. Following radiolabelling, cell cultures were treated with DTT. Cell extracts were 
prepared and complexes isolated using the E2-specific antibody, ALP98 (Fig. 4.15). This 
revealed that El continued to precipitate with E2 for strain H77 in the presence of DTT, 
indicative that, as for strain Glasgow, disulphide bonds are not required to stabilise the 
intermolecular interactions between the glycoproteins (Fig. 4.15, lanes 4-6). Under non­
reducing electrophoresis conditions, there was an increase in the abundance of E2 detected 
as compared to analysing the equivalent untreated sample also in a non-reducing gel 
(compare Fig 4.12 and Fig 4.15, lanes 2). This is presumably because of E2 dissociation 
from the aggregate in DTT-treated samples. In agreement with the data for strain Glasgow 
(Fig. 4.15, lanes 1 and 3), DTT can reduce disulphide bonds in aggregated E1E2 
complexes. In addition to bands specific for E l and E2, three additional novel bands were
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present in the lanes representing strain H77 samples treated with DTT (lanes 2 and 5; 
marked by ♦ ,  *, and ■). The * species was found consistently for this strain when the 
samples were prepared after DTT treatment. The band indicated by ♦ ,  is likely to 
represent glycosylated but uncleaved E1E2 precursor, while ■ may correspond to 
incompletely glycosylated E l. Glycosylation of E l is addressed further in the following 
chapter 5 (Section 5.2.2)
Detection of E2 by ALP98 is not abolished by DTT treatment in situ, presumably because 
the antibody recognises a linear epitope (Appendix 5). To analyse the effect of DTT on 
detection of the HCV glycoproteins by other antibodies, including those that are 
conformation-specific, cells were electroporated with pSFV/CElE2H77 and pSFVl RNAs. 
12 h post-electroporation parallel cell cultures were pulse-labelled for 2 min and chased for 
a period of 80 min in the presence and absence of DTT. Crude extracts derived from both 
sets of cells were analysed by immunoprecipitation with H53 as well as with anti-El 
antiserum R528, El-conformation sensitive MAb AP497, and E2-specific ALP98 (see 
Appendix 5). Analysis of precipitates under reducing conditions revealed that for non- 
DTT-treated samples equivalent amounts of E2 were precipitated by the E2-specific MAbs 
H53 and ALP98 (Fig 4.16, panel b, lanes 3 and 4). In addition similar amounts o f El (and 
associated E2) were precipitated by the El-specific antibodies R528 and AP497 (panel b, 
lanes 1 and 2). However, for samples derived from DTT-treated cells, reduced levels of 
E1E2 complexes were detected by the conformation-specific E l MAb AP497 and E2 MAb 
H53 (Fig 4.17, panel a, lanes 1 and 4) as compared to R528 and ALP98 precipitated 
material (lanes 2 and 3). This data suggests that the majority of E l and E2 do not form the 
conformations recognised by AP497 and H53 in the reduced state. This indicates that 
disulphide bond formation may be necessary to gain and stabilise the correct 
conformations in El and E2. However, a proportion of the glycoproteins did achieve the 
conformation necessary for immuno-detection, in particular with H53. Therefore, this 
antibody, along with ALP98, was used in a subsequent experiment to monitor complex 
formation at various times after synthesis.
To study the role of disulphide bonds at early stages of complex formation for the H77 
glycoproteins, cells electroporated with RNA from pSFV/CElE2n77 were chased for 
various periods following pulse labelling. Parallel cultures were radiolabelled in the 
presence of DTT to examine the affect on complex formation in the absence of disulphide
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bond formation. Immunoprecipitations were carried out on crude extracts with the two E2- 
specific antibodies, ALP98 and H53.
In the absence of DTT, H53 recognised a native form of the complex more efficiently then 
ALP98, as deduced from the higher abundance of El observed under non-reducing 
conditions (Fig 4.17, panels a and b, lane 4). The presence of E2 was obscured by other 
species in the immunoprecipitates. This complex was most apparent at later times in the 
pulse chase experiment in agreement with previously reported data (Deleersnyder et al., 
1997). It was found that, in these experiments, H53 precipitated also some aggregated 
material (panel b, lanes 1-4). In the presence of DTT, both antibodies precipitated El as 
well as E2 even at early chase times, although ALP98 was more efficient then H53 as was 
observed in the previous experiment (panels a-d, lanes 5 and 6). Nonetheless, in 
agreement with earlier data, DTT treatment in situ does not prevent association between El 
and E2. From comparison of the relative mobilities of El in Fig 4.17, it is evident that the 
oxidised form of El is present in untreated samples while only the reduced form is 
detected in those samples treated with DTT (panel b, compare lanes 3 and 4 with lanes 7 
and 8). This indicates that intramolecular disulphide bonds do not form in the presence of 
DTT, further highlighting that El and E2 association does not rely upon the formation of 
covalent linkages. This conclusion was confirmed in subsequent experiments (Section
5.4.2).
4.8. Discussion
Comparison of the mobilities of strains Glasgow and H77 E l and E2 glycoproteins 
revealed a difference in size between corresponding proteins for the two strains. Although 
an increase in mass is predicted in El from strain Glasgow on account of the histidine tag, 
the slower migration is also observed for untagged E l from the same strain. However, the 
predicted molecular weights of the nascent chains of El from strains Glasgow and H77 are 
almost identical. The predicted number of potential N-linked glycosylation sites in El for 
both strains also is conserved. E2 from strain Glasgow is predicted to have two fewer N- 
glycosylation sites than its counterpart from strain H77 and a change in glycosylation 
pattern could account for the difference in their mobilities. This cannot apply to E l, nor 
can the possibility of aberrant processing from the polyprotein, considering E2 is of the
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appropriate size. Therefore, additional processing to the El protein from strain Glasgow 
may occur and this issue is addressed in the following chapter.
Previous studies on the E2 species have reported inefficient processing at the E2/p7 
cleavage site for strain H but not for strain BK (Dubuisson et al., 1994; Lin et al., 1994; 
Dubuisson & Rice, 1996). Thus, the E2 species detected for strain H is a combination of 
E2 and E2-p7 proteins. Based on the apparent molecular weights of E2 from strains H77 
and Glasgow, both in the glycosylated and deglycosylated states (Table 4.1), it would 
appear that a proportion of E2 is not cleaved from p7. The precise ratio of E2 to E2-p7 in 
the studies presented here is not possible to ascertain given the lack of any antibodies 
against p7. It is also difficult to identify the nature of the different cleavage efficiencies 
between strains H and BK; the amino acid sequences flanking the cleavage sites are 
identical in the two strains although there are 14 amino acid changes elsewhere in p7. This 
is in addition to the differences in amino acid sequence in E2. In light of the uncertainty as 
to the proportion of E2:E2-p7 made by strains Glasgow and H77 using the SFV system, it 
is assumed that both species could be present in extracts. For simplicity, bands of 
approximately 60-69 kDa identified by E2 antibodies have been referred to as E2 
throughout this study with the caveat that both E2 and E2-p7 may be present in species of 
this size range.
Examination of complex formation by strain Glasgow E2 and histidine-tagged or untagged
E l, under non-reducing conditions, revealed little evidence of native complexes and
essentially only an aggregated complex was detected. This does not preclude the
possibility that an antibody, which is specific for a particular conformation, may identify
some native complexes formed by strain Glasgow (see Sections 5.3.3 and 6.1.4). By
contrast, a native complex was detected for strain H77 glycoproteins. This suggests that
the presence of the histidine tag was not in itself a cause for the reduction in native
complex formation by strain Glasgow E l and E2. The reduction could have been a
consequence of differences in amino acid sequence between the strains; there are 9 and 30
residue changes in E l and E2 respectively. Moreover, there are two fewer predicted N-
glycosylation sites in E2 from strain Glasgow. Proper N-linked glycosylation and
oligosaccharide trimming is necessary for glycoprotein folding as part of the ER quality
control mechanism (Section 1.4.5; Hammond & Helenius, 1995). For example, influenza
virus HA contains of seven N-glycosylation consensus sequences. Mutations that removed
individual N-linked glycans affected the rate and efficiency of HA folding (Hebert et al.,
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1997). Abolition of glycosylation at one site (residue 81 in HA) disrupted formation of a 
crucial disulphide bond between cysteine residues 67 and 76, which is close to this glycan. 
This inhibited folding and HA trimer formation. The additional two N-glycosylation sites 
present in E2 from strain H77 may also participate in protein folding, particularly as one of 
these sites (at residue 532) is conserved in other HCV genotypes. The second site is 
located within the second variable region in E2 (aa 476; see Fig 1.13). In a more recent 
study, analysis of the association of El glycosylation mutants with E2 indicated that the 
absence of a glycan at a single site was sufficient to impair native complex formation 
(Meunier et al., 1999). Thus for strain Glasgow, the lack of two glycosylation sites as 
compared to strain H77 may account for the lower amount of native E1E2 complexes 
detected. Furthermore, the presence of p7 does not appear to contribute to the formation of 
either the native or aggregated complexes, as this peptide remains linked to a proportion of 
E2 from both strains Glasgow and H77. An earlier study showed that expression of aa 1- 
1207 of strain H by both Sindbis and vaccinia viral vectors generated native complexes 
that contained incompletely processed E2-p7 species (Dubuisson et al., 1994).
In light of the detection of disulphide-linked aggregated complexes, the requirement for 
these covalent bonds was examined further by the use of DTT. Previous studies had 
indicated that the presence of the reducing agent, DTT, in cell culture media did not have 
significant effects on cellular functions such as translation, translocation, signal sequence 
processing, N-linked glycosylation and transport beyond the ERGIC (Braakman et al., 
1992a; Desilva et al., 1993; Verde et al., 1995). However, this agent does profoundly 
affect the redox potential of the ER that results in the reduction of cysteine residues in the 
active site of PDI, which catalyses disulphide bond formation (Section 1.4.3), and renders 
it inactive (Holst et al., 1997). This prevents appropriate disulphide bond formation in 
proteins translocated to the ER lumen, including VSV G, influenza HA and CD8 ERGIC 
(Braakman et al., 1992a; Tatu et al., 1993; Verde et al., 1995). These earlier studies using 
DTT for in situ reduction showed that de novo synthesised influenza virus HA and VSV G 
were retained in the ER in an unfolded state (Braakman et al., 1992a). Following the 
removal of DTT, they folded correctly, as shown by conformation-specific antibodies. In 
addition, they were transported from the ER to the Golgi network, where they were 
assembled into proper oligomers detected on virions. Since folding of proteins can occur 
after removal of DTT, it was possible that E l and E2 from strain Glasgow may fold and 
associate to give increased amounts of native complex upon removal of the reducing agent. 
However, E1E2 aggregated complexes, not native complexes, reformed relatively soon
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after the removal of DTT, which suggests that manipulation of the intracellular 
environment does not overcome this intrinsic behaviour of E l and E2 to form aggregates.
In another study, using an alternative approach to reduce the levels of aggregated 
complexes, the abundance of calnexin, calreticulin or BiP was increased. However this did 
not induce any elevated levels of native complex (Choukhi et al., 1998).
Investigation of the aggregated complexes formed by strains Glasgow and H77 El and E2 
glycoproteins following reduction in situ showed that these proteins continued to co­
precipitate. This was a somewhat unexpected result given that aggregated complexes were 
considered to represent association of El and E2 by disulphide links. Thus, DTT treatment 
has uncovered non-covalent interactions between E l and E2 in the aggregated complex. 
There are a number of possibilities which may account for their continued association: a) 
the disruption of intermolecular disulphide bonds may have exposed regions o f El and E2 
which can then interact non-covalently, b) E l and E2 may form homo-oligomers which 
retain the ability to interact non-covalently with each other, and c) in addition to covalent 
interactions, E l and E2 associate via non-covalent interactions simultaneously in the 
aggregated material. Possibility b) is unlikely since analysis of homo-oligomerisation of 
El shows that such forms can be detected more readily upon expression of El alone than 
in combination with E2 (see Section 5.2.2). It is difficult to distinguish between 
possibilities a) and c) with the result presented in this chapter. However, in the following 
results section, mutation of cysteine residues in E l, such that disulphide bond formation is 
not possible, does not abolish complex formation but E2 in these complexes is in an 
aggregated state. Therefore, aggregated complexes can contain both non-covalent and 
covalent interactions between El and E2.
For two antibodies (AP497 and H53) that recognise conformational epitopes, disruption of 
disulphide bonds by DTT did reduce their capacity to recognise E l and E2. Therefore, 
disulphide bond formation is important either to generate or stabilise particular 
conformations of the proteins. In a study using a truncated form of E2 as antigen, Lee et 
al. (1997) showed that sera from infected individuals retained the ability to recognise 
protein denatured by heat or SDS treatment. However, treatment of E2 with p-ME, a 
reducing agent, dramatically decreased recognition by most sera. This indicates an 
important role for disulphide bonds in generation of antigenic epitopes in the 
glycoproteins. The studies with DTT indicated that generation of such conformations is
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not a pre-requisite for interaction between El and E2. However, these interactions may be 
those that occur in an aggregated but not a native complex.
Pulse-labelling experiments revealed that the aggregates for both strains Glasgow and H77 
formed much earlier than the native complex in strain H77. The slower occurrence of 
native complexes has been described (Dubuisson & Rice, 1996), and it has been suggested 
that disulphide bond isomerisation in strain H El protein is rate limiting for E1E2 
association in a native complex. For N-glycosylation mutants of influenza virus HA, the 
appearance of a conformational epitope appears more rapidly than in wild type protein 
(Hebert et al., 1997). The mutant protein does not associate with calreticulin at early 
stages following synthesis and does not achieve a proper folded state (Hebert et al., 1997). 
This was explained by the masking of calnexin-HA binding sites within the improperly 
folded protein. Thus for HCV El and E2, the speed of aggregated complex formation may 
prevent the ER chaperone-assisted folding mechanisms to operate (Section 1.4.4). This 
possibility is discussed further in Chapter 7.
Non-covalent interactions have been identified in the native E1E2 complex while both 
covalent and non-covalent associations are found in aggregated forms of E1E2. It is 
therefore possible that regions required for non-covalent interactions are identical in both 
types of complex, but they may be distinct from areas containing cysteine residues that are 
involved in intermolecular disulphide bond formation. In an attempt to distinguish 
between these regions, a series of E l and E2 internal deletion mutants were made and are 
described in Chapters 5 and 6 respectively. Furthermore, the influence of E2 on El folding 
and vice versa was also further investigated in the following chapters.
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Strain Protein Predicted MW of 
nascent protein (kDa)
Predicted MW of 
modified protein
(~kDa)*
Glasgow E l (E lhis) 20.9 (21.9) 28.9 (29.9)#
E2 (aa 384-745) 40.0 58.0
E2-p7 (384-810) 47.1 65.1
H77 El 20.9 28.9#
E2 (aa 384-745) 40.1 62.1
E2-p7 (aa 384-810) 47.2 69.2
Table 4.1. Predicted molecular weights (MW) of E l and E2 proteins made by strains 
Glasgow and H77. * It is assumed that addition of a high mannose oligosaccharide 
increased the molecular weight of nascent protein by -2 .0  kDa per glycosylation site 
(Komfeld & Komfeld, 1985). # It is assumed that glycosylation at amino acid position 325 
in E l does not occur as reported by Meunier et al. (1999).
Antibody Type Epitope Specificity Reactivity
H77
' to strain 
Glasgow
H2 mouse
monoclonal
Conformational E2 + -
H33 mouse
monoclonal
Conformational E2 +++ -
H47 mouse
monoclonal
Conformational E2 ++ -
H53 mouse
monoclonal
Conformational E2 ++ -
1A7 human
monoclonal
Conformational E1+E2 ++++ -
2H1 human
monoclonal
Conformational E1+E2 ++++ -
4F7 human
monoclonal
Conformational E2 - -
4F1 human
monoclonal
Conformational E2 + -
E1F mouse
monoclonal
Linear E l - ++++
E2G mouse
monoclonal
Linear E2 - ++
ALP98 mouse
monoclonal
Linear E2 +++ +++
Table 4.2. Summary of the characteristics of the antibodies used in this study.
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Fig 4.1. Mobilities of strain Glasgow Elhis and E2 examined 
under reducing and non-reducing electrophoresis conditions.
Cells electroporated with pSFV/ElhisE2 RNA were radiolabelled 
between 4-12 h after electroporation with 35S-methionine. Following 
lysis in the presence of 20mM NEM, soluble crude cell extract was 
applied to Ni-NTA agarose. Bound proteins were examined under 
reducing (R, lane 1) and non-reducing (NR, lane 2) conditions on a 
12% polyacrylamide gel. Radiolabelled crude cell extract is shown 
in lane 3. The positions of Elhis, E2 and a high molecular weight 
aggregate (Agg), which fails to enter the resolving gel, are shown.
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Fig 4.2. Examination of the presence of non-aggregated Elhis at various time 
points after electroporation. Cells electroporated with RNA from pSFV/ElhisE2 
were harvested in the presence of 20mM NEM at 4 h (lanes 7 and 8), 6 h (lanes 6 and 
9), 8 h (lanes 5 and 10), 10 h (lanes 4 and 11), 12 h (lanes 3 and 12), 18 h (lanes 2 and 
13) and 22 h (lanes 1 and 14) post electroporation. Following removal of cell debris, 
duplicate aliquots of soluble material were subjected to electrophoresis on a 10% 
polyacrylamide gel under reducing (Red; lanes 8-14) and non-reducing (Non-red; 
lanes 1-7) conditions. Proteins separated under these conditions were transferred to 
membrane and examined by Western blot analysis using the Penta-His antibody, to 
detect histidine-tagged E l. The positions of the reduced (red), oxidised (ox) forms of 
Elhis and aggregated material (Agg) are indicated.
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Fig 4.3. Effect of addition of DTT in situ on strain  Glasgow E1-E2 complexes. Cells 
were electroporated with pSFV/Elh.sE2 RNA, 35S-methionine labelled between 4-12 h after 
electroporation and thereafter treated with CHX (200pg/ml) for 30 min prior to the 
addition of 5mM DTT. Cells were incubated in the presence of this reducing agent for 30 
min. A parallel cell culture was incubated with CHX but not treated with DTT. Cell 
extracts were prepared in binding buffer containing 20mM NEM and then subjected to Ni- 
NTA affinity chromatography. Bound proteins were electrophoresed on a 10% 
polyacrylamide gel under non-reducing (Non-red, lanes 1 and 2) and reducing (Red, lanes 
3 and 4) conditions. Samples derived from cells treated with (+) or without (-) DTT are 
indicated. The positions of E this, E2 and aggregated material (Agg), which fails to enter 
the resolving gel, are shown.
Fig 4.4. W estern blot analysis of Ni-NTA eluted m aterial derived from DTT-treated 
cells. Western blot analysis was performed on Ni-NTA resin eluted samples derived from 
cells treated with DTT and CHX. The eluted material was electrophoresed under reducing 
(Red) and non-reducing (Non-red) conditions. Material transfered to nitrocellulose 
membrane was analysed using anti-E2 antiserum, R 141. The positions of aggregated 
material (Agg) and E2 are indicated.
Fig 4.5. Effect on E1-E2 complexes with increasing DTT concentration in 
situ. Cells electroporated with RNA from pSFV/ElhisE2 were 35S-labelled 
from 4-12 h after electroporation followed with incubation for 30 min with cell 
culture media containing 200pg/ml CHX. Subsequently, parallel cell cultures 
were incubated with increasing concentrations of DTT prior to harvesting in 
binding buffer containing 20mM NEM. The concentration of DTT added to 
each cell culture is shown below the corresponding lane. Following Ni-NTA 
affinity chromatography, samples were electrophoresed on a 10% 
polyacrylamide gel under reducing (Red, lane 1) and non-reducing conditions 
(Non-red, lanes 2 to 7). Lanes 1 and 2 show control samples derived from 
cells not treated with DTT. Positions of E l his, E2, uncleaved precursor ElhisE2 
and aggregate (Agg) are shown.
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Fig 4.6. Effect on E1E2 complexes with increasing incubation time 
with DTT in situ. Experimental conditions were as described in Fig 4.5 
except cells were incubated in 5mM DTT for varying times. Incubation 
periods are indicated below each lane. Crude extracts prepared in binding 
buffer were subjected to Ni-NTA chromatrography and bound material 
was analysed under reducing (Red) and non-reducing conditions (Non- 
red). Lanes 1 and 2 show control samples derived from cells not treated 
with DTT. Positions o f E l his, E2, unprocessed precursor ElhisE2 and 
aggregate (Agg) are indicated.
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Fig 4.7. The effect of removal of DTT on E1E2 complexes. Cells were 
electroporated with pSFV/ElhisE2 RNA and 35S-labelled between 4-12 h after 
electroporation. CHX and DTT were added to cells as described for Fig 4.3, 
followed by washing the cells with media lacking the reducing agent and 
incubation in the absence of DTT for the times indicated below each sample. 
Cells were lysed in binding buffer and subjected to Ni-NTA affinity 
chromatography. Bound proteins were analysed by electrophoresis on a 10% 
polyacrylamide gel under reducing (Red, lane 1) and non-reducing conditions 
(Non-red, lanes 2 to 9). Control samples were derived from non-treated cells 
(-) (lanes 1 and 3) and treated cells (+) (lane 2) harvested immediately after 
the removal of DTT. The sample in lane 9 was also examined under reducing 
conditions (lane 10). The positions of E 1 his, E2, unprocessed ElhisE2 
polyprotein and aggregated material (Agg) are indicated.
Fig 4.8. Effect of DTT on complex formation by de novo 
synthesised E l and E2. Cells were electroporated with 
pSFV/ElhisE2 RNA and incubated at 37°C for 12 h. 
Subsequently, they were 35S-labelled for 1 h in the absence (-) 
(lanes 2 and 4) or presence (+) (lanes 1 and 3) of 5mM DTT. 
Following cell lysis, extracts were subjected to Ni-NTA 
affinity chromatography and analysed under reducing (Red) 
and non-reducing (Non-red) conditions on a 10% 
polyacrylamide gel. The positions o f E l his, E2, ElhisE2 
precursor and aggregated material (Agg) are indicated.
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Fig 4.9. Characterisation of complexes formed by de novo synthesised 
E l and E2 in the presence and absence of DTT. Cells were 
electroporated with pSFV/ElhisE2 RNA and incubated at 37°C for 12 h. 
Subsequently, cells were labelled for 2 min and then chased for the times 
indicated. In panels a and c, samples are from cells incubated in the 
presence of DTT (+DTT) from 15 min prior to labelling until they were 
harvested. Immunoprecipitations were performed on cell extracts with 
anti-E2 antiserum R141 and bound proteins were electroporated on 10% 
polyacrylamide gels under non-reducing (Non-red, panels a and b) and 
reducing (Red, panels c and d) conditions. The positions of aggregated 
material (Agg), E l his, E2 and oxidised E2 (ox) are shown.
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Fig 4.10. Cloning of the strain H77 E l and E2 coding region into pGEM l. The FspI- 
B glll segment encoding El to NS2 was excised from pGEM/CE1E2h77 and introduced into 
the vector backbone o f pGEM/CElE2n77 that had been cut with Bglll. A PCR fragment 
(over-lined in red) bridged the Fspl (in the El sequence; residues in brown) and B glll sites 
in the vector. The PCR product coded for the El signal peptide (residues in purple) and 
was generated using pGEM/CElE2H77 as template. The forward PCR primer introduced 
B glll and Nsil sites at the 5’ terminus (nucleotides in italics) followed by an ATG start 
codon. The resultant construct was named pGEM/AEl E2h77.
CAA CCT CGA GGT AGA CGT CAG CCT ATC ATG CAT ATG CTT CCT GGT TGC 
Q P R G R R Q P  I M H M L P G C  
58 65 169
Fig 4.11. Fusion of a N-terminal region of core protein to the N-terminus of the E l 
signal peptide. Two DNA fragments, a Hindlll-Xhol fragment from pGEM/CElE2n77 
which encodes the N-terminal region o f core (aa 1-58), and a Nsil-EcoRI fragment from 
pGEM/AElE2 which encodes El to NS2, were inserted into pGEMl (digested with 
H indlll and EcoRI) along with an oligonucleotide (over-lined in red) to bridge the Xhol 
and N sil sites. This linked the N-terminal 65 residues o f core (shown in blue) to 3 non- 
HCV residues (shown in black) followed by the signal peptide sequence for El (shown in 
purple). This construct was called pGEM/ElE2n77.
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Fig 4.12. Comparison of the relative mobilities of El and E2 made 
by strains Glasgow and H77. Cells were electroporated with RNA and 
35S-labelled between 4-12 h post electroporation. Following lysis, the 
glycoproteins were immunoprecipitated from cell extracts using E2- 
specific MAb ALP98. Immunoprecipitates were electrophoresed on a 
12% polyacrylamide gel under reducing (Red) and non-reducing 
conditions (Non-red). Samples were derived from cells electroporated 
with RNA from the following constructs: pSFV/CElE2Gia (lanes 1 and 
4), pSFV/CElE2H77 (lanes 2 and 5), pSFV/ElhisE2 (lanes 3 and 6). The 
positions of E l and E2 from strain Glasgow (Gla) and H77 are indicated. 
The position of the aggregated material (Agg) is also shown.
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Fig 4.13. Immunoprecipitation analysis of strains Glasgow and H77 
El and E2 proteins with E2-conformation specific antibodies. Cells 
electroporated with pSFV/CElE2Gia and pSFV/CElE2H77 R N A s were 
radiolabelled from 4-12 h after electroporation. Immunoprecipitations 
on crude extracts were performed and precipitates were analysed under 
reducing conditions on a 10% polyacrylamide gel. Immunoprecipitates 
derived from cells expressing strain Glasgow E l and E2 are shown in 
lanes 1-4 and those from strain H77 in lanes 5-8. Immunoprecipitations 
were performed with the following antibodies: H2 (lanes 1 and 5), H33 
(lanes 2 and 6), H47 (lanes 3 and 7), and H53 (lanes 4 and 8). Positions 
of E l, E2 and aggregated material (Agg) are indicated.
Glasgow H77
Fig 4.14. Im m unoprecipitation analysis of strains Glasgow and H77 
E l and E2 proteins with hum an monoclonal antibodies. Cells 
electroporated with pSFV/CElE2Gia and pSFV/CElE2H77 R N A s were 
35S-methionine labelled between 4-12 h after electroporation and lysed 
in immunoprecipiation buffer. Immunoprecipitations were performed 
on crude extracts using a panel of human monoclonal antibodies and are 
shown in the following order: 1A7 (lanes 1 and 5), 2H1 (lanes 2 and 6), 
4F7 (lanes 3 and 7), and 4F1 (lanes 4 and 8). Samples were 
electrophoresed under reducing conditions on a 10% polyacrylamide 
gel. Lanes 1-4 show the precipitates obtained from extracts containing 
strain Glasgow proteins and lanes 5-8 show those obtained from extracts 
containing strain H77 proteins. Positions of E l and E2 are indicated.
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Fig 4.15. Comparison of the effect of DTT on E l and E2 from strains Glasgow and 
H77. Cells were electroporated with RNA and radiolabelled from 4-12 h after 
electroporation with 35S-methionine. CHX and DTT were added to cultures as described in 
the legend to Fig 4.3. Crude extracts were prepared in immunoprecipitation buffer 
containing 20mM NEM and precipitates were obtained using the E2-specific MAb, 
ALP98. Samples were divided and electrophoresed on a 10% polyacrylamide gel under 
reducing (Red) and non-reducing conditions (Non-red). Samples were derived from cells 
electroporated with RNA from the following constructs: pSFV/CElE2Gia (lanes 1 and 4), 
pSFV/CElE2H77 (lanes 2 and 5), pSFV/Elh.sE2 (lanes 3 and 6). The positions of El (+ and 
- the histidine tag) and E2 from strain Glasgow (Gla) and H77 are indicated. Also shown 
are the positions of the E1-E2 precursor and aggregate (Agg). Bands indicated by symbols 
are discussed in the text.
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Fig 4.16. Analysis of de novo synthesised E l and E2 from strain H77 in the 
presence of DTT. Cells were electroporated with pSFV/CElE2H77 and pSFVl 
RNA and incubated for 12 h. Following pulse labelling for 2 min with 35S- 
methionine/cysteine and a chase period of 80 min in the presence (+) and 
absence (-) of DTT, cells were lysed in buffer containing 20mM NEM. 
Immunoprecipitations were performed on extracts using the following 
antibodies: El-specific MAb, AP497 (lanes 1 and 5), El-specific antiserum, 
R528 (lanes 2 and 6), E2-specific MAb, ALP98 (lanes 3 and 7), and E2- 
conformation-specific MAb, H53 (lanes 4 and 8). Immunoprecipitates were 
analysed on 10% polyacrylamide gels under reducing conditions. Lanes 1-4 
show immunoprecipitates from extracts obtained from pSFV/CElE2H77 RNA 
electroporated cells and lanes 5-8 from pSFVl RNA. For control purposes, 
crude extracts from DTT-treated cells that were used for immunoprecipitation 
from pSFV/CElE2H77- (lane 9) and pSFVl-electroporated cells (lane 10) are 
shown. Positions of E l, E2, E1-E2 precursor and aggregated material (Agg) 
are indicated.
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Fig 4.17. Complexes formed by strain H77 in the presence and absence of DTT.
Cells were electroporated with RNA from pSFV/CElE2H77 and incubated at 37°C for 12 
h. Subsequently, cells were pulse labelled for 2 min and chased for the indicated times 
either in the presence (+DTT) or absence of DTT (-DTT). Immunoprecipitations on 
crude cell extracts were performed using E2-specific MAbs ALP98 and H53. 
Precipitates were divided and electrophoresed on 10% polyacrylamide gels under either 
non-reducing (Non-red, panels a and b) or reducing conditions (Red, panels c and d). 
Panels a and c show proteins precipitated by ALP98 while b and d are those precipitated 
by H53. For a and b, the positions of the oxidised and reduced forms of E l, E2, 
aggregated material (Agg) and E1-E2 precursor molecules are shown.
Chapter 5 -  Results
Chapter 5 -  Characteristics of E l and Their Relationship to Complex 
Formation with E2 
5.1. Introduction
Despite a significant number of studies directed towards understanding the characteristics 
of HCV glycoprotein complexes, little is known about the properties of E l. Studies by 
both Ralston et al. (1993) and Foumillier-Jacob et al. (1996) indicated that the migratory 
properties and antigenicity of E l were altered when it is expressed in the absence of E2. 
Moreover, the oxidation state of E l also is dependent on E2 (Michalak et al., 1997). 
Therefore, the influence of E2 on the behaviour of El was examined further in this chapter. 
From Chapter 4, covalent and non-covalent bonds are necessary for the stabilisation of 
aggregated complexes while intermolecular non-covalent interactions occur in native 
complexes. In an attempt to distinguish regions which may be important for formation of 
either type of complexes, internal deletions within El were generated and examined for 
their ability to associate with E2. Given the controversy over the role of disulphide bonds 
in native complex formation, and as a development of the DTT studies presented in 
Chapter 4, cysteine point mutants in El were examined for their interaction with E2 and 
effect on the properties of E l.
5.2.1. Construction of pSFV Recombinant Vectors Expressing Glasgow 
and H77 E l in the Absence of E2
Plasmids expressing only the El glycoprotein from strains Glasgow and H77 were made 
by manipulating the parent constructs pGEM/ElhiSE2 and pGEM/ElE2n77 (described in 
Section 3.2 and 4.6 respectively). The coding region of E2 in these clones was replaced 
with oligonucleotides, which encoded sequences from residues 382-386 and thus 
reconstituted the proteolytic cleavage site between El and E2 at amino acid residue 383. 
Following the sequences for residue 386, an artificial stop codon was also introduced (Fig 
5.1 and Fig 5.2). pGEM/ElhiSE2 was digested with Sail and H indlll, whereas 
pGEM/E 1 E2h77 was treated with Sail and EcoRI. The H indlll and EcoRl sites in these 
constructs reside in the pGEMl vector, downstream from the E2 coding region. The Sail 
restriction enzyme site is conserved at the position encoding codon 381 in E l for both
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strains (Appendices 1 and 3). Insertion of oligonucleotides yielded plasmids that were 
named pGEM/Elcia and pGEM/Eln77 which encoded residues 169-386 corresponding to 
the El signal sequence, El protein and E2 signal sequence. The only differences between 
these plasmids were the presence of histidine tag in pGEM/Elcia (Section 3.2) and the 
presence of 68 residues upstream of the E l signal sequence in pGEM/ElH77 (Section 4.6). 
Bglll fragments produced from the two recombinant pGEM plasmids were then cloned into 
the pSFVl vector to create expression constructs called pSFV/Elcia and pSFV/ElH77-
5.2.2. Behaviour of E l on Expression in the Absence of E2
As stated in the introduction to this chapter, there is evidence that E2 affects the oxidation 
state of El (Michalak et al., 1997). To compare the behaviour of E l in the presence and 
absence of E2, cells were transfected with RNA from strain H77 constructs 
(pSFV/ElE2H77 and pSFV/ElH77) and strain Glasgow plasmids (pSFV/ElhisE2 and 
pSFV/Elcia). After radiolabelling, E l was isolated from extracts by either 
immunoprecipitation (for strain H77) or Ni-NTA agarose purification (for strain Glasgow).
For strain Glasgow, three El/E2-related products were isolated by Ni-NTA affinity 
chromatography from cells electroporated with pSFV/ElhiSE2 RNA (Fig 5.3, lane 1).
These corresponded to El (~32 kDa), E2 (diffuse material migrating between 60-65 kDa) 
and E1E2 polyprotein which had not been cleaved but was glycosylated (~97 kDa). As 
described in Chapter 3 (Section 3.7; Fig 3.16), E2 was isolated by virtue of complex 
formation with histidine-tagged E l . Ni-NTA chromatography on extracts from 
pSFV/Elcia-electroporated cells revealed not only a species corresponding to El(~32 kDa) 
but also a series of bands with apparent molecular weights of approximately 65, 100 and 
130 kDa. Given that E2 is not produced by pSFV/Elcia, these higher molecular weight 
species were likely to be derived from expression of E l alone. Indeed, from their sizes it is 
predicted that they correspond to dimeric (64 kDa), trimeric (96 kDa) and tetrameric (128 
kDa) forms of E l. To confirm the El-relatedness of these proteins, Western blot analysis 
was performed with the Penta-His antibody. Results revealed that the various high 
molecular weight species in the Ni-NTA purified material from pSFV/Elcia-electroporated 
cells were detected by the antibody (Fig 5.3, panel b, lane 2). The same species were 
recognised in the purified material expressed by pSFV/ElhisE2 but to a lesser extent (lane 
1). These data indicate that E l can homo-oligomerise but oligomeric products are formed 
less efficiently in the presence of E2.
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Similar examination of strain H77 E l expressed in the absence of E2 produced essentially 
identical results (Fig 5.4). In this case, immunoprecipitation assays were performed with 
cell lysates using two El-specific MAbs AP21.010 (panel a) and AP497 which is 
conformation-specific (panel b; Appendix 5). The AP21.010-eluted samples, when 
analysed under reducing conditions, showed obvious differences between material 
precipitated from the extract containing only E l expressed by pSFV/Eln77 (panel a, lane 1) 
to that containing El and E2 products made by p S F V /E 1 E 2 h77 (panel a, lane 2). Once 
again bands corresponding to E l (-30 kDa), E2 (-69 kDa) and to the unprocessed E1-E2 
polyprotein (-99 kDa) were precipitated from cells electroporated with pSFV/ElE2n77 
RNA. However, high molecular weight bands of approximately 60, 90, 120 and 150 kDa 
were detected in crude extracts derived from pSFV/ElH77-electroporated cells (panel a, 
lane 1). Immunoprecipitation data gained using AP497 revealed a similar pattern in 
precipitated material derived from cells expressing El in the absence and presence o f E2 
(compare panels a and b, lanes 1 and 2). In light of this, Western blot analysis was 
performed to confirm the identity of these additional bands using an anti-E 1 specific 
antiserum (R528) (Fig 5.4, panel c). Data showed that the higher molecular weight bands 
as well as monomeric El were indeed recognised by the anti-El antiserum (panel c, lane
1). By comparison, such high molecular weight species were not detected to the same 
degree in samples derived from pSFV/ElE2H77-electroporated cells expressing E l in the 
presence of E2 (panel c, lane 2) although the E1-E2 uncleaved product was recognised.
This shows that El expressed in the absence of E2, from both strains Glasgow and H77 
behave in a comparable manner. From data presented in Chapter 4 (Section 4.7, Fig 4.12), 
strain Glasgow El protein migrated more slowly than strain H77 E l, while the converse 
was true for E2 protein from the two strains. As a result, the dimeric form of strain 
Glasgow E l co-migrates with E2 while the El dimer for strain H77 has a lower apparent 
molecular weight than E2 for this strain. Overall, these data reveal the tendency of El to 
oligomerise in the absence of E2 and this behaviour is not strain-specific.
The second aspect regarding changes in the properties of El was discovered by analysis of 
the protein expressed in the absence or presence of E2 under non-reducing SDS-PAGE 
conditions. As described earlier, electrophoresis under these conditions does not interrupt 
intramolecular disulphide bonds within a protein, and thus the protein may migrate faster 
than its reduced counterpart since it can adopt a more compact structure. As strain
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Glasgow proteins were not efficiently detectable under non-reducing conditions (Section 
4.2, Fig 4.1), efforts to assess the contribution of E2 on E l oxidisation state were 
concentrated on the glycoproteins produced by strain H77. Cells were electroporated with 
RNA from strain H77 constructs pSFV/ElE2H77 and pSFV/Eln77 followed by 
radiolabelling for 4 to 12 h after electroporation. Proteins from these cells were isolated by 
immunoprecipitation using the El-specific monoclonal antibody, AP21.010 and examined 
by non-reducing (Fig 5.5, panel a) and reducing (panel b) polyacrylamide gel 
electrophoresis. Non-aggregated E l produced from both constructs was observed under 
non-reducing conditions (panel a). However, it was apparent that multiple monomeric 
forms of El were isolated from pSFV/ElH77-electroporated cells (lane 1), whereas a single 
predominant E l species was precipitated from cells expressing pSFV/ElE2n77 (lane 2). 
Moreover, none of the monomeric El species produced in the absence o f E2 co-migrated 
with the major E l species synthesised along with E2. Under reducing conditions however, 
these species did co-migrate (panel b, lanes 1 and 2). In panel a, samples were not reduced 
with DTT prior to electrophoresis and thus protein species would retain intramolecular 
disulphide bonds whereas in panel b, these bonds would be disrupted. Hence, the 
differential electrophoretic behaviour of the E l species under non-reducing conditions is 
due to an altered oxidation state of the protein that is dependent on the presence o f E2. It 
was concluded that interactions with E2 influence intramolecular disulphide bond 
formation in El.
MAb AP21.010 isolated multiple monomeric E l species (Figs 5.4 and 5.5, panel a,
labelled - ,  =, + and x), in addition to oligomeric forms from pSFV/ElH 7 7 -electroporated
cells. These multiple monomeric forms were less apparent on analysing pSFV/ElE2H77-
electroporated cells using this antibody. Further characterisation of these multiple
monomeric forms of El was achieved by examination with endo H f glycosidase treatment,
which removes N-linked high-mannose oligosaccharides. Crude extracts, derived from
cells electroporated with the pSFV/Eln77 RNA, were incubated with this enzyme and
analysed by Western blot analysis using R528 antiserum. Data revealed that the multiple
monomeric forms of El (Fig 5.6, panel a, lane 1), were reduced in size to a single species
by endo H f treatment (panel a, lane 2). This indicates that multiple monomeric bands
correspond to differentially glycosylated forms of E l . Since these differentially
glycosylated forms of El were more apparent in samples containing El in the absence of
E2 co-expression (Fig 5.4, panel a, compare lanes 1 and 2), E2 may also influence the
glycosylation pattern of E l . It is interesting to note that higher molecular bands recognised
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by the R528 antiserum that represent the oligomeric forms of El were also reduced in size 
by deglycosylation with endo Hf (Fig 5.6, panel b). This reinforces the El-relatedness of 
these bands.
From the above series of observations, three criteria were established by which El 
behaviour differed in the presence and absence of E2. These were oligomerisation, 
differential glycosylation, and oxidation state. Of these, differential glycosylation was 
occasionally less apparent since more than one monomeric species could be observed both 
in the presence and absence of E2 but there was a consistent difference in their relative 
abundance. These properties were used to further characterise E l and to assess the 
interactions that occur between E l and E2.
5.3.1. Construction of E l Internal Deletion Mutants
In order to examine regions of E l involved in association with E2, a panel of E l internal 
deletion mutants was constructed in both Glasgow and H77 strains, using the parent 
plasmids pGEM/ElhiSE2 and p G E M /E 1 E 2 h77, respectively. The panel of constructs was 
designed to encode El mutants lacking peptide regions in a sequential manner, which were 
defined by suitable restriction enzyme sites in the nucleotide sequence. For strain 
Glasgow, a N-terminal E l deletion mutant was created by replacing the coding region 
between amino acid residues 196 and 235 with the oligonucleotide indicated in Fig 5.7 
(panel a). This oligonucleotide re-constructed the flanking restriction sites (FspI [at codon 
195] m d X h o I  [at codon 236]) and the sequences coding for the histidine tag. The 
resultant plasmid was termed pGEM /ElAi96-235E2G]a. Subsequent deletions in the 
glycoprotein were created by employing restriction enzyme sites Xhol (at codon 209), Clal 
(at codon 262), M uni {2d codon 305), and BamHI {at codon 339) in the nucleotide sequence 
(see Appendices 1 and 3). These sites were bridged using oligonucleotides shown in Fig 
5.7 (panels b, c, and d), which encoded a few amino acid residues on either side of the 
region to be deleted and in-frame nucleotide sequences to re-introduce the enzyme sites. 
These plasmids were named pGEM/ElA2i3-26oE2cia, pGEM /ElA266-303E2cia, and 
pGEM /ElA309-338E2Gia. A final strain Glasgow E l mutant resulted in a deletion between 
residues 341 and 366, where restriction sites BamHI and HincII {at codon 381) were 
connected by an oligonucleotide. As depicted in Fig 5.7 (panel e), this oligonucleotide re­
constructed almost the entire coding sequence for the E l transmembrane/E2 signal peptide 
domain (codons 366-377); codons 363-365 for this domain were omitted. This ensured
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that the sequences required for E l anchorage to lipid membranes, E2 translocation to the 
ER and the E1-E2 protease cleavage site were maintained. This construct was termed 
pGEM/ElA34i-366E2Gia- After the transfer of coding regions containing HCV sequences 
from the above El deletion mutant plasmids into the pSFVl expression vector, the 
constructs were named pSFV/ElAi96-235E2Gia, pSFV/ElA2i3-26oE2Gia, pSFV/ElA266-303E2Gia, 
pSFV/ElA309-338E2Gia, andpSFV /ElA34i-366E2Gia, respectively.
For strain H77 E l, a histidine tag was not inserted at the N-terminus, and therefore, an 
alternative oligonucleotide (shown in Fig 5.8) was employed compared with that used to 
make pGEM/ElAi96-235E2Gia. A slightly smaller region was deleted since the 
oligonucleotide coded for additional in-frame sequences. Thereafter the construct was 
called pGEM/El ai99-233E2h77- Internal deletions between residues 213-260, 266-303 and 
309-338 were produced using strategies and oligonucleotides identical to those applied to 
construct similar deletion mutants in strain Glasgow (illustrated in Fig 5.7, panels b, c, and 
d). These constructs were termed p G E M /E lA2 ]3.26oE2 H77, p G E M /E lA266-303E2H77, and 
pGEM /ElA309-338E2H77- For the last mutant in strain H77, called pGEM /ElA34i.366E2H77 (Fig 
5.9), a different oligonucleotide from that used for strain Glasgow was employed to 
prevent incorporation of a naturally occurring amino acid change (aa 372) between the two 
strains. The introduction of strain H77 El internal deletion mutant sequences into pSFVl 
resulted in the following plasmids: pSFV/ElAi99.233E2H77, p S F V /E lA2 i3_26oE2 H77, 
pSFV/ElA266-303E2H77, pSFV/ElA309-338E2H77, and pSFV/ElA34i-366E2H77. For simplicity, a 
schematic representing the deleted regions in El is shown in Fig 5.10. Due to the cloning 
strategy, El mutants pSFV/ElAi96-235E2cia (A199-233 in the case of H77)and pSFV/ElA2i3. 
26oE2 have overlapping deleted regions between amino acid residues 213-235 and 213-233 
for strains Glasgow and H77 respectively. For all the above constructs, nucleotide 
sequences in the sense and anti-sense directions were determined to ensure the inserted 
oligonucleotides resulted in in-frame deletions.
5.3.2. Examination of the Properties of E l Deletion Mutants
Initially, characterisation of the El mutants was conducted to establish their behaviour on 
reducing SDS-PAGE and their glycosylation patterns. Cells were electroporated with 
RNA from the constructs containing wild type and mutant forms of El from strains 
Glasgow and H77. A portion of crude extract obtained from these cells was separated
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under reducing SDS-PAGE conditions and examined by Western blot analysis, probing for 
El using R528 (Fig 5.11). One of the features observed was the presence of multiple 
monomeric forms generated by strain H 7 7  mutant proteins (Fig 5.11, panel a, lanes 4, 6, 8, 
and 12), which were detected also for wild type El expressed in the presence and absence 
of E2 (lanes 2 and 13). This was particularly evident when using R528 antiserum. The 
only mutant for which multiple monomeric forms were less apparent was pSFV/ElA309- 
338E2h77 (lane 10). In addition, multiple species were discernible in samples obtained from 
three strain Glasgow El mutants, ElAi96-235Gia (Fig 5.11, panel a, lane 3), E lA34i-366Gia (lane
11) and to a limited extent E lA2i3-260Gia (lane 5). Multiple monomeric forms were not 
detected for wild type strain Glasgow E l and two mutants E lA266-303Gia and E lA309-338Gia 
(lanes 1, 7 and 9). Previously, multiple monomeric species were demonstrated to 
correspond to differentially glycosylated forms of monomeric E l by endo H f analysis 
(Section 5.3, Fig 5.6). To establish the nature of the multiple forms, crude extracts were 
subjected to deglycosylation by endo H f digestion and again examined by Western blot 
analysis using the anti-El antiserum, R528. The counterparts in strains Glasgow and H77 
were analysed in parallel (Fig 5.11, panel b) and revealed that deglycosylated mutants were 
represented by single monomeric species, thereby confirming that the multiple monomeric 
forms detected in the untreated samples indeed represented differentially glycosylated 
species.
Endo H f digestion also confirmed that the different mobilities of the processed proteins 
made by two corresponding mutants, E lAi96-235E2Gia and E 1Ai99-233E2h77 (compare panels a 
and b, lanes 3 and 4), were a consequence of differential glycosylation. In E lAi96-235E2Gia, 
three predicted glycosylation sites were removed as compared to one predicted site in 
E lAi99-233E2H77. Accordingly, the glycosylated mutant protein from strain Glasgow has 
greater mobility than its H 7 7  counterpart. Upon endo H f treatment however, the 
deglycosylated forms of the proteins made by these mutants have similar mobilities, and 
agree with the predicted molecular weights of the nascent polypeptides (Table 5.1). El 
mutants in strain Glasgow and H 7 7  which lack a single glycosylation site [E lA2i3- 
26oE2(H77/Gia) (lanes 5 and 6)] gave proteins with mobilities that were consistent with the 
loss of both amino acid residues as well as an oligosaccharide moiety. However, two 
mutants in each strain, E1A266-303E2(H77/Gia) (lanes 7 and 8) and E lA34i-366E2(H77/Gia) (lanes 11 
and 12) produced proteins with higher apparent molecular weights than would be predicted 
(Table 5.1). For all four mutant proteins, the highest molecular weight glycosylated form
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in each case co-migrated with or close to the wild type form of the El proteins. A similar 
picture emerged from examination of the endo Hf-treated samples. Thus, the discrepancy 
in the apparent molecular weights of proteins made by these mutants is not solely a 
consequence of glycosylation. Another feature observed from analysis of the mutants was 
the appearance of novel higher molecular weight proteins (indicated by *) made by E 1*266- 
303E2(H77/Gia) (50 kDa) and E1A309-338E2h77 (45 kDa). For the latter mutant, a novel species 
was not observed for the corresponding strain Glasgow mutant, E lA303-338E2Gia; this may be 
a consequence of the lower levels of El protein that were detected for this particular 
mutant. This feature is discussed further in section 5.3.4.
Finally, there was marked increase in the amount of uncleaved E1-E2 polyprotein detected 
for mutant E lA34i_366E2 for both strains (Fig 5.11, panels a and b, lanes 11 and 12). This 
suggests that, while the cleavage between El and E2 in the polyprotein is predicted to 
occur at residue 384 (Grakoui et al., 1993b; Ralston et al., 1993; Selby et al., 1994), amino 
acid sequences upstream of residue 366 in El A34i_366 mutants may be necessary to achieve 
efficient processing of the polyprotein.
5.3.3. Analysis of Complex Formation between E2 and E l Deletion 
Mutants
The purpose for creating El internal deletion mutants was to enable the identification of 
regions in El which may associate with E2 in heteromeric complexes. Removal of regions 
in El in a systematic fashion was anticipated to abolish interaction of deletion mutant El 
proteins with co-expressed wild type E2. Cells were electroporated with RNA from strain 
H77 constructs expressing wild type proteins and mutant El species along with E2. After 
S-labelling for 12 h, immunoprecipitations were performed on crude extracts obtained 
from these cells with anti-El antiserum, R528, and precipitates analysed by both non­
reducing and reducing polyacrylamide gel electrophoresis (Fig 5.12).
Under reducing conditions, it was apparent that all the El internal deletion mutants 
continued to co-precipitate E2, suggesting that interaction between mutant El and E2 was 
not abolished by deletion of any region of El (Fig 5.12, panel b). However, the 
glycoproteins detected under these conditions may represent disrupted aggregated material. 
To determine whether E l mutants could give rise to native complexes, the
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immunoprecipitates were analysed by non-reducing gel electrophoresis. Results showed 
that some non-aggregated monomeric forms of mutant El may be precipitated from 
samples derived from constructs pSFV/E1ai99-233E2H77, pSFV/E1A213-26oE2h77, and 
pSFV/El A266-303E2H77 (panel a, lanes 2, 3, and 4), but not apparently from those produced 
by constructs pSFV/E1A309-338E2h77 and pSFV/ElA34i.366E2H77 (lanes 5 and 6). Further, the 
co-elution of E2 with mutant E l proteins was not readily seen in the radiolabelled material, 
implying that the non-aggregated monomeric E l detected may correspond to E l molecules 
which are not associated with E2. For confirmation purposes, Western blot analysis was 
performed to detect E2 on duplicate precipitates separated under the same electrophoresis 
conditions. From these data E2, migrating as a diffuse band, co-precipitated with wild type 
El (Fig 5.13, lane 1). However, significantly reduced amounts of E2 eluted with mutants 
E 1 Ai99-233s E lA2i3-26o, and E la266-303 (lanes 2, 3, and 4, respectively). The failure to detect 
E2 in samples from pSFV/E1A309-338E2h77- and pSFV/ElA34i_366E2H77-electroporated cells 
(lanes 5 and 6), reflects the fact that no monomeric forms were detected for these mutant 
E l proteins under non-reducing conditions (Fig 5.12, panel a, lanes 5 and 6).
A reciprocal experiment was conducted to verify the above findings, in which 
immunoprecipitations were performed using the E2-specific MAb, ALP98. Analysis of 
the samples under reducing conditions indicated that E2 precipitated all the E l deletion 
mutants (Fig 5.14, panel b). By contrast, from non-reducing electrophoresis data, a 
monomeric species was readily detected only for wild type El (panel a, lanes 1-6). It was 
concluded that the El mutants from strain H77 do not efficiently form native complexes 
with E2 and that those complexes detected represented aggregates of E l and E2.
Examination of crude extracts of cells electroporated with strain Glasgow El mutant 
constructs, using R528 antiserum, revealed a similar pattern under reducing conditions, 
whereby all the mutant El proteins were found to associate with E2 (Fig 5.15, panel b).
For this strain, some non-aggregated El could be detected from pSFV/ElAi96-235E2Gia, 
pSFV/ElA2i3-26oE2Gia, and pSFV/ElA266-303E2Gia constructs (panel a, lanes 2, 3, and 4) in 
agreement with strain H77 El mutants, but again co-precipitation o f non-covalently linked 
E2 was not detected. Together, these data reveal that manipulation of internal regions of 
El increase the tendency for aggregate formation, and in turn, that the native complex is 
highly sensitive to changes in El.
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5.3.4. Further Characterisation of Deletion Mutants E lA266-303 and
E 1 a309-338
With the exception of mutants E1a266-303 and El A341-366 from both strains all the remaining 
E l deletion mutants migrated according to their predicted molecular weights by SDS- 
PAGE (see Section 5.3.2). Due to time constraints, only the behaviour of E lA266-303 mutant 
was further examined. Crude extracts derived from cells electroporated with constructs 
pSFV/ElE2H77, pSFV/E 1 a266-303E2h77> and pSFV/ElA309-338E2H77 were analysed in parallel 
by Western blot analysis using R528. Compared to wild type E l, mutant E lA266-303 lacks 
38 amino acid residues, but removal of these sequences should not affect the N- 
glycosylation sites. Therefore, the deletion should have resulted in a reduction of 
approximately 4.0 kDa (as predicted by ExPASy-PeptideMass program) as compared to 
wild type protein. However, wild type El and E lA266-303 essentially co-migrated (Fig 5.16, 
lanes 1 and 2) while mutant E 1a303-338 protein migrated more closely to its apparent 
molecular weight (lane 3). To assess whether glycosylation played a role in the 
unpredicted increase in molecular weight of this mutant, crude extracts were treated with 
endo Hf and PNGase F endoglycosidases. Western blot analysis on these samples revealed 
that deglycosylated E lA266-303, following treatment by either enzyme, continued to co- 
migrate with wild type El (Fig 5.16, lanes 4, 5, 7, and 8). In vitro transcription and 
translation of wild type El and mutant El proteins, where no post-translational 
modifications occur, suggested that E lA266-303 mutant protein did migrate according to its 
predicted molecular weight (Fig 5.17, lane 3). In this case, pGEMl constructs encoding 
wild type El and mutant E l proteins were linearised at codon position 381 using Sail 
restriction enzyme. This codon is situated two residues upstream of the authentic cleavage 
site between El and E2 in the polyprotein. The T7 promoter was utilised in the pGEMl 
vector to produce run-off transcripts coding for wild type E l and mutant E l proteins alone. 
The coupled transcription and translation reaction was performed in the presence of S- 
methionine and analysed by SDS-PAGE. The data from this experiment and those in Fig 
5.16 indicated that the unusual migratory characteristics of mutant E1a266-303 were not a 
consequence of alterations in glycosylation in tissue culture cells.
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Further examination of the Western blot and immunoprecipitation data presented in Figs 
5.11. (panel a and b, lanes 8 and 10) and 5.12 (panel b, lane 4) revealed the presence of 
higher molecular weight species made by strain H77 E1a266-303 and El A309-338 constructs 
(indicated by *), in addition to monomeric forms. These high molecular weight forms 
(~50 kDa and -46  kDa) may represent dimers for each of these mutant E l proteins based 
on their predicted molecular weights. The predicted molecular weights of fully 
glycosylated monomeric E lA266-303 and E1a309-338 of strain H77 were ~27 kDa and ~ 26 kDa 
respectively, and thus their corresponding dimers could be expected to be 54 kDa and 52 
kDa. To examine this hypothesis these mutant El proteins were expressed in the absence 
of E2; as shown earlier, under such circumstances, increased amounts of wild type El 
oligomers are detected (see Fig 5.4, panel a, compare lanes 1 and 2).
The constructs expressing these two mutant E l proteins alone were called pSFV/E 1a266- 
303H77 and pSFV/ElA309-338H77 (described in Fig 5.18). They were constructed by obtaining 
Nsil-BamHI fragments from their parent plasmids pSFV/ElA266-303H77E2 and pSFV/E 1A303- 
338H77E2 , which were inserted into the pSFV/ElH77 construct (see Section 5.2.1 and Fig 5.2) 
employing the same sites. Subsequently, cells were electroporated with pSFV/ElH77, 
pSFV/E 1 a266-303H77> and pSFV/ElA309-338H77 RNAs. For control purposes RNAs from 
pSFV/ElE2H77, pSFV/E 1a266-303 E2h77, and pSFV/E 1a309-33sE2h77 were also electroporated 
into cells. Immunoprecipitation assays using rabbit anti-sera R528 performed on crude 
extracts from these cells were analysed under reducing conditions (Fig 5.19). Data 
revealed that the ~50 kDa band detected for the pSFV/E 1a266-303E2h77 construct (lane 2) 
was also detected when E lA266-303 was expressed in the absence of E2 (lane 5). This 
suggested that the -50  kDa species did indeed represent a dimer of the mutant protein. In 
the case of mutant E1a309-338, a -46  kDa band, detected previously only by Western blot 
analysis (Fig 5.11, panel a, lane 10), was apparent upon expression of this mutant in the 
absence of E2; this species co-migrated with a 45 kDa background protein (Fig 5.19, lane
6). Based on its apparent molecular weight, it is likely to be a dimer of E lA309-338 protein. 
The ability to detect such forms of E l, even in the presence of E2, again highlights the 
sensitivity of El behaviour to removal of certain sequences.
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5.4.1. Construction of Cysteine Substitution Mutants
The detection of two forms of E1E2 complexes, the aggregate as well as the native 
complex, suggests that disulphide bonds play a role in the formation of the covalently 
aggregated material. However, sulphide groups on cysteine residues in the glycoproteins 
might also be involved in intramolecular disulphide bond formation in addition to the 
intermolecular links. Intramolecular disulphide bonds could indirectly influence E1E2 
complex formation by affecting the tertiary structure of the proteins. Therefore, in addition 
to internal deletion mutagenesis, another strategy followed to study the properties of El 
important for E1E2 complex formation involved the creation of cysteine substitution 
mutant E l proteins. There are eight cysteine residues in El (Fig 5.20, panel a), each of 
which is conserved throughout the HCV strain la genotypes.
The cysteine residues in strain H77 El were substituted by incorporation of point 
mutations at the cysteine-encoding codons via the introduction of oligonucleotides at 
appropriate restriction enzyme sites; this is illustrated schematically in Fig 5.20 (panel b-e). 
All the cysteine residues were substituted for serine residues, with the exception of the 
cysteine at residue 229, which was replaced by an alanine residue to avoid the creation of a 
novel glycosylation site (Fig 5.20, panel b). With the use of the unique Nsil site 
engineered at the N-terminus of the El signal sequence coding region and the BamHI site 
at codon 339 in E l, it was possible to construct all of these substitution mutants directly in 
the pSFVl vector. The vector and E2 sequences were derived from pSFV/E 1E2h77 
linearised at Nsil and BamHI, while the fragments encoding El were obtained from 
pGEM/ElE2H77 using suitable restriction sites. The fragments were bridged using 
oligonucleotides carrying point mutations at cysteine codons. The construct containing the 
substitution at position 207 was named pSFV/ElACys207E2 (panel b), whereas the remainder 
of the intermediate cysteine substitution mutants, where up to four cysteine residues were 
substituted at a time, were named pSFV/ElACys226,229,238E2 (panel c), 
pSFV/ElAcys272,28i,3mE2 (panel d) and pSFV/ElAcys272,28i,304>306E2 (panel e). The 
pSFV/E l Acys272,281.304.306E2 mutant was constructed using pSFV/E l Acys272,281.304E2 as the 
parent plasmid vector.
A mutant El protein in which all eight cysteine residues were substituted is shown in Fig 
5.21. Coding fragments derived from pSFV/ElACys207E2 and pSFV/ElAcys272,28i,304,306E2
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plasmids were ligated with the oligonucleotides originally used to make 
pSFV/E1 ACys226,2 2 9 ,2 3 8 ^ 2  (Fig 5.21). An Eagl-Xbal fragment was obtained from 
pSFV/ElAcys207E2 while pSFV/ElACys272,28i,304,306E2 provided a BstEII-Xbalfragment, in 
which the common Xbal site is situated in the pSFVl vector (Fig 3 . 3 ,  panel b) and EagI 
and BstEII sites are located within the coding sequence of El at codon positions 216 and 
241, respectively. This construct was called pSFV/ElA-CySE2, and the construct expressing 
El alone was called pSFV/ElA-cys- The latter plasmid was made by excising a Nsil-BamHI 
fragment from pSFV/ElA-CysE2 and introducing it into the vector generated from the 
pSFV/ElH77 construct (see Fig 5.2) using the same sites; a similar strategy is described in 
Fig 5.18.
5.4.2. Analysis of Cysteine Substitution Mutants
From the studies described in section 5.2.2, it was established that E l, when expressed in 
the absence of E2, tends to oligomerise. To address whether intramolecular disulphide 
bonds alone are involved in oligomerisation of E l, the properties of the El mutant in 
which all of the cysteine residues had been substituted were examined in the presence and 
absence of E2. Cells were electroporated with pSFV/ElA-cysE2 and pSFV/ElA-CyS; for 
comparative purposes, pSFV/ElE2n77 and pSFV/Eln77 were also used. 
Immunoprecipitations were performed on crude extracts from these cells with the anti-El 
antiserum, R528, and the precipitates analysed under reducing and non-reducing 
electrophoretic conditions (Fig 5.22). Data from the non-reducing gel revealed that a 
markedly reduced level of non-aggregated E2 co-precipitated with EU-cys (Fig 5.22, panel 
a, lane 2) as compared with the amount precipitated with wild type El (panel a, lane 1).
By contrast, from the reducing gel, it was apparent that approximately equivalent amounts 
of E2 were precipitated with both forms of El (panel b, compare lanes 1 and 2). This 
indicates that removal of all of the cysteine residues in El does not abolish complex 
formation with E2. However, the lack of monomeric E2 observed under non-reducing 
conditions indicates that the complexes formed by E l lacking cysteine residues are 
aggregated and non-native complexes.
Another feature apparent under non-reducing electrophoresis conditions was the 
appearance of multiple monomeric forms of E 1 A-Cys expressed in the presence and absence 
of E 2  (Fig 5 . 2 2 ,  panel a, lanes 2  and 3 ) .  Given that E U - c y s  protein cannot form either inter-
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or intramolecular covalent bonds, reducing agents such as DTT or p-mercaptoethanol 
would have no effect on its migration properties. Previous data suggested that these 
monomeric forms were found in increased amounts when E 1 was expressed alone (refer to 
Section 5 .2 .2 )  and, from endo H f deglycosylation analysis, represented differentially 
glycosylated species. To confirm that this was the case, crude extracts derived from cells 
electroporated with the four constructs stated above were subjected to deglycosylation by 
endo Hf. Western blot analysis on these samples did indeed show that all the multiple 
species were represented by a single non-glycosylated form (Fig 5 .2 3 , lanes 1-4).
Non-reducing electrophoresis data from Fig 5.22 showed also that wild type E l made in 
the presence of E2 (panel a, lane 1) had a greater mobility than the highest molecular 
weight species of El made by pSFV/ElH77, pSFV/ElA_cysE2 and pSFV/ElA_cys (panel a, 
lanes 2-4). Results presented earlier in this chapter (Section 5.2.2) had indicated that E2 
influenced the oxidation state of E l, whereby the oxidised form of El was not observed 
when synthesised in the absence of E2. In this instance, E l cysteine substitution mutants 
would not be expected to reach an oxidised state due to the absence of intramolecular 
disulphide links. It is therefore significant that the species made by E lA_cys co-migrated 
with El protein produced in the absence of E2 but not with El that was made in the 
presence of E2. This provides conclusive evidence that wild type El is indeed unable to 
reach an appropriate oxidised state in the absence of E2.
Finally, examination of wild type El and E lA.cys, when expressed in the absence of E2, 
under reducing SDS-PAGE conditions (Fig 5.22, panel b, lanes 3 and 4), revealed that E1A. 
cys is able to oligomerise, but to a lesser extent than wild-type protein. As would be 
predicted, these oligomers can be observed also under non-reducing conditions for E lA_cys 
protein (panel a, lane 3). This suggests that oligomer formation is not entirely dependent 
on disulphide bond formation and can be stabilised by non-covalent association. This 
observation is also reproduced when immunoprecipitations were performed with E l- 
specific antibody AP21.010 (Fig 5.24, panels a and b, lanes 7 and 8). There is a small but 
noticeable difference in mobilities observed between oligomeric forms of wild type El and 
E lA.cys. ExPASy-Peptide Mass program did not predict a significant difference in the 
molecular weight of wild type El and E lA.cys (20.9 and 20.8 kDa respectively), due to the 
cysteine substitutions. The possible basis for the altered mobilities of the oligomers is 
discussed in Section 5.5.
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5.4.3. Analysis of Partial Cysteine Substitution Mutants
To further study the effect of cysteine residue substitutions in E l on native complex 
formation, cells were electroporated with RNA from constructs encoding El mutants 
carrying up to 4 cysteine residue substitutions (pSFV/ElAcys207E2, pSFV/ElAcys226,229,238E2, 
pSFV/ElACys272,28i,304E2, and pSFV/ElACyS272,28i,304,306E2), as well as from constructs 
encoding El proteins with all the cysteine amino acids replaced (pSFV/ElA.CySE2 and 
pSFV/ElA_cys). For comparative purposes cells were also electroporated with 
pSFV/ElE2H77, p S F V /E 1 h77 and pSFVl. Immunoprecipitations were performed on the 
crude extracts obtained from these cells using the El-specific MAbs, AP21.010 and 
AP497, in addition to the E2-specific MAb, ALP98; the precipitates were examined under 
both reducing and non-reducing conditions. The non-reducing data for the El-specific 
antibody AP21.010 revealed that non-aggregated E l was recognised for all four 
intermediate mutants (Fig 5.24, panel a, lanes 2-5), although the relative amount of non­
aggregated E 1 Acys207 was somewhat reduced as compared to the other E l variants. Co­
precipitation of non-covalently linked E2 was not as obvious as in the case o f wild type El 
(panel a, compare lane 1 with lanes 2-5). However, under reducing conditions, where both 
the native and aggregated E1E2 complexes would be represented, relatively equal levels of 
E2 were co-precipitated by wild type El (panel b, lane 1) and by the cysteine substitution 
mutants E lAcyS207, E l^ 226,229,238 and E lA.cysE2 (panel b, lanes 2, 3 and 6 respectively). 
There was a slight reduction in the amount of E2 co-immunoprecipitated by AP21.010 
from extracts containing E lAcys272,28i,304 and E lAcys272,28i,304,306 (panel b, lanes 4 and 5). 
Nonetheless, these data indicated that El cysteine substitution mutants predominately 
formed aggregated but not native complexes with E2.
Closer examination of the relative mobilities of E l precipitated by AP21.010 under non­
reducing conditions revealed that the removal of a single cysteine residue at position 207 
abolished the formation of oxidised El despite co-expression and complex formation with 
E2 (Fig 5.24, panel a, compare lanes land 2). In addition, oxidised El was not detected for 
any of the other cysteine substitution mutants (Fig 5.24, panel a, lanes 3-7). This 
demonstrates the sensitivity of E l folding and oxidation to alterations at cysteine residues 
in the protein.
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As mentioned previously (Section 4.7), the ability o f AP497 to recognise El is sensitive to 
reduction of the protein by DTT. The antibody did not detect E l ACys226,229,238 protein under 
either reducing or non-reducing conditions (Fig 5.25, panels a and b, lanes 3). Thus 
neither the native nor the aggregated complexes formed by this mutant were recognised 
(Fig 5.25, panels a and b, lanes 3). As a consequence AP497 also did not precipitate El 
protein in which all of the cysteine residues were substituted (panels a and b, lanes 6 and
7). However, immunoprecipitation analysis with this antibody did confirm that non­
aggregated forms of the remaining E l cysteine substitution mutants were detected readily 
under non-reducing conditions (Fig 5.25, panel a, lanes 4 and 5) with the exception of 
E 1 ACys207 protein which was significantly reduced in abundance (Fig 5.25, panel a, lane 2). 
As found with AP21.010, the level of this mutant in the reducing gel was increased (panel 
b, lane 2) indicating that most of this protein is linked to other E l molecules or E2 by 
covalent intermolecular bonds. Once again only the reduced form of the El cysteine 
mutant proteins was detected under non-reducing conditions (panel a, lanes 4 and 5).
Finally, analysis of material precipitated by the E2-specific MAb, ALP98, under non­
reducing conditions showed that reduced amounts of non-aggregated E2 expressed in the 
presence of El cysteine substitution mutants were detected as compared to the wild type 
proteins (Fig 5.26, panel a, compare lane 1 with lanes 2-6). However, under reducing 
conditions, equivalent amounts of E2 were clearly observed with wild type as well as 
cysteine mutants in El (panel b, lanes 1-6). This result suggests that alterations at 
individual amino acids in El may significantly affect the formation of non-aggregated E2. 
Examination of ALP98-precipitated material also showed that non-aggregated E l could be 
detected for the cysteine mutants under non-reducing conditions (panel a, lanes 3-6) with 
the exception of ElAcys207 protein (lane 2). The protein was present under reducing 
conditions indicating that it did associate with E2. Thus, the reduced amount of the non- 
aggregated form of this protein was consistently found with three separate antibodies.
5.3.5. Discussion
Results presented in this and the previous chapter indicate that E l behaves unpredictably 
on examination in reducing polyacrylamide gels. Firstly, a difference in the mobilities of 
strains Glasgow and H77 was observed in Chapter 4, despite the prediction that both 
nascent polypeptides are of identical length and very similar molecular mass. In this
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chapter, deglycosylation of El from both strains with endo H f did not yield nascent 
proteins with similar mobilities, thus indicating that N-linked glycosylation is not 
responsible for the observed difference. The difference in apparent molecular weights for 
E l between the strains is approximately 1-2 kDa. There are 9 amino acid changes between 
the strains and it is possible that this has introduced an additional post-translational 
processing site into E l from strain Glasgow. Apart from N-glycosylation, the forms of 
covalent modifications that take place in the cell include acetylation, O-linked 
glycosylation, hydroxylation, methylation, nucleotidylylation, phosphorylation, ADP- 
ribosylation and ubiquitination. Further comparative studies would be necessary to 
examine whether additional modifications are present on strain Glasgow E l . This could be 
attempted through analysis of peptides derived from peptidase digestion of E l and accurate 
molecular weight derivation by mass spectrometry.
A second possible explanation for the apparent molecular weight difference in El between 
the strains could be aberrant mobility on polyacrylamide gels. Such a phenomenon was 
observed for two E l mutant proteins (E lA266-303 and E lA34i-366) and this was found for 
mutants in both strains. The apparent molecular weights for these proteins were greater 
than predicted and was not a result of alterations to the predicted patterns o f N- 
glycosylation. Interestingly, both of the regions removed are contained within 
hydrophobic segments of E l. Aberrant mobility for E l from strain H occurs also on 
removal of the E2 signal peptide sequence from the C-terminal end of E l (residues 371- 
383; Foumillier-Jacob et al., 1996). These authors concluded that this hydrophobic 
sequence was responsible for influencing the migratory characteristics of E l such that their 
removal decreased mobility of the protein on gels. A similar phenomenon may account for 
the behaviour o f E lA266-303 and E lA34i-366 mutant proteins. It is possible that the 
hydrophobic segments may retain or adopt a local compact configuration following 
denaturation which is sufficient to increase the mobility of E l on gels. Returning to the 
apparent difference in molecular weight of El between the two strains, no obvious 
difference was observed in the hydropathecity plots for this protein from both strains.
Under non-reducing conditions El synthesised on its own migrated differently from El
synthesised in the presence o f E2; E l expressed along with E2 in cis attained an oxidised
state while the majority of El expressed in the absence of E2 remained in a reduced state.
This finding confirms observations made by Michalak et al. (1997) which indicated that
the behaviour of El is altered in the absence of E2. From their analysis, an oxidised form
135
Chapter 5 -  Results
of vaccinia virus-expressed strain H El protein was detected after a 2 h chase period from 
a C-E1-E21.746 construct but no such species was observed from a construct expressing El 
residues from 1-383. In addition to this observation, two more criteria have been 
established in this study to differentiate between El synthesised in the presence and 
absence of E2 which are based on the behaviour of El-specific species under reducing 
conditions. In the absence of E2, El tends to form glycosylated oligomers and El 
monomers exist as a series of differentially glycosylated species.
The existence of oligomeric forms of El has not been reported previously. Oligomers may 
form through exposed regions of E l, not normally available when associated with E2, 
which interact with neighbouring El molecules in an identical state. The interactions 
between E l-E l proteins may be covalent or non-covalent or indeed a combination of both. 
The observation that El-specific oligomers exist under reducing conditions suggests that 
they are stabilised by non-covalent interactions. However, the level of El oligomerisation 
detected between El cysteine deletion mutants is reduced, which implies covalent as well 
as non-covalent interactions contribute to E l-E l association.
Evidence obtained from endo H f deglycosylation implied that E l formed significantly 
more differentially glycosylated monomeric forms when expressed in the absence o f E2. 
Four distinct monomeric El-specific bands were detected, all of which were higher in 
molecular weight than the endo H f deglycosylated form. The occurrence of four species 
implies the addition of four oligosaccharide moieties to E l, thus leaving one potential Fl­
unked glycosylation site unmodified. Studies conducted by Meunier et al. (1999) 
examining the utilisation of N-linked glycosylation sites with El from strain H  indicated 
that the C-terminal site at aa 325 is not modified. This was due to the presence of a proline 
residue at aa 328, since its substitution with a glycine residue led to the addition of N- 
linked oligosaccharide at position 325. In the absence of more direct evidence, as 
presented by Meunier et al. (1999), it was assumed that glycosylation did not occur at 
residue 325 in strains H 7 7  and Glasgow since their sequences also contain the proline 
residue found in strain H .
Differential glycosylation was observed for strain H77 but not for strain Glasgow E l in the
absence of E2. This difference in behaviour of strains Glasgow and H77 El may be due to
the differences in their amino acid sequences (see Appendix 2). Furthermore, these forms
are not recognised as efficiently using the conformation specific MAb AP497 (see Fig 5.4),
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implying that the epitope identified by this antibody is dependent on proper glycosylation 
of E l protein. Foumillier-Jacob et a l (1996) also observed the appearance of minor 
products, from El 174.370 and El 174.383 expressing constructs, which migrated faster than the 
major E l product. These were assumed to be incompletely glycosylated forms of E l. The 
efficient glycosylation of protein is dependent on a sufficient pool of precursor 
oligosaccharide structures attached to dolichol lipid, the efficiency of 
oligosaccharyltransferase, and a properly oriented and accessible Asn-X-Ser/Thr sequence 
on a nascent polypeptide (Komfeld & Komfeld, 1985). The appearance of differentially 
glycosylated forms of E l only in the absence of E2 is unlikely to be a result of depletion in 
oligosaccharide-dolichol lipid structure or the inefficiency of oligosaccharyltransferase. 
However, in the absence of E2 in the ER lumen, glycosylation sites in some nascent El 
molecules may not be accessible to the glycosylation machinery, for example due to 
misfolding. Evidence from examination of the oligomeric forms of E l may support this 
proposal. The apparent molecular weight of the oligomers are smaller than predicted. In 
addition, the oligomers for the El mutant protein lacking all of the cysteine residues have 
slightly less mobility than those for the wild type form of E l (see Fig 5.22, lanes 3 and 4; 
Fig 5.24, panel b, lanes 7 and 8 ). However, the endo Hf-digested products for El and E1A. 
cys oligomers are almost identical (Fig 5.23, lanes 1-4). This suggests that the oligomers of 
E lA.cys are glycosylated to a greater extent than those of wild type E l. Hence, disulphide 
bond formation in aggregates of El may render certain sites inaccessible to N-linked 
glycosylation. Alternatively, the various glycosylated forms of E l may represent 
intermediate deglycosylated species. Degradation of incorrectly folded glycoproteins in 
the ER follows a pathway which involves deglycosylation and targeting to the proteasome 
(Suzuki et al., 1998). Thus, El in the absence of E2 may encounter such deglycosylation 
processes but since the intermediate forms are relatively abundant, they appear capable of 
circumventing degradation.
Studies presented in Chapter 4 revealed that covalent as well as non-covalent bonds 
participated in stabilising the aggregated complexes between El and E2 proteins. In order 
to identify the regions involved in covalent and non-covalent interactions, a number of El 
internal deletion mutants were generated. Results indicated that native complexes did not 
form between mutant El and wild type E2, although E2 protein was co-precipitated from 
aggregated complexes formed by mutant E l . Therefore, it has been difficult to separate 
the two sets of interactions. Alterations to El appears to significantly affect the formation 
of a native complex, while aggregate formation may not be stringently dependent on
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protein sequence. This data suggests that caution should be exercised on the authenticity 
of regions which are identified as necessary for E1E2 association. This is particularly the 
case where denatured proteins have been used to map sequences for E1E2 binding such as 
studies employing Far-Western blot analysis (Yi et al., 1997a). While segments identified 
by such analysis may contribute to E1E2 association, their role in native complex 
formation as opposed to aggregation cannot be deduced.
Results with the E l cysteine substitution mutants indicated that mutation of these residues 
abolished the formation of native complex, emphasising the sensitivity of El to alterations 
to its primary sequence. Under non-reducing conditions, E l cysteine substitution mutants 
co-precipitated with E2, although, native E2 was not detected. Native complex formation 
was sensitive even to alteration at a single residue (Cys 207) thus reflecting the importance 
of cysteine residues in E l. In a study examining the role played by glycans on E1E2 native 
complex formation (Meunier et al., 1999) also confirmed the sensitivity of this complex to 
changes. In that instance, native complex between strain H El and E2 was abolished in the 
absence of one glycosylation site at residue 305 (Meunier et al., 1999).
The mutant in which all o f the cysteine residues in E l had been mutated also continued to 
interact with E2. It is presumed that this occurred through non-covalent association of El 
with aggregates of E2. The cysteine residues in El are well conserved in all genotypes and 
the results presented in this chapter indicate their importance to native complex formation. 
The data also provide firm evidence that not only do disulphide bonds exist between El 
and E2 in an aggregated complex but also non-covalent interactions can stabilise 
association between the glycoproteins in such complexes. This is in agreement with results 
presented in Chapter 4 where DTT treatment in situ could not disrupt E1E2 aggregate 
complexes.
As mentioned above, the inefficiency of MAb AP497 to immunoprecipitate the 
differentially glycosylated monomeric El species suggested that the epitope recognised by 
this antibody was dependent on glycosylation o f E l. Additional to this, substitution of 
cysteine residues at 226, 229 and 238 in El abolished recognition of these mutants by 
MAb AP497, revealing that these residues also play an essential role in the formation of 
the AP497-specific conformation epitope. Interestingly, substitution of a single cysteine 
residue at aa 207 eliminated the formation of oxidised El and a reduced level o f non- 
aggregated El for this mutant was precipitated by AP497. The involvement of cysteine
138
Chapter 5 -  Results
207 in E l oxidation and the ability of AP497 to recognise a particular oxidised and 
glycosylated form of El remain to be defined.
This chapter has highlighted the requirement for E2 for the appropriate folding of E l, 
which in turn affect the formation of native complex. In the following chapter the 
properties of E2 important for E1E2 complex formation and El folding were further 
examined.
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Strain
Glasgow
H77
Protein
E l his
E1a196-
t235
E1a2 13-260 
E 1A266-303
E l A309-338 
E1a34 1-366
E I wt
El A199-233 
E1a21 3-260
E l A266-303
E 1A309-338 
E l A341-366
No. of 
E l aa 
deleted
38
46
36
28
24
33
46
36
28
24
No. of potential 
N-glycan sites 
lost (aa)#
(196, 209, 234) 
 1 (234)........
0
1 (209)
1 £2342
......0 ......
.....0.....
0
Predicted MW 
of nascent 
protein (kDa)
21.9
17.7
16.9 
18 0
18.8
19.4
20.9
17.3
16.0
_ _
17.8
18.4
Predicted MW of 
modified protein
(~kDa)*
29.9
19.7
22.9
26.0
26.8
27.4
28.9
23.3
22.0
25.0
25.8
26.4
Table 5.1. Predicted molecular weights (MW) of E l internal deletion mutant proteins 
of strains Glasgow and H77. * It is assumed that addition of a high mannose
oligosaccharide increased the molecular weight of nascent protein by -2.0 kDa per 
glycosylation site (Komfeld & Komfeld, 1985). #It is assumed that glycosylation at amino 
acid residue 325 in E l does not occur as reported by Meunier et al. (1999). * Histidine 
residues corresponding to the tag replaced the deleted region within this mutant.
GGC GTC GAC GCG GAG ACC CAC TAA GAT CTA AGC TTG 
G V D A E T H *
3 8 0  3 8 6
Fig 5.1. Construction of a plasmid expressing strain Glasgow El in the absence of E2.
pGEM/ElhiSE2 plasmid was linearised by digesting with Sail (which lies in the 3’ coding 
region o f El position 1483; Appendix 1) and Hindlll (that lies in the pGEM vector 
downstream of E2 coding region). These sites were bridged using an oligonucleotide 
(over-lined in red). The oligonucleotide was designed to regenerate the proteinase cleavage 
site between E1-E2 at residues 383-384. This construct was termed pGEM/Elcia- A stop 
codon, introduced by the oligonucleotide is indicated by *. El residues are in brown, while 
E2 residues are shown in green.
GGC GTC GAC GCG GAA ACC CAC TAA GAT CTG AAT TCC 
G V D A E T H *
3 8 0  3 8 6
Fig 5.2. Construction of a plasmid expressing strain H77 El in the absence of E2.
The strategy employed was similar to that used to obtain strain Glasgow E l, except a Sall- 
EcoRI linear fragment from pGEM/ElE2n77 encoding the El sequences was re-circularised 
by inserting an oligonucleotide (over-lined in red). This construct was called 
pGEM/ElH77. The key stated for Fig 5.1 applies.
a. b.
Ni-NTA Penta-His WB
1 2 1 2 E l
f e d x4VRr
ElhisE2 97 |g }  jpg,
69 JUk h a
E2 ■  1 2 IV i
46
-  W ' :
30 « * 1 1 his El his •  • Xl
21
Fig 5.3. Behaviour of strain Glasgow E l glycoprotein expressed in the 
absence of E2. Cells were electroporated with pSFV/ElhisE2 and pSFV/Elda 
RNAs and radiolabelled from 4-12 h after electroporation. Crude cell extracts 
were prepared in binding buffer and applied to Ni-NTA agarose. The bound 
material was analysed under reducing conditions on a 10% polyacrylamide gel 
(panel a). Crude cell extracts from identical cell cultures, which were not 
radiolabelled, were examined by Western blot analysis using the Penta-his MAb 
to detect the histidine tag in E l (panel b). Lanes 1 in both panels show material 
derived from crude extracts from pSFV/ElhisE2 RNA-electroporated cells and 
lanes 2 were from pSFV/Elda RNA-electroporated cells. The positions of 
ElhisE2, E2 and the oligomers of E l his are shown.
IP (AP21.010) IP (AP497) R528 WB
1 2 E l 1 2
200
30f
Agg
E1E2
E2
El
«
x4
x3
x2
E1E2
E2
El 1
x4
x3 
x2
E1E2
xl
xl
E l
El
21
a. b. c.
Fig 5.4. Behaviour of strain H77 E l glycoprotein expressed in the absence of E2. Cells 
were electroporated with pSFV/ElE2H77 and pSFV/ElH77 RNAs and radiolabelled with 35S- 
methionine between 4-12 h after electroporation. Immunoprecipitations were performed on 
the crude extracts obtained from these cells with El-specific antibodies AP21.010 (panel a) 
and AP497 (panel b). Immunoprecipitates were analysed under reducing conditions on a 
10% polyacrylamide gel. Western blot analysis, following transfer from a 10% 
polyacrylamide gel, was performed on crude extracts from duplicated cell cultures with an 
El-specific antiserum, R528 (panel c). Lanes 2 show samples derived from cells 
electroporated with pSFV/ElE2H77 RNA and lanes 1 represent those obtained from cells 
electroporated with pSFV/ElH77 RNA. The positions of monomeric (xl), dimeric (x2), 
trimeric (x3), tetrameric (x4) El and E2 are indicated. Aggregated material (Agg) and E l- 
E2 precursor are also indicated. Bands marked by symbols are discussed in the text.
Fig 5.5. Oxidation state of strain H77 E l glycoprotein expressed 
in the absence of E2. Experimental conditions were identical to 
those described in Fig 5.4, except immunoprecipitates obtained using 
AP21.010 were analysed under non-reducing (panel a) and reducing 
(panel b) electrophoresis conditions. Lanes 2 and 4 show precipitated 
material derived from cells electroporated with pSFV/ElE2H77 RNA 
and lanes 1 and 3 show precipitates from cells electroporated with 
pSFV/El H77 RNA. The positions of oxidised (ox) and reduced (red) 
El and E2 are indicated. The aggregated material (Agg) is also 
shown. Bands marked by symbols are discussed in the text.
Endo Hf
a. b.
Fig 5.6. Analysis of strain H77 E l glycoprotein by treatm ent with 
endo Hf. Cells were electroporated with pSFV/ElH77 RNA. Crude 
extract obtained from these cells 16 h after electroporation was treated 
with endo Hf before separation by electrophoresis on a 12% 
polyacrylamide gel (lane 2) alongside untreated crude extract (lane 1). 
Western blot analysis was performed, probing for E l using the R258 
antiserum. Panel a represents a lower exposure of the same blot shown 
in panel b. The positions of glycosylated (gly+) and de-glycosylated 
(gly-) El oligomeric forms are indicated.
Fig 5.7. Construction of strain Glasgow E l deletion mutant constructs.
a. Two fragments generated by HindIII-FspIc\^s (coding for the N-terminus of E l) and 
XhoIC2 3 6~HindIII (coding for the remaining sequences of E l and E2) derived from 
pGEM/ElhiSE2 plasmid were ligated along with an oligonucleotide (over-lined in red) to 
bridge the FspI and Xhol sites. The Fspl site is positioned at codon (c) 195 (nucleotide 
position 925; Appendix 1), Xhol is at 236 (nucleotide position 1049; Appendix 1) while the 
Hindlll site is located within the pGEMl vector downstream of E2 coding region. The 
oligonucleotide coded for sequences flanking the restriction sites as well as sequences 
coding for the histidine tag and generated a deletion between residues 196 and 235. The 
resultant construct was called pGEM/ElAi96-235E2oia-
b. HindIII-XhoIC2 0 9  and Clalaei-Hindlll fragments from pGEM/ElhiSE2 were ligated using 
an oligonucleotide to bridge the Xhol and Clal sites (nucleotide positions 971 and 1127 
respectively; Appendix 1). The oligonucleotide encoded for sequences flanking the 
restriction sites and generated a deletion between residues 213 and 260. The construct was 
called pGEM/ElA2i3-26oE2Gia- The same oligonucleotide was employed to ligate EcoRI- 
Xhol and Clal-EcoRI fragments derived from plasmid pGEM/E 1E2h77, where EcoRI was 
located downstream of E2 coding region. This construct was named pGEM/E l A2i 3- 
26oE 2 h77-
c. HindllI-Clalc262 and Munl^o^-HindHI fragments from pGEM/ElhiSE2 were ligated using 
an oligonucleotide to bridge between Clal and Muni sites (nucleotide positions 1127 and 
1256 respectively; Appendix 1). The oligonucleotide encoded for sequences flanking the 
restriction sites and introduced a deletion between residues 266 and 303. This construct 
was called pGEM/pSFV/ElA266-303E2Gia- The same oligonucleotide was used to generate 
an equivalent deletion in strain H77, in which case EcoRI-Clal and Munl-Hindlll 
fragments derived from pGEM/E 1E2h77 were employed. This construct was called 
pGEM/E 1 A 2 6 6 - 3 0 3 E 2 h 7 7 -
d. Hindlll-Munlciosand BamHIa^-HindHI fragments from pGEM/E lhiSE2 were ligated 
using the oligonucleotide indicated, which generated a deletion between positions 309 and 
338. The Muni and BamHI sites are located at nucleotide positions 1256 and 1358 
respectively (Appendix 1). This construct was called pGEM/pSFV/ElA309-338E2Gia, and a 
construct containing a similar deletion in strain H77, using fragments EcoRI-MunI and 
BamHI-EcoRI derived from pGEM/E 1E2h77, was called pGEM/E 1a309-33sE2h77.
e. Hindlll-BamHIcng&nd H in d is  g i -HindiI I  fragments from pGEM/E lhiSE2 were joined by 
the oligonucleotide shown, which allowed the region between residues 341 and 366 to be 
deleted and re-introduced the E l C-terminal sequences required for anchoring E l to 
membrane and directing E2 sequences to the ER. This construct was called pGEM/E 1 A34i- 
366E2cia- The BamHI and HincII sites are located at nucleotide positions 1358 and 1485 
respectively (Appendix 1).
Restrictions sites are shown in italic, histidine tag residues in pink, E l amino acid 
sequences in brown and E2 signal sequence residues in purple.
Fig 5.7. a.
CAA GIG CGC AAC CAT CAT CAT CAT CAT CAT GCC ICG AOS TGT TGG
q  v  r  n  ii n  i; ii :i i: a  s  r  c w
195 196 235 236
b .
CCT AAC ICG AGT ATT CGA CGT CAC ATC GAT CTG
P N S S I V R H I D L
209 213 260 262
C.
CGT CAC A IC GAT CTG CFG GTC GGG TGC AAT TGI TOC
R H I D L L V G C N C S
262 266 303 305
d .
GGC TGC AAT TGT TCC ATC ta t CTC CGG ATC OCA
G C N C S I Y L R I P
304 309 338 339
e .
CGG ATC CCC GGG AAC TGG GCG AAG GTC CTG GCA GTG CTG CTG CIA TTT GCC GGC GTC GAC 
R I P G N W A K V L A V L L L F A G V D  
339 341 366 381
621? CGC AAT TCC TCG GGG GGT AAC GCG 2 0 ?  AGG 
V R N S S G G N A S R  
194 199 233  237
Fig 5.8. Construction of a N-terminal deletion mutant for strain H77 E l. Two
fragments EcoRl-FspIc\ s^ and X ho^^-E coR l obtained from pGEM/E 1E2h77 were ligated 
using an oligonucleotide (over-lined in red) to bridge the FspI and Xhol sites. The Fspl 
(nucleotide position 992) and Xhol (nucleotide position 1046) sites are shown in Appendix 
3 and the EcoRl site was located in the pGEM vector backbone. The oligonucleotide 
encoded sequences flanking the restriction sites and introduced a deletion between residues 
199 and 233. The construct was called pGEM/E 1ai99-233E2h77. Restriction sites are in 
italics and El residues are shown in brown.
CPC COG ATC CCA. GGG AAC TGG GOG AAG GTC CTG GEA CTG CTC CTG CTA TTT GCC GGC GTC <3*2 GOG 
L R I  P G N W A K V L V V L L L F A G V D A  
338 341 366 381
Fig 5.9. Construction of a C-terminal deletion mutant for strain H77 E l. EcoRl- 
BamHIC339 and SalICT,%\-EcoRI fragments obtained from pGEM/E 1E2h77 were ligated using 
the oligonucleotide (over-lined in red) which bridged between BamHI and Sail sites. The 
BamHI (position 1357) and Sail sites (position 1482) are shown in Appendix 3 and the 
EcoRl site was located in the pGEM vector backbone. The oligonucleotide encoded 
sequences flanking the restriction sites and generated a deletion between residues 341 and 
366. This construct was called pGEM/pSFV/ElA34i-366E2H77. Restriction sites are in italics, 
El amino acid sequences in brown, and the E2 signal sequence in purple.
E l E2
209 234 305 325196
C l a l B am H I S a l l / H i n c I IF s p I  X h o l  X h o l M u n i
F s p I
g -3 8 a a (G la )  V 
-33 aa (H77)
X h o l
\
pSFV/ElA196-235E2Gla and  p S F V /E 1 a!99-233E2h77
x h o l
-46 aa
pSFV/ElA213-26oE2Gla a n d  H 77
f'la  I
pSFV/ E 1 A266-303E2Gla and H 77
pSFV/El A 3 0 9 - 3 3 8 E 2 G | a a n d  H 77
C l a l  M u n i
I  i
-36 aa
f
'u n i
-28 aa
B am H I
p S F V / E 1 A 3 4 1 - 3 6 6 E 2 G |a a n d  H 7 7
B am H I S a l l ^ H l n c I I  
-24 aa
Fig 5.10. Schematic representation of the deletion mutants created in both strains 
Glasgow and H77 E l glycoproteins. Restriction enzyme sites used in the construction o f 
each mutant are shown, as are the numbers o f residues removed in each case. The location 
of the 5 predicted glycosylation sites in El are indicated. The predicted site at residue 325 
appears not to be utilised in tissue culture cells (Meunier et al., 1999). A downward arrow 
indicates the predicted cleavage site between El (brown) and E2 (green).
a. 1 3 4 5 6 7 8 9 10 11 12 13 14
97
21 
14
E1E2
x2
E l Gly+
AE1
Predicted MW (~kDa) 30 29 20 23 23 22 26 25 27 26 27 26 29
b. 1 2 3 4 5 6 7 8 9 10 11 12 13 14
97
69
46
14
30
*
n
Predicted MW (~kDa) 22 21 18 17 17 16 18 17 19 18 19 18 21
E1E2
x2
Gly-
E1/AE1
Fig 5.11. Endo Hf treatment of wild type and mutant El glycoproteins from strains 
Glasgow and H77. Cells were electroporated with RNA from SFV constructs. 12 h 
following electroporatation, crude extracts were prepared and either treated or not treated 
with endo Hf before loading on 12% reducing polyacrylamide gels. The corresponding 
deletion mutants from strain Glasgow and H77 were analysed beside one another for 
comparative purposes. Proteins were transferred to membranes and examined by 
Western blot analysis using El-specific antiserum, R528. Panels a and b show non­
treated and treated crude extracts, respectively. Samples were pSFV/ElE2Gia (lanes 1), 
pSFV/ElE2 H77 (lanes 2), pSFV/ElAi96-235E2Gia (lanes 3), p SFV/E1ai99-233E2h77 (lanes 4), 
pSFV/E 1 A2i3-26oE2Gia (lanes 5), pSFV/E1a213-26oE2h77 (lanes 6), pSFV/ElA266-303E2Gia (lanes 
7), pSFV/E 1 A266-303E2H77 (laneS 8 ) ,  pSFV/E lA309-338E2da (lanes 9), pSFV/E 1 a 3 0 9 -3 3 8 E 2 h 7 7  
(lanes 10), pSFV/ElA34i-366E2Gia(lanes 11), pSFV/E 1a34i-366E2h77 (lanes 12), pSFV/ElH77 
(lanes 13), and pSFVl (lanes 14). Positions of glycosylated (Gly+) and deglysoylated 
(Gly-) El molecules, as well as their predicted molecular weights (MW, below gel lanes) 
are shown. The bands indicated by * are examined further in Fig 5.16.
14
Non-red
a. b.
Red
Fig 5.12. Examination of E1E2 complexes formed by H77 E l deletion 
m utants using R528 an ti-E l antisera. Cells electroporated with RNA 
transcripts from pSFV wild type and mutant El constructs were radiolabelled 
from 4-12 h after electroporation with 35S-methionine. Immunoprecipitations 
were performed on crude extracts from these cells using El-specific antiserum 
R528. Precipitates were analysed on 12% polyacrylamide gels under non­
reducing (panel a) and reducing (panel b) conditions. Samples were 
pSFV/E 1E2h77 (lanes 1), pSFV/E 1ai99-233E2h77 (lanes 2), pSFV/E 1a213-26oE2h77 
(lanes 3), pSFV/E 1a266-303E2h77 (lanes 4), pSFV/E la309-33sE2h77 (lanes 5), and 
pSFV/E 1 a34i-366E2h77 (lanes 6). The positions of the aggregated material (Agg), 
E2, El and mutant El (AE1) proteins are indicated.
1 2 3 4 5 6
E1E2
E2
46
30
Non-red
Fig 5.13. Examination of E2 present in E1E2 complexes formed 
by E l deletion m utants by W estern blot analysis. The
experimental conditions were as described for Fig 5.12. with the 
exception that immunoprecipitations with R528 were performed on 
the crude extracts followed by Western blot analysis using E2-specific 
MAb ALP98. Samples were subjected to electrophoresis under non­
reducing conditions on a 10% polyacrylamide gel. Precipitates are 
shown in the following order: pSFV/E 1E2 h77 (lane 1), pSFV/E 1ai99- 
233E2  (lane 2), pSFV/E 1a213-26oE2 (lane 3), pSFV/E 1a266-303E2 (lane 4), 
pSFV/E 1a309-338E2 (lane 5), and pSFV/E 1a34i-366E2 (lane 6). Positions 
of E1E2 precursor and E2 are indicated.
1 2 3 4 5 6 7  1 2 3 4 5 6 7
E a
M-.r-.-J * ’ *  #  **
30
21
14
El
AE1
Non-red Red
a. b.
Fig 5.14. Examination of strain H77 E l deletion m utants using E2-specific 
MAb ALP98. Cells were electroporated with RNA from pSFV wild type and 
mutant El constructs and pSFVl. Cells were radiolabelled between 4-12 h after 
electroporation with 35S-methionine and lysed in immunoprecipitation buffer. 
The crude extracts were subjected to precipitation using E2-specific MAb 
ALP98. Precipitated material was analysed under non-reducing (panel a) and 
reducing (panel b) electrophoresis conditions on 10% polyacrylamide gels. 
Samples were pSFV/E 1E2 h77 (lanes 1), pSFV/E 1ai99-233E2h77 (lanes 2), 
pSFV/E 1a213-26oE2h77 (lanes 3), pSFV/E 1a266-303E2h77 (lanes 4), pSFV/ElA309- 
338E2h77 (lanes 5), pSFV/E 1a34i-366E2h77 (lanes 6 ), and pSFVl (lanes 7). The 
positions of aggregated material (Agg), E2, El and mutant El (AE1) proteins are 
indicated.
1 2 3 4 5 6
ElhisE2
E l his
30 
21 
14
Non-red
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Fig 5.15. Examination of E1E2 complexes formed by strain Glasgow El 
deletion m utants using anti-E l antiserum  R528. Cells electroporated with 
RNA transcripts from pSFV wild type and mutant El constructs for strain 
Glasgow were radiolabelled between 4-12 h with 35S-methionine. 
Immunoprecipitations were performed on crude extracts obtained from these cells 
using El-specific antiserum, R528. Precipitates were derived from 
pSFV/ElhisE2 (lanes 1), pSFV/E 1ai96-235E2gi3 (lanes 2), pSFV/ElA2i3-26oE2Gia (lanes
3), pSFV/E 1a266-303E2gi3 (lanes 4), pSFV/E 1a309-338E2gi3 (lanes 5), and pSFV/E 1a34i- 
366E2Gia (lanes 6), and analysed on 10% polyacrylamide gels under non-reducing 
(panel a) and reducing (panel b) conditions. Positions of the aggregated material 
(Agg), Elh.sE2 precursor molecules, E2, El his and mutant E l his (AElhis) proteins 
are indicated.
AElhis
Endo H f - -  - +  +  +  - -  .
PNGase F - - - _ +  + +
1 2 3 4 5 6 7 8 9
200
97
69
46
H b   *  ' * E1E2
AEt
^ m m r  ~]! E 1 -gly
2i IKmmm . J
Predicted MW (~kDa) 29 25 26 21 17 18 21 17 18
Fig 5.16. Endo Hr and PNGase F treatm ent of E l A266-303 m utant. Crude 
extracts derived from cells electroporated with RNA from pSFV/E 1E2h77 
(lanes 1, 4 and 7), pSFV/E l a266-303E2h77 (lanes 2, 5 and 8), and pSFV/E 1a309- 
338E2h77 (lanes 3, 6 and 9) were subjected to deglycosylation by endo Hf 
(lanes 4-6) and PNGase F (lanes 7-9). Samples were analysed along with 
equivalent amounts of untreated material (lanes 1-3) under reducing 
conditions on a 12% polyacrylamide gel. Positions of E1E2, E l, mutant 
El (AE1) and deglycosylated El (-gly) proteins are shown.
1 2 3 4 5 6
30
________    E l
21
dieted MW (~kDa) 21.9 16.9 18.0 18.8 19.4 21.9
AE1
Fig 5.17. In vitro transcription and translation of E l deletion m utants.
In vitro transcription and translation reactions were performed from 
linearised pGEM vectors encoding strain Glasgow wild type and mutant El 
proteins. Reactions were performed in the presence of 35S-methionine. 
Samples were analysed on a 12% polyacrylamide gel, and are presented in 
the following order: pGEM/Elda (lanes 1 and 6), pGEM/ElA2i3-26o (lane 2), 
pGEM/El A266-303 (lane 3), pGEM/El A309-338 (lane 4), and pGEM/El A341-366 (lane 
5). Positions of El and mutant El proteins (AE1) are indicated.
N sil BamHI
pSFV /E lji77
Fig 5.18. Schematic to illustrate the sites used for the construction of E l deletion 
mutants expressed in the absence of E2. A plasmid backbone was derived from 
pSFV/ElH77 (the pGEM precursor plasmid is described in Fig 5.2) cut with Nsil (a site 
engineered upstream of the El signal sequence coding region see Figs 4.10 and 4.11) and 
BamHI site (located at nucleotide position 1357; Appendix 3). Nsil-BamHI fragments 
obtained from constructs pSFV/E1A266-303E2h77 and pSFV/E1A309-338E2h77, encoding the 
mutant El sequences, were ligated directly into the linearised backbone plasmid. These 
constructs were called pSFV/E 1^ 66-3031377 and pSFV/ElA309-338H77-
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Fig 5.19. O ligom erisation pattern  of m utan t E l molecules com pared to 
oligom erisation of E l expressed alone. C ells w ere e lec troporated  and 
radiolabelled from 4-12 h after electroporation w ith 35S-m ethionine before lysis in 
im m unoprecipitation buffer. Precipitations were perform ed w ith crude cell extracts 
using E l-spec ific  antiserum  R528 and analysed under reducing conditions on a 12% 
polyacrylam ide gel. Sam ples are pSFV/E1E2h77 (lane 1), pSFV/ElA266-303E2H77(lane 
2), pSFV /E 1 a309-338E2h77 (lane 3), pSFV /E 1h77 (lane 4), pSFV /E l A266-303H77 (lane 5), 
and pSFV /E 1 A309-338H77 (lane 6). The positions o f  E2, E l ,  m utant E l (AE1) and 
oligom eric E l proteins are indicated.
Fig 5.20. Construction of cysteine substitution mutants in strain H77 E l. Cysteine 
substitution mutants were constructed by introducing point mutants via oligonucleotides 
inserted between appropriate restriction sites.
a. Schematic shows the positions of cysteine residues within E l and the restriction enzyme 
sites used for cloning purposes.
b. Substitution of cysteine residue 1 (C l) (207). A plasmid backbone was derived from 
pSFV/E 1E2h77 linearised with Nsil and BamHI (Fig 5.18). This fragment contained 
coding sequences for the E l signal peptide upstream of the Nsil site (see Fig 4.10) and 
those for E2 downstream of the BamHI site. Nsil-Fsphws and EagIC2 ie~BamHI fragments, 
derived from pGEM /ElE2n77, were ligated into the backbone plasmid using an 
oligonucleotide which bridged the FspI and EagI sites. The oligonucleotide encoded all 
the residues between the FspI and EagI sites, except that a cysteine codon (207) was 
substituted with an alanine codon to prevent the generation of a novel N-linked 
glycosylation site. This construct was called pSFV/ElAcys207E2.
c. Substitution of residues C2(226), C3(229) and C4(238). Nsil-EagIaxe and BstEIIC2A\- 
BamHI fragments obtained from pGEM /ElE2H77 were ligated into the backbone plasmid 
described in part b using an oligonucleotide which bridged between EagI and BstEII sites. 
The oligonucleotide encoded the residues between EagI and BstEII sites except that 
cysteine codons (226, 229, and 238) were substituted for serine codons. This construct 
was named pSFV/E l AcyS226>229>238E2.
d. Substitution of residues C5(272), C6(281) and C7(304). NsiI-ClaIC262 and M unl^04- 
BamHI fragments obtained from pGEM /ElE2n77 were ligated into the backbone plasmid 
along with an oligonucleotide. This oligonucleotide bridged between Clal and Muni sites 
and coded for the residues between Clal and Muni except that cysteine codons (272, 281, 
and 304) were substituted for serine codons. This construct called pSFV/E l Acys272,28i,304E2.
e. Substitution of C8(306) residue. A Nsil-M unich  fragment from p S F V /E lAcys272,28i>304E2 
was ligated into the backbone plasmid (part b) using an oligonucleotide which bridged 
between Muni and BamHI. The oligonucleotide coded for the residues between Muni and 
BamHI sites except that cysteine codon (306) was substituted for a serine codon. The 
plasmid was called pSFV/ElAcyS272,28i,304,306E2.
The restriction sites are shown in italics, amino acid residues in brown represent E l and 
residues in red show the modifications.
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Fig 5.21. Construction of E l with substitutions at each cysteine residue. The
oligonucleotide used for constructing pSFV/E lAcyS226,229,238E2 (Fig 5.20, panel c) was 
utilised again to bridge the EagI and BstEII sites from fragments Xbal-EagIC2\6 from 
pSFV/ElAcys207E2 plasmid (encoding the N-terminal portion of E l) and BstEIIC24\-Xbal 
from pSFV/ElAcys272,28i,304.306E2 plasmid (encoding the C-terminal region o f El and E2). 
The Xbal site is located in the pSFVl vector (see Fig 3.3). This construct was named 
pSFV/E l A-cysE2. The restrictions sites are shown in italics, amino acid residues 
representing El are shown in brown and substituted nucleotides and residues are shown in 
red.
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Fig 5.22. Examination of strain H77 E l cysteine substitution m utants using anti- 
E l an tiserum , R528. Cells were electroporated with RNA followed by 
radiolabelling between 4-12 h after electroporation with 35S-methionine. Crude 
extracts were subjected to immunoprecipitation with El-specific antiserum, R528 and 
precipitates were analysed under non-reducing (panel a) and reducing (panel b) 
conditions on 10% polyacrylamide gels. Samples were from cells electroporated 
with RNA from the following constructs: pSFV/E 1 E 2 h 77 (lanes 1), pSFV/E lA-cysE2 
(lanes 2), pSFV/EU-cys (lanes 3), and pSFV/E 1h77 (lanes 4). Positions o f the 
aggregated material (Agg), E2, oxidised (ox) and reduced (red) forms of E l, and 
oligomeric El proteins are shown.
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Fig 5 .23 . Endo Hr trea tm ent of stra in  H 77 E l cysteine substitution 
m utants. Experimental conditions were as for those described for Fig 5.22 
except the crude extracts obtained were treated with endo Hf, separated on a 
12% reducing polyacrylamide gel and transferred to membrane. Western blot 
analysis was performed using anti-El antiserum, R528. Samples were derived 
from pSFV/E 1E2h77 (lane 1), pSFV/E lA-cysE2 (lane 2), pSFV/EU-cys (lane 3), 
and pSFV/E 1 H77 (lane 4). The positions of monomeric and oligomeric forms of 
deglycosylated (gly-) El are shown.
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Fig 5.24. Exam ination of interm ediate E l cysteine substitution m utants using 
AP21.010, Cells, electroporated with RNA from pSFV constructs, were radiolabelled 
from 4-12 h after electroporation with 35S-methionine and lysed in immunoprecipitation 
buffer. The crude extracts were subjected to immunoprecipitation using El-specific MAb 
AP21.010 and precipitates were analysed under non-reducing (panel a) and reducing 
(panel b) conditions on 12% polyacrylamide gels. Samples were pSFV/E 1E2h77 (lanes 
1), pSFV/E lACys207E 2  (lanes 2), pSFV/E lACys226,229,238E 2  (lanes 3), pSFV/E lACys272,28i,304E2 
(lanes 4), pSFV/E lAcyS272,28i,304,306E2 (lanes 5), pSFV/E 1 A-cysE2 (lanes 6), pSFV/ElA-cys 
(lanes 7), pSFV/E 1h77 (lanes 8 ), and pSFVl ( lanes 9). The positions of aggregated 
material (Agg), E2, oxidised (ox), reduced (red) and oligomeric El proteins are shown.
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Fig 5.25. Exam ination of interm ediate E l cysteine substitution m utants using E l-  
specific MAb AP497. Experimental conditions were as for those described for Fig 5.24, 
except crude extracts were subjected to immunoprecipitation using El-specific MAb AP497 
and precipitates were analysed under non-reducing (panel a) and reducing (panel b) 
conditions on 10% polyacrylamide gels. Samples were pSFV/E 1E2h77 (lanes 1), 
pSFV/E lACys207E2 (lanes 2), pSFV/E 1 ACys226,229,238E2 (lanes 3), pSFV/ElACys272,281,304E2  (lanes
4), pSFV/E lACys272,281,304,306E2 (lanes 5), pSFV/E lA-CysE2 (lanes 6), pSFV/E lA-cys (lanes 7), 
pSFV/El H77 (lanes 8), and pSFVl (lanes 9). The positions of aggregated material (Agg), E2, 
oxidised (ox), reduced (red) and oligomeric El proteins are shown.
Fig 5.26. Examination of interm ediate E l cysteine substitution mutants 
using E2-specific ALP98. Experimental conditions were as for those described 
for Fig 5.24 except crude extracts were subjected to immunoprecipitation using 
E2-specific MAb ALP98. Precipitates were analysed under non-reducing (panel 
a) and reducing (panel b) conditions on 10% polyacrylamide gels. Samples were 
pSFV/ElE2H77 (lanes 1), pSFV/E lAcyS207E2 (lanes 2), pSFV/E 1 Acys226,229;238E2 
(lanes 3), pSFV/E lAcyS272,28i,304E2 (lanes 4), pSFV/E lAcys272,28i,304,306E2 (lanes 5), 
and pSFV/ElA-CysE2 (lanes 6). The positions of aggregated material (Agg), E2, 
oxidised (ox), and reduced (red) El proteins are shown.
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Chapter 6 -  Identification of a Region in E2 Required for the Folding of 
El 
6.1.1. Introduction
Results discussed in the preceding chapter had concentrated on identifying the properties in 
El that contribute towards the formation of a complex between E l and E2. As a logical 
progression, the contribution made by E2 with respect to complex formation was analysed. 
The strategy employed was similar to that used for studying E l, where internal deletions 
were introduced to identify the regions of the polyprotein involved in interacting with El.
In this case, the internal deletion mutants were only created in strain Glasgow as this was 
the only strain available at the time during which the construction of these mutants was 
underway. The final mutant in this series consisted of a truncated version of the strain 
Glasgow E2 that lacked the transmembrane domain. This particular mutation was 
duplicated in strain H77 for corroboration purposes. As a consequence of the results 
obtained from the investigation of truncated E2, the ecto- and transmembrane domains of 
E2 were used to analyse their influence on the folding of El and the formation of native 
complex.
6.1.2. Construction of Internal Deletion Mutants in Strain Glasgow E2
To identify regions within E2 involved in association with E l, a panel of E2 deletion 
mutants in strain Glasgow was constructed in which regions were sequentially removed. A 
detailed schematic diagram illustrating the construction of these deletion mutants is 
presented in Fig 6.1. In a strategy similar to that used for creating El internal deletion 
mutants, plasmid pGEM/ElhiSE2 (Section 3.2) was used as the parent construct. An N- 
terminal deletion in E2 was designed to remove sequences coding for residues 384 to 411. 
In this instance an oligonucleotide was inserted between Sail (at codon 381) and Bell (at 
codon 411) restriction enzyme sites, which reconstructed the predicted cleavage site 
between El and E2 at residues 383/384 (Fig 6.1, panel a). This construct was termed 
pGEM/ElhiSE2A384-4ii. Subsequent deletions in the E2 protein coding region were 
introduced using restriction sites Bell, MscI (at codon 457), AscI (at codon 523) and HincII
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(at codon 610) in the nucleotide sequence (Appendix 1). Once again the oligonucleotides 
employed in each instance encoded a few residues on either side of the deleted sequences 
and regenerated the restriction sites. These constructs were named pG EM /ElhiSE2 A4i 5-454, 
pGEM /ElhisE2A459-520, and pGEM /ElhiSE2A528-609 (Fig 6 .1, panels b-d). The final internal 
deletion mutant was engineered to remove sequences between codon 610 and 699 and was 
created using an alternative strategy. In this case, a PCR fragment was amplified and 
inserted at suitable restriction sites (Fig 6.2). The 5’-primer was designed to anneal to 
sequences encoding residues 699 to 706 and carried sequences for codons 609 and 610, 
which included an in-frame Sail restriction enzyme site. The second primer was 
complementary to the SP6 promoter sequences in the pGEMl vector (see Fig 3.3, panel a). 
This allowed amplification of the C-terminal coding region of E2 from pGEM /ElhjSE2, 
thus ensuring that the stop codon, Bglll and Hindlll sites downstream of the E2 coding 
sequences were maintained. The PCR product was digested with Sail and H indlll and the 
resultant fragment was inserted into pGEM/ElhisE2 linearised with Sail (situated at codon 
609) and H indlll enzymes. This construct was called pG EM /ElhiSE2A610-699.
Another construct made in this series encoded an E2 mutant truncated at residue 702, 
thereby removing the predicted C-terminal end o f  E2 and the p7/NS2 coding sequences. 
The truncated mutant was created using an oligonucleotide depicted in Fig 6.3 that was 
inserted between the Seal site, at codon 701, and H indlll site situated in the pGEM l vector 
o f  construct pGEM/ElhiSE2 (Fig 3.4). This construct was called pGEM/ElhiSE2384_702Gia, 
which designates the encoded section o f  strain Glasgow E2. Mutant E2 coding sequences 
constructed in the pGEM l vector were introduced into the pSFV l expression vector using 
the Bglll sites flanking the ORF. The resulting constructs were named as follows: 
pSFV/ElhisE2A384-411, pSFV/ElhisE2A4i5.454, pSFV/E lhisE2A459-520, pSFV/ElhisE2A528-609, 
pSFV/E lhiSE2A6i 0-699, and pSFV/E lhiSE2384-702Gia- A schematic o f  the regions deleted in the 
E2 proteins is shown in Fig 6.4. Collectively, these plasmids were termed the 
pSFV/E lhisE2A series.
For control purposes, a plasmid expressing E2/p7 and the N-terminal portion of NS2 
polypeptides was constructed. This was achieved by excising a BamHI-BglH fragment 
from pGEM/ElhiSE2 plasmid, and inserting it into the pSFVl expression vector. The 
BamHI site in E l is located at codon 340 and the resultant fragment incorporated the El 
transmembrane domain and E2 signal sequence. The Bglll site is situated at the 3’-
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terminal end of the ORF (extending to codon 851) in pGEM/ElhiSE2. An ATG codon 
located at codon 347 was predicted to be utilised as a start codon. This construct was 
termed pSFV/E234o-85iGia.
6.1.3. Properties of the E2 Deletion Mutants
Before investigating the consequences of mutagenesis of E2 on heteromeric complex 
formation with E l, proteins expressed by the constructs described above were initially 
characterised in terms of their molecular weights, glycosylation pattern and behaviour 
under non-reducing polyacrylamide gel electrophoresis conditions. Cells were 
electroporated with RNA transcribed from the constructs encoding strain Glasgow wild 
type (pSFV/E lhiSE2) and mutant E2 (pSFV/E lhiSE2A) plasmids. For control purposes RNA 
from pSFV/E234o-85iGia and pSFVl were also used to electroporate cells. Following 
incubation for 12h at 37°C, extracts from cells were prepared in immunoprecipition buffer. 
A portion of each extract was subjected to treatment with endo Hf to remove N-linked 
oligosaccharides and separated by polyacrylamide gel electrophoresis. Equal amounts of 
untreated crude cell extracts were separated by electrophoresis in parallel and analysed by 
Western blot using the E2-specific MAb, ALP98, (Fig 6.5, panels a and b). The same 
nitrocellulose blots were subsequently stripped of immunoglobulins and probed again with 
the anti-E2 antiserum, R141, (Fig 6.5, panels c and d). This second antibody was included 
because the linear epitope recognised by ALP98 MAb was found to lie within residues 610 
and 699 of E2 , a region which is deleted in mutant E2A6io-699 (panel a, lane 6).
Comparing the predicted molecular weights of wild type and E2 mutants (Table 6.1) and 
Western blot data of non-endo Hf treated proteins (panels a and c), all of the proteins 
migrated according to their estimated sizes. It was assumed that all eight potential 
glycosylation sites in wild type E2 were occupied by high mannose oligosaccharides.
Three mutants had sequences removed that contained glycosylation sites. The E2 proteins 
in these cases lost 4 (pSFV/E lhiSE2A415-454), 3 (pSFV/E lhiSE2A528-609) and 2 
(pSFV/E lhiSE2A610-699) glycosylation sites which account for their greater mobilities (panel 
a, lanes 3 and 5, panel c, lane 6 ; Table 6.1). This was further confirmed by data obtained 
from endo H^treated samples in which deglycosylated proteins migrated in accordance 
with the number of amino acids deleted from each mutant (Fig 6.5, panels b and d).
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In addition, Western blot analysis of the endo Hrtreated samples identified more than one 
species of E2 for each construct. The proteins with molecular weights greater than the 
major species may represent incomplete deglycosylated forms. Since strain Glasgow p7 
appears to be inefficiently cleaved from E2 (see Section 4.6), the minor lower molecular 
weight forms probably correspond to E2 proteins alone. The predicted molecular weights 
of E2 in the absence of p7 are shown in Table 6.1 (column 4) and support this hypothesis.
With reference to data presented in Chapter 4 (Section 4.2), some non-covalently linked 
complexes between strain Glasgow E1E2 are detected, but at a significantly lower level 
than the amount detected for strain H77 E1E2. Prior to assessing the affect of deletion 
mutations in E2 on non-covalent complex formation via immunoprecipitation assays, the 
ability of these mutants to form non-aggregated species was analysed by non-reducing 
SDS-PAGE. The crude extracts derived from cells electroporated with the constructs 
described above were separated under non-reducing conditions and examined by Western 
blot analysis for E2 again using ALP98. Non-aggregated E2 protein was detected in 
relatively equivalent amounts for the wild type form and proteins E2A384-4i i , E2A4i5-454, 
E2A459_52o, and E2A528-609 (Fig 6.6, lanes 1-5). However, the amount of non-aggregated 
material detected for E2384-702 and E2 expressed in the absence of E l, was reduced 
(compare lane 1 with lanes 7 and 8). In the case of the E2384-702Gia mutant protein, a 
proportion of this protein may have been secreted out of the cells since the C-terminal 
hydrophobic region, which contains the transmembrane domain, had been removed. 
However, using the available immunological reagents against E2, significant levels were 
never detected in cell supernatants. E2A610-699 mutant protein (lane 6) was not detected by 
ALP98 since the epitope for the antibody is located in the deleted region.
6.1.4. Complex Formation between Wild-type E l and E2 Deletion 
Mutants
Having established that the E2 deletion mutants were able to form non-aggregated 
molecules (Western blot analysis), the involvement of these species in non-covalently 
linked complexes was subsequently examined. Cells were electroporated with RNA from 
pSFV/E lhiSE2 and pSFV/E lhiSE2A constructs. For control purposes RNA from 
pSFV/E234o-85iGia and pSFVl were also electroporated. Following a 12 h incubation period 
in the presence of 35S-methionine, cells were lysed in immunoprecipitation buffer.
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Precipitation was performed using the E2-specific MAb ALP98 for crude extracts derived 
from all the constructs, with the exception of pSFV/ElhiSE2A6io-699, where the R141 anti-E2 
antiserum was employed (Fig 6.7, panels a and b, lane 6). Examination of the precipitated 
material under non-reducing conditions (panel a) revealed that non-covalently linked E2 
was not clearly detected. This was probably due to the diffuse nature of the oxidised forms 
of E2 and the presence of non-specifically precipitated cellular proteins of similar 
molecular weights. A diffuse band of approximately 35 kDa (panel a, lane 1) may 
correspond to the oxidised form of co-precipitated E l. This 35 kDa band was absent in the 
samples co-precipitated with the truncated E2 protein (panel a, lane 7), E2 expressed in the 
absence of El (panel a, lane 8) and in the control sample derived from cells electroporated 
with RNA from pSFVl (panel a, lane 9). Reducing gel data suggested that E l was clearly 
co-precipitated with all the mutant E2 proteins (panel b, lanes 2-6). For mutant E2384-702Gia 
protein, a reduced amount of the glycoprotein is detected which probably accounts for the 
coincident reduction in the abundance of El protein (panel b, lane 7).
Examination of duplicate crude extracts with the El-specific AP497 MAb revealed a 
similar immunoprecipitation pattern. Under non-reducing conditions neither oxidised El 
nor co-precipitated wild type and mutant E2 proteins were discernible (Fig 6.8, panel a).
By contrast, the reducing gel data indicated the co-precipitation of wild type E2 and all of 
the E2 deletion mutants with E l (panel b, lanes 1-7). Proportionally, there appeared to be 
more El than wild type or mutant E2, suggesting that not all El proteins detected by 
AP497 were associated with E2. Among the E2 mutant proteins, the only variant which 
co-precipitated with El to a comparatively lesser extent was E2384-702Gia protein which 
lacks the E2 transmembrane domain and p7 sequence.
Although wild-type and mutant forms of E2 could be detected under non-reducing
electrophoresis conditions by Western blot analysis, the data from immunoprecipitations
would indicate that the majority of E2 and associated El are in the form of an aggregated
complex. These covalent interactions between El and E2 were not abolished by removal
of any specific region of E2. However, there was a relative reduction in the amount of
complexes detected between truncated E2384-702Gia and E l. This suggests that the
transmembrane domain removed from mutant E2384-702Gia (and perhaps p7) may have role
in the formation of complexes with E l. Other studies at the time of obtaining this data had
focused on the importance of the E2 transmembrane domain in terms of ER retention
(Cocquerel et a l , 1998; Duvet et al., 1998). In light of the attention paid to this region of
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E2, an identical mutant was constructed in strain H77, to reinforce the observations made 
for the strain Glasgow truncated E2 mutant. Moreover, El and E2 from strain H77 
produce a greater amount of non-covalently linked complexes and thus studies could be 
performed on the effects of the E2 transmembrane domain on native complex formation.
6.2.1. Construction of Plasmids Expressing Strain H77 Truncated E2 
and E2 Alone
The C-terminal end of strain H77 E2 and the p7/NS2 sequences were replaced with an 
oligonucleotide, using pGEM/ElE2H77 as the parent plasmid. This plasmid was linearised 
at a Seal site at codon position 701 in E2 and the EcoRI site situated 3’ to the ORF in the 
pGEMl vector. The termini generated by these enzymes were bridged with an 
oligonucleotide, which introduced a stop codon, followed by a Bglll site and regenerated 
the restriction enzyme sites (Fig 6.9). This construct was called pGEM/ElE2384-702H77- 
The Bglll sites flanking the ORF were employed to generate a fragment that was inserted 
into the pSFVl expression vector. This procedure yielded a construct called 
pSFV/E 1E2384-702H77-
In addition, the sequences encoding strain H77 E2 and p7 proteins as well as the 5' 
terminal part of NS2 were introduced into the pSFVl vector using a strategy similar to that 
described for the construction of pSFV/E234o-85iGia- Digestion with BamHI, (located at 
codon 340 in pGEM/ElE2n77) and Bglll (located in the pGEMl vector) generated a 
fragment that encoded the E2 coding sequence, in addition to the E2 signal sequence and 
p7/NS2 sequences (Appendix 3). This fragment was introduced directly into the pSFVl 
vector and the resulting construct was named pSFV/E234o-836H77-
6.2.2. Characterisation of the Strain Glasgow and H77 E2 Truncated 
Mutants
Reports by Selby et al. (1994) and Michalak et al. (1997) had suggested that E2 proteins 
truncated at residue 715 resulted in their secretion, although mutants truncated at residue 
730 were not secreted. The truncated E2 proteins engineered in this study, which ended at 
residue 702, were assayed for secretion into the cell supernatant by Western blot analysis
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and immunoprecipitation, as well as for cell surface expression by indirect 
immunofluorescence.
Cells co-expressing wild type El and truncated E2 from constructs pSFV/ElE2384-702Gia 
and pSFV/EIE2384-702H77 were fixed with methanol and analysed with anti-El antiserum 
R528 and ALP98, the E2 MAb. Localisation of the glycoproteins was examined by 
confocal microscopy (Fig 6.10). The E2384-702 truncated mutants for both strains Glasgow 
and H77 were found to co-localise with El (panels c and f). Using paraformaldehyde only 
as a fixative, expression of truncated E2, on the cell surface was not detected (data not 
shown). Furthermore analysis of cell supernatants for these mutants also yielded negative 
results, implying that reagents against E2 may not efficiently recognise secreted forms of 
the protein or that significant amounts of E2 were not secreted. Therefore, it can be 
inferred from the data obtained in this experiment that truncated forms of E2 continue to be 
retained within the ER. From the immunofluorescence data it was noted that the level of 
strain Glasgow truncated E2 detected appeared to be reduced in amount compared to strain 
H77 truncated E2.
Endo H f sensitivity has been used as an assay for ER retained proteins in earlier sections 
(3.9 and 5.5.2), and provided confirmation of the ER retention of strain Glasgow E2384-702 
protein (Fig 6.5). To examine strain H 7 7  truncated E2384-702 in a similar manner, crude 
extracts derived from cells electroporated with RNA from the pSFV/E 1E2h77 and 
pSFV/E IE2384-702H77 constructs were prepared and treated with endo H f. The treated 
samples were analysed in parallel with untreated crude extracts by Western blot and 
probed for E2 using ALP98 (Fig 6.11). Data revealed a shift in the mobilities of endo H r 
treated strain H 7 7  wild type E2 as well as truncated E2384-702 (lanes 2 and 4), when 
compared to untreated samples (lanes 1 and 3). Therefore, data for both strains Glasgow 
and H 7 7  indicated that deglycosylation of truncated mutant E2 proteins was possible with 
endo Hf, and in turn that these proteins were not retrieved from the secretory pathway.
The effects of truncation of strain H77 E2 at residue 702 on complex formation was 
assessed by immunoprecipitation using the E2 MAb, ALP98, and AP21.010 MAb (raised 
against E l), in addition to the anti-El antiserum R528. Cells were electroporated with 
RNA from construct pSFV/E IE2384-702H77 and for control purposes with RNAs from 
pSFV/E 1E2h77 and pSFV/E234o-836H77- These cells were metabolically labelled with 35S- 
methionine and their crude extracts were prepared in immunoprecipitation buffer. The
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extracts were subjected to precipitation using ALP98, and eluted material was analysed 
under non-reducing and reducing conditions. Under non-reducing conditions, a non- 
covalently linked complex was only discernible for the wild type proteins (Fig 6.12, lane 
1). For pSFV/E 1E2384-702H77 and pSFV/E234o-836H77, there was little evidence of either 
monomeric El or E2 species (lanes 2 and 3). By contrast, examination of the reducing gel 
indicated that E2 was precipitated from all three extracts (lanes 4-6). However, compared 
to wild type proteins, little E l was co-precipitated with truncated E2384-702, thus suggesting 
that El was not even incorporated efficiently into the covalently associated aggregated 
material formed by this mutant (compare lanes 4 and 5). Data from reducing gels and 
previous Western blot analysis (Fig 6.11) hint that the level of truncated E2 detected for 
strain H77 does not appear to be significantly different from the amount detected for wild 
type protein, but there was a reduction in the amount o f non-aggregated E2384-702 (panel a, 
lane 2). In addition, a marked reduction in the amount of non-aggregated E2 expressed in 
the absence of E l was also observed for strains Glasgow (Fig 6.7, panel a, lane 7) and H77 
(Fig 6.12, lane 3 ). This correlates with data obtained in Chapter 5 (Section 5.3.3), where 
slight changes in E l, in terms of cysteine substitutions, affected the level of non- 
aggregated E2 detected. It appears therefore that the presence of wild type E l is necessary 
for the formation increased production of non-aggregated E2.
To further investigate the behaviour of strain H77 El expressed along with truncated E2 
with respect to complex formation, immunoprecipitations were performed using immune 
reagents directed against E l. Crude extracts were derived from cells electroporated with 
RNA from pSFV/E 1E2384-702H77, and from pSFV/E 1E2h77 and pSFV/E 1h77 for controls. 
Analysis of the precipitated material using the R528 antiserum and MAb AP21.010 
revealed that a non-covalently linked complex between E land E2 was detected for the wild 
type proteins (Fig 6.13, panels a and b, lanes 2 and 5). Non-aggregated El was observed 
under the non-reducing polyacrylamide electrophoresis conditions for the other two 
constructs (Fig 6.13., panels a and b, lanes 1 and 3), but truncated E2 was not as clearly 
distinguished under either non-reducing or reducing conditions (panels a and b, lanes 3 and 
6). Instead, in addition to monomeric E l, higher molecular weight species were 
precipitated from the sample derived from cells expressing pSFV/E lE2384-702 with the anti- 
El antibodies (panels a and b, lane 6). Interestingly these higher molecular weight species 
co-migrated with oligomeric forms of El (panels a and b, compare lanes 4 and 6), which 
predominantly occur when El is synthesised in the absence of E2 (see Fig 5.4). It is likely 
that any truncated E2 which co-precipitated with E l would co-migrate with the presumed
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dimeric (x2) form of El (panels a and b, lane 6). These data, from two different 
immunological reagents therefore suggest that although El is able to oligomerise in the 
absence of E2, it behaves similarly when made in the presence of a truncated form of E2 
lacking the E2 transmembrane domain. Furthermore, in the absence of E2, E l tends to 
form increased amounts of differentially glycosylated species and does not attain an 
oxidised state. In the presence of truncated E2384-702, the differentially glycosylated forms 
of El are apparent but occur to a lesser extent than with El expressed on its own. Also, 
the diffuse material representing monomeric E l may include some oxidised E l that 
corresponds to a population of El molecules which can interact with truncated E2. 
However, the substantial amount of El which oligomerises in the presence of truncated E2 
suggests that the transmembrane domain of E2 has a role in the folding of E l.
6.3.1. Use of Foreign Glycoprotein Sequences to Study the Properties of 
E2
Due to the aberrant behaviour of E l, in terms of formation of oligomers and the loss of 
non-covalently associated complexes with truncated E2 lacking the transmembrane 
domain, the influence of the E2 transmembrane domain (TM) on the properties of El was 
examined further. The first strategy tested the affect of substituting foreign glycoprotein 
transmembrane domains for the E2 TM. In parallel studies sequences containing the E2 
TM were fused to the ectodomain of a foreign glycoprotein to determine whether El could 
associate with the resultant chimeric protein.
6.3.2.1. Construction Of Chimeric Proteins - Cloning Of Full Length 
HSV-1 Glycoprotein D
In order to examine whether the E2 TM had a specific role in determining the behaviour of 
El described in section 6.1.6, this region was substituted with two different foreign 
transmembrane domains. The first of these was derived from HSV-1 gD. Published data 
had shown that gD is efficiently transported to the cell surface in the absence of any other 
HSV-1 proteins (Long et al., 1992). The second transmembrane sequence employed was 
derived from the rubella virus El glycoprotein. By contrast to gD, this glycoprotein is 
retained in the ER and sequences within its transmembrane domain have been implicated 
in conferring this property (Hobman et al., 1997).
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As an initial cloning step, a DNA fragment containing the coding sequences for full length 
gD protein was amplified and cloned into pG EM l. A plasmid called pAT153BamHu, that 
contained a region of the HSV-1 genome which spans nucleotides 136290 and 142746 was 
used as the template for PCR amplification (nomenclature as in McGeoch et al., 1988a). 
The primers (1 and 2; Fig 6.14) used were designed to introduce H indlll and Bglll sites at 
the 5’-terminus and EcoRI and Bglll sites at the 3’-terminus in the resulting PCR product. 
Digestion of this product with H indlll and EcoRI allowed the gD coding sequences to be 
cloned into the pGEMl vector, which was subsequently termed pGEM/gD.
6.3.2.2. Construction of E2 Chimeric Proteins
To create the first of the E2 chimeric proteins, the predicted E2 TM coding sequence was 
substituted by inserting a PCR fragment encoding the gD TM and cytoplasmic tail (Fig 
6.15, panel a). A PCR product was generated from pGEM/gD template plasmid using a 
forward primer (spanning nucleotides 139436-139454) that incorporated an in-frame Seal 
site and codon 702 of E2 at the 5’-terminus; Primer 2 (shown in Fig 6.14) was used as the 
reverse primer, thus maintaining the stop codon, Bglll and EcoRI sites. The PCR 
fragment, after treatment with Seal and EcoRI restriction enzymes, was introduced into the 
P G E M /E 1E 2 h77 plasmid linearised with the same enzymes. The Seal site in this plasmid 
was positioned at codon 701 in the polyprotein and the EcoRI site was located in the 
pGEMl vector downstream of the HCV coding sequences. The resulting plasmid was 
named pGEM/ElE2702gDtm, which signified the last codon of E2 (aa 702) directly followed 
by residues representing the gD TM and cytoplasmic tail. The equivalent SFV expression 
plasmid was termed pSFV/ ElE2702gDtm.
Oligonucleotides were employed to substitute the E2 transmembrane domain with that of 
rubella virus El glycoprotein (RVE1) (Fig 6.15, panel b). The RVE1 transmembrane 
domain is comparatively well defined and is composed of a stretch of 35 amino acid 
residues (Hobman et al., 1997). Therefore, the oligonucleotides encoded the sequence for 
the RVE1 transmembrane domain followed by an artificial stop codon. Suitable restriction 
enzyme sites were also included in the design of the oligonucleotides to allow their 
introduction at the Seal site at residue 701 and the EcoRI site in pGEM/ElE2n77.
Following insertion of the oligonucleotides the construct was called pGEM /ElE27oiRVEitm-
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The Bglll restriction sites flanking the coding sequences were used once again to introduce 
the ORF into pSFVl, which was subsequently called pSFV/ElE27oiRVEitm; this plasmid 
encoded E2 from aa 384 to 701 followed by the rubella virus El transmembrane domain.
6.3.2.3. Construction of gD Chimeric Proteins
The strategy employed placed the HSV-1 gD coding sequence downstream of and in-frame 
with the HCV El coding sequences. This enabled El and gD to be expressed as a single 
polyprotein, a normal feature of E l and E2 protein synthesis. In order to prevent 
disturbing the functions of the El C-terminal sequences, which act both as the El 
transmembrane domain and E2 signal sequence, the coding sequence for this region in El 
was maintained. Therefore, the segment encoding the gD signal sequence and the N- 
terminus (aa -24 to +10, see Appendix 4) was omitted from the El-gD chimera. A 
HindlH-Sall (at codon position 381 in E l) fragment derived from pGEM/ElE2n77 and an 
EcoRI-PvuII (at residue 29 in gD) fragment obtained from the pGEM/gD were ligated into 
Hindlll-EcoRI linearised pGEMl vector using an oligonucleotide to bridge between the 
Sail and PvuII sites (Fig 6.16, panel a). The oligonucleotide encoded residues in El and 
E2 that spanned the proteolytic cleavage site between El and E2 and a portion of the N- 
terminal region of gD, from residues 11 to 29. These residues contain the epitope for a 
gD-specific monoclonal antibody, 4846, which had been fully characterised (A. Cross and 
H. S. Marsden, unpublished results). The resulting construct was termed
p G E M / E l 3 8 7 g D i  1-370-
The transmembrane and cytoplasmic domain of gD, in the construct pGEM /El387gDi 1-370, 
was substituted with that of a region of the HCV polyprotein encoding the E2 TM coding 
sequence in order to study its properties in the absence of the E2 ectodomain (Fig 6.16, 
panel b). Due to the length of the E2 TM, the sequence encoding this region was amplified 
by PCR using primers that introduced an Eael at the 5’terminus of the amplified product.
In addition, Bglll and EcoRI sites were incorporated at the 3’terminus by the second 
primer, along with an artificial stop codon. The PCR product encoded residues 703 to 758 
of the HCV polyprotein and thus extended a short distance (13 residues) beyond the 
cleavage site between E2 and p7. It was presumed that cleavage by host cell signalases 
would occur at this site, although this need not necessarily be the case. Therefore, in the 
following section, this segment will be referred to as the E2TM with the caveat that
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chimeric proteins may contain also this short segment o f p7. The PCR fragment was 
inserted at the Eael site at codon 310 in gD, and EcoRI site within the pGEMl vector of 
plasmid pGEM /El387gD 11.370. This construct was called pGEM /El387gDii.3i2E2tm.
For control purposes the gD TM was substituted with the rubella virus El TM, and details 
for the design of this construct are shown in Fig 6.16 (panel c). An oligonucleotide 
encoding the RVE1 TM sequence was introduced at the Eael and EcoRI sites in the 
plasmid pGEM /El387gDi 1.370, resulting in pGEM /El387gDi i-3i2RVEitm. For all the 
constructs, Bglll fragments were transferred into pSFVl, and the resultant plasmids were 
called pSFV/El387gDi 1.370, pSFV/El387gDn.3i2E2tm and pSFV/El387gDn.3i2RVE]tm-
The constructs made in section 6 .3.2.2 and 6 .3.2.3 are referred to as the E2/gD chimera 
plasmids, and are shown diagrammatically in Fig 6.17.
6.3.3.I. Cellular Distribution of Chimeric Proteins - Indirect 
Immunofluorescence
To examine the effect of transmembrane domain substitutions on E2 and gD glycoproteins, 
the localisation of these proteins, along with E l, was investigated using indirect 
immunofluorescence combined with confocal microscopy. Cells electroporated with RNA 
from pSFV/E 1E2H77, pSFV/ElE2702gDtm and pSFV/ElE27oiR.vEitm were analysed by 
immunofluorescence using R528 anti-El antiserum and ALP98, the E2-specific MAb. 
Confocal images of these cells revealed the localisation of E27oiRVEitm was identical to that 
for El (Fig 6.18, compare panels g-i); an identical result was obtained for the wild type El 
and E2 proteins (panel a-c). For E27o2gDtm, the bulk of the detected staining coincided with 
that for E l, although some staining at the periphery of the cell was also found which did 
not overlap with El (compare panels d and e). This additional staining for E27o2gDtm is 
apparent in the merged image of panels d and e (panel f).
A similar assay was performed for the gD chimeric constructs, where cells were 
electroporated with RNA from plasmids pSFV/El387gDi 1.370, pSFV/El387gDn-3i2E2tm and 
pSFV/El387gDj i-3i2RVEitnv Immunofluorescence analysis was performed with the same 
anti-El antiserum (R528), but gD was detected using 4846 MAb. The confocal images 
obtained indicated that gD] 1.370 expressed downstream of El in the polyprotein (Fig 6.19,
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panel b), had a distinctive staining pattern at the cell periphery which was not apparent for 
co-expressed El (panels a and c). Such peripheral localisation of gD was observed on 
replacing the gD transmembrane and cytoplasmic domains with the transmembrane 
domain from RVE1, although the amount of staining at the cell periphery was 
comparatively reduced (compare panels b and h). However, fusion of the HCV E2 TM to 
gD gave a staining pattern for gD which was identical to that for HCV El (panels d-f) and 
there was little evidence of localisation at the cell periphery (compare panels b and e).
The above evidence suggested that the peripheral staining observed for E2 and gD 
chimeric proteins may represent protein localisation on the cell surface. This was 
examined further by comparing immunofluorescence patterns in permeabilised and non- 
permeabilised cells. Non-permeabilised cells were prepared by fixing with 
paraformaldehyde in the absence of any detergent (PFA). For analysis of permeabilised 
cells, fixation was carried out using a combination of paraformaldehyde and Triton X-100 
(PFAT). Cells electroporated with RNA from construct pSFV/ElE2702gDtm, in addition to 
pSFV/E lE27oiRVEitm and pSFV/E 1E2H77 constructs for control purposes, were fixed using 
the above described fixatives and processed for immunofluorescence. The confocal 
images derived from these cells revealed that cells expressing all o f the above constructs, 
when fixed with PFAT, stained for both El and E2 protein that localised intracellularly 
(Fig 6.20., panels b, d and f). However, in the case of PFA-treated cells (panels a, c and e) 
intracellular staining was absent for El indicating that these cells were not permeabilised. 
Thus, any fluorescence that was observed for cells fixed in this manner would represent 
proteins that were present on the cell surface. No cell surface expression of wild type E2 
was observed in cells expressing proteins from construct pSFV/E 1E2H77 (panel a). Weak 
fluorescence was observed for cells expressing E27o2gDtm (panel c), suggesting that the 
MAb ALP98 was able to detect some but barely detectable cell surface localisation of this 
chimeric E2 protein. There did appear also to be some cell surface expression of 
E27oiRVEitm, where E2 was fused to the rubella virus El TM (panel e). This data suggest 
that the HSV-1 gD and RVE1 transmembrane domains may not completely retain E2 in the 
ER.
For similar studies on cell surface expression of gD expressed in the context of E l, cells
were electroporated with RNA transcripts from constructs pSFV/El387gDi 1.370 and
pSFV/E 1387gDj 1-3i2E2tm and fixed with either PFA or PFAT. In this instance, gD was
visualised using MAb 4846. The PFA-treated cells expressing gDj 1.370 readily exhibited
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the presence of this protein on the cell surface (Fig 6.21, panel a) and in the parallel culture 
fixed with PFAT, there was additional intracellular localisation of the protein (panel b). 
Investigation of the cells expressing construct pSFV/E l 387gDn_3]2E2tm fixed with PFAT 
revealed intracellular localisation for the chimeric protein, gDn.3i2E2tm (panel d). However, 
in PFA-fixed cells, only a small amount of gD fused to the E2 transmembrane domain was 
evident on the cell surface (panel c). The level of immunofluorescence was significantly 
less than that detected for gDi 1.370, which contained its authentic transmembrane domain.
6.3.3.2. Endo Hf and PNGase F Sensitivity of Chimeric Proteins
Further analysis was conducted to investigate the cell surface expression seen for the 
gD/E2 chimeric proteins and gDi 1.370, when expressed downstream of E l, with the use of 
two endoglycosidase enzyme digestion assays, endo H f and PNGase F. The predicted 
molecular weights of the nascent and fully glycosylated chimeric proteins are stated in 
Table 6.2, where the typical molecular weight of complex type N-linked oligosaccharides 
present on mature VSV G protein is taken as ~3.3 kDa (Komfeld & Komfeld, 1985).
For endoglycosidase assays, cells were electroporated with RNA transcribed from 
pSFV/E1E2h77, pSFV/ElE2702gDtm, pSFV/El E27oiRVEitm, pSFV/El387gDi 1-370 and 
pSFV/E l 387gDi i-3i2E2tm. Portions of the crude extracts derived from these cells were 
treated with endo H f and PNGase F, and separated by polyacrylamide gel electrophoresis 
alongside corresponding untreated samples. Western blot analysis using ALP98 was 
performed on samples obtained from cells expressing wild type E 2 , E2702gDtm and 
E27oiRVEitm. The data revealed that the predominant species for wild-type E 2  was sensitive 
to endo H f digestion (Fig. 6 .2 2 , panel a, lanes 1 -3 ). A higher molecular weight species 
(indicated as ♦ )  also was sensitive to the enzyme and was assumed to be a glycosylated 
form of uncleaved E 1 E 2  (see Fig 3 .1 9 ) . For E 2 7o2gDtm, the predominant species was 
digested with endo H f, however a proportion of a higher molecular weight band remained 
resistant to endo H f but not PNGase F (indicated as ■, panel a, lanes 4 -6 ) .  This material in 
lane 4  may represent both glycosylated, uncleaved E l E 2 7o2gDtm and some E 2 7o2gDtm which 
is modified by transit beyond the ER. Such further modified protein would be resistant to 
endo H f and it was noted from the immunofluorescence analysis that some of the E2702gDtm 
protein was detected on the cell surface (Fig. 6 .2 0 , panel c). For E 2 70iRVEitm, endo H f  
treatment gave a smear of material (panel a, lanes 7-9) which was digested by the enzyme.
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By contrast, PNGase F digestion gave a single band. The smeared material could represent 
a complex series of molecules which have varying extents of endo Hf-sensitivity. 
Partially-resistant forms could occur through modification of glycans as a result of cycling 
between the ER and Golgi apparatus and again, it was noted that very small amounts of 
E27oiRVEitm were present on the cell surface (Fig. 6.20, panel e). A higher molecular 
weight species (indicated as ©, panel a, lane 7 )  was sensitive to endo H f and is therefore 
likely to be glycosylated, uncleaved E lE 27oiRVEitm- The slight increase in mobilities of 
PNGase F treated proteins is likely to result from the presence of single saccharide residues 
at each of the glycosylation sites in endo Hf-treated samples (panel a compare lanes 2, 5 
and 8 with lanes 3, 6 and 9); these saccharides are removed in PNGase F digests.
Western blot analysis of samples derived from cells expressing E l387gDn_37o and 
E l387gDn_3i2E2tm, was performed using 4846 MAb. Results revealed the presence of two 
gDi 1-370 -specific bands (Fig 6.22, panel b, lane 13). The lower molecular weight band 
probably corresponds to intracellular gDi 1.370 protein. The higher molecular weight 
species on the other hand is likely to represent the cell surface gDi 1.370 species, which 
contains complex type oligosaccharides that increase the molecular weight of the proteins. 
This observation is consistent with observations made by Long et al. (1992) in their studies 
characterising HSV-1 gD. After endo H f treatment, proteins represented by the upper band 
and some of the lower band remained resistant to deglycosylation with this enzyme (panel 
b, lane 14); this confirmed the notion that these proteins contain oligosaccharides modified 
in compartments other than the ER. The lower molecular weight proteins resistant to endo 
Hf may correspond to Golgi apparatus-localised species containing hybrid-type 
oligosaccharides. However, the production of a novel lower molecular weight band 
following endo H f treatment revealed that a proportion of gDi 1.370 proteins did localise in 
the ER. Treatment with PNGase F (panel b, lane 15) gave a single prominent band. The 
same blot shows the result for gDn.3i2E2tm, containing the E2 transmembrane domain.
Upon treatment with endo H f , the major species detected in the untreated sample was 
reduced in size to the same apparent molecular weight as in the PNGase F-treated sample 
(panel b, lanes 11 and 12), suggesting that the bulk of this protein remained in the ER. 
There were two minor bands (panel b, lane 10, indicated by *), which migrate faster after 
endo H f treatment, but which almost disappear after PNGase F treatment. These bands 
may represent forms of gDn_3i2E2tm, which have been further processed such that they 
contain partially-resistant oligosaccharide moieties. Although Western blot analyses data 
cannot be quantitatively interpreted, it was apparent that any cell surface species as
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identified by resistance to endo H f for E2702gDtm, E27oiRVEitm an<3 gDn.3i2E2tm, were 
significantly less prominent compared to the equivalent gDi 1.370 species (compare lanes 4, 
7, and 10 with lane 13).
The behaviour of El expressed from the chimera constructs used above was also analysed 
by endo H f treatment. Endo Hf-treated samples were analysed again alongside 
corresponding untreated crude extracts using AP21.010 MAb to probe for E l (Fig 6.23). 
As observed previously, El was sensitive to endo H f digestion. Furthermore, a distinct 
band representing a protein of approximately 65 kDa (marked by *) corresponded to a 
species detected by the gD-specific MAb 4846 (Fig 6.22, panel b, lane 10), which was 
sensitive to endo Hf. Given that both E l and gD-specific antibodies detected this species, 
it is likely to represent the uncleaved precursor polyprotein of E l387gDi i-3i2E2tm, which has 
been glycosylated.
Collectively, the data thus far have indicated that in contrast to wild type E2, a portion of 
chimeric E2 proteins carrying the foreign transmembrane segments is transported beyond 
the ER and these forms are resistant to endo Hf-deglycosylation but remain sensitive to 
PNGase F. Additionally, gD containing its own TM is localised in intracellular organelles 
as well as at the cell surface. However, the bulk of chimeric gD fused to the E2 TM is 
rendered sensitive to endo H f, and is thus an indication that this protein is retained in the 
ER by virtue of the HCV sequences.
6.3.4. Effect of Foreign Ecto- and Transmembrane Domains on E1E2 
Complex Formation
The principle aim in generating these chimeric proteins was to study the influence of 
sequences containing the E2 transmembrane domain on E1E2 complex formation and their 
influence on the behaviour of E l. Therefore, immunoprecipitation analysis was performed 
using various immunological reagents available. Cells were electroporated with RNA 
from constructs expressing wild type and chimeric proteins and pSFVl. Following 
radiolabelling with S-methionine, crude extracts of these cells were prepared in 
immunoprecipitation buffer. Immunoprecipitations were performed initially using the E2- 
specific MAb, ALP98, for the E2-containing extracts, and the gD-specific MAb, 4846, for 
the gD-containing extracts. The precipitated material was examined under both non­
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reducing and reducing conditions to enable non-covalently linked complexes to be 
distinguished from aggregated material. From the non-reducing gel, native E1E2 
complexes were identified for wild-type forms of the glycoproteins, in agreement with 
previous data (Fig 6.24, panel a, lane 1). However, on replacing the E2 TM with either gD 
or RVE1 TM segments, El was not present and chimeric E2 proteins were either absent or 
present in small amounts under such electrophoretic conditions (panel a, lanes 2 and 3). 
Examination of these samples under reducing conditions indicated that complex formation 
did occur between El and the chimeric E2 proteins (Fig 6.24, panel b, lanes 1-3).
However, these complexes are likely to represent covalently-linked aggregates and 
contained reduced amounts of E l. Therefore, substitution of the E2 transmembrane 
domain with equivalent domains from foreign glycoproteins does not prevent complex 
formation but non-covalently linked El and E2 is not readily detected. In particular, 
substitution with the RVE1 TM containing an ER retention signal was not sufficient to 
compensate for the authentic E2 transmembrane domain which has similar retention 
properties.
Immunoprecipitation with 4846 MAb did not reveal any significant co-precipitation of El 
with gDi 1-370 protein (Fig 6.24, panel a, lane 5). A small amount of El was observed to 
precipitate with gDi 1-370, however this was only detected under reducing conditions, and 
thus may represent aggregated material (panel b, lane 5). E l did co-precipitate with gD 
containing the E2 TM and this was observed under reducing and non-reducing conditions 
(panels a and b, lane 4). This suggests that El is non-covalently bound to the gD/E2 
chimeric protein. It was observed that increased levels of E l precipitated with the gD/E2 
chimeric protein as compared to wild type E2 protein however this may be a consequence 
of the different avidities of ALP98 and 4846 antibodies for E2 and gD respectively. A 
higher molecular weight band of -65 kDa represented the E l387gD] i-3i2E2tm precursor 
polyprotein (panel a and b, lanes 4, indicted by *), and a species of -55 kDa present in 
pSFV/El387gDi 1.370 (panel b, lane 5) was presumably gD protein that had been further 
processed beyond the ER (Fig 6.22, lane 13).
In parallel, identical ALP98 and 4846 immunoprecipitation samples from non­
radiolabelled cell extracts were examined by Western blot analysis using R528 to probe for 
E l (Fig 6.25). This analysis, performed on precipitated samples subjected to non-reducing 
gel electrophoresis, yielded a similar result to that obtained for radiolabelled precipitates. 
Hence, non-covalently-linked El was only precipitated by wild type E2 (lane 1) and the
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gDi i-3i2E2tm chimera with the gD ectodomain fused to the E2 TM (lane 4). This result 
confirms that the E2 transmembrane domain, when fused to gD allows the formation of a 
non-covalently linked complex with E l.
Complex formation was investigated also using reagents against E l, for which crude 
extracts were derived from cells expressing strain H77 E l alone, wild type El and E2 
proteins, and the chimeric E2/gD proteins. Analysis with anti-El antiserum, R528 (Fig 
6.26) revealed that, under non-reducing conditions, the differentially glycosylated forms of 
E l were detected preferentially when El was expressed in the absence of E2 (panel a, lane
1); this is in agreement with data presented in Chapter 5. Non-covalently-linked 
complexes, which occur between the wild type El and E2 proteins (panel a, lane 2), were 
observed also under non-reducing conditions. In this case, only one major glycosylated El 
species was detected which corresponded to the oxidised form of the protein according to 
its migration relative to El expressed in the absence of E2. Barely detectable levels of 
monomeric El were found when it was expressed in the context of E2702gDtm, E27oiRVEitm 
and g D n -370 chimeric proteins (panel a, lanes 4, 5 and 6, respectively). Also co­
precipitation of non-aggregated E27o2gDtm, E27oiRVEitm and gD n -370 was not observed. 
However, a prominent band representing El expressed along with gD] i-3i2E2tm fusion 
protein (panel a, lane 3) was detected in approximately similar amounts to that for El 
expressed along with wild type E2 (panel a, compare lanes 2 and 3). Comparing the 
migratory characteristics of this band with El expressed in the presence and absence of E2, 
it would appear to be an oxidised from of E l. Two other novel proteins co-precipitated 
with El expressed in the context of gD] i-3i2E2tm had apparent molecular weights of 
approximately 45 and 65 kDa. Western blot analysis using 4846 antibody of duplicate 
immunoprecipitations showed that the 45 kDa protein was gD containing the E2 TM and 
the 65 kDa protein, corresponded in size to uncleaved but glycosylated El-gD] i-3i2E2tm 
precursor protein (Fig 6.27, lane 5).
In an earlier section (6.1.6), oligomers of El were identified under reducing electrophoretic 
conditions on expression with E2 truncated at residue 702. To test whether oligomers 
could be detected with the E2 and gD chimeric proteins, immunoprecipitations with two 
anti-El reagents, R528 and AP497, were analysed under reducing conditions. Results 
revealed that both the monoclonal antibody and the rabbit antiserum were able to 
precipitate oligomeric forms of El expressed along with E 2 702gDtm, E 2 7oiRVEitm and gD] 1.370 
(Fig 6.26, panel b, lanes 4-6; Fig 6.28, lanes 4-6), which migrated with the El oligomers
157
Chapter 6 -  Results
produced in absence of E2 (Fig 6.26, panel b, lane 1 and Fig 6.28, lane 1). Additional 
protein bands (marked by ■ and 0 )  are predicted to correspond to E2702gDtm and 
E27oiRVEitm proteins, respectively, that are precipitated in the aggregated material (Fig 6.26, 
panel b, lanes 4 and 5; Fig 6.28, lanes 4 and 5). Significantly, oligomeric E l was not 
precipitated from extracts containing wild type E2 and gDi i-3i2E2tm (Fig 6.26, panel b, lanes 
2 and 3; Fig 6.28, lanes 2 and 3). Additional species observed in lanes 2 and 3 with 
apparent molecular weights of ~97 kDa and -65 kDa (indicated by ♦  and *) represent 
glycosylated forms of the precursor E 1E2H77 and E l387gDn.3i2E2tm polyproteins, 
respectively (see Section 6.3.3.2). These results provide substantial evidence for a critical 
role for sequences containing the E2 TM in complex formation with E l and the ability of 
El to form oligomers.
Further conclusive evidence of the specific influence sequences containing of the E2 TM 
on chimeric gD was provided from the examination of gD chimeric protein fused with the 
RVE1 TM. Cells were electroporated with RNA from constructs pSFV/El387gDn_3i2E2tm, 
pSFV/El387gDn_3i2RVEitm and pSFV/ElH77. 35S-methionine-labelled crude extracts were 
prepared from these cells and subjected to immunoprecipitation using R528, the anti-El 
antiserum. Analysis of the isolated material under non-reducing conditions showed that 
although El could be precipitated from all three crude extracts, gDj i-3i2E2tm protein but not 
gD] i-3i2RVEitm protein co-precipitation was detected (Fig 6.29, panel a, lanes 1 and 2). El 
precipitated by R528 from the pSFV/El387gDRVEitm extract had the same pattern of 
multiple species as E l expressed alone whereas El isolated from pSFV/El387gDn_3i2E2tm 
extract migrated as a smear of oxidised species (Fig 6.29, panel a, lanes 1-3). Therefore, 
oxidation of E l is dependent on sequences containing the E2 TM and cannot be substituted 
by other TM sequences with retention properties. Consistent with this conclusion, 
oligomeric forms of E l were detected on expression with gD fused to the rubella virus El 
TM (panel b, lanes 1-3) under reducing conditions. An additional observation was that the 
deglycosylated forms of El were less evident on co-precipitation of gD with either the E2 
or rubella virus El TM sequences (panel b, compare lanes 1 and 2 with lane 3). This may 
indicate that the multiple monomeric forms of El are a feature of E l expression in the 
absence of any other glycoprotein.
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6.4. Discussion
An ER retention signal has been mapped to the C-terminal 29 amino acid residues of E2 
which constitutes the hydrophobic transmembrane domain (Cocquerel et al., 1998). E2 
proteins from strain H truncated at residues 661, 669, 688, 704, 710 and 715, expressed by 
recombinant vaccinia viruses, were detected in HepG2 cellular extracts as well as in the 
supernatant of infected cells (Selby et al., 1994; Michalak et al., 1997). However, 
significantly reduced levels of truncation mutants E 237o-688, E237o-704, and E237o-7i5 were 
detected in the supernatant when expressed by recombinant Sindbis virus (Michalak et al.,
1997). Similarly in this study, expression of strains Glasgow and H77 E2 truncated at 
residue 702 using SFV, another alphavirus, led to intracellular retention o f this mutant 
rather than secretion. It is unlikely that retention is solely a consequence of misfolding of 
E2 since most forms of E2 secreted by the vaccinia virus system are apparently aggregated 
(Michalak et al., 1997). Therefore, it is possible that viral expression systems can have 
different effects on the ability of cells to secrete proteins. Sindbis virus and SFV 
expression systems might inhibit secretion of some proteins, or alternatively, the vaccinia 
virus system facilitates secretion. In this study, SFV-expressed gD, carrying its authentic 
transmembrane domain was efficiently transported through the secretory pathway to the 
cell surface. This provides evidence that SFV does not prevent movement of proteins from 
the ER. The level of protein expression achieved by vaccinia virus appears to be 
significantly higher than that achieved by recombinant Sindbis virus or SFV (Michalak et 
al., 1997; from this study data not presented). Therefore, the over-expression of 
glycoproteins by recombinant vaccinia virus perhaps imparts a greater strain on the ER 
quality control mechanisms that result in the escape of misfolded proteins from the ER.
Evidence for the existence of an ER-retention signal at the C-terminus of E2 was provided 
by expression of chimeric proteins in which E2 ecto- and transmembrane domains were 
exchanged with corresponding domains of a protein normally transported to the plasma 
membrane. E237i_7i7 fused to the CD4 anchor and cytoplasmic domain led to the 
expression of this E2 ectodomain on the cell surface (Cocquerel et al., 1998). In a separate 
study, E2 ectodomain (aa 371-742) fused to the transmembrane domain and cytoplasmic 
tail of VSV G was also transported to the cell surface (Lagging et al., 1998). Here, the
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fusion of HSV-1 gD and rubella virus E l transmembrane and cytoplasmic domains to 
E2384-702 led to the transport of only a small amount of chimeric E2 to the plasma 
membrane. The bulk of this chimeric protein was retained in the ER in a manner similar to 
truncated E2 (at aa 702) as shown by confocal microscopy and endo H f sensitivity. No 
previous studies have analysed the ER-retention properties of the HSV-1 gD 
transmembrane and cytoplasmic domain. In the case of the rubella virus El 
transmembrane domain, it efficiently retains the rubella virus El protein in the ER 
(Hobman et al., 1997). However, when associated to ectodomains of foreign glycoproteins 
this signal was less effective and fusion proteins did leave the ER (Hobman et al., 1997). 
Further studies revealed that sequences upstream of the rubella virus El transmembrane 
domain influenced the efficiency of ER retention by this domain (Hobman et al., 1997). 
The region containing the E2 transmembrane domain did efficiently sequester gD in the 
ER, indicative of an ER-retention signal. This agrees with an earlier study in which an ER- 
retention signal was mapped to the C-terminal 29 amino acids of E2 that constitutes the 
hydrophobic transmembrane domain (Cocquerel et al., 1998). However, there may be 
some contribution from ectodomain sequences in E2 since small amounts of gD fused to 
the segment containing the E2 transmembrane domain are present on the cell surface.
Data with strain Glasgow E2 deletion mutants failed to identify any regions in the protein 
whose removal prevented aggregated complex formation with E l . As mentioned 
previously for this strain, the abundance of native complex is barely detectable with the 
available antibodies. The overall conclusion therefore is that removing certain regions of 
E2 which may be involved in aggregate formation does not enhance production of native 
complex. In fact, it may be the case that any alteration to E2 promotes aggregation. 
Interestingly, analysis of secreted E2 truncated mutants revealed that apart from E234o-66i 
the remaining mutants did not migrate into non-reducing gels, which suggested that they 
formed aggregates (Michalak et al., 1997). This was confirmed by immunoprecipitations 
studies using a conformation-sensitive MAb H2, which failed to recognise secreted E237]. 
715 but efficiently precipitated secreted E237i_66i . These findings indicate that the nature of 
truncated E2 in functional studies (e.g. receptor binding; Pileri et a l, 1998) has to be 
evaluated carefully and reconfirmed using E1E2 complexes.
Fusion of a transmembrane domain from foreign glycoproteins (gD and rubella virus E l) 
to the ectodomain of E2 did not assist the formation of a native complex for either strain 
H77 or strain Glasgow. This was despite the presence of an ER retention signal in the
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rubella virus El transmembrane domain to anchor chimeric E2 to the ER. This suggests 
that retention of E2 in the ER per se was not sufficient to permit native complex formation. 
Pseudotype virus particles have been produced using chimeric HCV structural proteins 
(Lagging et al., 1998), in which the transmembrane domains of E l and E2 have been 
substituted by the equivalent region of VSV G, a viral glycoprotein which readily forms 
virus-like particles in the absence of other viral proteins (Rolls et al., 1994). From 
observations in this study using E2 fused to the transmembrane domain of foreign 
glycoproteins, caution should perhaps be applied to the use of the such pseudotype virus 
particles for infectivity of mammalian cells and neutralisation studies (Lagging et al.,
1998) since any E1E2 complexes are unlikely to be in a native form.
The amount of E l associated with E2 truncated at residue 702 was reduced, indicative of a
role for the C-terminal region of E2 in complex formation; this agrees with previous
studies (Selby et al., 1994; Cocquerel et al., 1998). Examination of the behaviour of E l in
the presence of truncated E2 revealed that El oligomerised in a manner similar to that in
the absence of E2. E l oligomerisation was observed also when E l was made along with
chimeric E2 molecules, consisting of the E2 ectodomain fused to either the gD or rubella
virus El transmembrane and cytoplasmic domains, and HSV-1 gD. Oligomerisation was
one of the criteria established in Chapter 5 to enable discrimination of E l folding in the
presence and absence of E2. In addition, oxidised forms of E l were not precipitated in
appreciable amounts with these chimeras. A significant finding in this study was that the
oligomerisation of El was not detected when a foreign glycoprotein (gD) ectodomain was
fused to sequences containing the E2 transmembrane domain (aa 703-758). An ElgDE2tm
complex was immunoprecipitated using both anti-gD and anti-El antibodies and the
complexed proteins migrated into non-reducing gels. In addition, E l protein was in an
oxidised state and there was little evidence of El oligomerisation products. This suggests
that chimeric gD, containing the E2 TM, was able to form a native-like complex with E l.
Therefore, in relation to the necessity for E2 for proper folding of E l and native complex
formation, a region spanning the C-terminal end of E2 and p7, which includes the E2
transmembrane domain appears critical for these two events. Previous studies have
suggested that E2 performs a chaperone function to aid El folding (Section 1.3.11.1). The
data presented here imply that a region containing the E2 transmembrane domain is
important for this process while the ectodomain can be substituted by a foreign sequence.
There may be additional important interactions between E 1 and the E2 ectodomain,
however, these are not sufficient to prevent El misfolding. Further studies are required to
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determine the limits of the region in E2 (and perhaps p7) that allow oxidation of El. 
Assuming that the E2 transmembrane domain is important in El oxidation, it would be 
predicted that interaction would occur with a hydrophobic region in E l. There are two 
hydrophobic segments in E l (Fig 3.8) and either of them may be involved in E2 
association.
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Strain
Glasgow
proteins
No. of 
aa 
deleted
No. of 
potential 
N-glycan 
sites lost
(aa
position)
Predicted 
MW of 
nascent E2
(kDa)
Predicted 
MW of 
nascent 
E2 + p7
(kDa)
Predicted 
MW of 
modified 
E2
(~kDa)*
Predicted 
MW of 
modified 
E2 + p7
(~kDa)*
E2384-745 - - 40.0 47.1 58.0 65.1
E2 A3 84-411 26 0 37.3 44.4 55.3 62.4
E2A415-454 38 4
(417,423,
430,448)
35.7 42.8 45.7 52.8
E2A459-520 60 0 33.5 40.6 51.5 58.6
E2a528-609 80 3
(540,556,
576)
31.2 38.3 43.2 50.3
E2A610-699 88 2
(623, 645)
29.6 36.7 43.6 50.7
E2384-702 43 0 35.0 - 53.0 -
Table 6.1. Predicted molecular weights (MW) of nascent and glycosylated forms of 
E2 deletion mutants. * It is assumed that addition of a high mannose oligosaccharide 
increased the molecular weight of nascent protein by -2.0 kDa (Komfeld & Kornfeld, 
1985).
1 Protein Predicted MW 
of nascent 
protein
(kDa)
Predicted MW with 
ER retained protein
(~kDa)*
Predicted MW with 
transported protein
(~kDa)#
E2384-810 
(H77 wt E2-p7)
47.2 69.2 83.5
E2702gDtm 41.3 63.3 77.6
E270]RVEltm 38.8 60.8 75.1
gDi 1-370 39.9 45.9 49.8
gDn-3i2E2tm 39.6 45.6 49.5
gDn-3i2RVEltm 37.7 43.7 47.6
Table 6.2. Predicted molecular weights (MW) for nascent and glycosylated forms of 
HCV E2, HSV-1 gD and chimeric proteins. * It is assumed that addition of a high 
mannose oligosaccharide increased the molecular weight of nascent protein by -2.0 kDa 
(Komfeld & Komfeld, 1985). # It is assumed that addition of complex oligosaccharides 
increased the molecular weight of nascent protein by 3.3 kDa (Komfeld & Kornfeld, 
1985).
a.
GCC GGC GTC GAC GCG GAG GTC CAG T TG ATC  AAC ACC 
A G V D A E V Q L I N T  
379 384 411 416
b.
GTC CAG T TG A  TC AAC GAG AGG TTG GCC AGC TGC
V Q L I N E R L A S C  
411 415 454 459
C.
AGG TTG GCT AGC TGC GAC AGG TCG GGC GCG CCT 
R L A S C D R S G A P  
455 459 520 525
d.
AGG TCG GGC GCG CCT ACC TAC AGC GTC GAC TAC CCG 
R S G A P T Y  S V D Y P  
521 528 609 612
Fig 6.1. Construction of strain Glasgow E2 internal deletion mutants.
a. Two fragments E coR l-Sall^\ and B cll^n-H indlll derived from pGEM/ElhiSE2 were 
ligated into the pGEMl vector (linearised with EcoRI and HindHI restriction enzymes) 
using an oligonucleotide (over-lined in red), which bridged the Sail and Bell sites 
(nucleotide positions 1483 and 1580; Appendix 1). The oligonucleotide encoded residues 
flanking the restriction sites and generated a deletion between residues 384 and 411. This 
construct was called pGEM/ElhiSE2A384-411.
b. EcoRI-BclIc413 and M sclasi-Hindlll fragments derived from pGEM/ElhiSE2 were 
ligated into the linearised pGEMl vector using an oligonucleotide which bridged the Bell 
and MscI sites (nucleotide positions 1580 and 1711 respectively; Appendix 1). The 
oligonucleotide encoded residues flanking the restriction sites and introduced a deletion 
between residues 415 and 454. The construct was named pGEM/ElhiSE2A415-454.
c. EcoRI-Mselc457 and AscIC523-HindIII fragments derived from pGEM/ElhisE2 were 
ligated into the linearised pGEMl plasmid using the oligonucleotide which bridged the 
MscI and AscI sites (nucleotide positions 1711 and 1910 respectively; Appendix 1). The 
oligonucleotide encoded residues flanking the restriction sites and generated a deletion 
between residues 459 and 520. This construct was named pGEM/ElhiSE2A459-520.
d. EcoRI-AseIc523 and H in d is \o-HindIII fragments obtained from pGEM/ElhiSE2 were 
ligated into the linearised pGEMl plasmid using an oligonucleotide that bridged the AscI 
and HincII sites (nucleotide position 1910 and 2169 respectively; Appendix 1). The 
oligonucleotide encoded residues flanking the restriction sites and generated a deletion 
between residues 528 and 609. This construct was named pGEM/ElhiSE2A528-609.
Restriction sites are shown in italics, amino acid residues shown in brown represent El and 
residues in green represent E2.
CTG GTC GAC GTG CAG TAC TTG TAC GGG GTG  ACC TGA TCT AGA TCT AAG CTT
L V D V Q T L Y G V  T
607 610 699 851
Fig 6.2. Construction of strain Glasgow E2 internal deletion A610-699. An EcoRl- 
SalIceo9 fragment derived from pGEM/ElhiSE2 and pGEMl plasmid linearised using EcoRI 
and H indlll restriction enzymes were ligated along with a PCR fragment that was prepared 
by digestion with Sail and H indlll restriction enzymes. The PCR fragment contained the 
coding sequence for the C-terminus o f E2, p7 and the N-termina! part o f NS2 from 
residues 699-851. The PCR fragment included an in frame 5’ Sail site (at codon 608) and 
a stop codon (*) following residue 851. This construct was called pGEM/ElhiSE2A610-699- 
Restriction sites are shown in italics, E2 amino acid residues are shown in green while the 
residue in black represents NS2.
GTG CAG TAC TTG TAG AGA TCT AAG CTT  GG
V Q Y L *
699 702
Fig 6.3. Construction of a truncated form of strain Glasgow E2. An EcoRl-ScaIc701
fragment derived from pGEM/ElhiSE2 and H indlll and EcoRI linearised pGEMl plasmid
were ligated along with an oligonucleotide (over-lined in red), which encoded sequences 
adjacent to the Seal site (nucleotide position 2443; Appendix 1) and introduced a stop 
codon ( ) after codon 702 in E2. This construct was called pGEM/ElE2384-702Gia- The 
restriction sites are shown in italics and E2 amino acid residues are shown in green.
El
417 423 430 448
I WVY
Strain Glasgow E2 
540 556 576 623 645
y y y y y
P?
S ail B ell MscI
3 8 1  4 1 3  4 5 7
AscI
5 2 3
Sall/HincII
6 1 0
Seal
7 0 1
Sail Bell
I
27aa
pSF V /E 1 hisE 2  A 3 8 4 -4 11
pSF V IE 1 h isE 2 A4J5-454
MSCI
61aa
AscI
L _
pSF V  IE 1 hisE2 A 4 5 9 -5 2 0
AscI
I 81aa
HincII
I
pSF V  IE 1 hiSE 2 A 5 2 8 -6 0 9
Sail Seal
I  _89aa
p S F V / E l h i s E 2 A 6 1 0 -6 9 9
Seal
J
43aa
pSF V IE 1 hisE2384-702Gla
Fig 6.4. A schematic representation of the amino acid deletions created in strain 
Glasgow E2 glycoprotein. Restriction enzyme sites used in the construction of each 
mutant are shown, as are the numbers o f residues removed in each case. Location of 
predicted glycosylation sites are indicated. Downward arrows indicate the predicted 
cleavage sites between E1-E2 and E2-p7. The brown block represents E l, green represents 
E2 and yellow indicates p7.
a.
Gly+
1 2 3 4 5 6 7 8
b.
Gly-
1 2 3 4 5 6 7 8 9
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Fig 6.5. Sensitivity of strain Glasgow E2 deletion m utants to endo Hf glycosidase. Cells 
were electroporated with RNA from pSFV strain Glasgow and incubated at 37°C for 12 h. 
These cells were lysed and a portion of crude cell extract was endo Hf-treated (panels b and 
d). An equal amount of untreated crude extract was analysed in parallel (panels a and c) by 
electrophoresis on 10% reducing, polyacrylamide gels. After transfer of proteins to 
membranes, Western blot analysis was conducted initially using E2-specific MAb, ALP98, 
(panels a and b). Subsequently, blots were stripped and reprobed with anti-E2 antiserum, 
R 141, (panels c and d). Samples were pSFV/ElhisE2 (panel a, lane 1; panel b, lanes 1 and 
2), PSFV/ElhisE2A384-4ii (panel a, lane 2; panel b, lane 3), pSFV/ElhisE2A4i5-454 (panel a, lane 
3; panel b, lane 4), pSFV/ElhisE2A459-52o (panel a, lane 4; panel b, lane 5), pSFV/ElhisE2A528-609 
(panel a, lane 5; panel b, lane 6), pSFV/ElhisE2A6io-699 (panel c, lane 6; panel d, lane 7), 
pSFV/ElhisE2384-702Gia (panel a, lane 7; panel b, lane 8), and pSFV/E234o-85iGia (panel a, lane 8; 
panel b, lane 9). Lane 1 in panels b and d show the untreated full-length E2 control 
samples. The predicted molecular weights (MW) of the wild type and mutant proteins are 
indicated below each corresponding lane; these molecular weights assume that p7 is 
inefficiently cleaved from E2. The positions of precursor polyprotein ElhiSE2, E2, mutant 
E2 (AE2) and deglycosylated (gly-) proteins are indicated.
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Non-red
Fig 6.6. Analysis of strain Glasgow E2 deletion m utants under non­
reducing electrophoresis conditions. Experimental conditions were as 
described in Fig 6.5. except the crude extracts were analysed by non­
reducing electrophoresis on a 10% polyacrylamide gel. Following 
transfer of proteins to membrane, Western blot analysis was performed 
using E2-specific MAb ALP98. Crude extracts were derived from cells 
electroporated with RNA from pSFV/ElhisE2 (lane 1), pSFV/ElhisE2A384- 
4ii (lane 2), pSFV/ElhisE2A4i5-454 (lane 3), pSFV/ElhisE2A459-52o (lane 4), 
pSFV/ElhisE2A528-609 (lane 5), pSFV/ElhisE2A6io-699 (lane 6), 
pSFV/ElhisE2384-702Gia (lane 7), pSFV/E234o-85iGia (lane 8), pSFVl (lane 9). 
The positions of Elh.sE2 precursor polyproteins, E2 and E2 mutants 
(AE2) proteins are shown.
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Fig 6.7. Complex formation between E2 deletion m utants and E l protein. Cells 
were electroporated with the RNA from pSFV strain Glasgow constructs and labelled 
from 4-12 h after electroporation in the presence of 35S-methionine. Cells were lysed 
and all crude extracts were subjected to immunoprecipitation using E2-specific antibody 
ALP98, except anti-E2 antiserum R141 was used for extract derived from 
pSFV/ElhisE2A6io-699-electroporated cells (lanes 6). Precipitated material was analysed 
under non-reducing (panel a) and reducing conditions (panel b) on 10% polyacrylamide 
gels. Samples were pSFV/ElhisE2 (lanes 1), pSFV/ElhisE2A384-4ii (lanes 2), 
pSFV/ElhisE2A4i5-454 (lanes 3), pSFV/ElhisE2A459-52o (lanes 4), pSFV/ElhisE2A528-609 (lanes
5), pSFV/Elh,sE2A6io-699 (lanes 6), pSFV/ElhisE2384-702Gia (lanes 7), pSFV/E234o-85iGia (lanes 
8), pSFVl (lanes 9). The positions of the aggregated material (Agg), oxidised (ox) and 
reduced (red) El and E2 proteins are indicated.
1 2 3 4 5 6 7 8 9  1 2 3 4 5 6 7 8 9
i i i i i H f  *.
0 7  W  ^
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Fig 6.8. Complex form ation between E2 deletion m utants and E l protein.
Experimental conditions were as for those described for Fig 6.7 except 
immunoprecipitations on crude extracts were performed using El-specific MAb 
AP497. The precipitated samples were analysed under non-reducing (panel a) and 
reducing (panel b) conditions on 10% polyacrylamide gels. Samples were 
pSFV/ElhisE2 (lanes 1), pSFV/ElhisE2A384-4ii (lanes 2), pSFV/ElhisE2A415-454 (lanes 3), 
pSFV/ElhisE2A459-52o (lanes 4), pSFV/ElhisE2A528-609 (lanes 5), pSFV/ElhisE2A610-699 (lanes
6), pSFV/ElhisE2384-702Gia (lanes 7), and pSFVl (lanes 9). The pSFV/E234o-85iGia (lanes 8) 
cell extract was precipitated with ALP98. The bands corresponding to the aggregated 
material (Agg), E l his and E2 proteins are labelled.
GTG CAG TAC TTG TAG AGA TCT GAC AGT GAA TTC CGG
V Q Y L *
69 9 702
Fig 6.9. Schematic illustrating the construction of the truncated form of strain H77
E2. pGEM/ElE2n77 (see Fig 4.11) was linearised at Seal (at codon 701) and EcoRI 
(positioned 3’ of the ORF within the pGEMl plasmid). This fragment which encoded El 
and the ectodomain of E2 was ligated using an oligonucleotide (over-lined in red) which 
bridged between the Seal and EcoRI sites. The oligonucleotide encoded sequences 
adjacent to the Seal site (nucleotide position 2442; Appendix 3) and a stop codon (*) 
following residue 702. This construct was called pGEM/E 1E2384-702H77-
Glasgow E1E2702 H77 E1E2702
c.
Fig 6.10. Localisation of E l and truncated E2 glycoproteins of strains 
Glasgow and H77. Cells were electroporated with RNA from pSFV/ElhisE2384- 
702Gia (panels a-c) and pSFV/ElE2384-702H77 (panels d-f) and incubated for 
approximately 12 h at 37°C. Methanol-fixed cells were analysed using anti-El 
antiserum, R528, (panels a and d) and E2-specific MAb, ALP98, (panels b and 
e). Panels c and f  represent the merged images of panels a and b, and d and e, 
respectively.
Endo Hf 
200
21
Fig 6.11. Endo Hf sensitivity of strain H77 truncated and full- 
length E2 proteins. Cells were electroporated with RNA from 
pSFV strain H77 constructs. A portion of crude extracts was 
treated with endo Hf (lanes 2 and 4) and analysed alongside 
untreated crude extracts (lanes 1 and 3) on a 10% polyacrylamide 
gel. Proteins were visualised by Western blot analysis using E2- 
specific MAb ALP98. Samples were pSFV/ElE2H77 (lanes 1 and
2) and pSFV/ElE2 384-702H77 (lanes 3 and 4). Positions of E2, 
truncated E2 (E2702) and deglycosylated E2 (E2giy-) proteins are 
shown.
Non-red Red
a. b.
Fig 6.12. Exam ination of complex form ation between strain  H77 
truncated E2 and E l proteins. Cells were electroporated with RNA and 
35S-labelled between 4-12 h after electroporation. Crude extracts derived 
from these cells were subjected to immunoprecipitation with the E2- 
specific MAb, ALP98. Precipitated material was analysed on 10% 
polyacrylamide gels under non-reducing (panel a) and reducing (panel b) 
conditions. Samples were pSFV/ElE2H77 (lanes 1 and 4), pSFV/ElE2384- 
702H77 (lanes 2 and 5), and pSFV/E234o-836H77 (lanes 3 and 6). The bands 
corresponding to E2 and truncated E2 (E2702) are labelled, as are 
aggregated material (Agg) and E 1.
R528 AP21.010
X2/E2702
30
21
a .  | - E l(x l)
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Fig 6.13. Examination of the behaviour of E l expressed along with truncated E2 
using El-specific antiserum  R528 and El-specific MAb AP21.010. Experimental 
conditions were as described in Fig 6.12. except immunoprecipitations were 
performed using El-specific antiserum R528 (panel a) and MAb AP21.010 (panel b). 
The precipitated material was analysed under non-reducing (Non-red) and reducing 
(Red) electrophoresis conditions on 10% polyacrylamide gels. Samples were 
pSFV/ElH77 (lanes 1 and 4), pSFV/ElE2H77 (lanes 2 and 5), and pSFV/ElE2384-702H77 
(lanes 3 and 6). The bands corresponding to E2, truncated E2 (E2702) and aggregated 
material (Agg) are labelled, as are the oligomeric forms of E l.
H i n d l l l  B g l l l
TAG CGA AAG CTT AGA TCT TCC GGT ATG GGG GGG GCT GCC GCC
M G G A A A 
- 2 5  - 2 0
Prim er 1
B g l l l  E c o R I  
TCG CAC CAG CCC TTG TTT TAC TAG AGA TCT GAA TTC
S H Q P L F Y *
+ 3 7 0
Prim er 2
Fig 6.14. Prim ers used for amplification of HSV-1 gD. The complete HSV-1 gD 
coding sequence (see Appendix 4) was amplified by PCR using primers 1 and 2. 
Additional nucleotide sequences included at the 5’- and 3’-termini o f the primers allowed 
the PCR product containing the gD ORF to be cloned into the pGEMl vector linearised 
with EcoRI and H indlll restriction enzymes. The resultant construct was called pGEM/gD.
a.
E2 gD
GTG CAG TAC TTG ATG GGC CTG ATC GCC CCC TTG TTT TAC TAG AGA TCT GAA
V Q Y L M G L I A  P L F Y *
69 9  702  3 1 6  37 0
b.
E2 RVEl
GTG CAG TAC 2GG TGG AAT CTG ACA TTA GGG GCC ATT TGT GCT CTG CCC CTA GTG GGT TTG 
V Q Y I I W I J L T L G A I  C A L P L V G L  
699 701 1 17
TTA GCA TGC TGC GCC AAG TGT TTG TAT TAC CTT CGC GGA GCG ATT GCC CCT AGG TAG AGA
L A C C A K C L Y Y L R G A I A P R  *
18 35
TCT GAA TTC CGG
Fig 6.15. Fusion o f the HSV-1 gD and rubella virus £1 transmembrane domains to 
the ectodomain of E2 .
a. p GEM/E1E2h77 was linearised at Seal (at codon 701, nucleotide position 2442; 
Appendix 3) and EcoRI (located 3’ o f the ORF within pGEMl plasmid) to generate a 
fragment coding for El and the ectodomain o f E2. This fragment was ligated along with a 
PCR fragment (over-lined in red) which bridged the Seal and EcoRI sites. The PCR 
product was generated using pGEM/gD plasmid as a template and coded for the gD 
transmembrane domain (residues 316-370; Appendix 4) as well as the authentic gD stop 
codon. This construct was called pGEM/ElE2702gDtm-
b. The Scal-EcoRI fragment from pGEM/ElE2n77 described in part a was ligated along 
with an oligonucleotide (over-lined in red) which bridged the Seal and EcoRI sites. The 
oligonucleotide encoded the rubella virus El transmembrane domain and a stop codon. 
This construct was called pGEM/E 1E2701rveitm•
Restriction sites are shown in italics while amino acid sequences in green, lime and light 
blue represent HCV E2, HSV-1 gD and rubella virus E l respectively.
Fig 6.16. Construction of HSV-1 gD chimeric proteins.
a. A HindIII-SalIc381 fragment derived from pGEM /ElE2n77 (see Fig 4.11) and PvuIIc2 9 -  
EcoRI fragment from pGEM/gD (see Fig 6.14 and Appendix 4) were ligated along with an 
oligonucleotide (over-lined in red) and pGEMl linearised with H indffl and EcoRI. The 
oligonucleotide bridged the Sail (nucleotide residue 1482; Appendix 3) and Pvull 
(nucleotide position 138574; Appendix 4) sites and encoded residues which span the E l- 
E2 proteolytic cleavage site and residues 11-28 of gD. This construct was called 
pGEM/El387gD] 1- 370 .
b. pGEM /El387gD n .370 plasmid was partially digested with Eael restriction enzyme (a site 
at codon 310 in gD; nucleotide position 139419; Appendix 4) and EcoRI (which lies 
downstream of the ORE within the pGEMl vector) to generate a linear fragment 
containing sequences for E l and the ectodomain of gD. This fragment was ligated with a 
PCR fragment (over-lined in red) that was produced using pGEM /ElE2n77 plasmid as a 
template. The PCR fragment bridged the Eael and EcoRI sites and coded for the C- 
terminus of E2 and N-terminus of p7 (residues 703-758) followed by a stop codon. This 
construct was called pG EM /El387gDn.3i2E2tm-
c. The Eael-EcoRI fragment generated from pGEM /El387gDi 1.370 in part b was ligated 
with an oligonucleotide (over-lined in red), which bridged the Eael and EcoRI sites. The 
oligonucleotide encoded the rubella virus E l transmembrane domain followed by a stop 
codon. This construct was called pGEM /El387gDn.3i2RVEitm-
Restriction sites are in italics, while amino acid sequences in brown, green, yellow, lime 
and light blue represent E l, E2, p7, gD and rubella virus E l respectively.
Fig 6.16. a.
E2 gD
GCC GGC GTC GAC GCG GAA ACC CAC GTC AAG ATG GCC GAC CCC AAT CGC TTT CGC GGC AAA
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Fig 6.17. A schematic representation of the chimeric HCV E2 and HSV-1 gD 
proteins, ss and tm indicate signal sequence and transmembrane segments respectively.
ElE2wt ElE2702gDtm ElE2701RVEltm
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Fig 6.18. Localisation of E2 proteins fused to transmembrane domains of HSV-1
gD and rubella virus E l. BHK cells electroporated with RNA from pSFV/ElE2H77 
(panels a-c), pSFV/ElE2702gDtm (panels d-f) and pSFV/ElE27oiRVEitm (panels g-i) were 
incubated at 37°C for 12 h, fixed in methanol and processed for indirect 
immunofluorescence using anti-El antiserum R528 (panels a, d and g) and E2-specific 
MAb ALP98 (panels b, e and h). Panels c, f  and i represent merged images of panels a 
and b, d and e, and g and h, respectively.
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Fig 6.19. Localisation of HSV-1 gD fused to transmembrane domains of HCV E2
and rubella virus E l. BHK cells were electroporated with RNA from 
pSF V /E1 387gD 11-370 (panels a-c), pSFV/El387gDn-3i2E2tm (panels d-f), and 
pSFV/E 1387gDii-3i2RVEitm (panels g-i) and incubated for 12 h. Subsequently, cells were 
fixed in methanol before being processed for indirect immunofluorescence using anti- 
El antiserum, R528, (panels a, d, and g) and gD-specific MAb 4846 (panels b, e, and 
h). Panels c, f  and i show the merged images of panels a and b, d and e, and g and h, 
respectively.
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Fig 6.20. Cell surface localisation of E2 fused to the HSV-1 gD and rubella virus E l 
transmembrane domains. BHK cells electroporated with RNA transcripts were 
incubated at 37°C for 12 h and fixed with paraformaldehyde (PFA). Parallel cultures 
were fixed and permeabilised with PFA containing 0.1% Triton X-100 (PFAT). These 
cells were processed for indirect immunofluorescence using anti-El antiserum R528 and 
E2-specific MAb ALP98 and images were captured by confocal microscopy. Panels a, c 
and e are images derived from cells fixed with PFA alone, whereas panels b, d and f  are 
images obtained from PFAT treated cells. Constructs were pSFV/ElE2H77 (panels a and 
b), pSFV/ElE2702gDtm (panels c and d), and pSFV/ElE27o iRVEitm (panels e and f).
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Fig 6.21. Cell surface expression of HSV-1 gD fused to the HCV E2 
transmembrane domain. Experimental conditions were as described in Fig
6.20. except fixed cells were processed for indirect immunofluorescence using 
gD-specific MAb 4846. Panels a and c are images obtained from cells treated 
with PFA and panels b and d are those derived from PFAT treated cells. 
Constructs were pSFV/Eh87gDi 1-370 (panels a and b) and pSFV/El387gDn- 
312E2tm (panels c and d).
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Fig 6.22. Endo Hf sensitivity of HCV E2 and HSV-1 gD chimeric proteins. Cells, 
electroporated with RNA transcripts, were incubated for 12 h at 37°C and lysed. Portions 
of the crude extracts were treated with endo Hf and PNGase F and analysed in parallel 
with untreated extracts by electrophoresis on 10% polyacrylamide gels. After transferring 
proteins to membranes, Western blot analysis was performed using E2-specific MAb 
ALP98 (panel a) and gD-specific MAb 4846 (panel b). Lanes 2, 5, 8, 11 and 14 show 
samples subjected to endo Hf treatment and those in lanes 3, 6, 9, 12 and 15 were PNGase 
F-treated. Remaining lanes represent untreated proteins. Samples were pSFV/ElE2n77 
(lanes 1-3), pSFV/ElE2702gDtm (lanes 4-6), pSFV/ElE27oiRVEitm (lanes 7-9), pSFV/El387gDn- 
312E2tm (lanes 10-12), pSFV/El387gDi 1-370 (lanes 13-15). Positions of E2, deglycosylated E2 
(gly-), gD and deglycosylated gD are shown. Bands indicated by symbols are described in 
the text.
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Fig 6.23. Sensitivity to endo Hf of E l expressed in the context of chimeric 
proteins. Experimental conditions were as described in Fig 6.22 except crude extracts 
were treated only with endo Hf. Following electrophoresis on a 12% polyacrylamide 
gel, samples were analysed alongside untreated material by Western blot analysis 
using E l -specific AP21.010 MAb. Lanes 2, 4, 6, 8, 10 and 12 show the endo Hf 
treated samples, while remaining lanes represent untreated proteins. Samples were 
pSFV/ElH77 (lanes 1 and 2), pSFV/ElE2H77 (lanes 3 and 4), pSFV/El387gDn-3i2E2tm 
(lanes 5 and 6), pSFV/ElE2702gDtm (lanes 7 and 8), pSFV/ElE27oiRVEitm (lanes 9 and 
10), and pSFV/Eh87gDi 1-370 (lanes 11 and 12). Oligomers o f  E l and deglycosylated  
forms o f  El (-gly) are shown along with an cleaved form o f  E lg D  polyprotein (*).
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Fig 6.24. Examination of complex formation by chimeric E2 and gD proteins with 
E l using E2-specific MAb ALP98 and gD-specific MAb 4846. Cells electroporated 
with RNA were 35S-labelled from 4-12 h after electroporation. Following cell lysis, crude 
extracts were subjected to immunoprecipitation using E2-specific MAb ALP98 (lanes 1-
3) and gD-specific MAb 4846 (lanes 4-6). Precipitated material was examined under 
non-reducing (panel a) and reducing (panel b) conditions on 10% polyacrylamide gels. 
Samples were derived from pSFV/ElE2H77 (lanes 1), pSFV/ElE2 702gDtm (lanes 2), 
pSFV/ElE2701 RVEitm (lanes 3), pSFV/El 387g D n - 3i2E2tm (lanes 4), pSFV/El 387g D n  -370 (lanes 
5), and pSFVl (lane 6). Positions of oxidised (ox) and reduced (red) El and E2 are 
indicated, as are those of gD and uncleaved ElgD precursor protein. Bands indicated by 
* are discussed in the text.
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Fig 6.25. Co-precipitation of E l with wild type E2 and chimeric gD 
proteins. Experimental conditions were as described for Fig 6,24 except 
cells were not 35S-labelled. Following immunoprecipitation using E2- 
specific ALP98 and gD -specific 4846, precipitates were separated by 
electrophoresis on a non-reducing 10% polyacrylamide gel and transferred 
to membrane. Western blot analysis was performed using anti-El antiserum 
R528. Samples were pSFV/ElE2H77 (lane 1), pSFV/ElE2702gDtm (lane 2), 
pSFV/ElE270iRVEitm (lane 3), p S F V /E l 387gDn-3i2E2tm (lane 4), 
pSFV/El387gDi 1-370 (lane 5), and pSFV l (lane 6). Bands representing 
oxidised E l (ox) are indicated. The additional bands represent the heavy 
and light chains o f  the immunoglobulins used for immunoprecipitation.
Fig 6.26. Examination of complex formation between E l and chimeric E2 and 
gD proteins. Experimental conditions were as described for Fig 6.24 except 
immunoprecipitations were performed using anti-El antiserum R528. The 
precipitated samples were analysed under non-reducing (panel a) and reducing (panel 
b) electrophoresis conditions on 10% polyacrylamide gels. Samples were pSFV/ElH77 
(lanes 1), pSFV/ElE2H77 (lanes 2), pSFV/El387gDii-3i2E2tm (lanes 3), pSFV/ElE2702gDtm 
(lanes 4), pSFV/ElE27oiRVEitm (lanes 5), pSFV/Eh87gD 11-370 (lanes 6), and pSFVl (lane 
7). Bands representing aggregated material (Agg), gD and E2 are indicated. Oxidised 
(ox), reduced (red) and oligomeric El are also shown. Bands indicated by symbols 
are discussed in the text.
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Fig 6.27. Exam ination of El-specific R528 im m unoprecipitated 
m aterial for the co-precipitation of gD. Experimental conditions were 
as described for Fig 6.26 except proteins were not radiolabelled. 
Samples were separated under non-reducing conditions on a 10% 
polyacrylamide gel and transferred to membrane for Western blot 
analysis using gD-specific MAb 4846. Samples analysed were 
pSFV/ElH77 (lane 1), pSFV/ElE2702gDtm (lane 2), pSFV/ElE27oiRVEitm 
(lane 3), p SFV/E1E2h77 (lane 4), pSFV/El387gDn-3i2E2tm (lane 5), 
pSFV/Eh87gDi 1-370 (lane 6), and pSFVl (lane 7). Bands representing gD 
and precursor E lgD  polyprotein are indicated. The remaining bands 
represent heavy and light chains of immmunoglobulins used for 
immunoprecipitation.
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Fig 6.28. Analysis of complex formation of chimeric E2 and gD 
proteins with E l. Experimental conditions were as described for 
Fig 6.26 except immunoprecipitations were performed using E l- 
specific MAb AP497 and precipitated material was examined under 
reducing electrophoretic conditions on a 10% polyacrylamide gel. 
Samples were pSFV/ElH77 (lane 1), pSFV/ElE2H77 (lane 2), 
pSFV/E 1 387gDii-3i2E2tm (lane 3), pSFV/ElE2702gDtm (lane 4), 
pSFV/ElE27oiRVEitm (lane 5), pSFV/El387gDn-37o (lane 6), and 
pSFVl (lane 7). Positions of E2, gD, aggregated material (Agg), 
and oligomerised forms of El are indicated. Bands indicated by 
symbols are discussed in the text.
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Fig 6.29. Examination of the behaviour of El expressed along 
with gD fused to rubella virus E l transmembrane domain.
RNA-electroporated cells were incubated at 37°C and labelled 
between 4-12 h after electroporation with 35S-methionine. Crude 
extracts derived from these cells were subjected to 
immunoprecipitation using anti-El antiserum R528. Precipitates 
were examined under non-reducing (panel a) and reducing (panel 
b) electrophoresis conditions on a 10% polyacrylamide gel. 
Samples were pSFV/El387gDn-3i2E2tm (lanes 1), pSFV/El387gDn- 
3 i2RVEitm (lanes 2), and pSFV/ElH77 (lanes 3). Positions of 
aggregated material (Agg), gD, oxidised (ox), reduced (red) and 
oligomerised El proteins are indicated.
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7.1. The Arrangement of E l and E2 on the HCV Polyprotein
The presence of E2 is necessary for El to attain its stable oxidised state, suggesting that E2 
plays a critical role in E l folding by interacting directly with the protein. It is possible that 
correct protein folding and hetero-oligomerisation in some enveloped viruses require 
certain structural constraints which are provided by protein-protein associations between 
monomers within the assembled oligomer. Since expression of E2 in vivo occurs from the 
same polyprotein as El (in cis), this could ensure that the subunits for a complex are 
generated by proteolytic cleavage of a common translation product. This local recruitment 
of subunits may increase the efficiency of oligomerisation and folding. Structural proteins 
from several vimses are expressed in a similar fashion (e.g., flavi-, rubella-, alpha-, and 
bunya-viruses). For TBE virus, a flavivirus, co-expression of PrM and E membrane-bound 
proteins is necessary for proper folding (Section 1.5.2; Heinz et al., 1994). PrM functions 
in the PrM-E heterodimer to prevent E from undergoing an acid-catalysed conformational 
change during transit of the immature virions through an acidic intracellular compartment. 
In the case of rubella virus, despite its Golgi localisation signal, E2 remains associated with 
E 1 in the ER during which shuffling of the intramolecular disulphide bonds in E 1 takes 
place (Hobman et al., 1993). In addition, complete folding o f Sindbis virus glycoprotein 
E l protein is not achieved in the absence of oligomerisation with PE2 (Carleton et al.,
1997). Therefore, it may be that stable protein-protein interactions between HCV El and 
E2 enable El to reach an oxidised form rather than E2 performing a specific chaperone­
like function where interactions would be transient. Indeed, results in this study have 
shown that the substitution of the E2 ectodomain with that of a foreign glycoprotein was 
sufficient to prevent the misfolding of El (see Section 6.3.4).
The nature of HCV genomic organisation is such that the El polypeptide sequence is 
translated first and translocated into the ER before the E2 sequences. Dimerisation of SFV 
structural proteins El and preE2 takes place rapidly and efficiently in the ER, with both 
proteins originating from the same translation product (termed heterodimerisation in cis\ 
Barth et al., 1995). In this case, preE2 is made before El during 26S mRNA translation. It 
is proposed that the preE2 polypeptide chain is retained at its translocation site until the El 
chain is synthesised and translocated into the same site. Since the production of HCV E2
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follows the synthesis of E l, the mechanism by which E2 affects El folding is not 
consistent with this model.
As an alternative to heterodimerisation in cis during translocation into the ER, E l protein 
may encounter pre-folded E2 subunits made from different polyprotein molecules, which 
block El misfolding and form heteromeric E1E2 complexes. Heterodimerisation in trans 
takes place for the envelope heterodimeric complex (G1G2) of the bunyavirus Uukuniemi 
virus (Persson & Pettersson, 1991). G1 and G2 polypeptides are separated following 
cleavage from a common translation product soon after synthesis. The two proteins fold 
independently of each other and then form a complex. However, G1 and G2 in the 
complex need not have arisen from the same precursor protein. A similar mechanism may 
also operate for HCV El and E2 heterodimerisation, in which slowly-folding El may 
interact with E2 molecules that are already present in the ER. Speed with which aggregate 
formation takes place (as established in this study) and the reliance of E l on E2 to prevent 
E l oligomerisation suggests that the presence of E2 in the lumen of the ER may be 
necessary during the synthesis of El polypeptide. Since El is synthesised first, in the 
event of insufficient pre-formed E2 molecules, El polypeptides would remain in an 
unstable reduced form that may result in association with similarly reduced neighbouring 
El molecules and lead to aggregation. Although these may reflect a phenomenon of the 
method of expression in vitro, a similar process could occur in vivo.
7.2. Formation of E1E2 Aggregates -  An Intrinsic Property of the 
Glycoproteins or an I n  V itr o  Artefact?
Two types of complex have been identified between HCV glycoproteins El and E2. In a 
native complex, El and E2 are held together by non-covalent interactions while aggregated 
complex is stabilised by both non-covalent and covalent associations. For the structural 
proteins from the related flavi- and pestiviruses, only one form of complex is found. 
Examination of pestivirus CSFV structural proteins either expressed by recombinant 
vaccinia virus or derived from CSFV virions has revealed that structural proteins Erns and 
E2 form disulphide-linked homodimers, while El and E2 form disulphide-linked 
heterodimers (Thiel et al., 1991). By contrast, heterodimers formed by structural proteins 
PrM and E of three flaviviruses (West Nile virus, YFV and TBE virus) contain non- 
covalent interactions (Nowak & Wengler, 1987). Apart from the pestivirus glycoproteins,
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several other viral envelope proteins require intermolecular disulphide bonds to attain an 
appropriately folded state. As examples, pseudorabies virus gM and gN, HCMV gH and 
gL, and Moloney murine leukemia virus gp70 and Prl5E form heteromeric disulphide- 
linked complexes (Jons et al., 1998; Opstelten et al., 1998; Huber & Compton, 1999). In 
common with the flaviviruses, the structural proteins of rubella virus (El and E2), SFV 
(preE2 and E l), and Sindbis virus (pE2 and E l) form non-covalently linked heteromeric 
complexes (Hobman et al., 1993; Barth et al., 1995; Carleton et al., 1997).
The failure to detect intermediate oligomers of E1E2 heterodimers has led to the 
conclusion that the high molecular weight covalently-linked complexes represent 
misfolded protein aggregates (Dubuisson et al., 1994; Dubuisson & Rice, 1996). These 
observations were made directly from tissue culture experiments where recombinant viral 
systems may account for the incorrect folding of highly expressed proteins. Aggregation 
may result from over-expression, an incompatible environment for protein folding or 
exhaustion of normal chaperone mechanisms. However, aggregated complexes have been 
detected also in cell lines where expression is tightly regulated (Duvet et al., 1998; 
Moradpour et al., 1998). Moreover, various sera derived from HCV-infected patients have 
been able to detect native as well as aggregated complexes (Cardoso et al., 1998; 
Habersetzer et al., 1998). This suggests that proteins in the aggregate do adopt at least a 
partially-folded structure that is recognised by conformation-sensitive antibodies which 
would not be present on denatured proteins (Lee et al., 1997). Examination of aggregates 
(or inclusion bodies) formed as a result of expression of tailspike endorhamnosidase in E. 
coli showed that aggregation occurs by the association of partially folded monomeric 
intermediates with significant secondary structure rather than the fully native or completely 
unfolded species (Speed et al., 1995 and 1996).
Aggregation is observed for several other virus structural proteins but occurs mainly as a 
result of mutations in the proteins (Einfeld & Hunter, 1997) or non-typical methods of 
expression (Andersson et al., 1997). The SFV El protein, expressed independently from 
upstream E2 sequences, forms disulphide-linked aggregates (Andersson et al., 1997) which 
indicates that El protein synthesised in a manner dissimilar to the situation in vivo, results 
in abnormally folded products. In addition, a glycosylated precursor protein (Env), 
encoded by retroviral Rous sarcoma virus, is cleaved during intracellular maturation to a 
transmembrane subunit (TMS) and a surface subunit (SUS). Mutations to the C-terminus 
of TMS, which is a type 1 glycoprotein, result in non-specific aggregation of mutant TMS
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(Einfeld & Hunter, 1997). This could be applicable to El which appears to be particularly 
sensitive to alteration. Studies have shown that while E2 behaviour remains comparable 
when synthesised in the presence or absence of E l, this is not the case for E l . El 
expressed in the absence of the E2 transmembrane domain forms oligomers, which 
suggests that El is more prone to aggregation than E2. Moreover, some E l deletion 
mutants are not rescued from the oligomerisation-aggregation pathway in the presence of 
E2 (Section 5.3.4). It is perhaps possible that the ability of E l to aggregate may be an 
intrinsic property of the protein. An example of homo-oligomerisation is provided by the 
HCV NS3 proteinase, where the presence of the co-factor NS4A is necessary for efficient 
proteolytic activity (Love et a l, 1996). The crystal structure of NS3, revealed that, in the 
absence of NS4A, hydrophobic patches are exposed on NS3 molecules which interact with 
adjacent molecules to form NS3-NS3 complexes (Love et al., 1996). However, these 
hydrophobic patches are buried under conditions where NS4A is present (Kim et al.,
1996). The presence of pre-folded E2 may prevent exposure of hydrophobic regions of El 
to other neighbouring El molecules.
Covalent oligomerisation, however, may not necessarily be a non-functional event, since 
aggregation of a baculovirus structural protein is essential for infection (Markovic et al.,
1998). Baculovirus gp64 monomers are not transported to the surface of the infected cell, 
but instead remain in the ER and are degraded. Phosphorylated, acylated and N- 
glycosylated trimers of gp64 are successfully transported to the surface of infected cells, 
where they are stabilised by intermolecular disulphide bonds formed post-translationally. 
These disulphide-linked aggregates are thought to mediate fusion of host cell membranes. 
However, in the case of HCV envelope protein aggregation, it is not possible to comment 
on the extent to which aggregation is a functional feature of the infectious process.
Protein aggregates have been implicated as aetiologic agents for human diseases such as 
Alzheimer’s and Creutzfeldt-Jacob (Kocisko et al., 1995). Alzheimer’s disease is 
clinically characterised by the abnormal accumulation of amyloid aggregates. The 
aggregate plaques are composed of variously-sized amyloid peptides (e.g., Ap42 and Ap4o) 
derived through proteolytic processing of the p-amyloid precursor protein (PAPP). 
Mutations within PAPP that alter its metabolism may lead to Alzheimer’s disease. From 
tissue culture experiments, AP42 is made and retained within the ER in an insoluble state 
while Ap4o is generated exclusively within the TGN (Greenfield et a l, 1999). The AP40
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species assume soluble and detergent-insoluble complexes; the latter form remains within 
the TGN. HCV may use E1E2 aggregation to control the production of virus particles. 
Since these complexes are recognised by sera from HCV-infected patients, they may exist 
in vivo. Stable aggregates which are not subject to degradation also may limit the 
processing of proteins to peptide for presentation on the cell surface. In this way, HCV 
could avoid detection by the immune system (Aridor & Balch, 1999) and such a 
mechanism may contribute to persistence. CSFV also establishes a persistent infection, 
with the majority of assembled infectious virions remaining cell-associated (Moormann & 
Hulst, 1988). Accumulation of HCV E1E2 aggregates also may play a role in 
pathogenesis. For example, ER accumulation of VSV G reduced levels of COPII vesicle 
formation in cultured cells (Aridor et al., 1999). This has a generalised negative impact on 
the normal transport pathway from the ER. In HCV-infected hepatocytes, accumulation of 
aggregates of El and E2 could also impair trafficking of cellular proteins from the ER. 
Indeed, a variant of a  1-antitrypsin called Pi2 accumulates in the ER of hepatocytes and is 
associated with liver injury in certain individuals (Sifers, 1995). Thus, aggregation of El 
and E2 could contribute to development of liver disease in HCV-infected individuals.
The continued sensitivity to DTT by both the aggregated and native complexes of HCV El 
and E2 may suggest that neither of the complexes has acquired a stable state. Taking 
Sindbis virus E1-PE2 as an example, these proteins are sensitive to DTT reduction at early 
stages after synthesis (Carleton & Brown, 1996). However, resistance to DTT is achieved 
following the adoption of fully oxidised conformations in the ER. Sindbis virus El folds 
through a series of disulphide intermediates that are associated with the ER-resident 
molecular chaperone BiP. Once El assumes a particular late intermediate conformation it 
forms a heterodimer with PE2 resulting in the simultaneous completion of El folding and 
dissociation from BiP. Heterodimerisation bestows increased resistance to DTT to the 
later folding intermediates, which is indicative of inaccessibility by DTT and stabilisation 
of the complex (Carleton & Brown, 1996). A similar series of events occurs during 
maturation of influenza virus HA and VSV G proteins (Tatu et al., 1993; Tatu & Helenius, 
1995). However, though strain H77 El and E2 in the native complex are believed to be in 
their fully oxidised states, no DTT-resistant species of E l were observed after a 12 h 
incubation period (see Fig 4.15). DTT-resistant forms of El would be expected to migrate 
faster than the DTT-sensitive forms due to their more compact structure. Therefore, the 
native E1E2 complexes may not represent an authentic complex found on HCV particles. 
Clearly, it is also possible that a DTT-resistant state is never achieved even by authentic
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complexes. Such questions can only be addressed in a system allowing efficient 
propagation of the virus.
7.3. Retention of E l and E2 Glycoproteins within the ER
Endogenous ER-resident membrane proteins are thought to be retained in the ER rather 
then retrieved from the cis Golgi, as is the case for several KDEL, K(X)KXX, and RR 
containing lumenal or membrane ER proteins (see Section 1.4.8). The distinction between 
retrieval and retention is made by the absence of Golgi modifications to N-linked 
oligosaccharides attached to the endogenous proteins. HCV El and E2 are resistant to 
deglycosylation with endo D, which suggests that these proteins remain in the ER without 
cycling between this organelle and the cis Golgi (Duvet et al., 1998). Lumenal chaperones 
including BiP, calnexin and calreticulin interact with newly synthesised El and E2 in the 
ER, and this event is presumed to assist their folding (Choukhi et al., 1998). However, 
following dissociation o f some E 1E2 complexes from these chaperones, they remain in the 
ER. Chimeric proteins constructed utilising the El and E2 ectodomains have shown that 
the transmembrane domains from both proteins are necessary and sufficient for ER 
retention (Cocquerel et al., 1998; Cocquerel et al., 1999; Flint & McKeating, 1999). The 
experiments presented here confirm this role for the E2 transmembrane domain.
Examination of endogenous membrane-spanning ER proteins has led to the proposal of 
two models for retention, one is based on retention through transmembrane domain 
oligomerisation and the second relies on retention though differences in membrane 
thickness along the exocytic pathway (Nilsson & Warren, 1994). Although it is not certain 
which of these mechanisms is correct or indeed if both operate, examples of Golgi- 
localised proteins that use each of these models are known. The replacement of the 
membrane-spanning domain of a2,6-sialyltransferase (SialylT; TGN resident protein) with 
a stretch of polyleucines did not prevent localisation to the Golgi (Munro, 1991). This and 
the observation that the membrane-spanning domains of Golgi resident proteins are shorter 
than those of plasma membrane proteins led to the suggestion that the thickness of the 
membrane determined the point at which resident Golgi enzymes are retained (Bretscher & 
Munro, 1993). As an example for the second model, the first membrane-spanning domain 
(stretch of 22 amino acids) of the M glycoprotein of an avian coronavirus, infectious 
bronchitis virus (IBV), mediates oligomerisation in the Golgi when this segment was fused
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to VSV G protein (Weisz et al., 1993). Extensive mutational analysis o f the IBV E l 
membrane-spanning domain showed that polar residues, lining one face of a predicted a - 
helix, are important both for the retention and oligomerisation o f this molecule (Machamer 
et al., 1993). There are 4 polar amino acid residues in the predicted 
hydrophobic/membrane-spanning region of HCV E l, while 9 polar residues are identified 
in the equivalent region in HCV E2 (Appendix 1 and 3). However, the importance of these 
residues in both proteins to either retention or oligomerisation is yet to be examined.
The transmembrane domains are important in heterodimer complex formation between 
structural proteins E l and E2 of rubella virus (Hobman et al., 1997). For this virus, wild 
type E l is efficiently transported to the Golgi apparatus due to its association with E2 
(Hobman et al., 1993). This is despite the ER retention signal identified in the El 
transmembrane and cytoplasmic tail, suggesting that association with E2 results in the 
appropriate folding of E l . This process may override the ER retention signal, thus 
allowing transport of E l away from the ER. Such a phenomenon is also demonstrated by 
pseudorabies virus glycoproteins gN and gM (Jons et al., 1998) and bunyavirus G1 and G2 
glycoproteins (Persson & Pettersson, 1991), where gN and G1 are retained in the ER until 
heteromeric complex formation permits their relocation. By contrast to the above 
examples, HCV E l and E2 never leave the ER in detectable amounts in heterologous 
expression systems. In addition, ER-retained rubella virus E1E2 heterodimers do not 
appear to form very large complexes, whereas HCV E l and E2 retained proteins do 
accumulate as aggregates.
In terms of the influence of length of transmembrane domains on ER retention, an example
has been provided by the analysis of ER-associated UBC6 , an ER resident protein with no
known retention/retrieval signal. Functionally the protein has been implicated in targeting
the ER translocator, Sec 61, for degradation by catalysing ubiquitin-conjugation. It is a
member of the C-terminal anchored type IV transmembrane proteins and is characterised
by the N-terminal of the protein facing the cytosolic side o f the ER membrane.
Examination of chimeric proteins in which the cytosolic domain of UBC6 was linked to a
heterologous transmembrane domain, or in which the UBC6 transmembrane domain was
appended to an unrelated soluble protein, led to the conclusion that the transmembrane
domain of UBC6 played a dominant role in its ER localisation (Yang et al., 1997).
Lengthening the wild type UBC6 hydrophobic segment from 17 to 21 amino acids resulted
in re-targeting to the Golgi complex from the ER. Furthermore, an increase in length to 26
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amino acids allowed the modified protein to traverse the secretory pathway and locate to 
the plasma membrane. This finding suggested that in the absence of specific targeting 
determinants, proteins could be sorted within the secretory pathway based on interactions 
between their transmembrane domains and the surrounding lipid bilayer. The minimum 
length o f the C-terminal portion of rubella virus El required for its retention in the ER is 
35 amino acids (Hobman et al., 1997). For rotavirus VP7, another ER-retained protein, 31 
residues (with three essential residues Ile-9, Thr-10, and Gly -11) from the N-terminus are 
sufficient to retain a reporter protein (Maass & Atkinson, 1994). Hydropathicity profiles 
predict a stretch of 20 and 32 C-terminal hydrophobic amino acid residues for HCV El and 
E2 respectively (Appendices 1 and 3). While these residues may represent the 
transmembrane domain sequences, it is not clear whether any of them correspond to the 
cytoplasmic tails for E l and E2. Therefore, it is difficult to state how the length of El and 
E2 transmembrane domains influence their ER retention. Furthermore, if  there are C- 
terminal E l- and E2-specific residues on the cytoplasmic side of the ER they may also play 
a role in retention by interaction with cytoplasmic components. This is observed for 
rubella virus El retention (Hobman et al., 1997). Since cytoplasmic tails are undefined for 
HCV El and E2, their role in ER retention cannot be excluded.
7.4. Role of Covalent Modifications on E l Folding
As discussed earlier in this chapter, a consequence of the arrangement of HCV 
glycoprotein coding sequences is that El is translocated into the ER before E2. If 
aggregation is an intrinsic property of E l, then the virus may have evolved mechanisms to 
counteract this process. One mechanism could involve the N-linked glycosylation sites of 
El which are located close to the N-terminus. Three of the four glycosylation sites are 
located within 43 residues of the N-terminus of E l. Thus, these sites would be recognised 
and glycosylated during the earlier stages of E l synthesis. Glycosylation is associated with 
enhancing solubility of proteins in the ER and interactions with chaperones such as 
calreticulin and calnexin (Section 1.4.5). Therefore, glycosylation in the N-terminal region 
of E l may aid retention of the protein in a non-aggregated state prior to the availability of 
E2. Interaction of E2 with El would then facilitate correct folding of E l.
E2 is apparently essential for folding of El to an oxidised form. As described previously 
(Section 1.4.3), disulphide bond formation is catalysed by PDI, however this enzyme is 
unlikely to play a specific role in protein folding. The data in this study would indicate
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that the C-terminal region of E2 including the transmembrane domain plays a key role in 
intramolecular disulphide bond formation in E l. The ability to replace most of E2 with a 
foreign glycoprotein suggests that these ectodomain sequences may act indirectly to block 
El misfolding, perhaps by acting as a buffer between adjacent ectodomains of E l 
molecules. Additional studies are required to examine the oxidised state of E l in the 
presence of E2 and foreign ectodomain sequences to reveal whether intramolecular 
disulphide bonds occur between the same cysteine residues in both situations. As well as 
E2, the primary sequence of E l is likely to contribute also to its folding and further 
analysis is required to identify these residues. Possible interactions with other cellular 
proteins, such as ERp57 which may play a more active role in folding and oxidation 
(Section 1.4.4), may also shed further light on E l folding.
7.5. Model for the Role of E l and E2 in HCV Particle Assembly
The failure to detect HCV El and E2 on the cell surface is comparable with pestivirus 
structural proteins, which also are absent from this location (Gray & Nettleton, 1987). 
Electron microscopic examination of BVDV and border disease virus suggests that 
pestiviruses mature in intracellular vesicles and may be released by exocytosis (Gray & 
Nettleton, 1987). The majority of CSFV infectious particles also remain cell associated 
(Moormann & Hulst, 1988). Electron microscopic studies of YFV-infected cells observed 
morphologically mature virions in the ER, which then accumulate within disordered 
membrane-bound vesicles (Ishak et al., 1988). Thus, for pesti- and flaviviruses, vesicular 
transport through the host secretory pathway is believed to be involved in transporting 
nascent virions from the ER to the plasma membrane where they are released by 
exocytosis. Evidence for this is provided by the observed modification of West Nile virus 
E and PrM glycans, to forms which are characteristic of carbohydrates present on host 
plasma membrane glycoproteins (Nowak et al., 1989). Despite budding of flaviviruses 
into the ER, there have been no reports to date of ER retention signals identified in the 
structural proteins E and PrM. The failure to detect budding intermediates and cytoplasmic 
nucleocapsids has suggested that the assembly process of flaviviruses occurs rapidly. This 
may abolish the need for prolonged retention of the structural proteins in the ER.
HCV particle assembly may also occur in the ER, however reports on virion 
morphogenesis suffer from a lack of reproducibility. Virus-like particles of 50-60nm have 
been identified in cytoplasmic vesicles following transfection of Daudi cells with full-
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length genomic RNA (Shimizu et al., 1996b). Moreover, particles have also been 
produced in insect cells from recombinant baculovirus expressing core, E l and E2 
(Baumert et al., 1998). However, these observations have not always been successfully 
reproduced (Wang at e l,  1997) and it is also not clear whether these particles are capable 
o f attachment to cells.
In vivo, in infected hepatocytes, budding of capsids into the ER may drive virion 
morphogenesis. Data presented earlier (see Section 3.9) revealed that E l and E2 are not 
distributed throughout the entire ER but are likely to be present in sub-compartments. 
Within these sub-compartments, El and E2 could exist either as native or aggregated 
complexes. Therefore, budding would presumably have to occur at such sub­
compartments. The ectodomains of the HCV glycoproteins need not have a direct 
influence on budding, however their status, whether aggregated or native, may be relayed 
via their transmembrane/cytoplasmic domains to allow incorporation o f appropriate folded 
proteins into the virus envelope. Sequences corresponding to a cytoplasmic tail are not 
defined for E l and E2, although comparison with equivalent flavivirus glycoproteins 
suggests that these segments may be small. Despite the size of cytoplasmic domains, the 
transmembrane anchors of flaviviruses are highly conserved and are believed to be 
involved in envelope-nucleocapsid interaction (Rice, 1996). Once budding into the ER 
occurs, the El and E2 transmembrane domains would not remain continuous with the ER 
membrane and therefore would no longer operate as ER retention signals. Apart from the 
segments of El and E2 interacting with the nucleocapsid, other viral transmembrane 
proteins may also influence budding and force the formation of premature particles. For 
example, efficiently processed p7 may perform this function. Subsequent maturation could 
occur during exit from the cell. However, these events can only be fully understood in an 
appropriate virus propagation system either in vitro or in vivo.
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Appendix 1 -  Strain Glasgow Core, E l and E2 Nucleic Acid and Amino 
Acid Sequence
A p a ll
CCGrPQCAOC ATG AGC ACG AAT CCT AAA. CCT CAA AGA AAA ACC AAA CGT AAC ACC AAC CGT 393  
M S T N P K P Q R K T K R N T N R
+10
CGC CCA CAG GAC GTT AAG TTC COG GGT GGC GOT CAG ATC GTT GOT GGA CTT TAC TTG TTG 453  
R P Q D V K F P G G G Q I V G G V Y L L  
+20 +30
COG CGC AGG GGC CCT AGA TTG GOT GTG CGC GCG ACG AGG AAG ACT TOC GAG GGG TCG CAA 513  
P R R G P R L G V R A T R K T S E R S Q  
+40 +50
X h ol
CCT CGA GOT AGA COT CAG CCT ATC CCC AAG GCA COT CGG CCC AAG GGC AGG AAC TGG GOT 573  
P R G R R Q P I  P K A R R P K G R N W A  
+60 +70
CAG CCC GGG TAT CCT TGG CCC CTC TAT GGC AAT GAG GGG TTC GGG TGG GCG GGA TGG CTC 633
Q P G Y P W P L Y  G N E G F G W A G W L  
+80 +90
CCG TOC CCC CCT GGC TOT CGG OCT ACT TGG GGC CCC AAC GAC CCC CGA CCT AGG TCG CGC 693
P S P R G S R P S W G P N D P R R R S R  
+100 +110
m»T
AAT TTG GOT AAG (CTC ATC GAT ACC CTT ACG TGC GGC TTC CTC GAT CTC ATG GGG TAC ATA 753  
N L G K V I D T L T C G F V D L M G Y  I  
+120 +130
CCG CTC GTC GGC GCC CCT CTT AGA GGC GCT GCC AGG GCC CTG GCG CAT GGC GTC CGG GTT 813
P L V G A P L R G A A R A L A H G V R V  
+140 +150
CTG GAA GAC GCT (CTG AAC TAT GCA ACA GCT AAC CTT CCT GCT TGC TOT TTC TCT ATC TTC 873
L E D G V N Y A T G N  L P G C S F S I F  
+160 +170
F spI
CTT CTG GCC CTG CTC TCT TGC CTG ACT GTG CCC GCT TCA GCC TAC CAA GTG CGC AAC TOC 933
L L A L L S C L T V P A S A  Y Q V R N___ S
+180 ^ +190
X hol
ACG GGG CTT TAC CAT CTC ACC AAT GAT TGC CCT AAC TOG ACT ATT GTG TAC GAG GCG GTC 993
T G L Y H V T N D C P  N S S I  V Y E A V
+200 +210
X hol
GAT GCC ATC TTG CAC ACT CCG GGG TCT GTC CCT TGC CTT CGC GAG GOT AAC GCC TOG AGG 1053
D A I L H T P G C V P C V R E G  N A S  R
+220 +230
M scI
TCT TGG GTG GCG ATG ACC CCC ACG GTG GCC ACC AGG GAC GGC AGA CTC CCC ACA ACG CAG 1113
C W V A M T P T V A T R D G R L P T T Q  
+240 +250
d a l
CTT CGA CCT CAC ATC GAT CTG CTG GTC GGG ACT GCC ACC CTT TCT TCG GCC CTT TAC GTG 1173
L R R H I D L L V G S  A T L S A L Y V
+260 +270 =
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GGG GAC CTG TGC GGG TCT GTC TTC CTT GTC GGC CAA CTG TTT ACT TTC TCC CCC AGA CGC 1233
G D L C G S V F L  V G Q L F T F S P R R  
+280 +290
M a il
CAC TGG ACG ACG CAA GGC TGC AAT TOT TOC ATC TAT CCC GGC CAT ATA ACG GCT CAT CGC 1293
H W T T Q G C N C  S I Y P G H I T G H R
+300 +310
ATG GCA TGG GAT ATG ATG ATG AAC TGG TCC CCC ACG ACG GCG TTG CTG CTA GCT CAG CTG 1353
M A W D M M M N W S  P T T A L V V A Q L
+320 +330
VLm iTT
CTC CGG ATC CCA CAA GCC ATC TTG GAC ATG ATC GCT GCT GCT CAC TGG GGA GTC CTG GCG 1413
L R I  P Q A I L P M I A G A H W G V L A  
+340 +350
GGC ATG GCG TAT TTC TCC ATG GTC GGG AAC TGG GCG AAG GTC CTC GCA GTC CTG CTG CTA 1473
G M A Y F S M V G N W A K V L A V L L L  
+ 36(T “ +370 '
S a l T /H in d i
TTT GCC GGC GTC GAC GCG GAG ACC CAC GTC ACC GGG GGA GCT GCC GCC CGC AGC ACG CTT 1533
F A G V D A E T H V T G G A A A R S T L  
+380 “  “  +390 “
Bc.1T
CAG CTT GCC GCT CTC TTT CAA CCA GGC GCC AAG CAG AAC GTC CAG TTC ATC AAC ACC AAC 1593
g L A G L F g P G A K g N V Q L I N T N  
+400 “  “  +410
GGC AGC TGG CAT GTC AAT CGC ACG GCC TTG AAC TGC AAT GAT AGC CTT AAC ACC GGC TOG 1653
G S W H V N R T A L N C N D S L N T G W
+420 +430
M scI
ATA GCA GGG CTT TTC TAT TAC CAC GGA TTC AAT TCT TCA GGC TCT TCC GAG AGG TTC GCC 1713
I A G L F Y Y H G F  N S S G C S E R L A
+440 +450
AGC TGC CGA TCC CTT ACC GAC TTT GAC CAA GCT TGG GGC CCT ATC ACT TAT GCC GGC GGA 1773
S C R S L T D F D Q G W G P I  S Y A G G  
+460 +470
GGC GGC CCC GAC CAT CGC CCC TAT TGC TGG CAC TAC CCC CCA AAG CCC TGC GCT ATT CTG 1833
G G P D H R P Y C W H Y P P K P C G I V  
+480 “  +490
CCC GCA AAG AGC CTG TCT GGC CCG CTA TAT TCT TTC ACT CCC AGC CCC GTG GTG GTC GGA 1893
P A K S V C G P V Y C F T P S P V V V G  
+500 +510
A s c I
ACG ACC GAC AGG TCG GGC GOG CCT ACC TAC AGC TGG GCT GCA GAT GAT ACG GAC GTC TTC 1953
T T D R S G A P T Y S W G A D D T D V F  
+520 +530
M uni
GTC CTT AAT AAC ACC AGG CCA CCG CTG GGC AAT TGG TTC GCT TCT ACC TGG ATG AAC TCA 2013
V L N N T R P P L G N W F G C T W M  N S
+540 +550
ACT GGA TTC ACC AAA GTC TGC GGA GCG CCC CCT TCT GTC ATC GGA GGG CTG GGC AAT AAC 2073
T G F T K V C G A P P C V I G G V G  N N
+560 +570
ACC TTC CAC TGC CCC ACT GAT TCT TTC CGC AAG CAT CCG GAA GCC ACA TAC TCT CGG TGC 2133
T L H C P T D C F R K H P E A T Y  S R C  
+580 +590
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S a ll/H in c I I
GGC TCC GGT CCC TGG CTT ACA CCC AGG TGC CTG CTC GAC TAC CCG TAT AGG CTT TGG CAT 2193
G S G P W L T P R C L V D Y P Y R L W H  
+600 +610
TAC CCT TCT ACC ATC AAC CAC AGC ATA TTC AAA GTC AGG ATG TAC GTG GGA GGG GTC GAG 2253
Y P C T I  N H S I  F K V R M Y V G G V E
+620 +630
M uni
CAC AGG CTG GAC GCT GCC TGC AAT TGG ACG CGG GGC GAA CCT TCT GAT CTG GAA GAC AGG 2313
H R L D A A C N W T R G E R C D L E D R
+640 +650
GAC AGG TCC GAG CTT AGC CCG TTG CTG CTG TCC ACC ACA CAG TGG CAG GTC CTT CCG TCT 2373
D R S E L S P L L L S T T Q W Q V L P C  
+660 +670
TCC TTC ACG ACC CTG CCA GCC TTG TCC ACC GGC CTC ATC CAC CTC CAC CAG AAC ATT GTG 2433
S F T T L P A L S T G L I  H L H Q N I V  
+680 +690
S e a l
GAC GTG CAG TAC TTG TAC GGG GTG GGG TCA AGC ATC GCG TCC TGG GCC ATC AAG TGG GAA 2493
D V Q Y L Y G V G S S I A s W A I K W E
+700 +710
TAC GTC GTT CTC CTG TTC CUT CTG CTT GCA GAC GCG CGC GTC TGC TOC TGC TTG TGG ATG 2553
Y V V L L F L J. L A D A R V C S C L W M
+720 +730
S e a l
ATG TTA CTC ATA TCC CAA GCG GAG GCG GCT TTG GAA AAC CTC CTA GZA CTC AAT GCA GCA 2613
M L L I S Q A E i 1 A r_< C if r 7 7 r if A
+740 +750
TCC CTG GCC GGG ACG CAT GCT CTT GTG TCC TTC CTC GTG TTC TTC TGC TTT GCG TGG TTT 2673
L A J V i l u r 7 '•J r 7 i' i ’ /» i* vf i'
+760 +770
CTG AGG GCT AAG TGG GTG CCC GGA GCG GTC TAC GCC CTC TAC GGG ATG TGG OCT CTC CTC 2733
r it G r? J 7 J *J A 7 f A r f J •I J r r
+780 +790
CTG CTC CTG TTG GCG TTG CCC CAG CGG GCA TAC GCG CTG GAC ACG GAG CTA GCC GCG TCG 2793
r—i r r—i —i r r £ O j# A / r —j 0 T E V A A S
+800 +810
E c o 4 7 III
TCT GGC GGC GTT GTT CTC GTC GGG TTA ATG GCC CTA ACT CTG TCA CCA TAT TAC M G  CGC 2853
C G G V V L V G L M A L T L S P Y Y K R
+820 +830
2AT ATC AGC TGG TGC TTG TGG TGG CTG CAG TAT TTT CTG ACC 2856  
Y I S W C L W W L Q T F L T  
+840 +850
Key
Cysteine residue 
N - X - S / T  Potential N-linked glycosylation site 
L P G Predicted single sequence to direct protein into the ER
Q A I  Predicted hydrophobic/transmembrane domain
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M S T Core or NS2 protein amino acid sequence
Y Q V El glycoprotein amino acid sequence
E T H E2 glycoprotein amino acid sequence
£ I h E2 glycoprotein hypervariable regions
A A £ p7 amino acid sequence
GTG CAC Endonuclease restriction site
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Appendix 2 - Amino Acid Sequence Alignment of Strain Glasgow and 
H77 Core, E l and E2
C e l e 2 a l i n e . Con  
G l a c e l e 2 . F r g  
H 7 7 c e l e 2 . F r g
C e l e 2 a l i n e . C on  
G l a c e l e 2 . F r g  
H 7 7 c e l e 2 . F r g
C e l e 2 a l i n e . Con  
G l a c e l e 2 . F r g  
H 7 7 c e l e 2 . F r g
C e l e 2 a l ± n e . Con  
G l a c e l © 2 . F r g  
H 7 7 c e l e 2 . F r g
C e l e 2 a l ± n e . Con  
G l a c e l e 2 . F r g  
H 7 7 c e l e 2 . F r g
C e l e 2 a l i n e . C on  
G l a c e l e 2 . F r g  
H 7 7 c e l© 2 . F r g
C e l e 2 a l i n e . Con  
G l a c e l e 2 . F r g  
H 7 7 c e l e 2 . F r g
C e l e 2 a l ± n e . Con  
G l a c e l e 2 . F r g  
H 7 7 c e l e 2 . F r g
C e l e 2 a l i n e . Con  
G l a c e l e 2 . F r g  
H 7 7 c e l e 2 . F r g
C e l e 2 a l ± n e . C on  
G l a c e l e 2 . F r g  
H 7 7 c e l e 2 . F r g
C e l e 2 a l ± n e . Con  
G l a c e l e 2 . F r g  
H 7 7 c e l e 2 . F r g
1 5 0
MSTNPKPQRK TKRNTNRRPQ DVKFPGGGQI VGGVYLLPRR GPRLGVRATR 
MSTNPKPQRK TKRNTNRRPQ DVKFPGGGQI VGGVYLLPRR GPRLGVRATR 
MSTNPKPQRK TKRNTNRRPQ DVKFPGGGQI VGGVYLLPRR GPRLGVRATR
5 1  1 0 0
KTSERSQPRG RRQPIPKARR P.GR.WAQPG YPWPLYGNEG . GWAGWL. SP  
KTSERSQPRG RRQPIPKARR PKGRNWAQPG YPWPLYGNEG FGWAGWLPSP 
KTSERSQPRG RRQPIPKARR PEGRTWAQPG YPWPLYGNEG CGWAGWLLSP
1 0 1  1 5 0
RGSRPSWGP. DPRRRSRNLG KVIDTLTCGF . DLMGYIPLV GAPL. GAARA 
RGSRPSWGPN DPRRRSRNLG KVIDTLTCGF VDLMGYIPLV GAPLRGAARA 
RGSRPSWGPT DPRRRSRNLG KVIDTLTCGF ADLMGYIPLV GAPLGGAARA
1 5 1  2 0 0
LAHGVRVLED GVNYATGNLP GCSFSIFLLA LLSCLTVPAS AYQVRNS. GL 
LAKGVRVLED GVNYATGNLP GCSFSIFLLA LLSCLTVPAS AYOVRNSTGL 
LAHGVRVLED GVNYATGNLP GCSFSIFLLA LLSCLTVPAS AYQVRN S S GL
2 0 1  2 5 0
YHVTNDCPNS S IV Y E A .D A I LHTPGCVPCV REGNASRCWV A . TPTVATRD 
YHVTNDCPNS SIVYEAVDAI LHTPGCVPCV REGNASRCWV AMTPTVATRD 
YHVTNDCPNS SIVYEAADAI LHTPGCVPCV REGNASRCWV AVTPTVATRD
2 5 1  3 0 0
G.LPTTQLRR HIDLLVGSAT LCSALYVGDL CGSVFLVGQL FTFSPRRHWT 
GRLPTTQLRR HIDLLVGSAT LCSALYVGDL CGSVFLVGQL FTFSPRRHWT 
GKLPTTQLRR HIDLLVGSAT LCSALYVGDL CGSVFLVGQL FTFSPRRHWT
3 0 1  3 5 0
TQ .C N CSIY P GHITGHRMAW DMMMNWSPT. ALW AQLLRI PQAI.DM IAG  
TQGCNCSIY P GHITGHRMAW DMMMNWSPTT ALW AQLLRI PQAILDMIAG 
TQDCNCSIY P GHITGHRMAW DMMMNWSPTA ALW AQLLRI PQAIMDMIAG
3 5 1  4 0 0
AHWGVLAG. A YFSMVGNWAK V L . VLLLFAG VDAETHVTGG . A . R . T . . L .  
AHWGVLAGMA YFSMVGNWAK VLAVLLLFAG VDAETHVTGG AAARSTLQLA 
AHWGVLAG I A YFSMVGNWAK VLW LLLFAG VDAETHVTGG NAGRTTAGLV
4 0 1  4 5 0
GL..PGAKQN . QLINTNGSW H .N.TALNCN . SLNTGW. AG L F Y .H .F N S S  
GLFQPGAKQN VOLINTNGSW HVNRTALNCN DSLNTGWIAG LFYYHGFNSS 
GLLTPGAKQN IQLINTNGSW HINSTALNCN ESLNTGWLAG LFYOHKFNSS
4 5 1  5 0 0
GC. ERLASCR . LT D F. QGWG P IS Y A .G .G . D.RPYCWHYP P . PCGIVPAK 
GCSERLASCR SLTDFDQGWG PISYAGGGGP DHRPYCWHYP PKPCGIVPAK 
GCPERLASCR RLTDFAQGWG PISYANGSGL DERPYCWHYP PRPCGIVPAK
5 0 1  5 5 0
SVCGPVYCFT PSPVW GTTD RSGAPTYSWG A . DTDVFVLN NTRPPLGNWF 
SVCGPVYCFT PSPVW GTTD RSGAPTYSWG ADDTDVFVLN NTRPPLGNWF 
SVCGPVYCFT PSPVW GTTD RSGAPTYSWG ANDTDVFVLN NTRPPLGNWF
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5 5 1 6 0 0
C e l e 2 a l ± n e . C on GCTWMNSTGF TKVCGAPPCV IGGVGNNTL. CPTDCFRKHP EATYSRCGSG
G l a c e l e 2 . F r g GCTWMNSTGF TKVCGAPPCV IGGVGNNTLH CPTDCFRKHP EATYSRCGSG
H 7 7 c e l e 2 . F r g GCTWMNSTGF TKVCGAPPCV IGGVGNNTLL CPTDCFRKHP EATYSRCGSG
6 0 1 6 5 0
C e l e 2 a l i n e . C on PW .TPRC.VD YPYRLWHYPC T I N . . IFKVR MYVGGVEHRL . AACNWTRGE
G l a c e l e 2 . F r g PWLTPRCLVD YPYRLWHYPC TINHSIFKVR MYVGGVEHRL DAA NWTRGE
H 7 7 c e l e 2 . F r g PWITPRCMVD YPYRLWHYPC TINYTIFKVR MYVGGVEHRL EAA NWTRGE
6 5 1 7 0 0
C e l e 2 a l i n e . C on RCDLEDRDRS ELSPLLLSTT QWQVLPCSFT TLPALSTGLI HLHQNIVDVQ
G l a c e l e 2 . F r g RCDLEDRDRS ELSPLLLSTT QWQVLPCSFT TLPALSTGLI HLHQNIVDVQ
H 7 7 c e l e 2 . F r g RCDLEDRDRS ELSPLLLSTT QWQVLPCSFT TLPALSTGLI HLHQNIVDVQ
7 0 1 7 5 0
C e l e 2 a l ± n e . C on YLYGVGSSIA SWAIKWEYW LLFLLLADAR VCSCLWMMLL ISQAE.ULLGif
G l a c e l e 2 . F r g YLYGVGSSIA SWAIKWEYW LLFLLLADAR VC SCLWMMLL ISQAE-^LLGif
H 7 7 c e l e 2 . F r g YLYGVGSSIA SWAIKWEYW LLFLLLADAR VCSCLWMMLL ISQAEAtLLGif
7 5 1 8 0 0
C e l e 2 a l i n e . Con L7. LiL'-ASL*'. j j Y r G A /'A L ICii . I J L L L L L
G i a c e l e 2 . F r g LVVLi .V-A2LA oi'usLvsFL y iC ii'& '& L L L L L i
H 7 7 c e l e 2 . F r g L ' /L L L l^ A Z L A ai'UGLViiFLY i ’i  CFA'-fJljG J,i7iCA7Y*\L
8 0 1 8 3 8
C e l e 2 a l i n e . C on r. r. '.<•>> / . \ r. I TEVAASCGG WLVGLMALT LSPYYKRY
G l a c e l e 2 . F r g r.'-/ |Vy / /  r. TEVAASCGG WLVGLMALT LSPYYKRY
H 7 7 c e l e 2 . F r g I - ' ‘ly  / *. 1 TEVAASCGG WLVGLMALT LSPYYKRY
Key
C
N - X - S / T
M S T
Y 0 V
E T H
E T H
Cysteine residue
Potential N-linked glycosylation site 
Core or NS2 protein amino acid sequence 
El glycoprotein amino acid sequence 
E2 glycoprotein amino acid sequence 
p7 amino acid sequence 
Amino acid sequence changes
2 1 2
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Appendix 3 -  Strain H77 Core, E l, and E2 Nucleic Acid and Amino Acid 
Sequence
A paL I
CCGTGCACC ATG AGC ACG AAT CCT AAA CCT CAA AGA AAA ACC AAA CGT AAC ACC AAC CGT 392  
M S T N P K P Q R K T K R N T N R
+10
CGC CCA CAG GAC CTC AAG TTC CCG GCT GGC GCT CAG ATC GTT GCT GGA GTT TAC TTG TTG 452  
R P Q D V K F P G G G Q I V G G V Y L L  
+20 +30
CCG CGC AGG GGC CCT AGA TTG GCT GTG CGC GCG ACG AGG AAG ACT TCC GAG CGG TCG CAA 512  
P R R G P R L G V R A T R K T S E R S Q  
+40 +50
X hol
CCT CGA GCT AGA CCT CAG CCT ATC CCC AAG GCA CCT CGG CCC GAG GGC AGG ACC TGG GCT 572  
P R G R R Q P  I  P K A R R P E G R T W A  
+60 +70
CAG CCC GGG TAC CCT TGG CCC CTC TAT GGC AAT GAG GCT TGC GGG TGG GCG GGA TGG CTC 632
Q P G Y P W P L Y G N E G C G W A G W L  
+80 +90
CTG TCT CCC CCT GGC TCT CGG CCT AGC TGG GGC CCC ACA GAC CCC CGG CCT AGG TCG CGC 692
L S P R G S R P S W G P T D P R R R S R  
+100 +110
d a l
AAT TTG GCT AAG GTC ATC GAT ACC CTT ACG TGC GGC TTC GCC GAC CTC ATG GGG TAC ATA 752  
N L G K V I D T L T C G F A D L M G Y I  
+120 +130
CCG CTC GTC GGC GCC OCT CTT GGA GGC GCT GCC AGG GCC CTG GCG CAT GGC GTC CGG GTT 812
P L V G A P L G G A A R A L A H G V R V  
+140 +150
CTG GAA GAC GGC GTG AAC TAT GCA ACA GGG AAC CTT CCT GCT TGC TCT TTC TCT ATC TTC 872
L E D G V N Y A T G N  L P G C S F S I F  
+160 +170
F apI
CTT CTG GCC CTG CTC TCT TGC CTG ACT GTG CCC GCT TCA GCC TAC CAA GIG CGC AAT TCC 932
L L A L L S C L T V P A S A  y q v  r  n ___ §
+180 +190
X h o l E a g I
TCG GGG CTT TAC CAT GTC ACC AAT GAT TGC CCT AAC TCG ACT ATT GTG TAC GAG GCG GCC 992
S G L Y H V T N D C P  N S S I  V Y E A A
+200 +210
X h o l
GAT GCC ATC CTG CAC ACT CCG GGG TCT GTC CCT TGC GTT CGC GAG GCT AAC GCC TCG AGG 1052
D A I L H T P G C V P C V R E G  N A S  R 
+220 +230
B s tE I I
TCT TGG GTG GCG GTG ACC CCC ACG GTG GCC ACC AGG GAC GGC AAA CTC CCC ACA ACG CAG 1112
C W V A V T P T V A T R D G K L P T T Q  
+240 +250
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d a  r
CTT CGA CCT CAT ATC GAT CTG CTT GTC GGG AGC GCC ACC CTC TGC TCG GCC CTC TAC GTG 1172
L R R H I D L L V G S  A T L C S A L Y V  
+260 +270
GGG GAC CTG TGC GGG TCT GTC TTT CTT CTT GCT CAA CTG TTT ACC TTC TCT CCC AGG CGC 1232
G P L  G S V F L V G Q L F T F S P R R
+280 " “ +290
Mbnl
CAC TGG ACG ACG CAA GAC TGC AAT TCT TCT ATC TAT CCC GGC CAT ATA ACG GCT CAT CGC 1292
H W T T Q D C N C S I Y P G H I T G H R  
+300 +310
ATG GCA TOG GAT ATG ATG ATG AAC TGG TOC CCT ACG GCA GCG TTG GTG GEA GCT CAG CTG 1352
M A W D M M M N W S  P T A A L V V A Q L  
+320 +330
B anSI
CTC CGG ATC CCA CAA GCC ATC ATG GAC ATG ATC GCT GCT GCT CAC TGG GGA GTC CTG GCG 1412
L R I  P O A I M D M I A G A  H W G V I. A 
+340 +350
GGC ATA GCG TAT TTC TCC ATG GTG GGG AAC TGG GCG AAG GTC CTG CTA GTG CTG CTG CTA 1472
G I  A Y F S M V G N W A K V L V V L L L  
+360 " +370
S a i l
TTT GCC GGC GTC GAC GCG GAA ACC CAC GTC ACC GGG GGA AAT GCC GGC CGC ACC ACG GCT 1532
F A G V D A E T H V T G G N A G R T T A  
+380 ~  “  +390 - - - - -
GGG CTT GTT GCT CTC CTT ACA CCA GGC GCC AAG CAG AAC ATC CAA CTG ATC AAC ACC AAC 1592
G L V G L L T P G A K g N I Q L I N T N  
+400 -  +410
GGC ACT TGG CAC ATC AAT AGC ACG GCC TTG AAT TGC AAT GAA AGC CTT AAC ACC GGC TGG 1652
 § W H I  N S T A L N C N E S L N T G W
+420 ~ “ +430
TTA GCA GGG CTC TTC TAT CAA CAC AAA TTC AAC TCT TCA GGC TCT CCT GAG AGG TTG GCC 1712
L A G L F Y Q H K F  N S S G C P E R L A
+440 +450
AGC TGC CGA CGC CTT ACC GAT TTT GCC CAG GGC TGG GCT CCT ATC ACT TAT GCC AAC GGA 1772
S C R R L T D F A Q G W G P I S Y A  N G
+460 +470
AGC GGC CTC GAC GAA CGC CCC TAC TGC TGG CAC TAC CCT CCA AGA CCT TCT GGC AIT GTG 1832
S G L D E R P Y C W H Y P P R P C G I V  
+480 “  +490
CCC GCA AAG AGC GTG TCT GGC CCG CTA TAT TGC TTC ACT CCC AGC CCC GTG GTG GTG GGA 1892
P A K S V C G P V Y C F T P S P V V V G  
+500 +510
A a c l
ACG ACC GAC AGG TOG GGC QOS CCT ACC TAC AGC TGG GCT GCA AAT GAT ACG GAT GTC TTC 1952
T T D R S G A P T Y  S W G A  N D T D V F 
+520 +530
M uni
GTC CTT AAC AAC ACC AGG CCA CCG CTG GGC AAT TOG TTC GCT TCT ACC TGG ATG AAC TCA 2012
v  L N N T R P P L G N W F G C T W M  N S
+540 +550
ACT GGA TIC  ACC AAA GTG TGC GGA GCG CCC CCT TCT GTC ATC GGA GGG GTG GGC AAC AAC 2072
T_ G F T K V C G A P P C V I G G V G  N N
+560 +570
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ACC TTG CTC TGC CCC ACT GAT TGC TTC CGC AAA CAT CCG GAA GCC ACA TAC TCT CGG TGC 2132
T L L C P T D C F R K H P E A T Y S R C  
+580 +590
S a i l
GGC TCC GGT CCC TGG ATT ACA CCC AGG TGC ATG GTC GAC TAC CCG TAT AGG CTT TGG CAC 2192
G S G P W I T P R C M V D Y P Y R L W H  
+600 +610
TAT CCT TCT ACC ATC AAT TAC ACC ATA TTC AAA GTC AGG ATG TAC GTG GGA GGG CTC GAG 2252
Y P C T I  N Y T I  F K V R M Y V G G V E
+620 +630
CAC AGG CTG GAA GCG GCC TGC AAC TGG ACG CGG GGC GAA CGC TCT GAT CTG GAA GAC AGG 2312
H R L E A A C N W T R G E R C D L E D R
+640 +650
GAC AGG TCC GAG CTC AGC CCG TTG CTG CTG TCC ACC ACA CAG TGG CAG CTC CTT CCG TCT 2372
D R S E L S P L L L S T T Q W Q V L P C  
+660 +670
TCT TTC ACG ACC CTG CCA GCC TTG TCC ACC GGC CTC ATC CAC CTC CAC CAG AAC AIT GTG 2432
S F T T L P A L S T G L I H L H Q N I V  
+680 +690
S e a l
GAC GTG CAG TRC TIG TAC GGG CTA GGG TCA AGC ATC GCG TCC TGG GCC ATT AAG TGG GAG 2492
D V Q Y L Y G V G S S  I A S W A I K W E  
+700 +710
TAC GTC GTT CTC CTG TTC CTT CTG CTT GCA GAC GCG CGC GTC TGC TCC TGC TTG TGG ATG 2552
Y V V L L F  L L L A  D A R V S L W M
+720 ~  ' +730
ATG TTA CTC ATA TCC CAA GCG GAG GCG GCT TTG GAG AAC CTC GTA ATA CTC AAT GCA GCA 2612
M L L I  S Q A E A  A  I. 3  if  L 7  I  L if  A  A
+740 +750
TCC CTG GCC GGG ACG CAC GCT CTT CTG TCC TTC CTC GTG TTC TTC TGC TTT GCG TGG TAT 2672
1  A  O 1* :I G L V 3 F L 7  i ’ i ’ C i' A .1 I
+760 +770
CTG AAG GCT AGG TGG GTG CCC GGA GCG GTC TAC GCC CTC TAC GGG ATG TOG CCT CTC CTC 2732
1  i t  0  i t  .1 7  P  O A  7  t  A  L I  G  i l  ,1 j f  Li L
+780 +790
CTG CTC CTG CTG GCG TTG CCT CAG CGG GCA TAC GCA CTG GAC ACG GAG CTG GCC GCG TOG 2792
L 1  L L A L P O it A I  A L D T E V A A S
+800 +810
E c o 4 7 III
TCT GGC GGC CTT GTT CTT CTC GGG TTA ATG GCG CTG ACT CTG TCG CCA TAT TAC AAG CGC 2852  
C G G V V L V G L M A L T L S P Y Y K R  
+820 +830
TAT 2855
Y
Key
Cysteine residue
Potential N-linked glycosylation site 
Predicted single sequence for insertion into the ER
C
N - X - S / T  
L P 6
215
Appendix
Q A  I
M S T 
Y Q V 
E T H 
L I U
A A L 
GTG CAC
Predicted transmembrane domain 
Core or NS2 protein amino acid sequence 
El glycoprotein amino acid sequence 
E2 glycoprotein amino acid sequence 
E2 glycoprotein hypervariable regions 
p7 amino acid sequence 
Endonuclease restriction site
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Appendix 4 - HSV-1 Glycoprotein D Nucleic Acid and Amino Acid 
Sequence
CCTTCCQCT ATG GGG GGG GCT GCC GCC AGG TTG GGG GCC CTG ATT TTG TTT GTC GTC ATA 138469
M G G A A A R L G A V I L F V V I  
-20  -10
Eam I
GPG GGC CPC CAT GGG GTC CGC AGC AAA TAT GCC TTG GTG GAT GCC TCT CTC AAG ATC GCC 138529
V G L H G V R S K Y A L V D A S L K M A
-1 +1 +10
P vu II
GAC CCC AAT CGC TTT CGC GGC AAA GAC CTT COG GTC CTG GAC CAG CTO ACC GAC CCT COG 138589  
D P N R F R G K D L P V L D Q L T D P P
+20 +30
GGG GTC CGG CGC GTG TAC CAC ATC CAG GCG GGC CIA CCG GAC CCG TTC CAG CCC CCC AGC 138649  
G V R R V Y H I Q A G L P D P F Q P P S
+40 +50
CTC COG ATC ACG CTT TAC TAC GCC GTG TTG GAG CGC GCC TGC CGC AGC GTG CTC CTA AAC 138709  
L P I T V Y Y A V L E R A C R S V L L N
+60 +70
GCA CCG TOG GAG GCC CCC CAG ATT GTC CGC GGG GCC TOC GAA GAC CTC CGG AAA CAA CCC 138769
A P S E A P Q I V R G A S E D V R K Q P
+80 +90
TAC AAC CTG ACC ATC GCT TGG TTT CGG ATG GGA GGC AAC TCT GCT ATC CCC ATC ACG GTC 138829
Y N L T I A W F R M G G N C A I  P I T V
+100 +110
ATG GAG TAC ACC GAA TGC TCC TAC AAC AAG TCT CTG GGG GCC TOT CCC ATC CGA ACG CAG 138889  
M E Y T E C S Y  N K S L G A C P I R T Q
+120 +130
CCC CGC TGG AAC TAC TAT GAC AGC TTC AGC GCC GTC AGC GAG GAT AAC CTG GGG TTC CTG 138949
P R W N Y Y D S F S A V S E D N L G F L
+140 +150
ATG CAC GCC CCC GCG TTT GAG ACC GCC GGC ACG TAC CTG CGG CTC GTG AAG ATA AAC GAC 139009
M H A P A F E T A G T Y L R L V K I N D
+160 +170
TGG ACG GAG ATT ACA CAG TTT ATC CTG (3W5 CAC CGA GCC AAG GGC TOC TCT AAG TAC GCC 139069
W T E I T Q F I L E H R A K G S C K Y A
+180 +190
CTC CCG CTG CGC ATC CCC OCG TCA GCC TGC CTC TCC CCC CAG GCC TAC CAG CAG GGG CTG 139129
L P L R I  P P S A C L S P Q A Y Q Q G V
+200 +210
ACG GTG GAC AGC ATC GGG ATG CTG CCC CGC TTC ATC CCC GAG AAC CAG CGC ACC GTC GCC 139189  
T V D S  I  G M L  P R F  I  P E N Q R T V A
+220 +230
CTA TAC AGC TTG AAG ATC GCC GGG TGG CAC GGG CCC AAG GCC CCA TAC ACG AGC ACC CTG 139249
V Y S L K I A G W H G P K A P Y T S T L
+240 +250
CTG CCC CCG GAG CTG TCC GAG ACC CCC AAC GCC ACG CAG CCA GAA CTC GCC CCG GAA GAC 139309
L P P E L S E T P  N A T  Q P E L A P E D
+260 +270
CCC GAG GAT TOG GCC CTC TTG GAG GAC CCC GTG GGG ACG GTG GOG CCG CAA ATC CCA CCA 139369
P E D S A L L E D P V G T V A P Q I P P
+280 +290
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EaeJ
AAC TOG CAC ATA CCG TOG ATC CAG GAC GCC GOG ACG CCT TAC CAT CCC COG GOC ACC CCG 139429  
N W H  I  P S  I Q D A A T P Y H P P A T P
+300 +310
AAC AAC ATG GGC CTG ATC GCC GGC GCG CTG GGC GGC ACT CTC CTG GCA GOC CTG GTC ATT 139489
N N M G L I A G A V G G S L L A A L V I
+320 +330
TGC GGA ATT GTG TAC TGG ATG CGC CGC CAC ACT CAA AAA GOC CCA AAG CGC ATA CGC CTC 139549
C G I  V Y W M R R H T Q K A P K R I R L
+340 +350
CCC CAC ATC CGG GAA GAC GAC CAG CCG TOC TCG CAC CAG CCC TTG TTT TAC TAG AIAGOC 139609
P H I R E D D Q P S S H Q P L F Y *
+360 +370
Key
Cysteine residue 
N -X -S /T  Potential N-linked glycosylation site
L P G Predicted single sequence for insertion into the ER
D A I  Predicted transmembrane domain
M S T Glycoprotein D amino acid sequence
A A L Cytoplasmic domain amino acid sequence
G7UCAC Endonuclease restriction site
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Appendix 5 -  Characteristics of E l and E2 Specific Antibodies 
Generated by Dr A Patel
Antibody Type Epitope Specificity Reactivity
H77
r to Strain 
Glasgow
R141 rabbit
polyclonal
Linear E2
(aa 384-410)
+++
R528 rabbit
polyclonal
Linear E l +++ +++
ALP98 mouse
monoclonal
Linear E2
(aa 610-699)
+++ +++
| AP21.010 mouse
monoclonal
Linear E l
(aa 191-236)
+++ +++
AP497 mouse
monoclonal
Conformational E l
(aa 191-236)
+++ +++
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Appendix 6 -  Restriction Enzymes Employed to Generate DNA Clones
Recognition sequence
(/ indicates site of cleavage)
Restriction enzyme
G/TGCACApaLI
GG/CGCGCCAscI
G/GATCCBamHI
Bell T/GATCA
BgUI A/GATCT
G/GTNACC
C 7 a / AT/CGAT
Y/GGCCREael
C/GGCCG£ ag /
Eco47III AGC/GCT
G/AATTCEcoRI
TGC/GCAFsy?/
GTY/RACH in d i
Hindlll A/AGCTT
GGTAC/CKpnl
TGG/CCAMscI
C/AATTGM uni
ATGCA/TA to7
CAG/CTGP v m / /
G/TCGAC5a//
AGT/ACTSea/
X6a/ T/CTAGA
C/TCGAGXhol
220
irn a l o f  G eneral V irology  (1999), 80, 1681-1 690. Printed in Great Britain
Dvalent interactions are not required to permit or stabilize 
le non-covalent association of hepatitis C virus glycoproteins 
1 and E2
lisha Patel, Arvind H. Patel and John McLauchlan
i
;C V irology Unit, Division of Virology, University o f Glasgow, Church Street, Glasgow G 1 1 5JR, UK
Hepatitis C virus (HCV) encodes two glycoproteins, E1 and E2, which are thought to locate to  the 
envelope of virus particles. These proteins form two complexes in tissue culture systems, a high 
molecular mass aggregate that contains intermolecular covalent bonds and a native complex in 
which E1 and E2 associate by non-covalent interactions. The contribution of either complex to the 
structures of the proteins on virus particles is not known. Using dithiothreitol to reduce inter- and 
intramolecular disulphide bonds in situ, we have studied the nature of the interactions within the 
aggregate and the role of covalent bonds in the early stages of E1-E2 association. Results with two 
HCV type 1a strains, Glasgow and H77, showed that the aggregate contains not only covalent 
interactions but also non-covalent associations between E1 and E2. These non-covalent 
associations are complex since deletion mutant analysis failed to identify any single region which 
was required for non-covalent interaction. Complex formation by de novo synthesized proteins was 
not arrested under reducing conditions which prevented the production of inter- and in­
tramolecular disulphide bonds. Moreover, a conformation-specific antibody continued to 
recognize the E2 protein in reduced complexes, indicating that covalent bonds do not stabilize 
certain structures of E2 that can interact with E1. These data suggest that disulphide bonds are not 
required either to allow association between the proteins or to stabilize E1-E2 complexes.
roduction ______________________________
Chronic infection with hepatitis C virus (HCV) is the major 
se of non-A, non-B viral hepatitis. The virus is a member of 
Flaviv ir idae  and has a positive-sense, single-stranded 
lome of about 9 '6 kb which encodes a polyprotein of 
^veen 3008 and 3037 amino acids (reviewed in Clarke, 
>7). Three proteins generated by host cell signalase cleavage 
fn the N-terminal portion of the polyprotein, termed core, 
and E2, are the proposed proteinaceous com ponents of 
ons,- the core protein is thought to constitute the capsid 
h E l and E2 forming the virus envelope. Num erous studies 
e reported that E l and E2 are glycosylated and associate to 
n a heteromeric complex (Grakoui et a l ,  1993; Ralston et a l ,  
•3; Matsuura el al., 1994; Selby et al., 1994). The nature of 
authentic association between E l and E2 is the subject of 
ate since both covalent and non-covalent interactions have
thor for correspondence: John McLauchlan 
< + 4 4  141 3 3 7  2 2 3 6 . e-mailj.mclauchlan@vir.gla.ac.uk
been identified (Grakoui et al., 1993; Ralston el al., 1993). 
Although direct analysis of HCV virions has not been possible, 
it is considered that the non-covalent interactions are authentic 
while covalent associations m ay represent aggregation of 
misfolded proteins (Dubuisson et  al., 1994; Deleersnyder et a l ,  
1997). From studies on the formation of the E1-E2 complex, E2 
acquires disulphide bonds rapidly but this process is slower 
with E l (Dubuisson & Rice, 1996). Since the tw o proteins 
appear to associate soon after synthesis, disulphide bond  
formation within E2 may be important for interaction with E l 
and, moreover, may induce conformational changes in El, 
including disulphide bond formation.
A  convenient method to determine the role of disulphide 
bonds in proteins which cycle through the endoplasmic 
reticulum (ER) is addition of the reducing agent dithiothreitol 
(DTT) to cells during protein synthesis (Braakman et al., 1992). 
In this way, proteins can be reversibly reduced and reoxidized 
within a cellular environment. DTT does not seriously impair 
translation, translocation, N -glycosylation or signal sequence 
removal and the secretory pathway from the intermediate
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compartment and G olgi complex also continues to function 
although export from the ER m ay be reduced (Verde et al., 
1995). This m ethod ology  also has been used to identify DTT- 
resistant forms of the E l glycoprotein in Sindbis virus which 
arise upon heteromeric complex formation with the precursor 
E2 protein and are considered to represent species that have 
achieved a particular stage of the maturation process (Carleton 
& Brown, 1996, 1997).
Using DTT to create a reducing environment within cells, 
w e have examined the role of disulphide bonds in E1-E2 
com plexes formed by tw o type la  strains of HCV, a local 
isolate called strain G lasgow (M. McElwee & R. M. Elliott, 
unpublished data) and H77 (Ogata et al,  1991). This has 
allowed us to determine whether disulphide bonds are 
necessary for stabilizing interactions between the proteins and 
to study their involvem ent in the initial stages of complex 
formation.
M ethods
■  Construction of plasmids. Details of the regions used in this 
study to express core, E l and E2 from both H77 and Glasgow strains are 
given in Fig. 1. Cloned cD N A  fragments from HCV strain Glasgow, 
which has a la  genotype, were kindly provided by M. McElwee and R. 
M. Elliott. A  plasmid, pCV-H77C (kindly supplied by J. Bukh), carrying 
the infectious full-length cD N A  sequence of HCV strain H77 (Yanagi et 
al, 1997), provided the fragment for the H77 construct. All fragments 
were initially cloned into vector pGEM-1 (Promega) and then flanked by 
Bgtll sites. For expression purposes, BglU fragments containing HCV 
sequences from these plasmids were introduced into the unique BamHl 
site of the Semliki Forest virus expression vector, pSFVl (Liljestrom & 
Garoff, 1991). E2 deletion mutants in Fig. 1 were derived from 
pSFV /E lhisE2 and therefore contain the histidine tag in El. Constructs 
were made by standard methods using restriction enzyme fragments 
along with synthetic oligonucleotides to combine fragments with 
incompatible termini. PCR was used only to construct the 3 /-terminal 
HCV sequences in pG EM /A 609-698. The nucleotide sequences of all 
regions that were modified as a consequence of cloning procedures were 
determined before insertion into pSFVl.
■  Maintenance of tissu e culture cells. BHK C l3  cells were grown 
and maintained in G lasgow minimal Eagle's Medium supplemented with 
10% newborn calf serum (NCS), 4% tryptose phosphate broth and 
100 IU /m l penicillin/streptomycin (ETC10).
■  In vitro transcription and electroporation of SFV RNA into 
cells. Recombinant SFV plasmids were linearized by Spel digestion and 
then used as templates for in vitro transcription essentially as described by 
Liljestrom & Garoff (1991). Typically, 25 pi transcription reactions 
contained 40 mM Tris—HC1, pH 7-9, 6 mM M gCl2, 2 mM spermidine, 
10 mM NaCl, 5 mM  DTT, 1 mM each of ATP, CTP and UTP, 500 pM 
GTP, 1 mM cap analogue m 7G(5')ppp(5/)G (Boehringer Mannheim), 40 
units RNasin and 50 units SP6 RNA polymerase (apart from cap 
analogue, all reagents were supplied by Pharmacia). Reactions were 
incubated at 37 °C for 2 h.
For electroporation, cells were grown to confluence, trypsinized and 
resuspended in ETC10 medium. Cells were pelleted by centrifugation at 
400 g at room temperature for 5 min, resuspended in PBSA and repelleted 
as before. The cell pellet was finally resuspended in PBSA to give
PSFV/CE1E2H77
pSrV/CElE2o,
I  El I
pSFV/EluE2
pSFV/A385-410
pSFV/A416453
pSFV/A460-519
pSFV/A52M08
pSFV/A61<W97
pSFV/169-703
(xHja
|  p7/NS2
B Z I
Ml
X U
J Z 3
XU
Fig. 1. Details of the regions of HCV expressed using the SFV system. The 
positions of cleavage sites between core/E 1, E1 /E2 and E 2/p7/N S2 are 
arrowed. With the exception of pSFV/1 6 9 - 7 0 3 ,  all constructs terminated 
translation at amino acid residue 8 3 7  of the HCV polyprotein. In 
pSFV/CE1 E2H77 and pSFV/CE1 E2G!a, translation w as initiated at residue 1 
of the HCV polyprotein, whereas in the remaining constructs translation 
began at HCV residue 1 69 . The histidine tag, which introduced six 
histidine residues into the E1 sequences in pSFV/E1 hisE2, w as present in 
the E2 deletion mutants also. For the deletion mutants, constructs are 
named according to the residues which were removed. Filled boxes 
denote the hydrophobic domains which contain the signal sequences that 
direct cleavage within the polyprotein.
107 cells/ml. Cell suspension (800 pi) was mixed by inversion with 25 pi 
of in vitro transcription reactions and the mixture electroporated (Bio-Rad 
Gene Pulser II) with two consecutive pulses at 1-2 kV and 25 pF at room 
temperature. Electroporated cells were diluted 1 /2 0  in ETC10 and seeded 
onto 35 mm tissue culture dishes.
■  Metabolic labelling of proteins. For extended labelling times, 
cells were washed and incubated in BHK medium with reduced 
concentrations of NCS (2%) and methionine (1 /5  normal concentration) 
at 3-5 h post-electroporation. After incubation at 37 °C for 30  min, 
proteins were radiolabelled by addition of lO pC i/m l [35S]methionine 
(1175 Ci/m m ol; Amersham) and incubation at 37 °C was continued for 
a further 8 h before harvesting.
In pulse—chase experiments, cells were incubated at 37 °C for 11-5 h 
following electroporation and then incubated in media with reduced 
concentrations of NCS (1%), methionine and cysteine (1/5 normal 
concentration) for 30 min prior to labelling. Cells were radiolabelled with 
150 pCi Promix ( >  lOOOCi/mmoI; Amersham) in 500 pi PBS containing 
1% NCS for the appropriate length of time and chased in ETC10 
supplemented with 0 ‘5 m g/m l methionine and cysteine.
■  DTT treatm ent of cells. In experiments analysing the effects of 
reducing agent on preformed complexes, cells which had been radio- 
labelled were firstly incubated in 200 p g/m l cycloheximide to block 
translation followed by addition of DTT at concentrations and for times 
indicated in the text. In pulse—chase experiments, 5 mM DTT was added 
to cells 15 min prior to and maintained at that concentration during the 
pulse—chase period.
For harvesting, cells were washed twice in cold PBS containing 
20 mM N-ethylmaleimide (NEM) and harvested in either 500 pH lysis 
buffer (25 mM Tris-HCl, pH S'O, 40 mM imidazole, 300 mM NaCl, 1% 
Triton X-100, 20 mM NEM, 1 mM PMSF) for purification by Ni—NTA
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a g a r o s e  o r  5 0 0  pi im m u n o p r e c ip i ta t io n  b u ffe r  (2 5  m M  T r is—H C l, p H  7-5 , 
3 0 0  m M  NaCl, 1%  T r ito n  X - I 0 0 ,  2 0  m M  N E M , 1 m M  E D T A , 1 m M  
P M S F ). C e l l s  w e r e  ly s e d  fo r  1 0  m in  o n  ic e  b e fo r e  c e n tr i fu g a tio n  at 
13 0 0 0 #  t o  r e m o v e  in s o lu b le  ce ll d eb r is .
■  Endo H d ig estio n  of g lycoprote ins . L y s a te s  fro m  c e lls  w e r e  
d e n a tu r e d  in 0 -5 %  S D S , 1%  // -m e r c a p to e th a n o l  a t 1 0 0  °C  fo r  1 0  m in . 
S o d iu m  c i t r a te  w a s  a d d e d  to  5 0  m M  f o l lo w e d  b y  2 0 0 0  u n its  o f  e n d o  H r 
( N e w  E n g la n d  B io la b s) a n d  th e  r e a c tio n  w a s  in c u b a te d  a t 3 7  °C  fo r  1 h.
■  N i-N T A  agarose  purification  and im m un op rec ip ita tio n  of 
E 1 -E 2  com plexes . F or im m u n o p r e c ip ita t io n , ce ll ly s a t e s  w e r e  in c u ­
b a te d  o v e r n i g h t  in 1 - 5  pi o f  th e  a p p r o p r ia te  a n t ib o d y  (d ilu te d  1 / 5 0 0 )  at 
4 °C , f o l l o w e d  b y  a d d it io n  o f  5 0  g l P r o te in  A - S e p h a r o s e  (S ig m a ) an d  
in c u b a t io n  a t 4  °C  fo r  a fu rth er  1 h. T h r e e  a n ti-E 2  im m u n o lo g ic a l  
r e a g e n ts  w e r e  u se d :  t w o  m o n o c lo n a l  a n t ib o d ie s , H 5 3  (C o c q u e r e l et al„ 
1 9 9 8 ;  k in d ly  p r o v id e d  b y  J. D u b u is s o n )  an d  A L P 9 8  (ra ised  a g a in s t  s tra in  
G la s g o w  E 2 ), an d  a rab b it a n tise r u m , R 1 4 1  (ra ise d  a g a in s t  th e  
h y p e r v a r ia b le  r e g io n  o f  s tra in  G la s g o w  E2). I m m u n e  c o m p le x e s  a t ta c h e d  
to  S e p h a r o s e  w e r e  p e l le t e d  at 1 0 0 0 0 #  fo r  3 0  s  an d  w a s h e d  th r e e  t im e s  
w ith  im m u n o p r e c ip i ta t io n  b u ffer . P r o te in s  b o u n d  to  S e p h a r o s e  w e r e  
r e m o v e d  b y  a d d it io n  o f  2 0 0  m M  T r is -H C l ,  p H  6 -8, 0 5 %  S D S , 10%  
g ly c e r o l  a n d  0 -0 1 %  b r o m o p h e n o l  b lu e .
P u r if ic a t io n  o n  N i—N T A  a g a r o s e  w a s  a c c o m p lis h e d  b y  a d d in g  5 0  g l 
o f  e q u il ib r a te d  N i - N T A  resin  to  c e ll ly s a t e s  an d  r o ta t in g  th e  m ix tu r e  at  
4 °C  fo r  J lh. R e s in  w a s  p e l le te d  a t 1 0 0 0 0 #  fo r  3 0  s an d  w a s h e d  th r e e  
t im e s  w ith  l y s i s  b u ffe r  c o n t a in in g  5 0  m M  im id a z o le . P r o te in s  w e r e  e lu te d  
u s in g  th e  b u f f e r  d e s c r ib e d  a b o v e .
■  PAGE and  W estern  b lo t analysis. S a m p le s  w e r e  p rep a re d  for  
e l e c t r o p h o r e s is  b y  h e a t in g  to  9 5  °C . F or e le c tr o p h o r e s is  u n d e r  r e d u c in g  
c o n d it io n s ,  D T T  w a s  a d d e d  to  s a m p le s  t o  a fin al c o n c e n tr a t io n  o f  2 0  m M  
b e fo r e  h e a tu n g . S a m p le s  w e r e  c o o le d  a n d  e l e c t r o p h o r e s e d  o n  1 0  o r  1 2 %  
p o ly a c r y la m id e  g e l s  c r o ss - lin k e d  w ith  2 -5 %  ( w / w )  N ,N ' - m e t h y le n e  
b is a c r y la m id e  (L a em m li, 1 9 7 0 ) . P o ly p e p t id e s  w e r e  d e te c t e d  b y  a u t o ­
r a d io g r a p h y  u s in g  X S -1  X -ray  film  (K od ak ).
For W e s t e r n  b lo t  a n a ly s is , p r o te in s  w e r e  s e p a r a te d  o n  p o ly a c r y la m id e  
g e ls  an d  tr a n s fe r r e d  to  n it r o c e l lu lo s e  m e m b r a n e  (T o w b in  et <?/., 1 9 7 9 ) .  
A fte r  b lo c k in g  w ith  3 %  g e la t in , 4  m M  T r is -H C l,  p H  7-4 , 10 0  m M  N a C l, 
th e  m em b ra  n e  w a s  in c u b a te d  w ith  a m o n o c lo n a l  a n t ib o d y  sp e c if ic  fo r  th e  
h is t id in e  t a g  (P e n ta -H is  a n t ib o d y ;  Q ia g e n )  for  4  h in 1%  g e la t in , 4  m M  
T r is -H C l ,  p H  7 -4, 1 0 0  m M  N a C l, 0 0 5 %  T w e e n  2 0 . A f te r  w a s h in g ,  
b o u n d  a n t ib o d y  w a s  d e te c t e d  u s in g  a h o r s e r a d is h  p e r o x id a s e - c o n j u g a te d  
s e c o n d a r y  a n t ib o d y  f o l lo w e d  b y  e n h a n c e d  c h e m ilu m in e s c e n c e  
(A m e r s h a m ).
R esults
The com p lexes  formed by E1 and E2 from HCV strain 
Glasgow contain intermolecular disulphide bonds
E xp re ss io n  of the  structural p ro te ins  from H C V  strains 
G la sg o w  a n d  H 7 7  w as  ach ieved  using the Semliki Forest virus 
(SFV) e x p re s s io n  sys tem . T h e  p a ren t  plasmid used to  const ruc t  
d e r iv a t iv e s  fo r  express io n  of H C V  p ro te ins  w as  p S F V l,  w hich  
carries the c o d in g  reg ions  for the  SFV replication  p ro te ins  bu t 
lacks any  s truc tura l  genes. D etails  of the  reg ions  ex p ressed  
using the SFV sy s te m  are sh o w n  in Fig. 1. T o  facilitate 
purif ica tion  o f  E l and  any  associa ted  E2, a his tid ine tag  w as 
in troduced  b e tw e e n  am ino  acids 195 and  196 in the strain
(A ) 1 2  3 (B) 1 2
Ml
E2
f t
(C )  1 2  3
A88
E 2 » -
El
El Ers'y
Fig. 2. (A) C o m p a r iso n  o f th e  re la tive  m o b ilit ie s  o f  E1 an d  E2 m a d e  by  
stra in s G la sg o w  an d  H 7 7 . C ells  w e r e  e le c tr o p o r a te d  w ith  RNA an d  la b e lled  
b e tw e e n  4  an d  1 2  h a fter e lec tro p o ra tio n . A fter ly s is , th e  g ly c o p r o te in s  
w e r e  im m u n o p rec ip ita ted  from  ce ll e x tr a c ts  u sin g  A L P 98 . 
Im m u n o p rec ip ita tes  w e r e  e le c tr o p h o r e s e d  o n  a p o ly a cry la m id e  g e l u n d er  
red u c in g  co n d it io n s . S a m p le s  w e r e  d er iv ed  from  c e lls  e le c tr o p o r a te d  with  
RNA from  th e  fo llo w in g  c o n s tr u c ts :  lan e 1, pSF V /E 1 hisE 2 ; lan e 2 ,  
pSFV /C E1 E 2 H77; lan e 3 , pSF V /C E 1 E 2G)a. T h e  p o s it io n s  o f  E1 an d  E2 are  
in d ica ted . (B) S en sitiv ity  o f g ly c o p r o te in  E1 to  e n d o  H d ig e s t io n . C ells  
w e r e  e le c tr o p o r a te d  w ith RNA from  p S F V /E lhisE2 an d  ra d io la b e lled  a s  
d e s c r ib e d  in (A ). A fter ly s is , a  p ortion  ( 1 / 5 0 )  o f  th e  ce ll ex tra c t w a s  
d ig e s te d  w ith  e n d o  H. D ig e s te d  (la n e  2 )  an d  u n d ig e s te d  (lan e 1) s a m p le s  
w e r e  e le c tr o p h o r e s e d  on a  p o ly a cr y la m id e  g e l u n d er  r e d u c in g  c o n d it io n s  
an d  th en  e x a m in e d  b y W estern  b lo t a n a ly s is  u sin g  th e  P e n ta -H is  a n tib od y , 
w h ich  r e c o g n iz e s  th e  h istid in e  ta g  in E 1 . T h e  p o s it io n s  o f  g ly c o sy la te d  
(E 1) an d  d e -g ly c o sy la te d  form s (E1 gly) o f  E1 are  in d ica ted . (C) A n a ly sis  
o f  th e  E 1 -E 2  c o m p le x  fo rm ed  b y  strain  G la sg o w  u n d er re d u c in g  an d  n on ­
red u c in g  c o n d it io n s . C ells  w e r e  e le c tr o p o r a te d  w ith  p S F V /E 1 hlsE 2 an d  
lab elled  a s  d e s c r ib e d  in (A ). A ce ll ex tra c t w a s  p rep a red  an d  s u b je c te d  to  
N i-N T A  affin ity ch ro m a to g ra p h y . B ou n d  p ro te in s  w e r e  e le c tr o p h o r e s e d  on  
a  p o lyacry lam id e  g e l u n d er r e d u c in g  (la n e  1) an d  n o n -r ed u c in g  (la n e  2 )  
co n d itio n s . L ane 3  s h o w s  th e  c r u d e  ex tra c t a p p lie d  to  th e  N i-N T A  a g a r o s e  
co lu m n . T h e p o s it io n s  o f E 1, E2 an d  a  h igh  m o le cu la r  m a s s  a g g r e g a te  
(A g g ) w h ich  fa ils to  en ter  th e  re so lv in g  g e l are sh o w n .
G la sg o w  sequence, four am in o  acids from the  c leavage  site 
which defines the N te rm inus  of E l ;  this m odification  g a v e  a 
construc t  called p S F V / E l hisE2.
Transcr ip ts  syn th es ized  in vitro  w ere  in t ro d u c ed  by  e lec tro ­
p o ra t ion  in to  BHK C l 3  cells to  ach ieve  exp ress io n  of E l  and 
E2. Express ion  of E l  and  E2 w as rep ro du c ib ly  d e te c te d  in 
6 0 - 9 0 %  of e lec t ro po ra ted  cells as d e te rm in ed  b y  indirect 
im m unofluo rescence  (data n o t  show n). Extrac ts from cells 
analysed  b y  W e s te rn  b lo t  analys is  u s ing  E l -  and  E2-specific 
an tibod ies  indicated  tha t  th e  strain G la sg o w  g ly c o p ro te in s  had 
molecular m asses o f a b o u t  35 kD a (for E l)  and  65 kD a (for E2; 
da ta  n o t  show n). C o m p a r iso n  of the  mobili ties o f strain 
G la sg o w  g ly co p ro te in s  w i th  the ir  c o u n te rp a r t s  in strain H 7 7  
w as  ana lysed  using an E2-specific a n t ib o d y  w hich  im m u n o ­
precip ita tes  n o t  on ly  E2 bu t  also E l  tha t  is co m p lex ed  to  E2 
(Fig. 2 A). This  revealed  th a t  E2 from strain G la sg o w  has a 
g re a te r  m o b ili ty  than  E2 from  H 7 7  w hile  the co n v e rse  is the 
si tua t ion  for the  app a ren t  m olecu la r  m asses  of the  co r re ­
sp o n d in g  E l  p ro te ins  m ad e  b y  the  tw o  strains (Fig. 2 A, 
com p are  lanes 1 and 2). T h e  difference in mobili ties for the  E l  
g ly c o p ro te in s  is n o t  a c o n seq u en ce  o f  the  presence  o f  the 
his tidine tag  since u n ta g g e d  E l  m ad e  b y  strain G la sg o w  also
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Fig. 3. E ffect o f  DTT on  E 1 - E 2  c o m p le x e s  fo rm ed  b y strain  G la sg o w . (A) 
C ells  w e r e  e lec tr o p o r a te d  w ith  p S F V /E lhlsE2 RNA, ra d io la b e lled  an d  
tr ea te d  w ith  c y c lo h e x im id e  an d  DTT a s  d e s c r ib e d  in th e  tex t. Cell ex tra c ts  
w e r e  s u b je c te d  to  N i-N T A  affinity ch ro m a to g ra p h y  an d  b o u n d  p ro te in s  
w e r e  e le c tr o p h o r e s e d  o n  a p o lyacry lam id e g e l u n d er n o n -r ed u c in g  (NR; 
la n e s  1 an d  2 )  and  red u cin g  (R; la n es  3  an d  4 )  c o n d itio n s . S a m p le s  
d er iv ed  from  c e lls  trea te d  w ith  ( +  ) or w ith o u t DTT ( — ) are in d ica ted . (B) 
E xp erim en tal d e ta ils  are a s  d e sc r ib e d  for (A) e x c e p t  th at th e  co n ce n tra tio n  
o f DTT a d d e d  to  c e lls  w a s  varied . The co n ce n tra tio n  o f  DTT a d d e d  to  c e lls  
is s h o w n  b e lo w  e a c h  lan e. F o llow in g  N i-N T A  affinity ch ro m a to g ra p h y , 
s a m p le s  w e r e  e le c tr o p h o r e s e d  on  a  p o ly a cry la m id e  g e l u n d er  re d u c in g  (R; 
lan e 1) an d  n o n -r ed u c in g  c o n d itio n s  (NR; la n e s  2  to  7 ) .  T h e p o s it io n s  of  
E 1 , E2 an d  h igh  m o lecu lar  m a s s  a g g r e g a te s  (A gg) w h ich  fail to  en te r  th e  
re so lv in g  g e l are sh o w n  in (A) an d  (B).
has a g rea te r  app a re n t  m olecular mass than H 7 7  E l  (Fig. 2 A, 
lanes 2 and  3). From com par ison  of the  am ino  acid sequences  
for the  tw o  strains, E2 from strain G la sg o w  lacks tw o  p red ic ted  
g lyco sy la t ion  sites w h ich  are p resen t  in the  H 7 7  sequence  
(O g a ta  et al., 1991; M . M cElw ee & R. M. Elliott, unpub lished  
data). H ow ever ,  the difference in the ap paren t  mobili ties of E l  
b e tw ee n  the  strains d o es  n o t  ap pea r  to  result from varia tions  
in e ither  the  pred ic ted  molecular m asses o r  g ly co sy la t io n  
patterns.  Hence, at p resen t  the basis for the different m obili ties 
of E l from strain G la sg o w  and H 7 7  is unclear.  It was n o te d  also 
tha t  the  E2 species for b o th  strains o ften  reso lved  in to  tw o  
bands  (see Fig. 2 A  and  Fig. 3 A, B). T hese  m a y  arise from 
inefficient c leavage  at the  E 2 /p 7  site. Such species h av e  been 
identif ied p rev iously  for strain H (D ubu isson  et al., 1994 ; Lin et 
a l,  1994), w hich is h ig h ly  h o m o lo g o u s  to  strain H77. In strain 
G lasgow , ho w ever ,  w e  cann o t  rule o u t  the poss ib il ity  th a t  th e y  
result from differential g ly cosy la t io n  of E2. For simplicity, 
these  species will be referred to  as E2. F rom  indirect 
im m unofluorescence  studies, b o th  p ro te ins  m ade  b y  the  
G la sg o w  strain w ere  localized to  and  reta ined  in the  ER (data 
n o t  show n). ER re ten t ion  w as confirm ed by  en d o  H c leavage  of 
ex trac ts  w hich sh o w e d  tha t E l  w as  sensitive to  e n z y m e  
d iges tion  (Fig. 2B, lanes 1 and  2); E2 d isp layed  similar 
sensit iv ity  to  en d o  H cleavage (data n o t  show n). T h e se  da ta  
are co nsis ten t w ith  p rev iou s  findings (Cocquere l  et al., 1998).
T h e  a b o v e  da ta  clearly d e m o n s tra te  that, in accordance  
w ith  the  g lyco p ro te in s  m ade  by  o th e r  H C V  strains, E l  and  E2 
from the G la sg o w  strain form a com plex . T h e  n a tu re  o f  the
in terac t ion  b e tw een  the  p ro te ins  w as  fu r the r  s tud ied  by  
co m p ar in g  their mobilities u nd er  reduc ing  and  non-red uc ing  
e lec trophores is  condit ions . O n  this occasion, ex trac ts  from 
cells e le c t rop o ra ted  w ith  p S F V / E l hisE2 R N A  w ere  m ix ed  with 
N i—N T A  agarose  from w hich b o u n d  p ro te in s  w ere  eluted. 
Exam ination of b o u n d  material und er  redu c ing  e lec trophores is  
cond it ions  revealed  the  p resence  of tw o  m ajo r  species of 35 
and  65 kD a (Fig. 2 C , lane 1) w hich  w ere  confirm ed  to be 
h is t id ine - tagg ed  E l  and E2 respec tive ly  b y  W e s te rn  b lo t  
analysis (data n o t  shown). H o w ev er ,  little m o n o m e r ic  E l  and 
E2 was de tec ted  u nd er  n o n -red uc ing  co n d i t io n s  and  m o s t  of 
the  N i—N T A  b o u n d  material failed to  m ig ra te  in to  the 
reso lv ing  c o m p o n e n t  of the  gel (Fig. 2 C, lane 2), ind ica tive  tha t  
the  com plex  conta ins  in term olecu lar d isu lph ide  bond s .  This 
p ro p e r ty  for the  E 1-E 2  com plex  m ade  b y  strain G la sg o w  was 
n o t  a co nsequence  of the  his tidine tag  at the  N -te rm ina l  end of 
E l  since com plexes  c o m p o s e d  of u n ta g g e d  E l  and  E2 b eh av ed  
identically u n der  n o n -red uc ing  e lec trophores is  co n d i t io n s  (data 
n o t  shown). O th e r  s tudies  h av e  sh o w n  a similar b e h av io u r  for 
the  E l —E2 com plex  a l th o u g h  the  p ro p o r t io n  o f  E l  and  E2 
presen t as a d isulphide-linked co m p lex  as co m p a re d  to  a non-  
cov a len tly  associa ted  co m p lex  varies from s tu d y  to  s tu dy  
(Grakoui et al., 1993; R alston  et al., 1993 ; D u b u is so n  et al., 
1994). W hile  these  differences m ay  reflect in part  the 
ex press ion  sy s tem  and  cell ty p e  used, the  h igh  p ro p o r t io n  of 
d isulphide-Iinked com p lexes  fo rm ed  b y  the  G la s g o w  strain E l  
and  E2 p ro te in s  are likely to  result from p ro per t ie s  inheren t to  
their sequences.
Treatment of cells with DTT reveals non-covalent  
interactions between E1 and E2
It has been  p ro p o s e d  that the d isulph ide-linked  com plex es  
form ed b y  El and  E2 rep resen t  a g g re g a te s  o f  misfo lded  
p ro te ins  (D ubu isson  et al., 1994; D e lee rsn y d e r  et al., 1997); 
h o w ev er ,  their c o n tr ib u t io n  to  virion s truc tu re  and  the 
assem bly  process  are n o t  k n o w n  since direct analys is  o f H C V  
particles has n o t  been  possible. T o  fur ther  ex am ine  the 
c on tr ibu t ion  of d isu lph ide  b o n d s  to  E l —E2 co m p le x  form ation , 
w e  analysed  the  p roper t ie s  of the  co m p lex  un d e r  reduc ing  
cond it ions  in situ. From p rev ious  studies, t r ea t ing  cells in situ 
w ith  D T T  reversib ly  reduces d isulph ide  b o n d s  w ith in  p ro te in s  
(Braakman et al., 1992). T herefore ,  w e  dev ised  a series of 
exp e r im en ts  em p lo y in g  this m e th o d  to  ana lyse  th e  effect of 
such t r e a tm en t  on  the  strain G la sg o w  E l —E2 com plexes .  
Initially, w e  in ves t ig a ted  the  effect o f D T T  ad d it ion  o n  the 
stabil ity  o f  the  p re fo rm ed  com plexes. Cells w ere  e lec t ro p o ra te d  
w ith  p S F V / E l hisE2 R N A  and  p ro te ins  w ere  radiolabelled  w ith  
['‘■’Sjm eth ion ine  4 h after e lec tropora t ion .  Labell ing was 
con tinu ed  for a fu r ther 8 h at w hich  p o in t  cy c lohex im ide  was 
a d d ed  to  block translation. Follow ing  incuba t ion  for 30  m in  in 
the presence  of cyclohexim ide , D T T  w as  a d d ed  to  cells at a 
final co n c en tra t io n  of 5 m M  and  cells w ere  h a rves ted  a f te r  a 
fu r ther 30  min incuba tion ; in a parallel culture, cells w e re
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trea te d  w i th  cyc lo he x im id e  bu t  n o t  w ith  D T T . Extrac ts w ere  
then  p r e p a r e d  in the  presence  of N E M , an alky la ting  ag en t  
w h ich  b lo c k s  free su lp h yd ry l  g ro u ps .  F o llow ing  purification 
b y  N i—N T A  affinity c h ro m a to g ra p h y ,  b o u n d  p ro te in s  w ere  
a n a ly s e d  u n d e r  b o th  reduc ing  and no n -red u c in g  condit ions .
T h e  E I —E2 co m p lex es  purified from cells th a t  had  n o t  been  
t rea ted  w i th  D T T  b e h a v e d  in an identical m an n e r  to  those  
sh o w n  in Fig. 2(C );  E l  and  E2 m ig ra ted  as m o n o m e rs  u nd er  
re d u c in g  con d it io ns  (Fig. 3 A, lane 4) bu t  m ain ly  as a h igh  
m o le c u la r  mass com p lex  in the  absence  of reduc ing  a g e n t  (lane 
2). F ro m  the  ex trac ts  o f  cells trea ted  w ith  D T T , E2 con tin ued  
to  c o -p u r i fy  w ith  h is t id ine - tag ged  E l  as b o th  p ro te in s  are 
fou nd  in  gels run u n d e r  reduc ing  co nd it ion s  (Fig. 3 A, lane 3). 
S ign ifican tly ,  u n d e r  n o n -red u c in g  condit ions , E l  and  E2 no 
lo ng er  m agra ted  as a h igh  m olecu lar mass c om plex  b u t  ra ther  
as m o n o m e r i c  p ro te in s  (Fig. 3 A, lane 1). F rom  these  data, w e 
co n c lu d e  tha t  the  in te rm olecu la r  d isu lph ide  b o n d s  w ith in  the 
E l — E2 c o m p le x  h av e  b een  reduced . H o w ev e r ,  d is rup tion  of 
these  c o v a le n t  in te rac t ions  did n o t  d issociate  the  p re -fo rm ed  
E l — E2 c o m p lex .  Hence, sp l it ting  the  co va len t  in terac t ions 
u n c o v e r e d  n o n -co v a len t  associa tions w hich  are p resen t  in 
E l —E2 icom plexes th a t  are ap p a ren t ly  a g g reg a te d .
F o l lo w in g  this o b se rv a t io n ,  w e  so u g h t  to  fu r ther  charac­
terize t h e  effect o f D T T  o n  E l — E2 com plexes .  In a sub sequ en t  
e x p e r im e n t ,  the  result of  va ry in g  the  co n cen tra t io n  of D T T  on 
the  h ig h  m o lecu la r  mass material and  the  no n -c o v a len t  E l —E2 
in te ra c t io n s  was exam ined .  A gain , radio labelled  com p lex es  
b o u n d  to N i—N T A  w ere  ana lysed  u n d e r  no n -red u c in g  c o n ­
d it ions  to  m o n i to r  the  loss of h igh  m olecu lar mass material.  A t 
low er  c o n c e n t r a t io n s  of D T T  ( 0 5  and  TO m M ;  Fig. 3 B, lanes 
4 and  5), there  w as ev iden ce  tha t  reduc t ion  of E l and  E2 had 
o cc u r red  in situ; h o w ev e r ,  a considerab le  a m o u n t  o f h igh 
m o lecu la r  mass material rem ained. A t  h ig he r  co n c en tra t io n s  of 
D T T  (5 a n d  10 m M ), the  h igh  m olecu lar mass material had 
d i s a p p e a re d  and the  p r e d o m in a n t  species p resen t  w ere  m o n o ­
meric E l  and E2 (Fig. 3 B, lanes 7 and 8). Thus, ev en  at 
c o n c e n t ra  tions of D T T  a b o v e  5 m M , the  no n -c o v a le n t ly  linked 
E l and  E 2  com plex  is stable. In su bse q u en t  experim en ts ,  D T T  
was a d d e d  to  cells at a final co n cen tra t io n  of 5 m M , a 
c o n c e n t r a t io n  w hich is cons is ten t  w ith  tha t used  in o th e r  
studies (Braakm an et a l,  1992). A nalys is  of the  time required  to 
fully r e d u c e  the h igh  m olecu la r  mass com plex  in 5 m M  D T T  
s h o w e d  th a t  reduc t ion  is o b se rv e d  b y  5 min fo l low ing  the 
ad d i t io n  o f  D T T  to  cells and  is com p le te  by  20 min (data  no t  
shown).. T h ere fo re ,  o u r  results  p ro v id e  s t ro n g  ev id enc e  tha t 
the  n o n -c o v a l e n t  in terac t ions  b e tw e e n  E l  and  E2 are no t  
stab il ized  by  in te rm olecu la r  d isu lph ide  b o n d s  p resen t  in 
a g g r e g a t e s  of the  com plex .
The high molecular mass material rapidly reforms 
upon rem oval of DTT from cells
T o  d e te r m in e  w h e th e r  reduc t ion  of the  d isu lph ide  b o n d s  in 
E l  and  E2 m ed ia ted  a c h a n g e  in e i ther  the  co n fo rm at ion  of the
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Fig. 4. E ffect o f  rem oval o f  DTT on  E 1 - E 2  c o m p le x e s ,  C e lls  w e r e  
e le c tr o p o r a te d  w ith  p S F V /E 1 hisE2 an d  ra d io la b e lle d  b e tw e e n  4  an d  1 2  h 
a fter  e lec tro p o ra tio n . C y c lo h ex im id e  an d  DTT w e r e  a d d e d  to  c e lls  a s  
d e s c r ib e d  for Fig. 3  (A ). S a m p le s  tr ea te d  w ith  5  mM DTT for 3 0  min ( +  ) 
or w ith o u t DTT ( — ) a s  in d ica ted . D T T -treated  s a m p le s  w e r e  w a s h e d  w ith  
m e d ia  lacking th e  re d u cin g  a g e n t  an d  th en  in c u b a te d  a t 3 7  °C in th e  
a b s e n c e  o f  DTT for th e  t im e s  in d ica te d  ( — DTT). C ell e x tr a c ts  w e r e  
s u b je c te d  to  N i-N T A  affinity c h ro m a to g ra p h y  an d  b o u n d  p ro te in s  w e r e  
e le c tr o p h o r e s e d  on  a  p o ly a cry la m id e  g e l u n d er r e d u c in g  (R; la n e s  1 an d  
2 )  an d  n o n -r ed u c in g  c o n d it io n s  (NR; la n e s  3 - 9 ) .
E l and  E2 pro te ins  o r  the  com p lex  w h ich  th e y  form, the effect 
o f  rem oval  of D T I  w as exam ined .  Cells ex p ress in g  E l and  E2 
sy n th es ized  from p S F V /E l , lisE2 R N A  w ere  trea ted  w ith  
cy c lohe x im ide  and  D TT, after w hich  the  cultures  w ere  w ashed  
w i th  m ed ium  lacking D T T  and  th en  h a rv e s te d  at various times 
fo l low ing  rem oval of the  reduc ing  agen t .  W e  found  tha t h igh  
m olecu la r  mass material could  be d e te c te d  w ith in  5 min of 
D T T  rem oval (Fig. 4, c o m p are  lanes 4 an d  5) and  it was the 
p re d o m in a n t  species by  15 m in (lane 6). Hence, the  effect of 
D T T  is reversible  and d isu lph ide  b o n d  fo rm a tio n  recurs up o n  
its rem oval.  H ow ever ,  n o n -a g g re g a te d  form s o f  the  com plex  
are n o t  recovered , su g g e s t in g  tha t  ev e n  tr ans ien t release from 
poss ib ly  incorrect in term olecu lar  co v a le n t  linkages d oes  n o t  
a llow  re -o rdering  of the  n o n -co v a len t  in te rac t ions  to  g en e ra te  
co m p lexes  w hich  d o  n o t  ag g reg a te .
Disulphide bond formation is not required for the  
initial interactions betw een  E1 and E2
T h e  data  described thus  far ex am in e d  the  function of 
d isu lph ide  b o n d s  in p re -ex is t ing  com plexes .  T o  address  any  
role  for such cova le n t  linkages in initial in te rac t ions  b e tw e e n  
E l  and  E2, w e  ana lysed  com p lex es  fo rm ed  b y  de novo  
sy n th es ized  El and  E2 in the  presence  a nd  absence  of D T T . 
E lec t ro po ra ted  cells w e re  pu lse-labelled  for 2 min w ith  
['{oS ]m e th io n in e /cy s te in e  and  th en  chased  for up to  10 min. T o  
p re v e n t  d isulphide b o n d  fo rm ation  d u r in g  the  pulse—chase 
period , D T T  w as a d d ed  to  o n e  set o f  cells 15 min prio r to  
ad d it io n  of the radiolabelled am in o  acids and  w as  m ain ta ined
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F ig . 6 . C o m p le x e s  fo rm ed  by E2 d e le t io n  m u tan ts  in th e  p r e s e n c e  o f  DTT. 
C ells  w e r e  e le c tr o p o r a te d  w ith  RNA from  e a c h  co n s tr u c t  an d , at 1 2  h p o st­
e lec tro p o ra tio n , th e y  w e r e  trea te d  w ith  DTT 1 5  m in prior to  lab ellin g . C ells  
w e r e  p u lse  la b e lled  for 2  min an d  th en  c h a s e d  for 1 0  m in, all in th e  
p r e s e n c e  o f  DTT. Im m u n op rec ip ita tion s w e r e  p erfo rm ed  w ith  an ti-E 2  
a n tiseru m  R1 41  an d  b o u n d  p ro te in s  w e r e  e le c tr o p h o r e s e d  on  a  
p o lyacry lam id e  g e l u n d er  n o n -r ed u c in g  c o n d itio n s . L a n es  1 an d  2  con ta in  
c r u d e  e x tra c ts  from  tw o  cellu lar p rep a ra tio n s an d  th e  rem ain in g  la n e s  
s h o w  b o u n d  p ro te in s  fo llo w in g  im m u n op recip ita tion . S a m p le s  w e r e  
d er iv ed  from  c e lls  e le c tr o p o r a te d  w ith  RNA from  th e  fo llo w in g  c o n s tr u c ts :  
la n e s  1 an d  3 , p S F V /E 1 hlsE 2; la n e s  2  an d  1 0 , pSFV1 ; lan e 4 , 
p S F V / A 3 8 5 - 4 1 0 ;  lan e 5 , p S F V /A 4 1 6 - 4 5 3 ;  lan e 6 , p S F V / A 4 6 0 - 5 1 9 ;  
lan e 7 , p S F V / A 5 2 9 - 6 0 8 ;  lan e 8 ,  p S F V /A 6 1 0 - 6 9 7 ;  lan e 9 ,  
p S F V /1 6 9 - 7 0 3 .
0  2 5 1 0  0 2 5 1 0  m in  c h a s e
+  D T T  -  D T T
F ig. 5 . F orm ation  o f  de novo s y n th e s iz e d  E 1 -E 2  c o m p le x e s  in th e  
p r e s e n c e  an d  a b s e n c e  o f DTT. C ells  w ere  e lec tro p o ra te d  w ith  
p S F V /E 1 hlsE 2 an d  in cu b a ted  a t 3 7  °C for 1 2  h. C ells  w e r e  la b e lled  for 
2  m in an d  th e n  c h a s e d  for th e  t im e s  in d icated . In p a n e ls  (A) an d  (C) 
s a m p le s  a re  from  c e l ls  in cu b a ted  in th e  p r e s e n c e  o f  DTT from  1 5  min prior 
to  lab ellin g  until th ey  w e r e  h a r v e s te d . Im m u n op rec ip ita tion s w e r e  
p er fo rm e d  o n  ce ll e x tr a c ts  w ith  anti-E 2 a n tiseru m  R 14 1  an d  b ou n d  
p ro te in s  w e r e  e le c tr o p h o r e s e d  on  p o lyacry lam id e g e ls  u n d er  n o n -r ed u c in g  
(NR; p a n e ls  A an d  B) an d  red u c in g  (R; p a n e ls  C an d  D) co n d it io n s .
until the cells w e re  h arves ted .  Im m unoprec ip ita tion  w ith  E l -  
specific an t ise ru m  R141 sh o w e d  tha t E l  was co m plex ed  to  E2 
at 2 min af ter  the  pulse in b o th  D T T -t re a ted  and  no n - t rea te d  
sam ples (Fig. 5 C  and  D, lane 2). The p resence  of m o n o m er ic  E l  
and  E2 in n o n -redu c in g  gels  verified tha t in term olecu lar  
d isu lph ide  b o n d s  had  no t  fo rm ed in p ro te ins  sy n thes ized  in the  
p resence  o f  D T T  (Fig. 5 A, lanes 1—4). By com par ison ,  in 
sam ples n o t  trea ted  w ith  D T T , only  small quanti t ies  o f  E2 and  
n o  E l  cou ld  be  d e tec ted  in non-red uc ing  gels and  the  
a b u n d an ce  o f  m o n o m er ic  E2 prote in  decreased at lo n ger  chase 
tim es (com pare  lanes 1—4 in Fig. 5 B). T h e  lack of m o n o m er ic  E l  
a n d  the red uced  a m o u n t  o f  m onom eric  E2 result from the  
fo rm a tio n  o f  h igh  m olecu lar mass material w hich  bare ly  en te rs  
th e  re so lv in g  gel.  Similar da ta  w ere  o b ta in ed  b y  N i—N T A  
c h ro m a to g r a p h y  o f  E 1-E 2  com plexes  (data n o t  show n). From 
these  data ,  w e  conc lude  th a t  n on-cova len t  associa tion  of E l  
and  E2 occurs  rap id ly  fo l low ing  syn thes is  and  d isu lph ide  b o n d  
fo rm a tio n  is no t  necessary  fo r  such interactions.
Effect of DTT on com plexes formed by E2 deletion  
mutants
It w as an tic ipa ted  that reduc tion  of E l  and  E2 in situ  m ay  
p rov id e  a m eans  o f  d is t ingu ish ing  b e tw e e n  reg ions  in the 
p ro te ins  w hich in teract b y  e ither  cova len t  o r  n o n -cov a len t  
interactions. Hence, a series of de le t ion  m u tan ts  w as  derived  
from p S F V / E l hisE2 w hich sequentia lly  r e m o v e d  reg ions  o f  E2 
(Fig. 1). From several ex pe r im en ts  w ith  these  m u tan ts  using  
e ither  im m un op rec ip a t io n  o r  N i—N T A  affinity c h ro m a to ­
g rap hy ,  w e  found  tha t  E2 m u tan t  p o ly p ep t id e s  re ta ined  the 
capacity  to  in teract w ith  E l b o th  in the presence  and  absence  
of D TT. A  typical set o f  da ta  o b ta in ed  is sh o w n  in Fig. 6. Here, 
com plex  fo rm ation  has been  assessed b y  N i—N T A  affinity 
c h ro m a to g ra p h y  o f  radiolabelled ex trac ts  p repa red  from D T T -  
trea ted  cells e le c t rop o ra ted  w ith  the  E2 m u ta n ts  sh o w n  in Fig. 
I. Each m u tan t  E2 species co-purified w ith  E l  su g g es t in g  tha t  
E l  and  E2 can n o n -co va len tly  associate  at m ultip le  sites.
Effect of DTT treatment on E 1-E2 com plexes formed 
by HCV strain H77
D u ring  the  course  of ou r  studies, it w as  rep o r ted  tha t  R N A s  
syn th es ized  from c D N A s  c o m p o s e d  of the  consensus  sequence  
for H C V  strain H 7 7  w ere  infectious in ch im panzees  
(K olykhalov  et al., 1997; Y anagi et al., 1997). Published d a ta  
also sh o w ed  tha t  b o th  co va len t ly  and  n o n -co v a len t ly  linked 
E 1-E 2  com p lexes  could  be identif ied w ith  the  H C V  H strain, 
w hich was isolated from a ch im panzee  infected w ith  strain H 7 7  
and  has v e ry  h igh  h o m o lo g y  to  H 7 7  (Inchauspe et al., 1991 ;
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Fig . 7 .  C o m p le x e s  fo rm ed  by strain  H 7 7  in th e  p r e s e n c e  an d  a b s e n c e  o f DTT. C ells  w e r e  
e le c tr o p o r a te d  w ith  RNA from  pSF V /C E 1 E 2 H77 an d  in cu b a ted  a t 3 7  °C for 1 2  h. C ells  w e r e  p u ls e -  
la b e lled  for 2  min an d  c h a s e d  for th e  in d ica ted  t im e s  e ith er  in th e  p r e s e n c e  ( +  DTT) or a b s e n c e  o f  
DTT ( — DTT). Im m u n op rec ip ita tion s on  ce ll e x tra c ts  w e r e  p erfo rm ed  w ith  an ti-E 2  m o n o c lo n a l  
a n tib o d ie s  A L P 9 8  an d  H 5 3 . B ou n d  p ro te in s  w e r e  e le c tr o p h o r e s e d  on  p o ly a cry la m id e  g e l s  u n d er  
eith er  n o n -r ed u c in g  (n o n -red ; p a n e ls  A and  B) or red u cin g  c o n d it io n s  (red ; p a n e ls  C an d  D ). P a n e ls  
(A) an d  (C) s h o w  th e  p ro te in s  p rec ip ita ted  by A L P 98  w h ile  (B) an d  (D ) are  t h o s e  p rec ip ita ted  b y  
H 5 3 . In (A) an d  (B ), th e  p o s it io n s  o f  th e  o x id iz e d  an d  re d u c e d  form s o f E 1 , E2 an d  th e  E 1 -E 2  
p recu rso r  are sh o w n . Panel (E) s h o w s  a  con tro l ex p er im en t from  c e lls  e le c tr o p o r a te d  w ith  RNA from  
eith er  p S F V /C E l E 2 H77 ( la n e s  1 an d  2 )  or pSFV1 ( la n e s  3 an d  4 ) .  E lectro p o ra ted  c e lls  w e r e  
in cu b a ted  a t 3 7  °C for 1 2  h, p u lse - la b e lle d  for 2 m in an d  c h a s e d  for 8 0  m in in th e  a b s e n c e  o f DTT. 
Im m u n o p rec ip ita tes  from  ce ll e x tr a c ts  in cu b ated  w ith  A L P 98  ( la n e s  1 an d  3 )  an d  H 5 3  ( la n e s  2  
an d  4 )  w e r e  e le c tr o p h o r e s e d  u n d er  red u cin g  c o n d itio n s . T h e b a n d s  in d ica ted  a s  p rec u r so rs  in 
p a n e ls  (A )- (E )  co n ta in  a m ixture o f  E 1 - E 2 - p 7 /N S 2  an d  E 1 -E 2  m o le c u le s  w h ich  h a v e  b e e n  
g ly c o sy la te d  but n o t c le a v e d  to  c o m p le tio n .
D u b u is s o n  et a l ,  1994). M o re o v e r ,  the  no n -co v a len t ly  linked 
c o m p le x  could  be reco g n ize d  b y  conform ation-specific  an t i­
bo d ies  (D e le e rs n y d e r  et al., 1997; M ichalak  et al., 1997; 
C o c q u e re l  et al., 1998). For co m p a ra t iv e  purposes,  w e  exam ined  
the e ffec t  o f  D T T  o n  E l —E2 com p lex  fo rm ation  in strain H77. 
Cells w e r e  e le c t ro p o ra te d  w ith  R N A  from p S F V /C E l E 2 H77 
and  a p u ls e —chase  e x p e r im e n t  pe rfo rm ed  on  cultures e ither  in 
the p re s e n c e  o r  absence  o f  D T T . Im m u no prec ip i ta t ion s  w ere  
carr ied o u t  w ith  tw o  an t ib o d ie s ;  ALP98, w hich  de tec ts  a linear 
e p i to p e  in E2, and  H53, w h ich  recognizes  a confo rm at ion-
d e p e n d e n t  na tive  form of E2 (Cocquerel et al., 1998). T hese  
an tibodies  prec ip ita ted  b o th  E2 and  El,  w hich  often  m igra ted  
as a series of differentially g ly co sy la ted  species (Fig. 7E, 
com pare  lanes 1 and 2 w ith  lanes 3 and 4). T h e  id en t i ty  o f E l 
w as  confirmed by  W e s te rn  b lo t  analysis  using  an E l-specific 
a n t ib o d y  (data no t  show n).
In the  absence  of D T T , H 53  recogn ized  a na tive  fo rm  of the 
complex, as d edu ced  from e lec trophores is  un d e r  n on -red u c in g  
condit ions , m ore  efficiently than  A L P 98  (com pare  lanes 1 - 4  in 
Fig. 7 A and  B). This  co m plex  w as  m o s t  app a re n t  at la ter  times
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in the pulse—chase experiment, in agreement with previously 
reported data (Deleersnyder et al., 1997). W e also found that, 
in these experiments, H53 precipitated some aggregated  
material (Fig. 7B and D, lanes 1—4). In the presence of DTT, 
both antibodies precipitated E l as well as E2 even at early 
chase times (see lanes 5 and 6 in Fig. 7 A  and B), although  
ALP98 was more efficient than H53; this may reflect the 
specificity of H53 for a particular conformation of E2. 
Nonetheless, treatment with DTT does not disrupt the 
conformation detected by H53 and, in agreement with our 
earlier data, does not prevent E l association with E2. It is also 
of interest to note that H53 recognized E1-E2 precursor 
proteins in DTT-treated samples (Fig. 7 B and D, lanes 5 and 6) 
but with markedly reduced efficiency in untreated samples (Fig. 
7B and D, lanes 1-4). By contrast, ALP98 recognized these 
precursors with greater efficiency than H53 in both DTT- 
treated and untreated samples (Fig. 7 A  and C, lanes 1-8). 
Coupled with the ability of H53 to precipitate E2 soon after 
synthesis (Fig. 7B and D, lane 5), it would appear that the 
conformation detected by the antibody can form rapidly in the 
presence of reducing agent.
From comparison of the relative mobilities o f E l and E2 in 
Fig. 7 (B), it is evident that oxidized forms of both E l and E2 are 
present in untreated samples (lane 4) while only the reduced 
forms are detected in those samples treated with DTT (lanes 
6—8). This indicates that intramolecular disulphide bonds do 
not form in the presence of DTT, further highlighting that El 
and E2 association does not rely upon the formation of 
covalent linkages.
Discussion _______________________________
W e have examined the effect of creating reducing con­
ditions within cells on E l—E2 complex formation. In agreement 
with a previous report which examined E2—NS2 cleavage 
(Dubuisson & Rice, 1996), w e find that addition of DTT to cells 
does not impair cleavage and processing of the glycoproteins 
from precursor molecules. However, w e have considerably 
expanded this finding to examine the wider role of disulphide 
bonds in E l—E2 complex formation. Given the lack of a system  
for efficient propagation of HCV and the difficulties associated 
with recovering virus particles from infected sera, it is difficult 
to formulate a pathway for E l—E2 interactions and the folding 
which occurs in vivo. To date, two complexes have been 
identified: an aggregate in which intermolecular covalent 
interactions occur and a native complex com posed of non- 
covalently associated E l and E2 (Deleersnyder et al., 1997; 
Michalak et al., 1997). While there is growing belief that non- 
covalent associations represent the authentic interactions 
between E l and E2, a contribution of covalent interactions to 
E l—E2 com plexes remains a possibility. Hence, analysis of the 
role of covalent interactions may shed light on the inter­
mediates which could occur during E l—E2 association.
E l and E2 from HCV strain H associate to give both types 
of complex. The native com plex can be detected by  
conformation-specific antibodies and forms more slowly than 
the aggregate (Deleersnyder et al, 1997; Michalak et al., 1997). 
Using the SFV system  and a conformation-specific antibody, 
w e also have detected both types of E l—E2 complex with 
strain H77, which is highly hom ologous to strain H. 
A ggregates containing associated E l and E2 occur soon after 
synthesis and processing of the polypeptides while the native 
form appears later. With strain Glasgow, there was reduced 
accumulation of the native complex. W e conclude that this 
occurs as a result of sequence differences between the two  
strains. Comparison of the predicted amino acid sequences 
from both strains showed that the cysteine residues are 
conserved in both proteins as are the predicted N- 
glycosylation sites in El. However, E2 from strain Glasgow is 
predicted to have tw o fewer N -glycosylation sites. The ,oss of 
these modification sites could at least partially account lor the 
reduced ability of the G lasgow strain to form native El—E2 
complexes. E l glycoprotein from strain G lasgow  also has 
lower mobility on gels as compared to its counterpart in H77. 
Since the predicted molecular masses of the non-glycosylated  
species are very similar and the predicted glycosylation  
patterns of the tw o proteins are identical, there is no obvious 
reason for the different mobilities. M oreover, the endo H 
digestion products of H77 and strain G lasgow E l do rot co- 
migrate (data not shown); thus the observed molecular mass 
difference is not due to differences in glycosylation  Our 
observations are similar to those noted by Foumillier-Jazob et 
al. (1996), in which the mobility of E l was dependent on HCV 
sequences flanking the polypeptide. W e suggest that there 
may be additional processing to the E l protein from strain 
G lasgow which, as yet, has not been identified, and this also 
may contribute to the reduced production of a native complex 
by this strain.
The occurrence of non-covalent interactions between E l 
and E2 within the aggregated com plex has not been previously 
reported. From our results, covalent interactions within the 
aggregate can be disrupted by DTT in situ yet E l remains non- 
covalently attached to E2. O ne interpretation of these data is 
that reduction of covalent bonds by DTT exposes regions of 
E l and E2 which can then interact non-covalently. Aterna- 
tively, E l and E2 may form hom o-oligom ers which rehin the 
ability to interact non-covalently with each other. We have 
expressed separately both E l and E2 and find that both 
proteins multimerize through covalent interactions (data not 
shown). A  third option is that covalent and non-covalent 
associations can occur simultaneously between individual E l 
and E2 molecules. Under such circumstances, it would be 
predicted that segments in E l and E2 which form either type 
of interaction would be separable and thus identified by  
deletion analysis. However, w e have been unable to icentify 
such regions from our E2 mutants. This suggests that the 
interactions which can occur between E l and E2 are complex.
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It is n ot possible to state whether the non-covalent interactions 
which are present in the native com plex also participate in the 
formation of the aggregate. If there are tw o sets of interactions 
which are mutually exclusive, each specific for either native or 
aggregated com plexes, then caution should be exercised on 
the authenticity of regions which have been identified as 
necessary for E l—E2 association. This may be particularly the 
case w here m ethods such as Far-Western blot analysis have 
been used  to map sequences required for E l—E2 binding but 
which do not directly analyse the nature of the com plex (Yi 
et al,  1997).
Our data with E2 deletion mutants failed to identify any 
regions in the protein w hose removal prevented com plex 
formation with E l. This included a truncated form of E2 lacking 
the C-terminal transmembrane domain. Previous results using 
the vaccinia virus expression system  have indicated that 
deletion of the equivalent region in E2 abolishes interaction 
with E l (Selby et al, 1994; Michalak et al,  1997). However, 
unlike the vaccinia virus system, E2 truncated at residue 703 
was n o t secreted in our SFV system ; similar data have been 
observed also on expression of truncated forms of E2 with a 
Sindbis virus vector (Michalak et al, 1997). Thus, truncated E2 
produced by SFV may reside within an intracellular com ­
partment where it retains the capacity to interact with E l 
through the E2 ectodomain. By contrast, vaccinia virus 
expression of truncated E2 may direct the protein to a different 
compartment as part of the secretory process, thereby reducing 
the ability to associate with E l. W e note also that our 
truncated form of E2 rem oves sequences which would encode 
p7. Since E l and E2 continue to form a com plex in the absence 
of these sequences, w e conclude that p7 is not critical for their 
interaction.
W e have used a conformation-specific antibody which 
recognizes the native complex and find that this reagent does 
not lo se  specificity with de novo synthesized complexes 
produced under reducing conditions. Therefore, the con­
formation for E2 required for antibody recognition is not 
dependent on disulphide bonds for stability. By contrast, a 
recent report showed that, following reduction, a truncated 
form o f E2 was detected less efficiently by antibodies in 
approxim ately half of the infected sera tested (Lee et a l,  1997). 
Thus, covalent bonds may function to stabilize certain 
conform ations of E2 but our data would suggest that they are 
not required for E l—E2 interactions.
In conclusion, w e have shown that intra- and intermolecular 
covalent interactions are not required for non-covalent as­
sociation of E l and E2. Since E l and E2 can form both native 
and aggregated  com plexes through non-covalent bonding, 
this h ighlights a difficulty in identifying authentic interactions 
which occur during virus assembly and maturation.
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